<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"
 xml:base="http://www.reactome.org/biopax/91/168256#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:PathwayStep rdf:ID="PathwayStep1712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1518" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1714">
 <bp:stepProcess rdf:resource="#Pathway195" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis490">
 <bp:controlled rdf:resource="#BiochemicalReaction1525" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1713">
 <bp:stepProcess rdf:resource="#Catalysis489" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1520" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis491">
 <bp:controlled rdf:resource="#BiochemicalReaction1529" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1716">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1522" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis492">
 <bp:controlled rdf:resource="#BiochemicalReaction1530" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1715">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1521" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis493">
 <bp:controlled rdf:resource="#BiochemicalReaction1532" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1524" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis494">
 <bp:controlled rdf:resource="#BiochemicalReaction1533" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1717">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1523" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis495">
 <bp:controlled rdf:resource="#BiochemicalReaction1535" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1517" />
 <bp:stepProcess rdf:resource="#Catalysis488" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction776" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep836">
 <bp:stepProcess rdf:resource="#Pathway61" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep837">
 <bp:stepProcess rdf:resource="#BiochemicalReaction777" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep838">
 <bp:stepProcess rdf:resource="#BiochemicalReaction778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep839">
 <bp:stepProcess rdf:resource="#BiochemicalReaction779" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis485">
 <bp:controlled rdf:resource="#BiochemicalReaction1501" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis486">
 <bp:controlled rdf:resource="#BiochemicalReaction1509" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1719">
 <bp:stepProcess rdf:resource="#Catalysis490" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1525" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis487">
 <bp:controlled rdf:resource="#BiochemicalReaction1516" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction771" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis488">
 <bp:controlled rdf:resource="#BiochemicalReaction1517" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep831">
 <bp:stepProcess rdf:resource="#BiochemicalReaction772" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis489">
 <bp:controlled rdf:resource="#BiochemicalReaction1520" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep832">
 <bp:stepProcess rdf:resource="#BiochemicalReaction773" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep833">
 <bp:stepProcess rdf:resource="#BiochemicalReaction774" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep834">
 <bp:stepProcess rdf:resource="#BiochemicalReaction775" />
 <bp:stepProcess rdf:resource="#Catalysis168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1723">
 <bp:stepProcess rdf:resource="#Catalysis491" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1529" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1725">
 <bp:stepProcess rdf:resource="#Pathway196" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis480">
 <bp:controlled rdf:resource="#BiochemicalReaction1493" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1724">
 <bp:stepProcess rdf:resource="#Catalysis492" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1530" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis481">
 <bp:controlled rdf:resource="#BiochemicalReaction1494" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1727">
 <bp:stepProcess rdf:resource="#Pathway198" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis482">
 <bp:controlled rdf:resource="#BiochemicalReaction1497" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1726">
 <bp:stepProcess rdf:resource="#Pathway197" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis483">
 <bp:controlled rdf:resource="#BiochemicalReaction1499" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1729">
 <bp:stepProcess rdf:resource="#Catalysis493" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1532" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis484">
 <bp:controlled rdf:resource="#BiochemicalReaction1500" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1531" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1527" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction783" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction784" />
 <bp:stepProcess rdf:resource="#Catalysis171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep848">
 <bp:stepProcess rdf:resource="#BiochemicalReaction785" />
 <bp:stepProcess rdf:resource="#Catalysis172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep849">
 <bp:stepProcess rdf:resource="#BiochemicalReaction786" />
 <bp:stepProcess rdf:resource="#Catalysis173" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis474">
 <bp:controlled rdf:resource="#BiochemicalReaction1472" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis475">
 <bp:controlled rdf:resource="#BiochemicalReaction1474" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep840">
 <bp:stepProcess rdf:resource="#Pathway62" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis476">
 <bp:controlled rdf:resource="#BiochemicalReaction1481" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep841">
 <bp:stepProcess rdf:resource="#Pathway63" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis477">
 <bp:controlled rdf:resource="#BiochemicalReaction1484" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep842">
 <bp:stepProcess rdf:resource="#BiochemicalReaction780" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis478">
 <bp:controlled rdf:resource="#BiochemicalReaction1486" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep843">
 <bp:stepProcess rdf:resource="#BiochemicalReaction781" />
 <bp:stepProcess rdf:resource="#Catalysis169" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis479">
 <bp:controlled rdf:resource="#BiochemicalReaction1491" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep844">
 <bp:stepProcess rdf:resource="#Catalysis170" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction782" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep845">
 <bp:stepProcess rdf:resource="#Pathway64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1734">
 <bp:stepProcess rdf:resource="#Catalysis496" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1536" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1733">
 <bp:stepProcess rdf:resource="#Catalysis495" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1535" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1736">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1537" />
 <bp:stepProcess rdf:resource="#Catalysis497" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1738">
 <bp:stepProcess rdf:resource="#Pathway201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1737">
 <bp:stepProcess rdf:resource="#Pathway200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1730">
 <bp:stepProcess rdf:resource="#Catalysis494" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1533" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1731">
 <bp:stepProcess rdf:resource="#Pathway199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction792" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep858">
 <bp:stepProcess rdf:resource="#Pathway67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction793" />
 <bp:stepProcess rdf:resource="#Catalysis177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep851">
 <bp:stepProcess rdf:resource="#Pathway65" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep852">
 <bp:stepProcess rdf:resource="#Pathway66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep853">
 <bp:stepProcess rdf:resource="#BiochemicalReaction788" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep854">
 <bp:stepProcess rdf:resource="#Catalysis174" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction789" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep855">
 <bp:stepProcess rdf:resource="#Catalysis175" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction790" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction791" />
 <bp:stepProcess rdf:resource="#Catalysis176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1745">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1544" />
 <bp:stepProcess rdf:resource="#Catalysis501" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1744">
 <bp:stepProcess rdf:resource="#Pathway202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1546" />
 <bp:stepProcess rdf:resource="#Catalysis503" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1545" />
 <bp:stepProcess rdf:resource="#Catalysis502" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1749">
 <bp:stepProcess rdf:resource="#Pathway203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1748">
 <bp:stepProcess rdf:resource="#Catalysis504" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1741">
 <bp:stepProcess rdf:resource="#Catalysis499" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1540" />
 <bp:stepProcess rdf:resource="#Catalysis498" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1543" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1742">
 <bp:stepProcess rdf:resource="#Catalysis500" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1542" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep868">
 <bp:stepProcess rdf:resource="#Catalysis184" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction800" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep869">
 <bp:stepProcess rdf:resource="#Catalysis185" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction801" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction794" />
 <bp:stepProcess rdf:resource="#Catalysis178" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis496">
 <bp:controlled rdf:resource="#BiochemicalReaction1536" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep861">
 <bp:stepProcess rdf:resource="#BiochemicalReaction795" />
 <bp:stepProcess rdf:resource="#Catalysis179" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis497">
 <bp:controlled rdf:resource="#BiochemicalReaction1537" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep862">
 <bp:stepProcess rdf:resource="#BiochemicalReaction796" />
 <bp:stepProcess rdf:resource="#Catalysis180" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis498">
 <bp:controlled rdf:resource="#BiochemicalReaction1540" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep863">
 <bp:stepProcess rdf:resource="#Pathway68" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis499">
 <bp:controlled rdf:resource="#BiochemicalReaction1541" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep864">
 <bp:stepProcess rdf:resource="#Catalysis181" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction797" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep865">
 <bp:stepProcess rdf:resource="#Pathway69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep866">
 <bp:stepProcess rdf:resource="#BiochemicalReaction798" />
 <bp:stepProcess rdf:resource="#Catalysis182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep867">
 <bp:stepProcess rdf:resource="#Catalysis183" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction799" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1298">
 <bp:evidence rdf:resource="#Evidence1449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1297">
 <bp:evidence rdf:resource="#Evidence1448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1296">
 <bp:evidence rdf:resource="#Evidence1447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1295">
 <bp:evidence rdf:resource="#Evidence1444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1294">
 <bp:evidence rdf:resource="#Evidence1443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1293">
 <bp:evidence rdf:resource="#Evidence1442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1292">
 <bp:evidence rdf:resource="#Evidence1441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis450">
 <bp:controlled rdf:resource="#BiochemicalReaction1442" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1291">
 <bp:evidence rdf:resource="#Evidence1440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis451">
 <bp:controlled rdf:resource="#BiochemicalReaction1443" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1290">
 <bp:evidence rdf:resource="#Evidence1438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis449">
 <bp:controlled rdf:resource="#BiochemicalReaction1438" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis441">
 <bp:controlled rdf:resource="#BiochemicalReaction1406" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis442">
 <bp:controlled rdf:resource="#BiochemicalReaction1409" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis443">
 <bp:controlled rdf:resource="#BiochemicalReaction1410" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis444">
 <bp:controlled rdf:resource="#BiochemicalReaction1415" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis445">
 <bp:controlled rdf:resource="#BiochemicalReaction1422" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis446">
 <bp:controlled rdf:resource="#BiochemicalReaction1429" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis447">
 <bp:controlled rdf:resource="#BiochemicalReaction1430" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1299">
 <bp:evidence rdf:resource="#Evidence1450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis448">
 <bp:controlled rdf:resource="#BiochemicalReaction1433" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis440">
 <bp:controlled rdf:resource="#BiochemicalReaction1394" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction744" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis438">
 <bp:controlled rdf:resource="#BiochemicalReaction1389" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction745" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis439">
 <bp:controlled rdf:resource="#BiochemicalReaction1391" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction746" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction747" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction748" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep807">
 <bp:stepProcess rdf:resource="#BiochemicalReaction749" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep808">
 <bp:stepProcess rdf:resource="#BiochemicalReaction750" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep809">
 <bp:stepProcess rdf:resource="#BiochemicalReaction751" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis430">
 <bp:controlled rdf:resource="#BiochemicalReaction1366" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis431">
 <bp:controlled rdf:resource="#BiochemicalReaction1367" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis432">
 <bp:controlled rdf:resource="#BiochemicalReaction1369" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis433">
 <bp:controlled rdf:resource="#BiochemicalReaction1376" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis434">
 <bp:controlled rdf:resource="#BiochemicalReaction1379" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis435">
 <bp:controlled rdf:resource="#BiochemicalReaction1381" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep800">
 <bp:stepProcess rdf:resource="#BiochemicalReaction742" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis436">
 <bp:controlled rdf:resource="#BiochemicalReaction1386" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep801">
 <bp:stepProcess rdf:resource="#BiochemicalReaction743" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis437">
 <bp:controlled rdf:resource="#BiochemicalReaction1388" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis470">
 <bp:controlled rdf:resource="#BiochemicalReaction1467" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis471">
 <bp:controlled rdf:resource="#BiochemicalReaction1468" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis472">
 <bp:controlled rdf:resource="#BiochemicalReaction1470" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis473">
 <bp:controlled rdf:resource="#BiochemicalReaction1471" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep813">
 <bp:stepProcess rdf:resource="#BiochemicalReaction755" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep814">
 <bp:stepProcess rdf:resource="#BiochemicalReaction756" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep815">
 <bp:stepProcess rdf:resource="#Pathway60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep816">
 <bp:stepProcess rdf:resource="#BiochemicalReaction757" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep817">
 <bp:stepProcess rdf:resource="#Catalysis166" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction758" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction759" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction760" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis463">
 <bp:controlled rdf:resource="#BiochemicalReaction1460" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis464">
 <bp:controlled rdf:resource="#BiochemicalReaction1461" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis465">
 <bp:controlled rdf:resource="#BiochemicalReaction1462" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis466">
 <bp:controlled rdf:resource="#BiochemicalReaction1463" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis467">
 <bp:controlled rdf:resource="#BiochemicalReaction1464" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep810">
 <bp:stepProcess rdf:resource="#BiochemicalReaction752" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis468">
 <bp:controlled rdf:resource="#BiochemicalReaction1465" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep811">
 <bp:stepProcess rdf:resource="#BiochemicalReaction753" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis469">
 <bp:controlled rdf:resource="#BiochemicalReaction1466" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep812">
 <bp:stepProcess rdf:resource="#BiochemicalReaction754" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1701">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1509" />
 <bp:stepProcess rdf:resource="#Catalysis486" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1508" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1703">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1511" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1510" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1513" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis460">
 <bp:controlled rdf:resource="#BiochemicalReaction1457" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1512" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis461">
 <bp:controlled rdf:resource="#BiochemicalReaction1458" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1515" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis462">
 <bp:controlled rdf:resource="#BiochemicalReaction1459" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1514" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction765" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep825">
 <bp:stepProcess rdf:resource="#BiochemicalReaction766" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep827">
 <bp:stepProcess rdf:resource="#Catalysis167" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction768" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep828">
 <bp:stepProcess rdf:resource="#BiochemicalReaction769" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction770" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis452">
 <bp:controlled rdf:resource="#BiochemicalReaction1445" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1516" />
 <bp:stepProcess rdf:resource="#Catalysis487" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis453">
 <bp:controlled rdf:resource="#BiochemicalReaction1446" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1708">
 <bp:stepProcess rdf:resource="#Pathway194" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis454">
 <bp:controlled rdf:resource="#BiochemicalReaction1448" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis455">
 <bp:controlled rdf:resource="#BiochemicalReaction1449" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep820">
 <bp:stepProcess rdf:resource="#BiochemicalReaction761" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis456">
 <bp:controlled rdf:resource="#BiochemicalReaction1450" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction762" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis457">
 <bp:controlled rdf:resource="#BiochemicalReaction1453" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction763" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis458">
 <bp:controlled rdf:resource="#BiochemicalReaction1454" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction764" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis459">
 <bp:controlled rdf:resource="#BiochemicalReaction1455" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1254">
 <bp:evidence rdf:resource="#Evidence1396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Secreted CD14 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1491" />
 <bp:stepProcess rdf:resource="#Catalysis479" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1253">
 <bp:evidence rdf:resource="#Evidence1394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAM:TLR4:LY96:LPS:CD14 recruits TRIF (TICAM1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1490" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1252">
 <bp:evidence rdf:resource="#Evidence1393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63-linked ubiquitination of RIP1 bound to the activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1251">
 <bp:evidence rdf:resource="#Evidence1392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF:activated TLR3/TLR4 complex recruits RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep790">
 <bp:stepProcess rdf:resource="#BiochemicalReaction732" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1250">
 <bp:evidence rdf:resource="#Evidence1391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKG subunit of IKK complex binds polyubiquinated RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction733" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep792">
 <bp:stepProcess rdf:resource="#BiochemicalReaction734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction735" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1483" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1482" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1485" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1484" />
 <bp:stepProcess rdf:resource="#Catalysis477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1487" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1674">
 <bp:stepProcess rdf:resource="#Catalysis478" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1486" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1489" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1488" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis405">
 <bp:controlled rdf:resource="#BiochemicalReaction1318" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis406">
 <bp:controlled rdf:resource="#BiochemicalReaction1331" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis407">
 <bp:controlled rdf:resource="#BiochemicalReaction1332" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis408">
 <bp:controlled rdf:resource="#BiochemicalReaction1333" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis409">
 <bp:controlled rdf:resource="#BiochemicalReaction1340" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1492" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction736" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep795">
 <bp:stepProcess rdf:resource="#BiochemicalReaction737" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction738" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction739" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1259">
 <bp:evidence rdf:resource="#Evidence1403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis400">
 <bp:controlled rdf:resource="#BiochemicalReaction1311" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction740" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1258">
 <bp:evidence rdf:resource="#Evidence1402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis401">
 <bp:controlled rdf:resource="#BiochemicalReaction1312" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction741" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1257">
 <bp:evidence rdf:resource="#Evidence1400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis402">
 <bp:controlled rdf:resource="#BiochemicalReaction1314" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1256">
 <bp:evidence rdf:resource="#Evidence1398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD14:LPS binds CR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis403">
 <bp:controlled rdf:resource="#BiochemicalReaction1315" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1255">
 <bp:evidence rdf:resource="#Evidence1397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPI-bound CD14 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis404">
 <bp:controlled rdf:resource="#BiochemicalReaction1316" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1265">
 <bp:evidence rdf:resource="#Evidence1411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1264">
 <bp:evidence rdf:resource="#Evidence1410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1689">
 <bp:stepProcess rdf:resource="#Pathway191" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1263">
 <bp:evidence rdf:resource="#Evidence1408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1262">
 <bp:evidence rdf:resource="#Evidence1407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1261">
 <bp:evidence rdf:resource="#Evidence1405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1260">
 <bp:evidence rdf:resource="#Evidence1404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1494" />
 <bp:stepProcess rdf:resource="#Catalysis481" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1493" />
 <bp:stepProcess rdf:resource="#Catalysis480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1495" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1683">
 <bp:stepProcess rdf:resource="#Pathway190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1686">
 <bp:stepProcess rdf:resource="#Catalysis482" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1497" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1496" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1688">
 <bp:stepProcess rdf:resource="#Catalysis483" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1499" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1498" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1691">
 <bp:stepProcess rdf:resource="#Catalysis485" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1501" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1690">
 <bp:stepProcess rdf:resource="#Catalysis484" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1500" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1269">
 <bp:evidence rdf:resource="#Evidence1415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1268">
 <bp:evidence rdf:resource="#Evidence1414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1267">
 <bp:evidence rdf:resource="#Evidence1413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1266">
 <bp:evidence rdf:resource="#Evidence1412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1276">
 <bp:evidence rdf:resource="#Evidence1422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1275">
 <bp:evidence rdf:resource="#Evidence1421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1274">
 <bp:evidence rdf:resource="#Evidence1420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1273">
 <bp:evidence rdf:resource="#Evidence1419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1272">
 <bp:evidence rdf:resource="#Evidence1418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1271">
 <bp:evidence rdf:resource="#Evidence1417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1270">
 <bp:evidence rdf:resource="#Evidence1416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1503" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1502" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1695">
 <bp:stepProcess rdf:resource="#Pathway192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1504" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1697">
 <bp:stepProcess rdf:resource="#Pathway193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1505" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1699">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1507" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1506" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis427">
 <bp:controlled rdf:resource="#BiochemicalReaction1362" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis428">
 <bp:controlled rdf:resource="#BiochemicalReaction1363" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis429">
 <bp:controlled rdf:resource="#BiochemicalReaction1365" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis420">
 <bp:controlled rdf:resource="#BiochemicalReaction1355" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis421">
 <bp:controlled rdf:resource="#BiochemicalReaction1356" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis422">
 <bp:controlled rdf:resource="#BiochemicalReaction1357" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis423">
 <bp:controlled rdf:resource="#BiochemicalReaction1358" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1279">
 <bp:evidence rdf:resource="#Evidence1425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis424">
 <bp:controlled rdf:resource="#BiochemicalReaction1359" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1278">
 <bp:evidence rdf:resource="#Evidence1424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis425">
 <bp:controlled rdf:resource="#BiochemicalReaction1360" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1277">
 <bp:evidence rdf:resource="#Evidence1423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis426">
 <bp:controlled rdf:resource="#BiochemicalReaction1361" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1287">
 <bp:evidence rdf:resource="#Evidence1433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1286">
 <bp:evidence rdf:resource="#Evidence1432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1285">
 <bp:evidence rdf:resource="#Evidence1431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1284">
 <bp:evidence rdf:resource="#Evidence1430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1283">
 <bp:evidence rdf:resource="#Evidence1429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1282">
 <bp:evidence rdf:resource="#Evidence1428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1281">
 <bp:evidence rdf:resource="#Evidence1427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1280">
 <bp:evidence rdf:resource="#Evidence1426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis416">
 <bp:controlled rdf:resource="#BiochemicalReaction1350" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis417">
 <bp:controlled rdf:resource="#BiochemicalReaction1352" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis418">
 <bp:controlled rdf:resource="#BiochemicalReaction1353" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis419">
 <bp:controlled rdf:resource="#BiochemicalReaction1354" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis410">
 <bp:controlled rdf:resource="#BiochemicalReaction1341" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis411">
 <bp:controlled rdf:resource="#BiochemicalReaction1343" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis412">
 <bp:controlled rdf:resource="#BiochemicalReaction1344" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis413">
 <bp:controlled rdf:resource="#BiochemicalReaction1345" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1289">
 <bp:evidence rdf:resource="#Evidence1437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis414">
 <bp:controlled rdf:resource="#BiochemicalReaction1348" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1288">
 <bp:evidence rdf:resource="#Evidence1436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis415">
 <bp:controlled rdf:resource="#BiochemicalReaction1349" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1210">
 <bp:evidence rdf:resource="#Evidence1345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1635">
 <bp:stepProcess rdf:resource="#Catalysis457" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1453" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1988">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1452" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1987">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1455" />
 <bp:stepProcess rdf:resource="#Catalysis459" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1986">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1454" />
 <bp:stepProcess rdf:resource="#Catalysis458" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1985">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1639">
 <bp:stepProcess rdf:resource="#Pathway184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1456" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1989">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1451" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1450" />
 <bp:stepProcess rdf:resource="#Catalysis456" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1633">
 <bp:stepProcess rdf:resource="#Pathway183" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1632">
 <bp:stepProcess rdf:resource="#Pathway182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep758">
 <bp:stepProcess rdf:resource="#Catalysis161" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep759">
 <bp:stepProcess rdf:resource="#BiochemicalReaction702" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1219">
 <bp:evidence rdf:resource="#Evidence1355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction694" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1218">
 <bp:evidence rdf:resource="#Evidence1354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1980">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep751">
 <bp:stepProcess rdf:resource="#BiochemicalReaction695" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1217">
 <bp:evidence rdf:resource="#Evidence1353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction696" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1216">
 <bp:evidence rdf:resource="#Evidence1352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction697" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1215">
 <bp:evidence rdf:resource="#Evidence1351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep754">
 <bp:stepProcess rdf:resource="#BiochemicalReaction698" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1214">
 <bp:evidence rdf:resource="#Evidence1350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1984">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep755">
 <bp:stepProcess rdf:resource="#BiochemicalReaction699" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1213">
 <bp:evidence rdf:resource="#Evidence1349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1983">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep756">
 <bp:stepProcess rdf:resource="#Catalysis160" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction700" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1212">
 <bp:evidence rdf:resource="#Evidence1348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1982">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep757">
 <bp:stepProcess rdf:resource="#Pathway58" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1211">
 <bp:evidence rdf:resource="#Evidence1347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1981">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1221">
 <bp:evidence rdf:resource="#Evidence1357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1646">
 <bp:stepProcess rdf:resource="#Pathway186" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1999">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1220">
 <bp:evidence rdf:resource="#Evidence1356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1461" />
 <bp:stepProcess rdf:resource="#Catalysis464" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1998">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1463" />
 <bp:stepProcess rdf:resource="#Catalysis466" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1997">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1462" />
 <bp:stepProcess rdf:resource="#Catalysis465" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1996">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1649">
 <bp:stepProcess rdf:resource="#Catalysis467" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1464" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep760">
 <bp:stepProcess rdf:resource="#Catalysis162" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction703" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1640">
 <bp:stepProcess rdf:resource="#Catalysis460" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1457" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1642">
 <bp:stepProcess rdf:resource="#Catalysis462" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1641">
 <bp:stepProcess rdf:resource="#Catalysis461" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1458" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1644">
 <bp:stepProcess rdf:resource="#Pathway185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1460" />
 <bp:stepProcess rdf:resource="#Catalysis463" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep769">
 <bp:stepProcess rdf:resource="#BiochemicalReaction712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction704" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1229">
 <bp:evidence rdf:resource="#Evidence1367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3/IRF7 is transported to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1991">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction705" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1228">
 <bp:evidence rdf:resource="#Evidence1365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 processing within TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1990">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction706" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1227">
 <bp:evidence rdf:resource="#Evidence1364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP3 binds TRIF to mediate necroptosis</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction707" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1226">
 <bp:evidence rdf:resource="#Evidence1363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4-induced ripoptosome assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep765">
 <bp:stepProcess rdf:resource="#BiochemicalReaction708" />
 <bp:stepProcess rdf:resource="#Catalysis163" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1225">
 <bp:evidence rdf:resource="#Evidence1361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1995">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction709" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1224">
 <bp:evidence rdf:resource="#Evidence1360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1994">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction710" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1223">
 <bp:evidence rdf:resource="#Evidence1359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1993">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep768">
 <bp:stepProcess rdf:resource="#Catalysis164" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction711" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1222">
 <bp:evidence rdf:resource="#Evidence1358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1992">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1232">
 <bp:evidence rdf:resource="#Evidence1370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1471" />
 <bp:stepProcess rdf:resource="#Catalysis473" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1966">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1231">
 <bp:evidence rdf:resource="#Evidence1369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is phosphorylated within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1470" />
 <bp:stepProcess rdf:resource="#Catalysis472" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1965">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1230">
 <bp:evidence rdf:resource="#Evidence1368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK binds K63-poly-Ub-TRAF3:TICAM1:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1473" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1964">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1472" />
 <bp:stepProcess rdf:resource="#Catalysis474" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1963">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1969">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction713" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1968">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep771">
 <bp:stepProcess rdf:resource="#Catalysis165" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction714" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1967">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1466" />
 <bp:stepProcess rdf:resource="#Catalysis469" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1650">
 <bp:stepProcess rdf:resource="#Catalysis468" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1653">
 <bp:stepProcess rdf:resource="#Catalysis471" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1468" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1652">
 <bp:stepProcess rdf:resource="#Catalysis470" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1467" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1469" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1654">
 <bp:stepProcess rdf:resource="#Pathway187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep772">
 <bp:stepProcess rdf:resource="#BiochemicalReaction715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction716" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1239">
 <bp:evidence rdf:resource="#Evidence1377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3 binds TICAM1:activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep774">
 <bp:stepProcess rdf:resource="#BiochemicalReaction717" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1238">
 <bp:evidence rdf:resource="#Evidence1376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction718" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1237">
 <bp:evidence rdf:resource="#Evidence1375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction719" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1236">
 <bp:evidence rdf:resource="#Evidence1374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK is ubiquitinated within TANK:K63polyUb-TRAF3:TRIF:activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1962">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep777">
 <bp:stepProcess rdf:resource="#Pathway59" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1235">
 <bp:evidence rdf:resource="#Evidence1373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TBK1 to K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1961">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction720" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1234">
 <bp:evidence rdf:resource="#Evidence1372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IKK&#949; (IKBKE) to K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1960">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction721" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1233">
 <bp:evidence rdf:resource="#Evidence1371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of phosphorylated IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1243">
 <bp:evidence rdf:resource="#Evidence1382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1480" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1977">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1242">
 <bp:evidence rdf:resource="#Evidence1381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is ubiquitinated within TBK1:K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1667">
 <bp:stepProcess rdf:resource="#Pathway189" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1976">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1241">
 <bp:evidence rdf:resource="#Evidence1380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is ubiquitinated within the activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1975">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1240">
 <bp:evidence rdf:resource="#Evidence1379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds TBK1 within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1481" />
 <bp:stepProcess rdf:resource="#Catalysis476" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1974">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction722" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction723" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1979">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction724" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1978">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1474" />
 <bp:stepProcess rdf:resource="#Catalysis475" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1476" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1475" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1664">
 <bp:stepProcess rdf:resource="#Pathway188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1478" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep783">
 <bp:stepProcess rdf:resource="#BiochemicalReaction725" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep784">
 <bp:stepProcess rdf:resource="#BiochemicalReaction726" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep785">
 <bp:stepProcess rdf:resource="#BiochemicalReaction727" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1249">
 <bp:evidence rdf:resource="#Evidence1389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction728" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1248">
 <bp:evidence rdf:resource="#Evidence1388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of TRAF6 bound to the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction729" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1247">
 <bp:evidence rdf:resource="#Evidence1387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR4:TICAM1 recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1973">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep788">
 <bp:stepProcess rdf:resource="#BiochemicalReaction730" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1246">
 <bp:evidence rdf:resource="#Evidence1386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TAK1 complex bound to activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1972">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction731" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1245">
 <bp:evidence rdf:resource="#Evidence1385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR4:TICAM1:K63pUb-TRAF6 recruits TAK1complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1971">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1244">
 <bp:evidence rdf:resource="#Evidence1384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated TAK1 leaves activated TLR receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1970">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1209">
 <bp:evidence rdf:resource="#Evidence1344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1208">
 <bp:evidence rdf:resource="#Evidence1342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1207">
 <bp:evidence rdf:resource="#Evidence1341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1206">
 <bp:evidence rdf:resource="#Evidence1340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1205">
 <bp:evidence rdf:resource="#Evidence1339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1204">
 <bp:evidence rdf:resource="#Evidence1338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1203">
 <bp:evidence rdf:resource="#Evidence1337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1202">
 <bp:evidence rdf:resource="#Evidence1336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1201">
 <bp:evidence rdf:resource="#Evidence1335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1200">
 <bp:evidence rdf:resource="#Evidence1333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction828" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction829" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction830" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction831" />
 <bp:stepProcess rdf:resource="#Catalysis200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep905">
 <bp:stepProcess rdf:resource="#Catalysis201" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction832" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction833" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep907">
 <bp:stepProcess rdf:resource="#BiochemicalReaction834" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep908">
 <bp:stepProcess rdf:resource="#Catalysis202" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction835" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep900">
 <bp:stepProcess rdf:resource="#BiochemicalReaction827" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1944">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1943">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1942">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1941">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1948">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1947">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1945">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1949">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep956">
 <bp:stepProcess rdf:resource="#Catalysis226" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction879" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep957">
 <bp:stepProcess rdf:resource="#BiochemicalReaction880" />
 <bp:stepProcess rdf:resource="#Catalysis227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep958">
 <bp:stepProcess rdf:resource="#BiochemicalReaction881" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep959">
 <bp:stepProcess rdf:resource="#BiochemicalReaction882" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep950">
 <bp:stepProcess rdf:resource="#Pathway77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep951">
 <bp:stepProcess rdf:resource="#BiochemicalReaction875" />
 <bp:stepProcess rdf:resource="#Catalysis223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep952">
 <bp:stepProcess rdf:resource="#Catalysis224" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction876" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1940">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep953">
 <bp:stepProcess rdf:resource="#BiochemicalReaction877" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep954">
 <bp:stepProcess rdf:resource="#Catalysis225" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep955">
 <bp:stepProcess rdf:resource="#Pathway78" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1428" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1955">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1601">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1427" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1954">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1429" />
 <bp:stepProcess rdf:resource="#Catalysis446" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1953">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1603">
 <bp:stepProcess rdf:resource="#Pathway176" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1952">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1431" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1959">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1430" />
 <bp:stepProcess rdf:resource="#Catalysis447" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1958">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1608">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1433" />
 <bp:stepProcess rdf:resource="#Catalysis448" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1957">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1607">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1432" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1956">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction888" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep968">
 <bp:stepProcess rdf:resource="#Catalysis232" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction889" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction890" />
 <bp:stepProcess rdf:resource="#Catalysis233" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis595">
 <bp:controlled rdf:resource="#BiochemicalReaction1715" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep960">
 <bp:stepProcess rdf:resource="#BiochemicalReaction883" />
 <bp:stepProcess rdf:resource="#Catalysis228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1609">
 <bp:stepProcess rdf:resource="#Pathway177" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis596">
 <bp:controlled rdf:resource="#BiochemicalReaction1716" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep961">
 <bp:stepProcess rdf:resource="#BiochemicalReaction884" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis597">
 <bp:controlled rdf:resource="#BiochemicalReaction1717" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep962">
 <bp:stepProcess rdf:resource="#Catalysis229" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction885" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis598">
 <bp:controlled rdf:resource="#BiochemicalReaction1718" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep963">
 <bp:stepProcess rdf:resource="#Pathway79" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1951">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis599">
 <bp:controlled rdf:resource="#BiochemicalReaction1719" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep964">
 <bp:stepProcess rdf:resource="#Pathway80" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1950">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction886" />
 <bp:stepProcess rdf:resource="#Catalysis230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep966">
 <bp:stepProcess rdf:resource="#Catalysis231" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction887" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1437" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1922">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1436" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1921">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1615">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1439" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1920">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1614">
 <bp:stepProcess rdf:resource="#Catalysis449" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1441" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1926">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1440" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1925">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1619">
 <bp:stepProcess rdf:resource="#Catalysis451" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1443" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1924">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1618">
 <bp:stepProcess rdf:resource="#Catalysis450" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1442" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1923">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1928">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1927">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction899" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep979">
 <bp:stepProcess rdf:resource="#Catalysis238" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep970">
 <bp:stepProcess rdf:resource="#BiochemicalReaction891" />
 <bp:stepProcess rdf:resource="#Catalysis234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep971">
 <bp:stepProcess rdf:resource="#BiochemicalReaction892" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep972">
 <bp:stepProcess rdf:resource="#BiochemicalReaction893" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction894" />
 <bp:stepProcess rdf:resource="#Catalysis235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction895" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction896" />
 <bp:stepProcess rdf:resource="#Catalysis236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction897" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep977">
 <bp:stepProcess rdf:resource="#BiochemicalReaction898" />
 <bp:stepProcess rdf:resource="#Catalysis237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1624">
 <bp:stepProcess rdf:resource="#Catalysis452" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1445" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1933">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1444" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1932">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1626">
 <bp:stepProcess rdf:resource="#Pathway181" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1931">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1625">
 <bp:stepProcess rdf:resource="#Catalysis453" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1446" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1930">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1448" />
 <bp:stepProcess rdf:resource="#Catalysis454" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1937">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1447" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1936">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1935">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep980">
 <bp:stepProcess rdf:resource="#BiochemicalReaction901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1449" />
 <bp:stepProcess rdf:resource="#Catalysis455" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1934">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1939">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1938">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1620">
 <bp:stepProcess rdf:resource="#Pathway178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1622">
 <bp:stepProcess rdf:resource="#Pathway180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1621">
 <bp:stepProcess rdf:resource="#Pathway179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction910" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep981">
 <bp:stepProcess rdf:resource="#BiochemicalReaction902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction903" />
 <bp:stepProcess rdf:resource="#Catalysis239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction904" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep984">
 <bp:stepProcess rdf:resource="#Catalysis240" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction905" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction906" />
 <bp:stepProcess rdf:resource="#Catalysis241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep986">
 <bp:stepProcess rdf:resource="#BiochemicalReaction907" />
 <bp:stepProcess rdf:resource="#Catalysis242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction908" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep988">
 <bp:stepProcess rdf:resource="#BiochemicalReaction909" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1177">
 <bp:evidence rdf:resource="#Evidence1304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1900">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1176">
 <bp:evidence rdf:resource="#Evidence1303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1175">
 <bp:evidence rdf:resource="#Evidence1299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SARM binds TICAM1:TRAM:TLR4:LY96:LPS:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1174">
 <bp:evidence rdf:resource="#Evidence1296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1 or p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1173">
 <bp:evidence rdf:resource="#Evidence1295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1904">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1172">
 <bp:evidence rdf:resource="#Evidence1294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1903">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis570">
 <bp:controlled rdf:resource="#BiochemicalReaction1676" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1171">
 <bp:evidence rdf:resource="#Evidence1293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1902">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis571">
 <bp:controlled rdf:resource="#BiochemicalReaction1678" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1170">
 <bp:evidence rdf:resource="#Evidence1292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1901">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis572">
 <bp:controlled rdf:resource="#BiochemicalReaction1683" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep909">
 <bp:stepProcess rdf:resource="#BiochemicalReaction836" />
 <bp:stepProcess rdf:resource="#Catalysis203" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1908">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1907">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1906">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1905">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1909">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep913">
 <bp:stepProcess rdf:resource="#BiochemicalReaction840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction841" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep915">
 <bp:stepProcess rdf:resource="#BiochemicalReaction842" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction843" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep917">
 <bp:stepProcess rdf:resource="#Pathway75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction844" />
 <bp:stepProcess rdf:resource="#Catalysis204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction845" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis562">
 <bp:controlled rdf:resource="#BiochemicalReaction1654" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis563">
 <bp:controlled rdf:resource="#BiochemicalReaction1656" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis564">
 <bp:controlled rdf:resource="#BiochemicalReaction1659" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis565">
 <bp:controlled rdf:resource="#BiochemicalReaction1660" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis566">
 <bp:controlled rdf:resource="#BiochemicalReaction1661" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis567">
 <bp:controlled rdf:resource="#BiochemicalReaction1668" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction837" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1179">
 <bp:evidence rdf:resource="#Evidence1307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis568">
 <bp:controlled rdf:resource="#BiochemicalReaction1669" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction838" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1178">
 <bp:evidence rdf:resource="#Evidence1305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis569">
 <bp:controlled rdf:resource="#BiochemicalReaction1673" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1188">
 <bp:evidence rdf:resource="#Evidence1318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1911">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1187">
 <bp:evidence rdf:resource="#Evidence1317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1910">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1186">
 <bp:evidence rdf:resource="#Evidence1316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1185">
 <bp:evidence rdf:resource="#Evidence1315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1184">
 <bp:evidence rdf:resource="#Evidence1314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1915">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1183">
 <bp:evidence rdf:resource="#Evidence1311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1914">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1182">
 <bp:evidence rdf:resource="#Evidence1310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis560">
 <bp:controlled rdf:resource="#BiochemicalReaction1648" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1913">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1181">
 <bp:evidence rdf:resource="#Evidence1309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis561">
 <bp:controlled rdf:resource="#BiochemicalReaction1650" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1912">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1180">
 <bp:evidence rdf:resource="#Evidence1308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1919">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1917">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1916">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep923">
 <bp:stepProcess rdf:resource="#Catalysis207" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction849" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis559">
 <bp:controlled rdf:resource="#BiochemicalReaction1647" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep924">
 <bp:stepProcess rdf:resource="#BiochemicalReaction850" />
 <bp:stepProcess rdf:resource="#Catalysis208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep925">
 <bp:stepProcess rdf:resource="#Pathway76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep926">
 <bp:stepProcess rdf:resource="#BiochemicalReaction851" />
 <bp:stepProcess rdf:resource="#Catalysis209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction852" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep928">
 <bp:stepProcess rdf:resource="#BiochemicalReaction853" />
 <bp:stepProcess rdf:resource="#Catalysis210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep929">
 <bp:stepProcess rdf:resource="#Catalysis211" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction854" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis551">
 <bp:controlled rdf:resource="#BiochemicalReaction1638" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis552">
 <bp:controlled rdf:resource="#BiochemicalReaction1639" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis553">
 <bp:controlled rdf:resource="#BiochemicalReaction1640" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis554">
 <bp:controlled rdf:resource="#BiochemicalReaction1641" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis555">
 <bp:controlled rdf:resource="#BiochemicalReaction1642" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction846" />
 <bp:stepProcess rdf:resource="#Catalysis205" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis556">
 <bp:controlled rdf:resource="#BiochemicalReaction1643" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction847" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis557">
 <bp:controlled rdf:resource="#BiochemicalReaction1644" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction848" />
 <bp:stepProcess rdf:resource="#Catalysis206" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1189">
 <bp:evidence rdf:resource="#Evidence1320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis558">
 <bp:controlled rdf:resource="#BiochemicalReaction1646" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1199">
 <bp:evidence rdf:resource="#Evidence1332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1198">
 <bp:evidence rdf:resource="#Evidence1331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1197">
 <bp:evidence rdf:resource="#Evidence1330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1196">
 <bp:evidence rdf:resource="#Evidence1329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis590">
 <bp:controlled rdf:resource="#BiochemicalReaction1710" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1195">
 <bp:evidence rdf:resource="#Evidence1328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis591">
 <bp:controlled rdf:resource="#BiochemicalReaction1711" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1194">
 <bp:evidence rdf:resource="#Evidence1327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis592">
 <bp:controlled rdf:resource="#BiochemicalReaction1712" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1193">
 <bp:evidence rdf:resource="#Evidence1325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis593">
 <bp:controlled rdf:resource="#BiochemicalReaction1713" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1192">
 <bp:evidence rdf:resource="#Evidence1323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis594">
 <bp:controlled rdf:resource="#BiochemicalReaction1714" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1191">
 <bp:evidence rdf:resource="#Evidence1322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1190">
 <bp:evidence rdf:resource="#Evidence1321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction859" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction860" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction861" />
 <bp:stepProcess rdf:resource="#Catalysis215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep937">
 <bp:stepProcess rdf:resource="#BiochemicalReaction862" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction863" />
 <bp:stepProcess rdf:resource="#Catalysis216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction864" />
 <bp:stepProcess rdf:resource="#Catalysis217" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis584">
 <bp:controlled rdf:resource="#BiochemicalReaction1701" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis585">
 <bp:controlled rdf:resource="#BiochemicalReaction1702" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis586">
 <bp:controlled rdf:resource="#BiochemicalReaction1705" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis587">
 <bp:controlled rdf:resource="#BiochemicalReaction1706" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep930">
 <bp:stepProcess rdf:resource="#Catalysis212" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction855" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis588">
 <bp:controlled rdf:resource="#BiochemicalReaction1707" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep931">
 <bp:stepProcess rdf:resource="#Catalysis213" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction856" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis589">
 <bp:controlled rdf:resource="#BiochemicalReaction1709" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep932">
 <bp:stepProcess rdf:resource="#Catalysis214" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction857" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep933">
 <bp:stepProcess rdf:resource="#BiochemicalReaction858" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis580">
 <bp:controlled rdf:resource="#BiochemicalReaction1695" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis581">
 <bp:controlled rdf:resource="#BiochemicalReaction1697" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis582">
 <bp:controlled rdf:resource="#BiochemicalReaction1698" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis583">
 <bp:controlled rdf:resource="#BiochemicalReaction1700" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction870" />
 <bp:stepProcess rdf:resource="#Catalysis220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep946">
 <bp:stepProcess rdf:resource="#BiochemicalReaction871" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep947">
 <bp:stepProcess rdf:resource="#BiochemicalReaction872" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction873" />
 <bp:stepProcess rdf:resource="#Catalysis221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction874" />
 <bp:stepProcess rdf:resource="#Catalysis222" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis573">
 <bp:controlled rdf:resource="#BiochemicalReaction1685" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis574">
 <bp:controlled rdf:resource="#BiochemicalReaction1686" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis575">
 <bp:controlled rdf:resource="#BiochemicalReaction1688" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep940">
 <bp:stepProcess rdf:resource="#Catalysis218" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction865" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis576">
 <bp:controlled rdf:resource="#BiochemicalReaction1691" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction866" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis577">
 <bp:controlled rdf:resource="#BiochemicalReaction1692" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep942">
 <bp:stepProcess rdf:resource="#BiochemicalReaction867" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis578">
 <bp:controlled rdf:resource="#BiochemicalReaction1693" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep943">
 <bp:stepProcess rdf:resource="#Catalysis219" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction868" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis579">
 <bp:controlled rdf:resource="#BiochemicalReaction1694" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction869" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1133">
 <bp:evidence rdf:resource="#Evidence1247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1558">
 <bp:stepProcess rdf:resource="#Pathway169" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1132">
 <bp:evidence rdf:resource="#Evidence1246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1557">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1390" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1131">
 <bp:evidence rdf:resource="#Evidence1243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1130">
 <bp:evidence rdf:resource="#Evidence1242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1559">
 <bp:stepProcess rdf:resource="#Catalysis439" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1391" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1384" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1554">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1387" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1553">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1386" />
 <bp:stepProcess rdf:resource="#Catalysis436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1556">
 <bp:stepProcess rdf:resource="#Catalysis438" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1389" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1388" />
 <bp:stepProcess rdf:resource="#Catalysis437" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis526">
 <bp:controlled rdf:resource="#BiochemicalReaction1588" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis527">
 <bp:controlled rdf:resource="#BiochemicalReaction1594" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis528">
 <bp:controlled rdf:resource="#BiochemicalReaction1595" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis529">
 <bp:controlled rdf:resource="#BiochemicalReaction1597" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1139">
 <bp:evidence rdf:resource="#Evidence1254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis520">
 <bp:controlled rdf:resource="#BiochemicalReaction1578" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1138">
 <bp:evidence rdf:resource="#Evidence1253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis521">
 <bp:controlled rdf:resource="#BiochemicalReaction1580" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1137">
 <bp:evidence rdf:resource="#Evidence1252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis522">
 <bp:controlled rdf:resource="#BiochemicalReaction1581" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1136">
 <bp:evidence rdf:resource="#Evidence1251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis523">
 <bp:controlled rdf:resource="#BiochemicalReaction1584" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1135">
 <bp:evidence rdf:resource="#Evidence1250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis524">
 <bp:controlled rdf:resource="#BiochemicalReaction1586" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1134">
 <bp:evidence rdf:resource="#Evidence1248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis525">
 <bp:controlled rdf:resource="#BiochemicalReaction1587" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1144">
 <bp:evidence rdf:resource="#Evidence1261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1400" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1143">
 <bp:evidence rdf:resource="#Evidence1260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1568">
 <bp:stepProcess rdf:resource="#Pathway170" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1142">
 <bp:evidence rdf:resource="#Evidence1259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1141">
 <bp:evidence rdf:resource="#Evidence1258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1140">
 <bp:evidence rdf:resource="#Evidence1257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1560">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1395" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1394" />
 <bp:stepProcess rdf:resource="#Catalysis440" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1397" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1396" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1399" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1398" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis515">
 <bp:controlled rdf:resource="#BiochemicalReaction1559" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis516">
 <bp:controlled rdf:resource="#BiochemicalReaction1561" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis517">
 <bp:controlled rdf:resource="#BiochemicalReaction1568" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis518">
 <bp:controlled rdf:resource="#BiochemicalReaction1571" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis519">
 <bp:controlled rdf:resource="#BiochemicalReaction1573" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1570">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1401" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1149">
 <bp:evidence rdf:resource="#Evidence1268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis510">
 <bp:controlled rdf:resource="#BiochemicalReaction1553" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1148">
 <bp:evidence rdf:resource="#Evidence1266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis511">
 <bp:controlled rdf:resource="#BiochemicalReaction1554" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1147">
 <bp:evidence rdf:resource="#Evidence1265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis512">
 <bp:controlled rdf:resource="#BiochemicalReaction1555" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1146">
 <bp:evidence rdf:resource="#Evidence1264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis513">
 <bp:controlled rdf:resource="#BiochemicalReaction1557" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1145">
 <bp:evidence rdf:resource="#Evidence1263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis514">
 <bp:controlled rdf:resource="#BiochemicalReaction1558" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1155">
 <bp:evidence rdf:resource="#Evidence1275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1889">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1154">
 <bp:evidence rdf:resource="#Evidence1274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1579">
 <bp:stepProcess rdf:resource="#Pathway172" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1888">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1153">
 <bp:evidence rdf:resource="#Evidence1273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1887">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1152">
 <bp:evidence rdf:resource="#Evidence1272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1886">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1151">
 <bp:evidence rdf:resource="#Evidence1271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1150">
 <bp:evidence rdf:resource="#Evidence1270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis550">
 <bp:controlled rdf:resource="#BiochemicalReaction1637" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1403" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1402" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1405" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1406" />
 <bp:stepProcess rdf:resource="#Catalysis441" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1575">
 <bp:stepProcess rdf:resource="#Pathway171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1408" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1407" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis548">
 <bp:controlled rdf:resource="#BiochemicalReaction1635" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis549">
 <bp:controlled rdf:resource="#BiochemicalReaction1636" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1581">
 <bp:stepProcess rdf:resource="#Catalysis443" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1410" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1409" />
 <bp:stepProcess rdf:resource="#Catalysis442" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis540">
 <bp:controlled rdf:resource="#BiochemicalReaction1624" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1881">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis541">
 <bp:controlled rdf:resource="#BiochemicalReaction1625" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1880">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis542">
 <bp:controlled rdf:resource="#BiochemicalReaction1626" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis543">
 <bp:controlled rdf:resource="#BiochemicalReaction1629" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1159">
 <bp:evidence rdf:resource="#Evidence1280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis544">
 <bp:controlled rdf:resource="#BiochemicalReaction1630" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1885">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1158">
 <bp:evidence rdf:resource="#Evidence1279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis545">
 <bp:controlled rdf:resource="#BiochemicalReaction1631" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1884">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1157">
 <bp:evidence rdf:resource="#Evidence1278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis546">
 <bp:controlled rdf:resource="#BiochemicalReaction1633" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1883">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1156">
 <bp:evidence rdf:resource="#Evidence1276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis547">
 <bp:controlled rdf:resource="#BiochemicalReaction1634" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1882">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1166">
 <bp:evidence rdf:resource="#Evidence1287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation within the complex activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1165">
 <bp:evidence rdf:resource="#Evidence1286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with the activated TLR receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1899">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1164">
 <bp:evidence rdf:resource="#Evidence1285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1898">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1163">
 <bp:evidence rdf:resource="#Evidence1284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1897">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1162">
 <bp:evidence rdf:resource="#Evidence1283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1161">
 <bp:evidence rdf:resource="#Evidence1282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1160">
 <bp:evidence rdf:resource="#Evidence1281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1412" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1411" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1413" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1415" />
 <bp:stepProcess rdf:resource="#Catalysis444" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1586">
 <bp:stepProcess rdf:resource="#Pathway173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1417" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1416" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis537">
 <bp:controlled rdf:resource="#BiochemicalReaction1618" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis538">
 <bp:controlled rdf:resource="#BiochemicalReaction1621" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis539">
 <bp:controlled rdf:resource="#BiochemicalReaction1622" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1418" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1592">
 <bp:stepProcess rdf:resource="#Pathway175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1591">
 <bp:stepProcess rdf:resource="#Pathway174" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1892">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis530">
 <bp:controlled rdf:resource="#BiochemicalReaction1601" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1891">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis531">
 <bp:controlled rdf:resource="#BiochemicalReaction1604" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1890">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis532">
 <bp:controlled rdf:resource="#BiochemicalReaction1606" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis533">
 <bp:controlled rdf:resource="#BiochemicalReaction1611" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1896">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1169">
 <bp:evidence rdf:resource="#Evidence1291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis534">
 <bp:controlled rdf:resource="#BiochemicalReaction1613" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1895">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1168">
 <bp:evidence rdf:resource="#Evidence1289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomerl:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis535">
 <bp:controlled rdf:resource="#BiochemicalReaction1614" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1894">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1167">
 <bp:evidence rdf:resource="#Evidence1288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis536">
 <bp:controlled rdf:resource="#BiochemicalReaction1616" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1893">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1352" />
 <bp:stepProcess rdf:resource="#Catalysis417" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1867">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1513">
 <bp:stepProcess rdf:resource="#Pathway163" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1866">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1516">
 <bp:stepProcess rdf:resource="#Catalysis419" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1354" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1865">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1515">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1353" />
 <bp:stepProcess rdf:resource="#Catalysis418" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1864">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1518">
 <bp:stepProcess rdf:resource="#Pathway164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1517">
 <bp:stepProcess rdf:resource="#Catalysis420" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1355" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1869">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep870">
 <bp:stepProcess rdf:resource="#Catalysis186" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction802" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1519">
 <bp:stepProcess rdf:resource="#Catalysis421" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1356" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1868">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1349" />
 <bp:stepProcess rdf:resource="#Catalysis415" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1351" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1511">
 <bp:stepProcess rdf:resource="#Catalysis416" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep879">
 <bp:stepProcess rdf:resource="#Catalysis192" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction810" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep871">
 <bp:stepProcess rdf:resource="#Catalysis187" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction803" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction804" />
 <bp:stepProcess rdf:resource="#Catalysis188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep873">
 <bp:stepProcess rdf:resource="#Pathway70" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep874">
 <bp:stepProcess rdf:resource="#BiochemicalReaction805" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep875">
 <bp:stepProcess rdf:resource="#Catalysis189" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction806" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1863">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction807" />
 <bp:stepProcess rdf:resource="#Catalysis190" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1862">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep877">
 <bp:stepProcess rdf:resource="#Catalysis191" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction808" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1861">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep878">
 <bp:stepProcess rdf:resource="#BiochemicalReaction809" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1860">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1100">
 <bp:evidence rdf:resource="#Evidence1207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR folding by chaperones GP96 and CNPY3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1525">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1361" />
 <bp:stepProcess rdf:resource="#Catalysis426" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1878">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1524">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1360" />
 <bp:stepProcess rdf:resource="#Catalysis425" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1877">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1363" />
 <bp:stepProcess rdf:resource="#Catalysis428" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1876">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1526">
 <bp:stepProcess rdf:resource="#Catalysis427" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1362" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1875">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1364" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1528">
 <bp:stepProcess rdf:resource="#Pathway166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction811" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep881">
 <bp:stepProcess rdf:resource="#BiochemicalReaction812" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1879">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1521">
 <bp:stepProcess rdf:resource="#Catalysis422" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1520">
 <bp:stepProcess rdf:resource="#Pathway165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1359" />
 <bp:stepProcess rdf:resource="#Catalysis424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1358" />
 <bp:stepProcess rdf:resource="#Catalysis423" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1109">
 <bp:evidence rdf:resource="#Evidence1219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep882">
 <bp:stepProcess rdf:resource="#Pathway71" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1108">
 <bp:evidence rdf:resource="#Evidence1218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1870">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep883">
 <bp:stepProcess rdf:resource="#Catalysis193" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction813" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1107">
 <bp:evidence rdf:resource="#Evidence1217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep884">
 <bp:stepProcess rdf:resource="#Catalysis194" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction814" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1106">
 <bp:evidence rdf:resource="#Evidence1216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep885">
 <bp:stepProcess rdf:resource="#Catalysis195" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction815" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1105">
 <bp:evidence rdf:resource="#Evidence1215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep886">
 <bp:stepProcess rdf:resource="#Catalysis196" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction816" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1104">
 <bp:evidence rdf:resource="#Evidence1214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1874">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep887">
 <bp:stepProcess rdf:resource="#Catalysis197" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction817" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1103">
 <bp:evidence rdf:resource="#Evidence1211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Flagellin binds to TLR5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1873">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction818" />
 <bp:stepProcess rdf:resource="#Catalysis198" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1102">
 <bp:evidence rdf:resource="#Evidence1209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Full-length TLR3/7/8/9 binds to UNC93B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1872">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction819" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1101">
 <bp:evidence rdf:resource="#Evidence1208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR processing at low pH</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1871">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1111">
 <bp:evidence rdf:resource="#Evidence1222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1371" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1845">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1110">
 <bp:evidence rdf:resource="#Evidence1221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1535">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1370" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1844">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1538">
 <bp:stepProcess rdf:resource="#Pathway167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1843">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1372" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1842">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1849">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction820" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1373" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1848">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction821" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1847">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep892">
 <bp:stepProcess rdf:resource="#BiochemicalReaction822" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1846">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1530">
 <bp:stepProcess rdf:resource="#Catalysis429" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1365" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1532">
 <bp:stepProcess rdf:resource="#Catalysis431" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1531">
 <bp:stepProcess rdf:resource="#Catalysis430" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1534">
 <bp:stepProcess rdf:resource="#Catalysis432" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1368" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis504">
 <bp:controlled rdf:resource="#BiochemicalReaction1547" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis505">
 <bp:controlled rdf:resource="#BiochemicalReaction1548" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis506">
 <bp:controlled rdf:resource="#BiochemicalReaction1549" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis507">
 <bp:controlled rdf:resource="#BiochemicalReaction1550" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis508">
 <bp:controlled rdf:resource="#BiochemicalReaction1551" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis509">
 <bp:controlled rdf:resource="#BiochemicalReaction1552" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep893">
 <bp:stepProcess rdf:resource="#BiochemicalReaction823" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1119">
 <bp:evidence rdf:resource="#Evidence1231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction824" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1118">
 <bp:evidence rdf:resource="#Evidence1230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep895">
 <bp:stepProcess rdf:resource="#Catalysis199" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction825" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1117">
 <bp:evidence rdf:resource="#Evidence1229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction826" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1116">
 <bp:evidence rdf:resource="#Evidence1228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep897">
 <bp:stepProcess rdf:resource="#Pathway72" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1115">
 <bp:evidence rdf:resource="#Evidence1227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis500">
 <bp:controlled rdf:resource="#BiochemicalReaction1542" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1841">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep898">
 <bp:stepProcess rdf:resource="#Pathway73" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1114">
 <bp:evidence rdf:resource="#Evidence1226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis501">
 <bp:controlled rdf:resource="#BiochemicalReaction1544" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1840">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep899">
 <bp:stepProcess rdf:resource="#Pathway74" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1113">
 <bp:evidence rdf:resource="#Evidence1225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis502">
 <bp:controlled rdf:resource="#BiochemicalReaction1545" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1112">
 <bp:evidence rdf:resource="#Evidence1224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis503">
 <bp:controlled rdf:resource="#BiochemicalReaction1546" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1122">
 <bp:evidence rdf:resource="#Evidence1234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1380" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1856">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1121">
 <bp:evidence rdf:resource="#Evidence1233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1379" />
 <bp:stepProcess rdf:resource="#Catalysis434" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1855">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1120">
 <bp:evidence rdf:resource="#Evidence1232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1854">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1381" />
 <bp:stepProcess rdf:resource="#Catalysis435" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1859">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1857">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1541">
 <bp:stepProcess rdf:resource="#Pathway168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1543">
 <bp:stepProcess rdf:resource="#Catalysis433" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1376" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1375" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1378" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1377" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1129">
 <bp:evidence rdf:resource="#Evidence1241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1128">
 <bp:evidence rdf:resource="#Evidence1240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1127">
 <bp:evidence rdf:resource="#Evidence1239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1126">
 <bp:evidence rdf:resource="#Evidence1238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1852">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1125">
 <bp:evidence rdf:resource="#Evidence1237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1851">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1124">
 <bp:evidence rdf:resource="#Evidence1236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1850">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1123">
 <bp:evidence rdf:resource="#Evidence1235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1420" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1419" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1596">
 <bp:stepProcess rdf:resource="#Catalysis445" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1422" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1421" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1598">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1672" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1900">
 <bp:stepProcess rdf:resource="#Pathway230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1674" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1673" />
 <bp:stepProcess rdf:resource="#Catalysis569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1905">
 <bp:stepProcess rdf:resource="#Catalysis570" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1675" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1907">
 <bp:stepProcess rdf:resource="#Catalysis571" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1678" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1909">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1908">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1679" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis290">
 <bp:controlled rdf:resource="#BiochemicalReaction1097" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis291">
 <bp:controlled rdf:resource="#BiochemicalReaction1101" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis292">
 <bp:controlled rdf:resource="#BiochemicalReaction1106" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis293">
 <bp:controlled rdf:resource="#BiochemicalReaction1107" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis294">
 <bp:controlled rdf:resource="#BiochemicalReaction1109" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis295">
 <bp:controlled rdf:resource="#BiochemicalReaction1113" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis296">
 <bp:controlled rdf:resource="#BiochemicalReaction1116" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis297">
 <bp:controlled rdf:resource="#BiochemicalReaction1118" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis287">
 <bp:controlled rdf:resource="#BiochemicalReaction1080" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis288">
 <bp:controlled rdf:resource="#BiochemicalReaction1083" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis289">
 <bp:controlled rdf:resource="#BiochemicalReaction1091" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis280">
 <bp:controlled rdf:resource="#BiochemicalReaction1063" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis281">
 <bp:controlled rdf:resource="#BiochemicalReaction1065" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis282">
 <bp:controlled rdf:resource="#BiochemicalReaction1068" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis283">
 <bp:controlled rdf:resource="#BiochemicalReaction1069" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis284">
 <bp:controlled rdf:resource="#BiochemicalReaction1071" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis285">
 <bp:controlled rdf:resource="#BiochemicalReaction1073" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis286">
 <bp:controlled rdf:resource="#BiochemicalReaction1079" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis276">
 <bp:controlled rdf:resource="#BiochemicalReaction1051" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis277">
 <bp:controlled rdf:resource="#BiochemicalReaction1053" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis278">
 <bp:controlled rdf:resource="#BiochemicalReaction1057" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis279">
 <bp:controlled rdf:resource="#BiochemicalReaction1058" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis298">
 <bp:controlled rdf:resource="#BiochemicalReaction1123" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis299">
 <bp:controlled rdf:resource="#BiochemicalReaction1125" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1717" />
 <bp:stepProcess rdf:resource="#Catalysis597" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1953">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1716" />
 <bp:stepProcess rdf:resource="#Catalysis596" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1956">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1719" />
 <bp:stepProcess rdf:resource="#Catalysis599" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1718" />
 <bp:stepProcess rdf:resource="#Catalysis598" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis250">
 <bp:controlled rdf:resource="#BiochemicalReaction975" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1958">
 <bp:stepProcess rdf:resource="#Pathway239" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis251">
 <bp:controlled rdf:resource="#BiochemicalReaction978" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1957">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1720" />
 <bp:stepProcess rdf:resource="#Catalysis600" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis252">
 <bp:controlled rdf:resource="#BiochemicalReaction980" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis253">
 <bp:controlled rdf:resource="#BiochemicalReaction987" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1959">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1721" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1950">
 <bp:stepProcess rdf:resource="#Pathway238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1952">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1715" />
 <bp:stepProcess rdf:resource="#Catalysis595" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1951">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1714" />
 <bp:stepProcess rdf:resource="#Catalysis594" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis243">
 <bp:controlled rdf:resource="#BiochemicalReaction914" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis244">
 <bp:controlled rdf:resource="#BiochemicalReaction915" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis245">
 <bp:controlled rdf:resource="#BiochemicalReaction917" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis246">
 <bp:controlled rdf:resource="#BiochemicalReaction918" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis247">
 <bp:controlled rdf:resource="#BiochemicalReaction924" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis248">
 <bp:controlled rdf:resource="#BiochemicalReaction926" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis249">
 <bp:controlled rdf:resource="#BiochemicalReaction929" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1727" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1964">
 <bp:stepProcess rdf:resource="#Catalysis604" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1726" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1729" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1728" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1731" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis240">
 <bp:controlled rdf:resource="#BiochemicalReaction905" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1968">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1730" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis241">
 <bp:controlled rdf:resource="#BiochemicalReaction906" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis242">
 <bp:controlled rdf:resource="#BiochemicalReaction907" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1961">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1723" />
 <bp:stepProcess rdf:resource="#Catalysis602" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1960">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1722" />
 <bp:stepProcess rdf:resource="#Catalysis601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1725" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1962">
 <bp:stepProcess rdf:resource="#Catalysis603" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1724" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction560" />
 <bp:stepProcess rdf:resource="#Catalysis132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep607">
 <bp:stepProcess rdf:resource="#BiochemicalReaction561" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep608">
 <bp:stepProcess rdf:resource="#BiochemicalReaction562" />
 <bp:stepProcess rdf:resource="#Catalysis133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction563" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis232">
 <bp:controlled rdf:resource="#BiochemicalReaction889" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis233">
 <bp:controlled rdf:resource="#BiochemicalReaction890" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis234">
 <bp:controlled rdf:resource="#BiochemicalReaction891" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis235">
 <bp:controlled rdf:resource="#BiochemicalReaction894" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction555" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis236">
 <bp:controlled rdf:resource="#BiochemicalReaction896" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep601">
 <bp:stepProcess rdf:resource="#Pathway47" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis237">
 <bp:controlled rdf:resource="#BiochemicalReaction898" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction556" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis238">
 <bp:controlled rdf:resource="#BiochemicalReaction900" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep603">
 <bp:stepProcess rdf:resource="#Catalysis131" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction557" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis239">
 <bp:controlled rdf:resource="#BiochemicalReaction903" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1737" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1975">
 <bp:stepProcess rdf:resource="#Pathway240" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis270">
 <bp:controlled rdf:resource="#BiochemicalReaction1044" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1978">
 <bp:stepProcess rdf:resource="#Catalysis605" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1739" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis271">
 <bp:controlled rdf:resource="#BiochemicalReaction1045" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1977">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1738" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis272">
 <bp:controlled rdf:resource="#BiochemicalReaction1046" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis273">
 <bp:controlled rdf:resource="#BiochemicalReaction1047" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1979">
 <bp:stepProcess rdf:resource="#Catalysis606" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1740" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis274">
 <bp:controlled rdf:resource="#BiochemicalReaction1048" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis275">
 <bp:controlled rdf:resource="#BiochemicalReaction1050" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1970">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1972">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1971">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1733" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1736" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1735" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep615">
 <bp:stepProcess rdf:resource="#Catalysis135" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction570" />
 <bp:stepProcess rdf:resource="#Catalysis136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction571" />
 <bp:stepProcess rdf:resource="#Catalysis137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep618">
 <bp:stepProcess rdf:resource="#BiochemicalReaction572" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction573" />
 <bp:stepProcess rdf:resource="#Catalysis138" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis265">
 <bp:controlled rdf:resource="#BiochemicalReaction1026" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis266">
 <bp:controlled rdf:resource="#BiochemicalReaction1030" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis267">
 <bp:controlled rdf:resource="#BiochemicalReaction1033" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction564" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis268">
 <bp:controlled rdf:resource="#BiochemicalReaction1034" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction565" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis269">
 <bp:controlled rdf:resource="#BiochemicalReaction1038" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction567" />
 <bp:stepProcess rdf:resource="#Catalysis134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep614">
 <bp:stepProcess rdf:resource="#BiochemicalReaction568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1745" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1986">
 <bp:stepProcess rdf:resource="#Pathway243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1989">
 <bp:stepProcess rdf:resource="#Catalysis608" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1747" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis260">
 <bp:controlled rdf:resource="#BiochemicalReaction1017" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1988">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1746" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis261">
 <bp:controlled rdf:resource="#BiochemicalReaction1018" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis262">
 <bp:controlled rdf:resource="#BiochemicalReaction1020" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis263">
 <bp:controlled rdf:resource="#BiochemicalReaction1021" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis264">
 <bp:controlled rdf:resource="#BiochemicalReaction1025" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1981">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1742" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1980">
 <bp:stepProcess rdf:resource="#Catalysis607" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1741" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1743" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1982">
 <bp:stepProcess rdf:resource="#Pathway241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1744" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1984">
 <bp:stepProcess rdf:resource="#Pathway242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep626">
 <bp:stepProcess rdf:resource="#BiochemicalReaction580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction581" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction582" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction583" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis254">
 <bp:controlled rdf:resource="#BiochemicalReaction996" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis255">
 <bp:controlled rdf:resource="#BiochemicalReaction999" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction574" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis256">
 <bp:controlled rdf:resource="#BiochemicalReaction1000" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction575" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis257">
 <bp:controlled rdf:resource="#BiochemicalReaction1012" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction576" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis258">
 <bp:controlled rdf:resource="#BiochemicalReaction1013" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction577" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis259">
 <bp:controlled rdf:resource="#BiochemicalReaction1016" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep624">
 <bp:stepProcess rdf:resource="#BiochemicalReaction578" />
 <bp:stepProcess rdf:resource="#Catalysis139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep625">
 <bp:stepProcess rdf:resource="#BiochemicalReaction579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1681" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1683" />
 <bp:stepProcess rdf:resource="#Catalysis572" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1682" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1914">
 <bp:stepProcess rdf:resource="#Catalysis573" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1685" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1913">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1684" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1687" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1915">
 <bp:stepProcess rdf:resource="#Catalysis574" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1686" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis207">
 <bp:controlled rdf:resource="#BiochemicalReaction849" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis208">
 <bp:controlled rdf:resource="#BiochemicalReaction850" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis209">
 <bp:controlled rdf:resource="#BiochemicalReaction851" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1689" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis200">
 <bp:controlled rdf:resource="#BiochemicalReaction831" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1917">
 <bp:stepProcess rdf:resource="#Catalysis575" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1688" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis201">
 <bp:controlled rdf:resource="#BiochemicalReaction832" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis202">
 <bp:controlled rdf:resource="#BiochemicalReaction835" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1690" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis203">
 <bp:controlled rdf:resource="#BiochemicalReaction836" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis204">
 <bp:controlled rdf:resource="#BiochemicalReaction844" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis205">
 <bp:controlled rdf:resource="#BiochemicalReaction846" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis206">
 <bp:controlled rdf:resource="#BiochemicalReaction848" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1692" />
 <bp:stepProcess rdf:resource="#Catalysis577" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1691" />
 <bp:stepProcess rdf:resource="#Catalysis576" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1923">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1694" />
 <bp:stepProcess rdf:resource="#Catalysis579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1693" />
 <bp:stepProcess rdf:resource="#Catalysis578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1925">
 <bp:stepProcess rdf:resource="#Pathway231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1924">
 <bp:stepProcess rdf:resource="#Catalysis580" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1695" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1926">
 <bp:stepProcess rdf:resource="#Pathway232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1929">
 <bp:stepProcess rdf:resource="#Catalysis582" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1928">
 <bp:stepProcess rdf:resource="#Catalysis581" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1697" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1932">
 <bp:stepProcess rdf:resource="#Catalysis583" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1700" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1702" />
 <bp:stepProcess rdf:resource="#Catalysis585" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1933">
 <bp:stepProcess rdf:resource="#Catalysis584" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1936">
 <bp:stepProcess rdf:resource="#Pathway234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1703" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis230">
 <bp:controlled rdf:resource="#BiochemicalReaction886" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1704" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis231">
 <bp:controlled rdf:resource="#BiochemicalReaction887" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1937">
 <bp:stepProcess rdf:resource="#Pathway235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1930">
 <bp:stepProcess rdf:resource="#Pathway233" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis229">
 <bp:controlled rdf:resource="#BiochemicalReaction885" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis221">
 <bp:controlled rdf:resource="#BiochemicalReaction873" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis222">
 <bp:controlled rdf:resource="#BiochemicalReaction874" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1705" />
 <bp:stepProcess rdf:resource="#Catalysis586" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis223">
 <bp:controlled rdf:resource="#BiochemicalReaction875" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis224">
 <bp:controlled rdf:resource="#BiochemicalReaction876" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis225">
 <bp:controlled rdf:resource="#BiochemicalReaction878" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis226">
 <bp:controlled rdf:resource="#BiochemicalReaction879" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis227">
 <bp:controlled rdf:resource="#BiochemicalReaction880" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis228">
 <bp:controlled rdf:resource="#BiochemicalReaction883" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1943">
 <bp:stepProcess rdf:resource="#Pathway236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1942">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1708" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1945">
 <bp:stepProcess rdf:resource="#Catalysis590" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1709" />
 <bp:stepProcess rdf:resource="#Catalysis589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1947">
 <bp:stepProcess rdf:resource="#Catalysis592" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1946">
 <bp:stepProcess rdf:resource="#Catalysis591" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1949">
 <bp:stepProcess rdf:resource="#Catalysis593" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1713" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis220">
 <bp:controlled rdf:resource="#BiochemicalReaction870" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1948">
 <bp:stepProcess rdf:resource="#Pathway237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1707" />
 <bp:stepProcess rdf:resource="#Catalysis588" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1940">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1706" />
 <bp:stepProcess rdf:resource="#Catalysis587" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis218">
 <bp:controlled rdf:resource="#BiochemicalReaction865" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis219">
 <bp:controlled rdf:resource="#BiochemicalReaction868" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis210">
 <bp:controlled rdf:resource="#BiochemicalReaction853" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis211">
 <bp:controlled rdf:resource="#BiochemicalReaction854" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis212">
 <bp:controlled rdf:resource="#BiochemicalReaction855" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis213">
 <bp:controlled rdf:resource="#BiochemicalReaction856" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis214">
 <bp:controlled rdf:resource="#BiochemicalReaction857" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis215">
 <bp:controlled rdf:resource="#BiochemicalReaction861" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis216">
 <bp:controlled rdf:resource="#BiochemicalReaction863" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis217">
 <bp:controlled rdf:resource="#BiochemicalReaction864" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1496">
 <bp:evidence rdf:resource="#Evidence1686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1495">
 <bp:evidence rdf:resource="#Evidence1685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization initiated from endosomal compartments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1494">
 <bp:evidence rdf:resource="#Evidence1683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1493">
 <bp:evidence rdf:resource="#Evidence1682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1492">
 <bp:evidence rdf:resource="#Evidence1681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1491">
 <bp:evidence rdf:resource="#Evidence1680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction512" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1490">
 <bp:evidence rdf:resource="#Evidence1679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction513" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction514" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep553">
 <bp:stepProcess rdf:resource="#Pathway40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep554">
 <bp:stepProcess rdf:resource="#Pathway41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction515" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction516" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep557">
 <bp:stepProcess rdf:resource="#Pathway42" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1499">
 <bp:evidence rdf:resource="#Evidence1689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep558">
 <bp:stepProcess rdf:resource="#BiochemicalReaction517" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1498">
 <bp:evidence rdf:resource="#Evidence1688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3  upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction518" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1497">
 <bp:evidence rdf:resource="#Evidence1687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep560">
 <bp:stepProcess rdf:resource="#BiochemicalReaction519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction522" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction523" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction524" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction525" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction527" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep570">
 <bp:stepProcess rdf:resource="#BiochemicalReaction529" />
 <bp:stepProcess rdf:resource="#Catalysis123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction530" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep572">
 <bp:stepProcess rdf:resource="#Pathway43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction531" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway11">
 <bp:pathwayOrder rdf:resource="#PathwayStep121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction111" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of IFNA/IFNB signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">There are several proteins and mechanisms involved in controlling the extent of ligand stimulation of IFNA/B signaling. These mechanisms can effect every step of the IFNA/B cascade. Dephosphorylation of JAK and STAT by SHP protein phosphatases, inhibition of STAT function in the nucleus by protein inhibitors of activated STATs (PIAS) proteins, inhibition of tyrosine kinase activity of JAKs by SOCS as well as inhibition of JAK and IFNAR2 interaction by UBP43 are few of the negative regulation mechanisms in controling type I IFN signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway12">
 <bp:pathwayOrder rdf:resource="#PathwayStep150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction133" />
 <bp:pathwayComponent rdf:resource="#Pathway13" />
 <bp:pathwayComponent rdf:resource="#Pathway14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction139" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon gamma signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon-gamma (IFN-gamma) belongs to the type II interferon family and is secreted by activated immune cells-primarily T and NK cells, but also B-cells and APC. INFG exerts its effect on cells by interacting with the specific IFN-gamma receptor (IFNGR). IFNGR consists of two chains, namely IFNGR1 (also known as the IFNGR alpha chain) and IFNGR2 (also known as the IFNGR beta chain). IFNGR1 is the ligand binding receptor and is required but not sufficient for signal transduction, whereas IFNGR2 do not bind IFNG independently but mainly plays a role in IFNG signaling and is generally the limiting factor in IFNG responsiveness. Both IFNGR chains lack intrinsic kinase/phosphatase activity and thus rely on other signaling proteins like Janus-activated kinase 1 (JAK1), JAK2 and Signal transducer and activator of transcription 1 (STAT-1) for signal transduction. IFNGR complex in its resting state is a preformed tetramer and upon IFNG association undergoes a conformational change. This conformational change induces the phosphorylation and activation of JAK1, JAK2, and STAT1 which in turn induces genes containing the gamma-interferon activation sequence (GAS) in the promoter.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway10">
 <bp:pathwayOrder rdf:resource="#PathwayStep120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction110" />
 <bp:pathwayComponent rdf:resource="#Pathway11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction94" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction92" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction93" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction98" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon alpha/beta signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Type I interferons (IFNs) are composed of various genes including IFN alpha (IFNA), beta (IFNB), omega, epsilon, and kappa. In humans the IFNA genes are composed of more than 13 subfamily genes, whereas there is only one IFNB gene. The large family of IFNA/B proteins all bind to a single receptor which is composed of two distinct chains: IFNAR1 and IFNAR2. The IFNA/B stimulation of the IFNA receptor complex leads to the formation of two transcriptional activator complexes: IFNA-activated-factor (AAF), which is a homodimer of STAT1 and IFN-stimulated gene factor 3 (ISGF3), which comprises STAT1, STAT2 and a member of the IRF family, IRF9/P48. AAF mediates activation of the IRF-1 gene by binding to GAS (IFNG-activated site), whereas ISGF3 activates several IFN-inducible genes including IRF3 and IRF7.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway15">
 <bp:pathwayOrder rdf:resource="#PathwayStep170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction155" />
 <bp:pathwayComponent rdf:resource="#Pathway16" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by CSF3 (G-CSF)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 (GCSF) is a cytokine that regulates production of neutrophils and granulocytes (reviewed in Panopoulos and Watowich 2008). CSF3 circulates extracellularly as a dimer and binds to the monomeric receptor CSF3R (GCSFR) on neutrophil precursors and mature neutrophils (reviewed in Futosi et al. 2013). CSF3R possesses no catalytic activity of its own and is constitutively associated with the kinases LYN (Corey et al. 1994) and JAK1 (Nicholson et al. 1994). Upon binding the CSF3 dimer, CSF3R dimerizes, is phosphorylated, and activates JAK-STAT signaling, RAS-RAF-MEK-ERK signaling, and PI3K signaling (reviewed in Basu et al. 2002, Roberts et al. 2005, Kendricks and Bogoyevitch 2007, Touw and van de Geijn 2007). After dimerization of CSF3R, JAK1 associated with CSF3R is required for phosphorylation of tyrosine residues in the cytosolic domain of CSF3R which recruit further kinases such as JAK2, SYK, HCK, and TYK2 (reviewed in Sampson et al. 2007). Phosphorylated JAK1 and JAK2 then appear to act redundantly to phosphorylate STAT proteins (STAT1, STAT3, STAT5) which dimerize and transit to the nucleus to activate gene expression. CSF3 signaling also activates the RAS pathway, resulting in activation of ERK1 and ERK2 and cellular proliferation. Phosphorylated CSF3R recruits both GRB2, which can act as a scaffold for RAS guanyl exchange factors SOS and VAV, and PTPN11 (SHP2), which activates RAS by dephosphorylating tyrosine-32 of RAS (Bunda et al. 2015). Association of SOS or VAV with the phosphorylated CSF3R has not yet been shown. The pathway to activation of PI3K is uncertain but appears to proceed via GAB2 bound to CSF3R. Mutations in CSF3R can occur during the course of Kostmann disease, a severe congenital neutropenia (reviewed in Zeidler and Welte 2002, Zeidler 2005, Ward 2007, Vandenberghe and Beel 2011). Somatic mutations in CSF3R, principally truncations of the C-terminal region, are involved in the pathogenesis of severe congenital neutropenia and are associated with progression to acute myeloid leukemia (Dong et al. 1995, reviewed in Ward 2007, Beekman and Touw 2010, Xing and Zhao 2016). Loss or mutation of the C-terminal region of CSF3R interferes with inhibition and turnover of the receptor. Mutation of Thr-618 to Ile-618 in CSF3R causes spontaneous dimerization and consequent autoactivation leading to CSF3-independent signaling and chronic neutrophilic leukemia (Maxson et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction532" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway16">
 <bp:pathwayOrder rdf:resource="#PathwayStep160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of CSF3 (G-CSF) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by CSF3 causes its own inactivation, thereby preventing overproliferation of neutrophils (reviewed in Beekman and Touw 2010, Palande et al. 2013). Activated CSF3R recruits and activates JAK2, which phosphorylates STAT1, STAT3, and STAT5. The phosphorylated STATs transit to the nucleus and enhance the expression of SOCS1 and SOCS3, inhibitors of CSF3R signaling (inferred from mouse homologs). SOCS3, the principle negative regulator, binds the phosphorylated C-terminal region of CSF3R (H&#246;rtner et al. 2002, van de Geijn et al. 2004, and inferred from mouse homologs) and acts in two ways: direct inhibition of the phosphorylation activity of JAK2 (van de Geijn et al. 2004) and promotion of endocytosis (Ward et al. 1999, Aarts et al. 2004, Irandoust et al. 2007) and ubiquitination (Irandoust et al. 2007, W&#246;lfler et al. 2009) of CSF3R.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction533" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway13">
 <bp:pathwayOrder rdf:resource="#PathwayStep130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNG signaling activates MAPKs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon-gamma (IFNG) signaling results in transient activation of MAPK1 (ERK2) and MAPK3 (ERK1) (Sakatsume et al. 1998, Ulloa et al. 1999). IFNG-mediated MAPK (ERK) activation is JAK1-dependent and RAS-independent (Sakatsume et al. 1998). It is thought to occur through JAK1-meidated phosphorylation of RAF1 (Sakatsume et al. 1998).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep576">
 <bp:stepProcess rdf:resource="#Pathway44" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway14">
 <bp:pathwayOrder rdf:resource="#PathwayStep141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction128" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of IFNG signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">At least three different classes of negative regulators exist to control the extent of INFG stimulation and signaling. These include the feedback inhibitors belonging to protein family suppressors of cytokine signaling (SOCS), the Scr-homology 2 (SH2)-containing protein tyrosine phosphatases (SHPs), and the protein inhibitors of activated STATs (PIAS). The induction of these regulators seems to be able to stop further signal transduction by inhibiting various steps in IFNG cascade.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction534" />
 <bp:stepProcess rdf:resource="#Catalysis124" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway19">
 <bp:pathwayOrder rdf:resource="#PathwayStep214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction196" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 signaling through SRC family kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Several SRC family kinases (SFKs) have been shown to interact with active FLT3 to modulate downstream signaling. These include FYN, HCK, LCK and SYK (Heiss et al, 2006; Mitina et al, 2007; Chougule et al, 2016; Dosil et al, 1993; Marhall et al, 2017; Puissant et al, 2014; reviewed in Kazi and Ronnstrand, 2019a,b). The role of SFKs downstream of FLT3 is complex and not fully elucidated. Some family members appear to contribute positively to signaling, as assessed by elevated STAT5 signaling, while others may contribute to ubiquitin ligation and downregulation of the receptor through interaction with CBL (Chougule et al, 2016; Heiss et al, 2006; Marhall et al, 2017; reviewed in Kazi and Ronnstrand, 2019a,b).   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction535" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction536" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway17">
 <bp:pathwayOrder rdf:resource="#PathwayStep192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction177" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone receptor signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone (Somatotropin or GH) is a key factor in determining lean body mass, stimulating the growth and metabolism of muscle, bone and cartilage cells, while reducing body fat. It has many other roles; it acts to regulate cell growth, differentiation, apoptosis, and reorganisation of the cytoskeleton, affecting diverse processes such as cardiac function, immune function, brain function, and aging.  GH also has insulin-like effects such as stimulating amino acid transport, protein synthesis, glucose transport, and lipogenesis. The growth hormone receptor (GHR) is a a member of the cytokine receptor family. When the dimeric receptor binds GH it undergoes a conformational change which leads to phosphorylation of key tyrosine residues in its cytoplasmic domains and activation of associated tyrosine kinase JAK2. This leads to recruitment of signaling molecules such as STAT5 and Src family kinases such as Lyn leading to ERK activation. The signal is attenuated by association of Suppressor of Cytokine Signaling (SOCS) proteins and SHP phosphatases which bind to or dephosphorylate specific phosphorylated tyrosines on GHR/JAK. The availability of GHR on the cell surface is regulated by at least two processes; internalization and cleavage from the suface by metalloproteases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway18">
 <bp:pathwayOrder rdf:resource="#PathwayStep250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep236" />
 <bp:pathwayOrder rdf:resource="#PathwayStep218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction221" />
 <bp:pathwayComponent rdf:resource="#Pathway19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction230" />
 <bp:pathwayComponent rdf:resource="#Pathway20" />
 <bp:pathwayComponent rdf:resource="#Pathway21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction216" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Feline McDonough Sarcoma-like tyrosine kinase (FLT3) (also known as FLK2 (fetal liver tyrosine kinase 2), STK-1 (stem cell tyrosine kinase 1) or CD135) is a member of the class III receptor tyrosine kinase family involved in the differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Upon FLT3 ligand (FL) binding, the receptor forms dimers and is phosphorylated. Consequently, adapter and signaling molecules bind with the active receptor and trigger the activation of various pathways downstream including PI3K/Akt and MAPK cascades (Grafone T et al. 2012). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep581">
 <bp:stepProcess rdf:resource="#Catalysis125" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep582">
 <bp:stepProcess rdf:resource="#Pathway45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction540" />
 <bp:stepProcess rdf:resource="#Catalysis126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction542" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction543" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction544" />
 <bp:stepProcess rdf:resource="#Catalysis127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction545" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1452">
 <bp:evidence rdf:resource="#Evidence1635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1877">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1655" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1451">
 <bp:evidence rdf:resource="#Evidence1632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1876">
 <bp:stepProcess rdf:resource="#Catalysis562" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1654" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1450">
 <bp:evidence rdf:resource="#Evidence1631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1879">
 <bp:stepProcess rdf:resource="#Pathway224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1878">
 <bp:stepProcess rdf:resource="#Catalysis563" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1656" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1871">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1649" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1870">
 <bp:stepProcess rdf:resource="#Catalysis560" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1648" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1873">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1651" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1650" />
 <bp:stepProcess rdf:resource="#Catalysis561" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1875">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1653" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1874">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction478" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway30">
 <bp:pathwayOrder rdf:resource="#PathwayStep350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep342" />
 <bp:pathwayOrder rdf:resource="#PathwayStep343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep339" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction317" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-9 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin 9  (IL9) binds interleukin 9 receptor  a chain (IL9R) and the interleukin 2 receptor common gamma chain  (IL2RG) to initiate IL9 signaling downstream cascade. IL9R colocalize with Interleukin 2 receptor &#945; chain and MHC molecules in lipid rafts of human T lymphoma cells (Nizsal&#243;czki et al. 2014). IL2RG is essential for IL9 dependent growth signal transduction (Kimura et al. 1995). IL9R (glycoprotein of 64 kDa) has saturable and specific binding sites with a Kd of 100 pM (Renauld et al. 1992). The activated IL9R complex recruits tyrosine kinase proteins from the Janus kinase (JAK) family: JAK1 (JAK1) and JAK3 (JAK3) for subsequent activation of the Signal transducer and activator of transcription (STAT) factors STAT1, STAT3 and STAT5. The activated STATs form STAT5 dimers and STAT1:STAT3 heterodimers (Neurath    Finotto 2016, Li    Rostami 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep519">
 <bp:stepProcess rdf:resource="#Catalysis122" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction481" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway33">
 <bp:pathwayOrder rdf:resource="#PathwayStep380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction349" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction348" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-21 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-21 (IL21) is a pleiotropic cytokine with four alpha-helical bundles. It is produced primarily by natural killer T cells, T follicular helper cells and TH17 cells, with lower levels of production by numerous other populations of lymphohaematopoietic cells (Spolski    Leonard 2014). IL21 binds Interleukin-21 receptor (IL21R, NILR) and Cytokine receptor common subunit gamma (IL2RG, GammaC). IL21R has significant homology with the class I cytokine receptors Interleukin-2 receptor subunit beta (IL2RB) and Interleukin-4 receptor subunit alpha (IL4R) and was predicted to similarly form a complex with IL2RG. IL21R dimers can weakly bind and signal in response to IL21 but IL21 generates a much stronger response when IL21R is combined with IL2RG, which is required for a fully signaling capable IL21 receptor complex (Ozaki et al. 2000, Asao et al. 2001, Habib et al. 2002). IL21R can bind Janus kinase 1 (JAK1) (Ozaki et al. 2000) but IL2RG is required for IL21 induced signaling (Asao et al. 2001). The heteromeric IL21 receptor complex can activate JAK1, JAK3, Signal transducer and activator of transcription 1 (STAT1), STAT3, STAT4 and STAT5, depending on the cell type. In cultured T-cells IL21 induced phosphorylation of JAK1, JAK3, STAT1, STAT3 and weakly STAT5 (Asao et al. 2001). In primary CD4+ T cells IL21 induced the phosphorylation of STAT1 and STAT3 but not STAT5, whereas IL2 induced the phosphorylation of STAT5 and STAT1 but not STA3 (Bennet et al. 2003). IL21 stimulation of primary splenic B cells and the pro-B-cell line Ba-F3 induced the activation of JAK1, JAK3 and STAT5 (Habib et al. 2002). In primary human NK cells or the NK cell line NK-92, IL21 induced the activation of STAT1, STAT3, and STAT4 but not STAT5 (Strengell et al. 2002, 2003). IL21 activated STAT1 and STAT3 in human monocyte-derived macrophages (Valli&#232;res    Girard 2017). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway34">
 <bp:pathwayOrder rdf:resource="#PathwayStep385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep400" />
 <bp:pathwayComponent rdf:resource="#Pathway35" />
 <bp:pathwayComponent rdf:resource="#Pathway36" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-6 family signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The interleukin-6 (IL6) family of cytokines includes IL6, IL11, IL27, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), cardiotrophin 1 and 2 (CT-1) and cardiotrophin-like cytokine (CLC) (Heinrich et al. 2003, Pflanz et al. 2002). The latest addition to this family is IL31, discovered in 2004 (Dillon et al. 2004). The family is defined largely by the shared use of the common signal transducing receptor Interleukin-6 receptor subunit beta (IL6ST, gp130). The IL31 receptor uniquely does not include this subunit, instead it uses the related IL31RA. The members of the IL6 family share very low sequence homology but are structurally highly related, forming anti-parallel four-helix bundles with a characteristic &#8220;up-up-down-down&#8221; topology (Rozwarski et al. 1994, Cornelissen et al. 2012).  Although each member of the IL6 family signals through a distinct receptor complex, their underlying signaling mechanisms are similar. Assembly of the receptor complex is followed by activation of receptor-associated Janus kinases (JAKs), believed to be constitutively associated with the receptor subunits.Activation of JAKs initiates downstream cytoplasmic signaling cascades that involve recruitment and phosphorylation of transcription factors of the Signal transducer and activator of transcription (STAT) family, which dimerize and translocate to the nucleus where they bind enhancer elements of target genes leading to transcriptional activation (Nakashima    Taga 1998).  Negative regulators of IL6 signaling include Suppressor of cytokine signals (SOCS) family members and PTPN11 (SHP-2).  IL6 is a pleiotropic cytokine with roles in processes including immune regulation, hematopoiesis, inflammation, oncogenesis, metabolic control and sleep.   IL6 and IL11 bind their corresponding specific receptors IL6R and IL11R respectively, resulting in dimeric complexes that subsequently associate with IL6ST, leading to IL6ST homodimer formation (in a hexameric or higher order complex) and signal initiation. IL6R alpha exists in transmembrane and soluble forms. The transmembrane form is mainly expressed by hepatocytes, neutrophils, monocytes/macrophages, and some lymphocytes. Soluble forms of IL6R (sIL6R) are also expressed by these cells. Two major mechanisms for the production of sIL6R have been proposed. Alternative splicing generates a transcript lacking the transmembrane domain by using splicing donor and acceptor sites that flank the transmembrane domain coding region. This also introduces a frameshift leading to the incorporation of 10 additional amino acids at the C terminus of sIL6R.A second mechanism for the generation of sIL6R is the proteolytic cleavage or &apos;shedding&apos; of membrane-bound IL-6R. Two proteases ADAM10 and ADAM17 are thought to contribute to this (Briso et al. 2008). sIL6R can bind IL6 and stimulate cells that express gp130 but not IL6R alpha, a process that is termed trans-signaling. This explains why many cells, including hematopoietic progenitor cells, neuronal cells, endothelial cells, smooth muscle cells, and embryonic stem cells, do not respond to IL6 alone, but show a remarkable response to IL6/sIL6R. It is clear that the trans-signaling pathway is responsible for the pro-inflammatory activities of IL6 whereas the membrane bound receptor governs regenerative and anti-inflammatory IL6 activities  LIF, CNTF, OSM, CTF1, CRLF1 and CLCF1 signal via IL6ST:LIFR heterodimeric receptor complexes (Taga    Kishimoto 1997, Mousa    Bakhiet 2013). OSM signals via a receptor complex consisting of IL6ST and OSMR. These cytokines play important roles in the regulation of complex cellular processes such as gene activation, proliferation and differentiation (Heinrich et al. 1998).   Antibodies have been developed to inhibit IL6 activity for the treatment of inflammatory diseases (Kopf et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway31">
 <bp:pathwayOrder rdf:resource="#PathwayStep352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction326" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin receptor SHC signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Shc at three tyrosine residues, 239, 240 (Gotoh et al. 1996) and 317 (Salcini et al. 1994) involves unidentified tyrosine kinases presumed to be part of the activated receptor complex. These phosphorylated tyrosines subsequently bind SH2 signaling proteins such as Grb2, Gab2 and SHIP that are involved in the regulation of different signaling pathways. Grb2 can associate with the guanosine diphosphate-guanosine triphosphate exchange factor Sos1, leading to Ras activation and regulation of cell proliferation. Downstream signals are mediated via the Raf-MEK-Erk pathway.Grb2 can also associate through Gab2 with PI3K and with SHIP.  Figure reproduced from Gu, H. et al. 2000. Mol. Cell. Biol. 20(19):7109-7120 Copyright American Society for Microbiology. All Rights Reserved.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway32">
 <bp:pathwayOrder rdf:resource="#PathwayStep370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction339" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2 (IL-2) is a cytokine that is produced by T cells in response to antigen stimulation. Originally, IL-2 was discovered because of its potent growth factor activity on activated T cells in vitro and was therefore named &apos;T cell growth factor&apos; (TCGF). However, the generation of IL-2- and IL-2 receptor-deficient mice revealed that IL-2 also plays a regulatory role in the immune system by suppressing autoimmune responses. Two main mechanisms have been identified that explain this suppressive function: (1) IL-2 sensitizes activated T cells for activation-induced cell death (AICD) and (2) IL-2 is critical for the survival and function of regulatory T cells (Tregs), which possess potent immunosuppressive properties.  IL-2 signaling occurs when IL-2 binds to the heterotrimeric high-affinity IL-2 receptor (IL-2R), which consists of alpha, beta and gamma chains. The IL-2R was identified in 1981 via radiolabeled ligand binding (Robb et al. 1981). The IL-2R alpha chain was  identified in 1982 (Leonard et al.), the beta chain in 1986/7 (Sharon et al. 1986, Teshigawara et al. 1987) and the IL-2R gamma chain in 1992 (Takeshita et al.). The high affinity of IL-2 binding to the IL-2R is created by a very rapid association rate to the IL-2R alpha chain, combined with a much slower dissociation rate contributed by the combination of the IL-2R beta and gamma chains (Wang    Smith 1987). After antigen stimulation, T cells upregulate the high-affinity IL-2R alpha chain; IL-2R alpha captures IL-2 and this complex then associates with the constitutively expressed IL-2R beta and gamma chains.  The IL-2R gamma chain is shared by several other members of the cytokine receptor superfamily including IL-4, IL-7, IL-9, IL-15 and IL-21 receptors, and consequently is often referred to as the Common gamma chain (Gamma-c). The tyrosine kinases Jak1 and Jak3, which are constitutively associated with IL-2R beta and Gamma-c respectively, are activated resulting in phosphorylation of three critical tyrosine residues in the IL-2R beta cytoplasmic tail. These phosphorylated residues enable recruitment of the adaptor molecule Shc, activating the MAPK and PI3K pathways, and the transcription factor STAT5. After phosphorylation, STAT5 forms dimers that translocate to the nucleus and initiate gene expression. While STAT5 activation is critical for IL-2 function in most cell types, the contribution of the PI3K/Akt pathway differs between distinct T cell subsets. In Tregs for example, PI3K/Akt is not involved in IL-2 signaling and this may explain some of the different functional outcomes of IL-2 signaling in Tregs vs. effector T cells. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway37">
 <bp:pathwayOrder rdf:resource="#PathwayStep430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep441" />
 <bp:pathwayOrder rdf:resource="#PathwayStep428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep445" />
 <bp:pathwayOrder rdf:resource="#PathwayStep424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep427" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction390" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction400" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction409" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction404" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction405" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction399" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction398" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction397" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-7 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-7 (IL7) is produced primarily by T zone fibroblastic reticular cells found in lymphoid organs, and also expressed by non-hematopoietic stromal cells present in other tissues including the skin, intestine and liver. It is an essential survival factor for lymphocytes, playing a key anti-apoptotic role in T-cell development, as well as mediating peripheral T-cell maintenance and proliferation. This dual function is reflected in a dose-response relationship that distinguishes the survival function from the proliferative activity; low doses of IL7 ( 1 ng/ml) sustain only survival, higher doses  (&gt;1 ng/ml) promote survival and cell cycling (Kittipatarin et al. 2006, Swainson et al. 2007).  The IL7 receptor is a heterodimeric complex of the the common cytokine-receptor gamma chain (IL2RG, CD132, or Gc) and the IL7-receptor alpha chain (IL7R, IL7RA, CD127). Both chains are members of the type 1 cytokine family. Neither chain is unique to the IL7 receptor as IL7R is utilized by the receptor for thymic stromal lymphopoietin (TSLP) while IL2RG is shared with the receptors for IL2, IL4, IL9, IL15 and IL21. IL2RG consists of a single transmembrane region and a 240aa extracellular region that includes a fibronectin type III (FNIII) domain thought to be involved in receptor complex formation. It is expressed on most lymphocyte populations. Null mutations of IL2RG in humans cause X-linked severe combined immunodeficiency (X-SCID), which has a phenotype of  severely reduced T-cell and natural killer (NK) cell populations, but normal numbers of B cells. In addition to reduced T- and NK-cell numbers, Il2rg knockout mice also have dramatically reduced B-cell populations suggesting that Il2rg is more critical for B-cell development in mice than in humans. Patients with severe combined immunodeficiency (SCID) phenotype due to IL7R mutations (see Puel    Leonard 2000), or a partial deficiency of IL7R (Roifman et al. 2000) have markedly reduced circulating T cells, but normal levels of peripheral blood B cells and NK cells, similar to the phenotype of IL2RG mutations, highlighting a requirement for IL7 in T cell lymphopoiesis. It has been suggested that IL7 is essential for murine, but not human B cell development, but recent studies indicate that IL7 is essential for human B cell production from adult bone marrow and that IL7-induced expansion of the progenitor B cell compartment is increasingly critical for human B cell production during later stages of development (Parrish et al. 2009).  IL7 has been shown to induce rapid and dose-dependent tyrosine phosphorylation of JAKs 1 and 3, and concomitantly tyrosine phosphorylation and DNA-binding activity of STAT5a/b (Foxwell et al. 1995). IL7R was shown to directly induce the activation of JAKs and STATs by van der Plas et al. (1996). Jak1 and Jak3 knockout mice displayed severely impaired thymic development, further supporting their importance in IL7 signaling (Rodig et al. 1998, Nosaka et al. 1995).  The role of STAT5 in IL7 signaling has been studied largely in mouse models. Tyr449 in the cytoplasmic domain of IL7RA is required for T-cell development in vivo and activation of JAK/STAT5 and PI3k/Akt pathways (Jiang et al. 2004, Pallard et al. 1999). T-cells from an IL7R Y449F knock-in mouse did not activate STAT5 (Osbourne et al. 2007), indicating that IL7 regulates STAT5 activity via this key tyrosine residue. STAT5 seems to enhance proliferation of multiple cell lineages in mouse models but it remains unclear whether STAT5 is required solely for survival signaling or also for the induction of proliferative activity (Kittipatarin    Khaled, 2007).  The model for IL7 receptor signaling is believed to resemble that of other Gc family cytokines, based on detailed studies of the IL2 receptor, where IL2RB binds constitutively to JAK1 while JAK3 is pre-associated uniquely with the IL2RG chain. Extending this model to IL7 suggests a similar series of events: IL7R constitutively associated with JAK1 binds IL7, the resulting trimer recruits IL2RG:JAK3, bringing JAK1 and JAK3 into proximity. The association of both chains of the IL7 receptor orients the cytoplasmic domains of the receptor chains so that their associated kinases (Janus and phosphatidylinositol 3-kinases) can phosphorylate sequence elements on the cytoplasmic domains (Jiang et al. 2005). JAKs have low intrinsic enzymatic activity, but after mutual phosphorylation acquire much higher activity, leading to phosphorylation of the critical Y449 site on IL7R. This site binds STAT5 and possibly other signaling adapters, they in turn become phosphorylated by JAK1 and/or JAK3. Phosphorylated STATs translocate to the nucleus and trigger the transcriptional events of their target genes.  The role of the PI3K/AKT pathway in IL7 signaling is controversial. It is a potential T-cell survival pathway because in many cell types PI3K signaling regulates diverse cellular functions such as cell cycle progression, transcription, and metabolism. The ERK/MAPK pathway does not appear to be involved in IL7 signaling (Crawley et al. 1996).  It is not clear how IL7 influences cell proliferation. In the absence of a proliferative signal such as IL7 or IL3, dependent lymphocytes arrest in the G0/G1 phase of the cell cycle. To exit this phase, cells typically activate specific G1 Cyclin-dependent kinases/cyclins and down regulate cell cycle inhibitors such as Cyclin-dependent kinase inhibitor 1B (Cdkn1b or p27kip1). There is indirect evidence suggesting a possible role for IL7 stimulated activation of PI3K/AKT signaling, obtained from transformed cell lines and thymocytes, but not confirmed by observations using primary T-cells (Kittipatarin    Khaled, 2007). IL7 withdrawal results in G1/S cell cycle arrest and is correlated with loss of cdk2 activity (Geiselhart et al. 2001), both events which are known to be regulated by the dephosphorylating activity of Cdc25A. Expression of a p38 MAPK-resistant Cdc25A mutant in an IL-7-dependent T-cell line as well as in peripheral, primary T-cells was sufficient to sustain cell survival and promote cell cycling for several days in the absence of IL7 (Khaled et al. 2005). Cdkn1b is a member of the CIP/KIP family of cyclin-dependent cell cycle inhibitors (CKIs) that negatively regulates the G1/S transition. In IL7 dependent T-cells, the expression of Cdkn1b was sufficient to cause G1 arrest in the presence of IL7. Withdrawal of IL7 induced the upregulation of Cdkn1b and arrested cells in G1 while siRNA knockout of Cdkn1b enhanced cell cycle progression. However, adoptive transfer of Cdkn1b-deficient lymphocytes into IL7 deficient mice indicated that loss of Cdkn1b could only partially compensate for the IL7 signal needed by T-cells to expand in a lymphopenic environment (Li et al. 2006), so though Cdkn1b may be involved in negative regulation of the cell cycle through an effect on cdk2 activity, its absence is not sufficient to fully induce cell cycling under lymphopenic conditions.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway38">
 <bp:pathwayOrder rdf:resource="#PathwayStep470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep481" />
 <bp:pathwayOrder rdf:resource="#PathwayStep482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep467" />
 <bp:pathwayOrder rdf:resource="#PathwayStep500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep504" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction462" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction425" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction427" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction438" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction449" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction453" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction418" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction415" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction458" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction416" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-20 family signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The interleukin 20 (IL20) subfamily comprises IL19, IL20, IL22, IL24 and IL26. They are members of the larger IL10 family, but have been grouped together based on their usage of common receptor subunits and similarities in their target cell profiles and biological functions. Members of the IL20 subfamily facilitate the communication between leukocytes and epithelial cells, thereby enhancing innate defence mechanisms and tissue repair processes at epithelial surfaces. Much of the understanding of this group of cytokines is based on IL22, which is the most studied member (Rutz et al. 2014, Akdis M et al. 2016, Longsdon et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1459">
 <bp:evidence rdf:resource="#Evidence1643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway35">
 <bp:pathwayOrder rdf:resource="#PathwayStep390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep393" />
 <bp:pathwayOrder rdf:resource="#PathwayStep394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep397" />
 <bp:pathwayOrder rdf:resource="#PathwayStep387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction359" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL-6-type cytokine receptor ligand interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The members involved in (interleukin)-6-type cytokine signalling are the IL-6, IL-11, LIF (leukaemia inhibitory factor), OSM (oncostatin M), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CTF1) and cardiotrophin-like cytokine factor 1 (CLCF1). Receptors involved in recognition of the IL-6-type cytokines can be subdivided in the non-signalling alpha-receptors (IL6R, IL 11R, and CNTFR) and the signal transducing receptors (gp130, LIFR, and OSMR). The latter associate with JAKs and become tyrosine phosphorylated in response to cytokine stimulation (Heinrich et al. 1998, 2003). IL27 and IL35 belongs to IL12 cytokine family but they share gp130 as a component of signalling receptor, along with IL-6, IL-11, LIF, OSM, CNTF, CTF1 and CLCF1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction472" />
 <bp:stepProcess rdf:resource="#Catalysis121" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1458">
 <bp:evidence rdf:resource="#Evidence1642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway36">
 <bp:pathwayOrder rdf:resource="#PathwayStep406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep412" />
 <bp:pathwayOrder rdf:resource="#PathwayStep402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep416" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction375" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-6 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in processes including immune regulation, hematopoiesis, inflammation, oncogenesis, metabolic control and sleep.  It is the founding member of a family of IL-6-related cytokines such as IL-11, IL-27 leukemia inhibitory factor (LIF), cilliary neurotrophic factor (CNTF) and oncostatin M.   The IL-6 receptor (IL6R) consists of an alpha subunit that specifically binds IL-6 and a beta subunit, IL6RB or gp130, which is the signaling component of all the receptors for cytokines related to IL-6. IL6R alpha exists in transmembrane and soluble forms. The transmembrane form is mainly expressed by hepatocytes, neutrophils, monocytes/macrophages, and some lymphocytes. Soluble forms of IL6R (sIL6R) are also expressed by these cells. Two major mechanisms for the production of sIL6R have been proposed. Alternative splicing generates a transcript lacking the transmembrane domain by using splicing donor and acceptor sites that flank the transmembrane domain coding region. This also introduces a frameshift leading to the incorporation of 10 additional amino acids at the C terminus of sIL6R.A second mechanism for the generation of sIL6R is the proteolytic cleavage or &apos;shedding&apos; of membrane-bound IL-6R. Two proteases ADAM10 and ADAM17 are thought to contribute to this (Briso et al. 2008). sIL6R can bind IL6 and stimulate cells that express gp130 but not IL6R alpha, a process that is termed trans-signaling. This explains why many cells, including hematopoietic progenitor cells, neuronal cells, endothelial cells, smooth muscle cells, and embryonic stem cells, do not respond to IL6 alone, but show a remarkable response to IL6/sIL6R. It is clear that the trans-signaling pathway is responsible for the pro-inflammatory activities of IL-6 whereas the membrane bound receptor governs regenerative and anti-inflammatory IL-6 activities  IL6R signal transduction is mediated by two pathways:the JAK-STAT (Janus family tyrosine kinase-signal transducer and activator of transcription) pathway and the Ras-MAPK (mitogen-activated protein kinase) pathway. Negative regulators of IL-6 signaling include SOCS (suppressor of cytokine signals) and SHP2. Within the last few years different antibodies have been developed to inhibit IL-6 activity, and the first such antibodies have been introduced into the clinic for the treatment of inflammatory diseases (Kopf et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction473" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1457">
 <bp:evidence rdf:resource="#Evidence1641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction474" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1456">
 <bp:evidence rdf:resource="#Evidence1639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction475" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1455">
 <bp:evidence rdf:resource="#Evidence1638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway39">
 <bp:pathwayOrder rdf:resource="#PathwayStep550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep551" />
 <bp:pathwayOrder rdf:resource="#PathwayStep516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep518" />
 <bp:pathwayOrder rdf:resource="#PathwayStep519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep533" />
 <bp:pathwayOrder rdf:resource="#PathwayStep512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep540" />
 <bp:pathwayOrder rdf:resource="#PathwayStep527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep520" />
 <bp:pathwayOrder rdf:resource="#PathwayStep542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep522" />
 <bp:pathwayOrder rdf:resource="#PathwayStep544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction469" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction504" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction477" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction496" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction513" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-4 and Interleukin-13 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-4 (IL4) is a principal regulatory cytokine during the immune response, crucially important in allergy and asthma (Nelms et al. 1999). When resting T cells are antigen-activated and expand in response to Interleukin-2 (IL2), they can differentiate as Type 1 (Th1) or Type 2 (Th2) T helper cells. The outcome is influenced by IL4. Th2 cells secrete IL4, which both stimulates Th2 in an autocrine fashion and acts as a potent B cell growth factor to promote humoral immunity (Nelms et al. 1999).   Interleukin-13 (IL13) is an immunoregulatory cytokine secreted predominantly by activated Th2 cells. It is a key mediator in the pathogenesis of allergic inflammation. IL13 shares many functional properties with IL4, stemming from the fact that they share a common receptor subunit. IL13 receptors are expressed on human B cells, basophils, eosinophils, mast cells, endothelial cells, fibroblasts, monocytes, macrophages, respiratory epithelial cells, and smooth muscle cells, but unlike IL4, not T cells. Thus IL13 does not appear to be important in the initial differentiation of CD4 T cells into Th2 cells, rather it is important in the effector phase of allergic inflammation (Hershey et al. 2003). IL4 and IL13 induce &#8220;alternative activation&#8221; of macrophages, inducing an anti-inflammatory phenotype by signaling through IL4R alpha in a STAT6 dependent manner. This signaling plays an important role in the Th2 response, mediating anti-parasitic effects and aiding wound healing (Gordon    Martinez 2010, Loke et al. 2002) There are two types of IL4 receptor complex (Andrews et al. 2006). Type I IL4R (IL4R1) is predominantly expressed on the surface of hematopoietic cells and consists of IL4R and IL2RG, the common gamma chain. Type II IL4R (IL4R2) is predominantly expressed on the surface of nonhematopoietic cells, it consists of IL4R and IL13RA1 and is also the type II receptor for IL13. (Obiri et al. 1995, Aman et al. 1996, Hilton et al. 1996, Miloux et al. 1997, Zhang et al. 1997). The second receptor for IL13 consists of IL4R and Interleukin-13 receptor alpha 2 (IL13RA2), sometimes called Interleukin-13 binding protein (IL13BP). It has a high affinity receptor for IL13 (Kd = 250 pmol/L) but is not sufficient to render cells responsive to IL13, even in the presence of IL4R (Donaldson et al. 1998). It is reported to exist in soluble form (Zhang et al. 1997) and when overexpressed reduces JAK-STAT signaling (Kawakami et al. 2001). It&apos;s function may be to prevent IL13 signalling via the functional IL4R:IL13RA1 receptor. IL13RA2 is overexpressed and enhances cell invasion in some human cancers (Joshi    Puri 2012).  The first step in the formation of IL4R1 (IL4:IL4R:IL2RB) is the binding of IL4 with IL4R (Hoffman et al. 1995, Shen et al. 1996, Hage et al. 1999). This is also the first step in formation of IL4R2 (IL4:IL4R:IL13RA1). After the initial binding of IL4 and IL4R, IL2RB binds (LaPorte et al. 2008), to form IL4R1. Alternatively, IL13RA1 binds, forming IL4R2. In contrast, the type II IL13 complex (IL13R2) forms with IL13 first binding to IL13RA1 followed by recruitment of  IL4R (Wang et al. 2009).  Crystal structures of the IL4:IL4R:IL2RG, IL4:IL4R:IL13RA1 and IL13:IL4R:IL13RA1 complexes have been determined (LaPorte et al. 2008). Consistent with these structures, in monocytes IL4R is tyrosine phosphorylated in response to both IL4 and IL13 (Roy et al. 2002, Gordon    Martinez 2010) while IL13RA1 phosphorylation is induced only by IL13 (Roy et al. 2002, LaPorte et al. 2008) and IL2RG phosphorylation is induced only by IL4 (Roy et al. 2002).  Both IL4 receptor complexes signal through Jak/STAT cascades. IL4R is constitutively-associated with JAK2 (Roy et al. 2002) and associates with JAK1 following binding of IL4 (Yin et al. 1994) or IL13 (Roy et al. 2002). IL2RG constitutively associates with JAK3 (Boussiotis et al. 1994, Russell  et al. 1994). IL13RA1 constitutively associates with TYK2 (Umeshita-Suyama et al. 2000, Roy et al. 2002, LaPorte et al. 2008, Bhattacharjee et al. 2013).   IL4 binding to IL4R1 leads to phosphorylation of JAK1 (but not JAK2) and STAT6 activation (Takeda et al. 1994, Ratthe et al. 2007, Bhattacharjee et al. 2013).   IL13 binding increases activating tyrosine-99 phosphorylation of IL13RA1 but not that of IL2RG. IL4 binding to IL2RG leads to its tyrosine phosphorylation (Roy et al. 2002). IL13 binding to IL4R2 leads to TYK2 and JAK2 (but not JAK1) phosphorylation (Roy    Cathcart 1998, Roy et al. 2002).  Phosphorylated TYK2 binds and phosphorylates STAT6 and possibly STAT1 (Bhattacharjee et al. 2013).    A second mechanism of signal transduction activated by IL4 and IL13 leads to the insulin receptor substrate (IRS) family (Kelly-Welch et al. 2003). IL4R1 associates with insulin receptor substrate 2 and activates the PI3K/Akt and Ras/MEK/Erk pathways involved in cell proliferation, survival and translational control. IL4R2 does not associate with insulin receptor substrate 2 and consequently the PI3K/Akt and Ras/MEK/Erk pathways are not activated (Busch-Dienstfertig    Gonz&#225;lez-Rodr&#237;guez 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction476" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1454">
 <bp:evidence rdf:resource="#Evidence1637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep515">
 <bp:stepProcess rdf:resource="#BiochemicalReaction477" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1453">
 <bp:evidence rdf:resource="#Evidence1636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1463">
 <bp:evidence rdf:resource="#Evidence1649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1888">
 <bp:stepProcess rdf:resource="#Pathway226" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1462">
 <bp:evidence rdf:resource="#Evidence1648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1887">
 <bp:stepProcess rdf:resource="#Pathway225" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1461">
 <bp:evidence rdf:resource="#Evidence1646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1460">
 <bp:evidence rdf:resource="#Evidence1644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1664" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1657" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1882">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1659" />
 <bp:stepProcess rdf:resource="#Catalysis564" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1881">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1658" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1884">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1661" />
 <bp:stepProcess rdf:resource="#Catalysis566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1883">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1660" />
 <bp:stepProcess rdf:resource="#Catalysis565" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1886">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1885">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1662" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction489" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep528">
 <bp:stepProcess rdf:resource="#BiochemicalReaction490" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction491" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway22">
 <bp:pathwayOrder rdf:resource="#PathwayStep280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction275" />
 <bp:pathwayComponent rdf:resource="#Pathway23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction232" />
 <bp:pathwayComponent rdf:resource="#Pathway24" />
 <bp:pathwayComponent rdf:resource="#Pathway25" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFR2 non-canonical NF-kB pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor necrosis factor-alpha (TNFA) exerts a wide range of biological effects through TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). Under normal physiological conditions TNFR2 exhibits more restricted expression, being found on certain subpopulation of immune cells and few other cell types (Grell et al. 1995 ). TNFR1 mediated signalling pathways have been very well characterized but, TNFR2 has been much less well studied. TNFR1 upon activation by TNFA activates apoptosis through two pathways, involving the adaptor proteins TNFR1-associated death domain (TRADD) and fas-associated death domain (FADD). In contrast, TNFR2 signalling especially in highly activated T cells, induces cell survival pathways that can result in cell proliferation by activating transcription factor NF-kB (nuclear factor-kB) via the alternative non-canonical route. TNFR2 signalling seems to play an important role, in particular for the function of regulatory T cells. It offers protective roles in several disorders, including autoimmune diseases, heart diseases, demyelinating and neurodegenerative disorders and infectious diseases (Faustman    Davis 2010). Activation of the non-canonical pathway by TNFR2 is mediated through a signalling complex that includes TNF receptor-associated factor (TRAF2 and TRAF3), cellular inhibitor of apoptosis (cIAP1 and cIAP2), and NF-kB-inducing kinase (NIK). In this complex TRAF3 functions as a bridging factor between the cIAP1/2:TRAF2 complex and NIK. In resting cells cIAP1/2 in the signalling complex mediates K48-linked polyubiquitination of NIK and subsequent proteasomal degradation making NIK levels invisible. Upon TNFR2 stimulation, TRAF2 is recruited to the intracellular TRAF binding motif and this also indirectly recruits TRAF1 and cIAP1/2, as well as TRAF3 and NIK which are already bound to TRAF2 in unstimulated cells. TRAF2 mediates K63-linked ubiquitination of cIAP1/2 and this in turn mediates cIAP dependent K48-linked ubiquitination of TRAF3 leading to the proteasome-dependent degradation of the latter. As TRAF3 is degraded, NIK can no longer interact with TRAF1/2:cIAP complex. As a result NIK concentration in the cytosol increases and NIK gets stabilised and activated. Activated NIK phosphorylates IKKalpha, which in turn phosphorylates p100 (NFkB2) subunit. Phosphorylated p100 is also ubiquitinated by the SCF-beta-TRCP ubiquitin ligase complex and is subsequently processed by the proteaseome to p52, which is a transcriptionally competent NF-kB subunit in conjunction with RelB (Petrus et al. 2011, Sun 2011, Vallabhapurapu    Karin 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway23">
 <bp:pathwayOrder rdf:resource="#PathwayStep260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction238" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFs bind their physiological receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Members of the tumour necrosis factor superfamily (TNFSF) and TNF receptor superfamily (TNFRSF) have crucial roles in both innate and adaptive immunity. These members are implicated in various acquired or genetic human diseases, ranging from septic shock to autoimmune disorders, allograft rejection and cancer (So et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway20">
 <bp:pathwayOrder rdf:resource="#PathwayStep230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction207" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of FLT3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 activity is negatively regulated through several mechanisms including dephosphorylation, interaction with protein partners that limit downstream signaling pathways, and by ubiquitin-mediated internalization and degradation (reviewed in Kazi and Roonstrand, 2019).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway21">
 <bp:pathwayOrder rdf:resource="#PathwayStep237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction218" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 Activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal transducer and activator of transcription (STAT) constitutes a family of universal transcription factors. STAT5 refers to two highly related proteins, STAT5A and STAT5B, with critical function in cell survival and proliferation. Several upstream signals including cytokines and growth factors can trigger STAT5 activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway26">
 <bp:pathwayOrder rdf:resource="#PathwayStep505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep836" />
 <bp:pathwayOrder rdf:resource="#PathwayStep716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep317" />
 <bp:pathwayComponent rdf:resource="#Pathway40" />
 <bp:pathwayComponent rdf:resource="#Pathway51" />
 <bp:pathwayComponent rdf:resource="#Pathway52" />
 <bp:pathwayComponent rdf:resource="#Pathway61" />
 <bp:pathwayComponent rdf:resource="#Pathway55" />
 <bp:pathwayComponent rdf:resource="#Pathway34" />
 <bp:pathwayComponent rdf:resource="#Pathway37" />
 <bp:pathwayComponent rdf:resource="#Pathway27" />
 <bp:pathwayComponent rdf:resource="#Pathway38" />
 <bp:pathwayComponent rdf:resource="#Pathway28" />
 <bp:pathwayComponent rdf:resource="#Pathway39" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Interleukins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukins are low molecular weight proteins that bind to cell surface receptors and act in an autocrine and/or paracrine fashion. They were first identified as factors produced by leukocytes but are now known to be produced by many other cells throughout the body. They have pleiotropic effects on cells which bind them, impacting processes such as tissue growth and repair, hematopoietic homeostasis, and multiple levels of the host defense against pathogens where they are an essential part of the immune system.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway27">
 <bp:pathwayOrder rdf:resource="#PathwayStep307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep302" />
 <bp:pathwayOrder rdf:resource="#PathwayStep313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction287" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-10 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-10 (IL10) was originally described as a factor named cytokine synthesis inhibitory factor that  inhibited T-helper (Th) 1 activation and Th1 cytokine production (Fiorentino et al. 1989). It was found to be expressed by a variety of cell types including macrophages, dendritic cell subsets, B cells, several T-cell subpopulations including Th2 and T-regulatory cells (Tregs) and Natural Killer (NK) cells (Moore et al. 2001). It is now recognized that the biological effects of IL10 are directed at antigen-presenting cells (APCs) such as macrophages and dendritic cells (DCs), its effects on T-cell development and differentiation are largely indirect via inhibition of macrophage/dendritic cell activation and maturation (Pestka et al. 2004, Mocellin et al. 2004). T cells are thought to be the main source of IL10 (Hedrich    Bream 2010). IL10 inhibits a broad spectrum of activated macrophage/monocyte functions including monokine synthesis, NO production, and expression of class II MHC and costimulatory molecules such as IL12 and CD80/CD86 (de Waal Malefyt et al. 1991, Gazzinelli et al. 1992). Studies with recombinant cytokine and neutralizing antibodies revealed pleiotropic activities of IL10 on B, T, and mast cells (de Waal Malefyt et al. 1993, Rousset et al. 1992, Thompson-Snipes et al. 1991) and provided evidence for the in vivo significance of IL10 activities (Ishida et al. 1992, 1993). IL10 antagonizes the expression of MHC class II and the co-stimulatory molecules CD80/CD86 as well as the pro-inflammatory cytokines IL1Beta, IL6, IL8, TNFalpha and especially IL12 (Fiorentino et al. 1991, D&apos;Andrea et al. 1993). The biological role of IL10 is not limited to inactivation of APCs, it also enhances B cell, granulocyte, mast cell, and keratinocyte growth/differentiation, as well as NK-cell and CD8+ cytotoxic T-cell activation (Moore et al. 2001, Hedrich    Bream 2010). IL10 also enhances NK-cell proliferation and/or production of IFN-gamma (Cai et al. 1999).    IL10-deficient mice exhibited inflammatory bowel disease (IBD) and other exaggerated inflammatory responses (Kuhn et al. 1993, Berg et al. 1995) indicating a critical role for IL10 in limiting inflammatory responses. Dysregulation of IL10 is linked with susceptibility to numerous infectious and autoimmune diseases in humans and mouse models (Hedrich    Bream 2010).   IL10 signaling is initiated by binding of homodimeric IL10 to the extracellular domains of two adjoining IL10RA molecules. This tetramer then binds two IL10RB chains. IL10RB cannot bind to IL10 unless bound to IL10RA (Ding et al. 2001, Yoon et al. 2006); binding of IL10 to IL10RA without the co-presence of IL10RB fails to initiate signal transduction (Kotenko et al. 1997).  IL10 binding activates the receptor-associated Janus tyrosine kinases, JAK1 and TYK2, which are constitutively bound to IL10R1 and IL10R2 respectively. In the classic model of receptor activation assembly of the receptor complex is believed to enable JAK1/TYK2 to phosphorylate and activate each other. Alternatively the binding of IL10 may cause conformational changes that allow the pseudokinase inhibitory domain of one JAK kinase to move away from the kinase domain of the other JAK within the receptor dimer-JAK complex, allowing the two kinase domains to interact and trans-activate (Waters    Brooks 2015).  The activated JAK kinases phosphorylate the intracellular domains of the IL10R1 chains on specific tyrosine residues. These phosphorylated tyrosine residues and their flanking peptide sequences serve as temporary docking sites for the latent, cytosolic, transcription factor, STAT3. STAT3 transiently docks on the IL10R1 chain via its SH2 domain, and is in turn tyrosine phosphorylated by the receptor-associated JAKs. Once activated, it dissociates from the receptor, dimerizes with other STAT3 molecules, and translocates to the nucleus where it binds with high affinity to STAT-binding elements (SBEs) in the promoters of IL-10-inducible genes (Donnelly et al. 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep520">
 <bp:stepProcess rdf:resource="#BiochemicalReaction482" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway24">
 <bp:pathwayOrder rdf:resource="#PathwayStep270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NIK--&gt;noncanonical NF-kB signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to the activation of canonical NF-kB subunits, activation of SYK pathway by Dectin-1 leads to the induction of the non-canonical NF-kB pathway, which mediates the nuclear translocation of RELB-p52 dimers through the successive activation of NF-kB-inducing kinase (NIK) and IkB kinase-alpha (IKKa) (Geijtenbeek    Gringhuis 2009, Gringhuis et al. 2009). Noncanonical activity tends to build more slowly and remain sustained several hours longer than does the activation of canonical NF-kB. The noncanonical NF-kB pathway is characterized by the post-translational processing of NFKB2 (Nuclear factor NF-kappa-B) p100 subunit to the mature p52 subunit. This subsequently leads to nuclear translocation of p52:RELB (Transcription factor RelB) complexes to induce cytokine expression of some genes (C-C motif chemokine 17 (CCL17) and CCL22) and transcriptional repression of others (IL12B) (Gringhuis et al. 2009, Geijtenbeek    Gringhuis 2009, Plato et al. 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction483" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1469">
 <bp:evidence rdf:resource="#Evidence1656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway25">
 <bp:pathwayOrder rdf:resource="#PathwayStep291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction272" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NF-kB is fundamental to signal transduction by members of the TNFRSF. Expression of NF-kB target genes is essential for mounting innate immune responses to infectious microorganisms but is also important for the proper development and cellular compartmentalization of secondary lymphoid organs necessary to orchestrate an adaptive immune response.  NF-kB transcription factor family is activated by two distinct pathways: the canonical pathway involving NF-kB1 and the non-canonical pathway involving NF-kB2. Unlike NF-kB1 signalling, which can be activated by a wide variety of receptors, the NF-kB2 pathway is typically activated by a subset of receptor and ligand pairs belonging to the tumor necrosis factor receptor (TNF) super family (TNFRSF) members. These members include TNFR2 (Rauert et al. 2010), B cell activating factor of the TNF family receptor (BAFFR also known as TNFRSF13C) (Kayagaki et al. 2002, CD40 (also known as TNFRSF5) (Coope et al. 2002, lymphotoxin beta-receptor (LTBR also known as TNFRSF3) (Dejardin et al. 2002), receptor activator for nuclear factor kB (RANK also known as TNFRSF11A) (Novack et al. 2003), CD27 and Fibroblast growth factor-inducible immediate-early response protein 14 (FN14 also known as TNFRSF12A) etc. These receptors each mediate specific biological roles of the non-canonical NF-kB. These non-canonical NF-kB-stimulating receptors have one thing in common and is the presence of a TRAF-binding motif, which recruits different TNF receptor-associated factor (TRAF) members, particularly TRAF2 and TRAF3, to the receptor complex during ligand ligation (Grech et al. 2004, Bishop    Xie 2007). Receptor recruitment of these TRAF members leads to their degradation which is a critical step leading to the activation of NIK and induction of p100 processing (Sun 2011, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction484" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1468">
 <bp:evidence rdf:resource="#Evidence1654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction485" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1467">
 <bp:evidence rdf:resource="#Evidence1653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep524">
 <bp:stepProcess rdf:resource="#BiochemicalReaction486" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1466">
 <bp:evidence rdf:resource="#Evidence1652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway28">
 <bp:pathwayOrder rdf:resource="#PathwayStep318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep337" />
 <bp:pathwayComponent rdf:resource="#Pathway30" />
 <bp:pathwayComponent rdf:resource="#Pathway33" />
 <bp:pathwayComponent rdf:resource="#Pathway31" />
 <bp:pathwayComponent rdf:resource="#Pathway32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction291" />
 <bp:pathwayComponent rdf:resource="#Pathway29" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2 family signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The interleukin-2 family (also called the common gamma chain cytokine family) consists of interleukin (IL)2, IL9, IL15 and IL21. Although sometimes considered to be within this family, the IL4 and IL7 receptors can form complexes with other receptor chains and are represented separately in Reactome. Receptors of this family associate with JAK1 and JAK3, primarily activating STAT5, although certain family members can also activate STAT1, STAT3 or STAT6. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep525">
 <bp:stepProcess rdf:resource="#BiochemicalReaction487" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1465">
 <bp:evidence rdf:resource="#Evidence1651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway29">
 <bp:pathwayOrder rdf:resource="#PathwayStep330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction306" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-15 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The high affinity Interleukin-15 receptor is a heterotrimer of Interleukin-15 receptor subunit alpha (IL15RA), Interleukin-2 receptor subunit beta (IL2RB, CD122) and Cytokine receptor common subunit gamma (IL2RG, CD132). IL2RB and IL2RG are also components of the Interleukin-2 (IL2) receptor. Treatment of human T cells with Interleukin-15 (IL15) results in tyrosine phosphorylation of Tyrosine-protein kinase JAK1 (JAK1, Janus kinase 1) and Tyrosine-protein kinase JAK3 (JAK3, Janus kinase 3) (Johnston et al. 1995, Winthrop 2017). IL15 can signal by a process termed &apos;trans presentation&apos;, where IL15 bound by IL15 on one cell is trans-presented to IL2RB:IL2RG on another cell (Dubois et al. 2002) but can also participate in more &apos;traditional&apos; cis signaling (Wu et al. 2008, Mishra et al. 2014) where all the three receptors are present on the same cell.  Stimulation of lymphocytes by IL15 release MAPK activation through GAB2/SHP2/SHC (GRB2-associated-binding protein 2/Tyrosine-protein phosphatase non-receptor type 11/SHC transforming protein 1 or 2) cascade activation (Gadina et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep526">
 <bp:stepProcess rdf:resource="#BiochemicalReaction488" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1464">
 <bp:evidence rdf:resource="#Evidence1650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1474">
 <bp:evidence rdf:resource="#Evidence1661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1899">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1671" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1473">
 <bp:evidence rdf:resource="#Evidence1660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1898">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1670" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1472">
 <bp:evidence rdf:resource="#Evidence1659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1471">
 <bp:evidence rdf:resource="#Evidence1658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1470">
 <bp:evidence rdf:resource="#Evidence1657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1665" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1890">
 <bp:stepProcess rdf:resource="#Pathway227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1893">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1892">
 <bp:stepProcess rdf:resource="#Pathway228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1668" />
 <bp:stepProcess rdf:resource="#Catalysis567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1667" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1897">
 <bp:stepProcess rdf:resource="#Pathway229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1669" />
 <bp:stepProcess rdf:resource="#Catalysis568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction500" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway51">
 <bp:pathwayOrder rdf:resource="#PathwayStep670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep669" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction618" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction612" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction614" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Other interleukin signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukins are low molecular weight proteins that bind to cell surface receptors and act in an autocrine and/or paracrine fashion. They were first identified as factors produced by leukocytes but are now known to be produced by many other cells throughout the body. They have pleiotropic effects on cells which bind them, impacting processes such as tissue growth and repair, hematopoietic homeostasis, and multiple levels of the host defense against pathogens where they are an essential part of the immune system.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction501" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway52">
 <bp:pathwayOrder rdf:resource="#PathwayStep690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep694" />
 <bp:pathwayOrder rdf:resource="#PathwayStep715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep687" />
 <bp:pathwayOrder rdf:resource="#PathwayStep688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction643" />
 <bp:pathwayComponent rdf:resource="#Pathway53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction640" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction662" />
 <bp:pathwayComponent rdf:resource="#Pathway54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction648" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction651" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction636" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-3, Interleukin-5 and GM-CSF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Interleukin-3 (IL-3), IL-5 and Granulocyte-macrophage colony stimulating factor (GM-CSF) receptors form a family of heterodimeric receptors that have specific alpha chains but share a common beta subunit, often referred to as the common beta (Bc). Both subunits contain extracellular conserved motifs typical of the cytokine receptor superfamily. The cytoplasmic domains have limited similarity with other cytokine receptors and lack detectable catalytic domains such as tyrosine kinase domains.   IL-3 is a 20-26 kDa product of CD4+ T cells that acts on the most immature marrow progenitors. IL-3 is capable of inducing the growth and differentiation of multi-potential hematopoietic stem cells, neutrophils, eosinophils, megakaryocytes, macrophages, lymphoid and erythroid cells. IL-3 has been used to support the proliferation of murine cell lines with properties of multi-potential progenitors, immature myeloid as well as T and pre-B lymphoid cells (Miyajima et al. 1992). IL-5 is a hematopoietic growth factor responsible for the maturation and differentiation of eosinophils. It was originally defined as a T-cell-derived cytokine that triggers activated B cells for terminal differentiation into antibody-secreting plasma cells. It also promotes the generation of cytotoxic T-cells from thymocytes. IL-5 induces the expression of IL-2 receptors (Kouro    Takatsu 2009). GM-CSF is produced by cells (T-lymphocytes, tissue macrophages, endothelial cells, mast cells) found at sites of inflammatory responses. It stimulates the growth and development of progenitors of granulocytes and macrophages, and the production and maturation of dendritic cells. It stimulates myeloblast and monoblast differentiation, synergises with Epo in the proliferation of erythroid and megakaryocytic  progenitor cells, acts as an autocrine mediator of growth for some types of acute myeloid leukemia, is a strong chemoattractant for neutrophils and eosinophils. It enhances the activity of neutrophils and macrophages. Under steady-state conditions GM-CSF is not essential for the production of myeloid cells, but it is required for the proper development of alveolar macrophages, otherwise, pulmonary alvelolar proteinosis (PAP) develops. A growing body of evidence suggests that GM-CSF plays a key role in emergency hematopoiesis (predominantly myelopoiesis)  in response to infection, including the production of granulocytes and macrophages in the bone marrow and their maintenance, survival, and functional activation at sites of injury or insult  (Hercus et al. 2009).   All three receptors have alpha chains that bind their specific ligands with low affinity (de Groot et al. 1998). Bc then associates with the alpha chain forming a high affinity receptor (Geijsen et al. 2001), though the in vivo receptor is likely be a higher order multimer as recently demonstrated for the GM-CSF receptor (Hansen et al. 2008).   The receptor chains lack intrinsic kinase activity, instead they interact with and activate signaling kinases, notably Janus Kinase 2 (JAK2). These phosphorylate the common beta subunit, allowing recruitment of signaling molecules such as Shc, the phosphatidylinositol 3-kinases (PI3Ks), and the Signal Transducers and Activators of Transcription (STATs). The cytoplasmic domain of Bc has two distinct functional domains: the membrane proximal region mediates the induction of proliferation-associated genes such as c-myc, pim-1 and oncostatin M. This region binds multiple signal-transducing proteins including JAK2 (Quelle et al. 1994), STATs, c-Src and PI3 kinase (Rao and Mufson, 1995). The membrane distal domain is required for cytokine-induced growth inhibition and is necessary for the viability of hematopoietic cells (Inhorn et al. 1995). This region interacts with signal-transducing proteins such as Shc (Inhorn et al. 1995) and SHP and mediates the transcriptional activation of c-fos, c-jun, c-Raf and p70S6K (Reddy et al. 2000).    Figure reproduced by permission from Macmillan Publishers Ltd: Leukemia, WL Blalock et al. 13:1109-1166, copyright 1999. Note that residue numbering in this diagram refers to the mature Common beta chain with signal peptide removed.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway50">
 <bp:pathwayOrder rdf:resource="#PathwayStep652" />
 <bp:pathwayOrder rdf:resource="#PathwayStep653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction606" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction605" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction603" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-38 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukins are immunomodulatory proteins that elicit a wide array of responses in cells and tissues. Interleukin 1 family member 10 (IL1F10, IL 38) is a member of the IL1 family (Lin et al. 2001, Bensen et al. 2001). IL1F10 is selectively produced by human apoptotic cells (Mora et al. 2016) and human epidermal keratinocytes (based on mRNA studies) (Boutet M A et al. 2016). IL1F10 can bind to interleukin 1 receptor like 2 (IL1RL2) and may result in the suppression of IL 17 and IL 22 and induction of IL 6 production (van de Veerdonk et al. 2012, Mora et al. 2016). IL1F10 is synthesized as precursors that require N terminal processing to attain full receptor agonist or antagonist function (Mora et al. 2016). Both full length (1 &#8211; 152 amino acids) and N terminal truncated (20 &#8211; 152 amino acids) IL1F10 can bind Interleukin 1 receptor accessory protein like 1 (IL1RAPL1) (Mora et al. 2016). The binding affinity of truncated IL1F10 is much higher than that of the full length.  However, binding of the full length or truncated forms has distinct outcomes; the former induces IL6 and the latter suppresses IL6 via JNK and AP1 signaling (Mora et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway55">
 <bp:pathwayOrder rdf:resource="#PathwayStep815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep717" />
 <bp:pathwayOrder rdf:resource="#PathwayStep730" />
 <bp:pathwayOrder rdf:resource="#PathwayStep757" />
 <bp:pathwayComponent rdf:resource="#Pathway60" />
 <bp:pathwayComponent rdf:resource="#Pathway56" />
 <bp:pathwayComponent rdf:resource="#Pathway57" />
 <bp:pathwayComponent rdf:resource="#Pathway58" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-12 family signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-12 (IL-12) is a heterodimer of interleukin-12 subunit alpha (IL12A, IL-12p35) and interleukin-12 subunit beta (IL12B, IL-12p40). It is a potent immunoregulatory cytokine involved in the generation of cell mediated immunity to intracellular pathogens. It is produced by antigen presenting cells, including dendritic cells, macrophages/monocytes, neutrophils and some B cells (D&apos;Andrea et al. 1992, Kobayashi et al.1989, Heufler et al.1996). It enhances the cytotoxic activity of natural killer (NK) cells and cytotoxic T cells, stimulating proliferation of activated NK and T cells and induces production of interferon gamma (IFN gamma) by these cells (Stern et al. 1990). IL-12 also plays an important role in immunomodulation by promoting cell mediated immunity through induction of a class 1 T helper cell (Th1) immune response.  IL-12 may contribute to immunopathological conditions such as rheumatoid arthritis (McIntyre et al. 1996). The receptor for IL-12 is a heterodimer of IL-12Rbeta1 (IL12RB1) and IL-12Rbeta2 (IL12RB2), both highly homologous to Interleukin-6 receptor subunit beta (IL6ST,gp130). Each has an extracellular ligand binding domain, a transmembrane domain and a cytosolic domain containing box 1 and box 2 sequences that mediate binding of Janus family tyrosine kinases (JAKs). IL-12 binding is believed to bring about the heterodimerization and generation of a high affinity receptor complex capable of signal transduction. In this model, receptor dimerization leads to juxtaposition of the cytosolic domains and subsequent tyrosine phosphorylation and activation of JAK2 and TYK2. These activated kinases, in turn, tyrosine phosphorylate and activate several members of the signal transducer and activator of transcription (STAT) family, mainly STAT4, while also STAT1, STAT3 and STAT5 have been reported to be activated (Bacon et al. 1995, Jacobson et al. 1995, Yu et al. 1996, Gollob et al.1995). The STATs translocate to the nucleus to activate transcription of several genes, including IFN gamma. The production of IFN gamma has a pleiotropic effect in the cell, stimulating production of molecules important to cell mediated immunity. In particular, IFN gamma stimulates production of more IL-12 and sets up a positive regulation loop between IL-12 signaling and IFN gamma (Chan et al. 1991). The importance of IL-12 for this loop is demonstrated by IL-12 and STAT4 knockout mice that are severely compromised in IFN-gamma production (Kaplan et al. 1996; Magram et al. 1996), as well as by patients with IL12B mutations that are severely compromised in IFN-gamma production (Altare et al.1998).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway56">
 <bp:pathwayOrder rdf:resource="#PathwayStep725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep728" />
 <bp:pathwayOrder rdf:resource="#PathwayStep718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep729" />
 <bp:pathwayOrder rdf:resource="#PathwayStep719" />
 <bp:pathwayOrder rdf:resource="#PathwayStep720" />
 <bp:pathwayOrder rdf:resource="#PathwayStep721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction669" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-23 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-23 (IL23) is a heterodimer of  Interleukin-12 subunit beta (IL12B, IL-12p40), which is shared with IL12, and Interleukin-23 subunit alpha IL23A (IL-23p19) subunit. The functional receptor for IL23 consists of Interleukin-12 receptor subunit beta-1 (IL12RB1), which is shared with the IL12 receptor, and Interleukin-23 receptor (IL23R). IL23R is mainly expresed on activated memory T cells, Natural Killer cells, monocytes/macrophage and at low levels on dendritic cells (DCs). IL23 is mainly secreted by activated macrophages and DCs in peripheral tissues such as skin, intestinal mucosa and lung.  IL23 is proinlflammatory and implicated in several autoimmune inflammatory disorders such as colitis, gastritis, psoriasis and arthritis. It is similar to IL-12 both in structure and its ability to  memory T cells to increase interferon-&#947; (IFN-&#947;) production and proliferation, the ability of IL-23 to induce IL-17. IL23 activates the Janus kinases JAK2 and TYK2, resulting in phosphorylation of the receptor complex, which forms the docking sites for Signal transducer and activator of transcription 3 (STAT3) and STAT4 to bind and become phosphorylated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway53">
 <bp:pathwayOrder rdf:resource="#PathwayStep680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction626" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin receptor SHC signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Shc at three tyrosine residues, 239, 240 (Gotoh et al. 1996) and 317 (Salcini et al. 1994) involves unidentified tyrosine kinases presumed to be part of the activated receptor complex. These phosphorylated tyrosines subsequently bind SH2 signaling proteins such as Grb2, Gab2 and SHIP that are involved in the regulation of different signaling pathways. Grb2 can associate with the guanosine diphosphate-guanosine triphosphate exchange factor Sos1, leading to Ras activation and regulation of cell proliferation. Downstream signals are mediated via the Raf-MEK-Erk pathway.Grb2 can also associate through Gab2 with PI3K and with SHIP.  Figure reproduced from Gu, H. et al. 2000. Mol. Cell. Biol. 20(19):7109-7120 Copyright American Society for Microbiology. All Rights Reserved.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway54">
 <bp:pathwayOrder rdf:resource="#PathwayStep714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep709" />
 <bp:pathwayOrder rdf:resource="#PathwayStep710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction658" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of signaling by CBL</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cbl is an E3 ubiquitin-protein ligase that negatively regulates signaling pathways by targeting proteins for ubiquitination and proteasomal degradation (Rao et al. 2002). Cbl negatively regulates PI3K via this mechanism (Dufour et al. 2008). The binding of Cbl to the p85 subunit of PI3K is mediated at least in part by tyrosine phosphorylation at Y731 (Dufour et al. 2008). Fyn and the related kinases  Hck and Lyn are known to be associated with Cbl (Anderson et al. 1997, Hunter et al. 1999). Fyn is proven capable of Cbl Y731 phosphorylation (Hunter et al. 1999).The association of Fyn and Cbl has been described as constitutive (Hunter et al. 1999). CBL further associates with the p85 subunit of PI3K (Hartley et al. 1995, Anderson et al. 1997, Hunter et al. 1997), this also described as constitutive and mediated by the SH3 domain of p85. Binding of the SH2 domain of p85 to a specific phosphorylation site in Cbl is postulated to explain the the increase in Cbl/p85 association seen in activated cells (Panchamoorthy et al 1996) which negatively regulates PI3K activity (Fang et al. 2001). The negative effect of increased Cbl-PI3K interaction is mediated by Y731 of Cbl. Cbl binding increases PI3K ubiquitination and proteasome degradation (Dufour et al. 2008).   Cbl is constitutively associated with Grb in resting hematopoietic cells (Anderson et al. 1997, Odai et al. 1995, Park et al. 1998, Panchamoorthy et al. 1996). Both the SH2 and SH3 domains of Grb2 are involved. Cbl has 2 distinct C-terminal domains, proximal and distal. The proximal domain binds Grb2 in resting and stimulated cells, and in stimulated cells also binds Shc. The distal domain binds the adaptor protein CRKL. Tyrosine phosphorylation of Cbl in response to IL-3 releases the SH3 domain of Grb2 which then is free to bind other molecules (Park et al. 1998). Cbl is tyrosine phosphorylated in response to many cytokines including IL-3, IL-2 (Gesbert et al. 1998) and IL-4 (Ueno et al. 1998). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep530">
 <bp:stepProcess rdf:resource="#BiochemicalReaction492" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway59">
 <bp:pathwayOrder rdf:resource="#PathwayStep790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep791" />
 <bp:pathwayOrder rdf:resource="#PathwayStep792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep793" />
 <bp:pathwayOrder rdf:resource="#PathwayStep813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep797" />
 <bp:pathwayOrder rdf:resource="#PathwayStep798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep782" />
 <bp:pathwayOrder rdf:resource="#PathwayStep802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep805" />
 <bp:pathwayOrder rdf:resource="#PathwayStep806" />
 <bp:pathwayOrder rdf:resource="#PathwayStep807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep809" />
 <bp:pathwayOrder rdf:resource="#PathwayStep783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep786" />
 <bp:pathwayOrder rdf:resource="#PathwayStep787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep801" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction740" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction743" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction726" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction748" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction745" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction744" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction747" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction734" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction755" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction735" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Experiments using human cord blood CD4(+) T cells show 22 protein spots and 20 protein spots, upregulated and downregulated proteins respectively, following Interleukin-12 stimulation (Rosengren et.al, 2005).  The identified upregulated proteins are:  BOLA2, PSME2,  MTAP, CA1,  GSTA2,  RALA,  CNN2,  CFL1,  TCP1,  HNRNPDL,  MIF,  AIP,  SOD1, PPIA and  PDCD4. And the identified downregulated proteins are: ANXA2, RPLP0, CAPZA1, SOD2, SNRPA1, LMNB1, LCP1, HSPA9, SERPINB2, HNRNPF, TALDO1, PAK2, TCP1, HNRNPA2B1, MSN, PITPNA, ARF1, SOD2, ANXA2, CDC42, RAP1B and GSTO1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep531">
 <bp:stepProcess rdf:resource="#BiochemicalReaction493" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep532">
 <bp:stepProcess rdf:resource="#BiochemicalReaction494" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway57">
 <bp:pathwayOrder rdf:resource="#PathwayStep736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep739" />
 <bp:pathwayOrder rdf:resource="#PathwayStep750" />
 <bp:pathwayOrder rdf:resource="#PathwayStep751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep731" />
 <bp:pathwayOrder rdf:resource="#PathwayStep753" />
 <bp:pathwayOrder rdf:resource="#PathwayStep732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep735" />
 <bp:pathwayOrder rdf:resource="#PathwayStep747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep742" />
 <bp:pathwayOrder rdf:resource="#PathwayStep743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction675" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction695" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction678" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-35 Signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin 35 (IL35) is an IL12 family cytokine produced by regulatory but not effector T-cells. It is a dimeric protein composed of IL-12RB2 and IL27RA chains. IL35 suppresses inflammatory responses of immune cells.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction495" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway58">
 <bp:pathwayOrder rdf:resource="#PathwayStep770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep760" />
 <bp:pathwayOrder rdf:resource="#PathwayStep771" />
 <bp:pathwayOrder rdf:resource="#PathwayStep758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep759" />
 <bp:pathwayOrder rdf:resource="#PathwayStep814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep775" />
 <bp:pathwayOrder rdf:resource="#PathwayStep765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction716" />
 <bp:pathwayComponent rdf:resource="#Pathway59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction704" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction756" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction713" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-12 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin 12 (IL-12) is heterodimeric cytokine produced by dendritic cells, macrophages and neutrophils. It is encoded by the genes Interleukin-12 subunit alpha (IL12A) and Interleukin-12 subunit beta (IL12B), which encode a 35-kDa light chain (p35) and a 40-kDa heavy chain (p40), respectively. The active IL12 heterodimer is sometimes referred to as p70. The p35 component has homology to single-chain cytokines, while p40 is homologous to the extracellular domains of members of the haematopoietic cytokine-receptor family. The IL12 heterodimer therefore resembles a cytokine linked to a soluble receptor.  IL12 is involved in the differentiation of naive T cells into Th1 cells and sometimes known as T cell-stimulating factor. IL12 enhances the cytotoxic activity of Natural Killer cells and CD8+ cytotoxic T lymphocytes. IL12 also has anti-angiogenic activity, mediated by increased production of CXCL10 via interferon gamma.  The IL12 receptor is a heterodimer formed by Interleukin-12 receptor subunit beta-1 (IL12RB1) and Interleukin-12 receptor subunit beta-2 (IL12RB2), both of which have extensive homology to IL6ST (gp130), the signal transducing receptor subunit of the IL6-like cytokine superfamily. IL-12RB2 is considered to play the key role in IL12 function, in part because its expression on activated T cells is stimulated by cytokines that promote Th1 cell development and inhibited by those that promote Th2 cells development. In addition, IL12 binding leads to IL12RB2 tyrosine phosphorylation, which provides binding sites for the kinases Non-receptor tyrosine-protein kinase TYK2 and Tyrosine-protein kinase JAK2. These activate transcription factor proteins in the Signal transducer and activator of transcription (STAT) family, particularly STAT4.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1479">
 <bp:evidence rdf:resource="#Evidence1667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction496" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1478">
 <bp:evidence rdf:resource="#Evidence1666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep535">
 <bp:stepProcess rdf:resource="#BiochemicalReaction497" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1477">
 <bp:evidence rdf:resource="#Evidence1664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 :oligo-Myd88:activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction498" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1476">
 <bp:evidence rdf:resource="#Evidence1663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction499" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1475">
 <bp:evidence rdf:resource="#Evidence1662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1485">
 <bp:evidence rdf:resource="#Evidence1674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1484">
 <bp:evidence rdf:resource="#Evidence1673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1483">
 <bp:evidence rdf:resource="#Evidence1672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1482">
 <bp:evidence rdf:resource="#Evidence1671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1481">
 <bp:evidence rdf:resource="#Evidence1670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1480">
 <bp:evidence rdf:resource="#Evidence1669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction502" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction511" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway40">
 <bp:pathwayOrder rdf:resource="#PathwayStep582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep646" />
 <bp:pathwayComponent rdf:resource="#Pathway41" />
 <bp:pathwayComponent rdf:resource="#Pathway50" />
 <bp:pathwayComponent rdf:resource="#Pathway44" />
 <bp:pathwayComponent rdf:resource="#Pathway45" />
 <bp:pathwayComponent rdf:resource="#Pathway42" />
 <bp:pathwayComponent rdf:resource="#Pathway43" />
 <bp:pathwayComponent rdf:resource="#Pathway49" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 family signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Interleukin-1 (IL1) family of cytokines comprises 11 members, namely Interleukin-1 alpha (IL1A), Interleukin-1 beta (IL1B), Interleukin-1 receptor antagonist protein (IL1RN, IL1RA), Interleukin-18 (IL18), Interleukin-33 (IL33), Interleukin-36 receptor antagonist protein (IL36RN, IL36RA), Interleukin-36 alpha (IL36A), Interleukin-36 beta (IL36B), Interleukin-36 gamma (IL36G), Interleukin-37 (IL37) and Interleukin-38 (IL38). The genes encoding all except IL18 and IL33 are on chromosome 2. They share a common C-terminal three-dimensional structure and  with apart from  IL1RN they are synthesized without a hydrophobic leader sequence and are not secreted via the classical reticulum endoplasmic-Golgi pathway. IL1B and IL18, are produced as biologically inactive propeptides that are cleaved to produce the mature, active interleukin peptide. The IL1 receptor (IL1R) family comprises 10 members: Interleukin-1 receptor type 1 (IL1R1, IL1RA), Interleukin-1 receptor type 2 (IL1R2, IL1RB), Interleukin-1 receptor accessory protein (IL1RAP, IL1RAcP, IL1R3), Interleukin-18 receptor 1 (IL18R1, IL18RA) , Interleukin-18 receptor accessory protein (IL18RAP, IL18RB), Interleukin-1 receptor-like 1 (IL1RL1, ST2, IL33R), Interleukin-1 receptor-like 2 (IL1RL2, IL36R), Single Ig IL-1-related receptor (SIGIRR, TIR8), Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1, TIGGIR2) and X-linked interleukin-1 receptor accessory protein-like 2 (IL1RAPL2, TIGGIR1). Most of the genes encoding these receptors are on chromosome 2.  IL1 family receptors heterodimerize upon cytokine binding. IL1, IL33 and IL36 bind specific receptors, IL1R1, IL1RL1, and IL1RL2 respectively.  All use IL1RAP as a co-receptor. IL18 binds IL18R1 and uses IL18RAP as co-receptor. The complexes formed by IL1 family cytokines and their heterodimeric receptors recruit intracellular signaling molecules, including Myeloid differentiation primary response protein MyD88 (MYD88), members of he IL1R-associated kinase (IRAK) family, and TNF receptor-associated factor 6 (TRAF6), activating Nuclear factor NF-kappa-B (NF&#954;B), as well as Mitogen-activated protein kinase 14 (MAPK14, p38), c-Jun N-terminal kinases (JNKs), extracellular signal-regulated kinases (ERKs) and other Mitogen-activated protein kinases (MAPKs).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway41">
 <bp:pathwayOrder rdf:resource="#PathwayStep555" />
 <bp:pathwayOrder rdf:resource="#PathwayStep556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction515" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-33 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-33 (IL33) cytokine is a member of the Interleukin-1 family. It can be classified as an alarmin because it is released into the extracellular space during cell damage. It acts as an endogenous danger signal (Liew et al. 2010).] The gene product is biologically active (full-length IL33). Its potency has been reported to increase significantly (up to 30x) after cleavage at the N-terminus by inflammatory proteases such as Cathepsin G (CTSG) and Neutrophil elastase (ELANE) (Lefran&#231;ais et al. 2012, Lefran&#231;ais et al. 2014) but others have suggested that processing inactivates IL33 (Cayrol    Girard 2009). IL33 can act as an extracellular ligand and an intracellular signaling molecule (Martin et al. 2013, 2016). Full-length IL33 has a nuclear localization sequence and can translocate to the nucleus, where it binds heterochromatin (Moussion et al. 2008, Carriere et al. 2007, Roussel et al. 2008, Kuchler et al. 2008, Sundlisaeter et al. 2012, Baekkevold et al. 2003). IL33 that has undergone proteolytic processing is unable to translocate to the nucleus (Martin et al. 2013, Ali et al. 2010). Binding of extracellular IL33 to its receptor Interleukin-1 receptor-like 1 (IL1RL1, suppression of tumorigenicity 2, ST2) initiates several cellular signaling pathways. Cell injury or death are the dominant mechanisms by which IL33 reaches the extracellular environment, IL33 is not actively secreted by cells (Martin et al. 2016, Kaczmarek et al. 2013, Vancamelbeke et al. 2017). Because IL33 is expressed constitutively by endothelial and epithelial cells it is immediately available to the extracellular microenvironment after cell injury and necrosis (Lefran&#231;ais et al. 2012). Increases in extracellular ATP or mechanical stress correlate with increased IL33 secretion by mast cells or cardiomyocytes, respectively (Shimokawa et al. 2017, Kakkar et al. 2012, Zhao et al. 2012, Sanada et al. 2007, Chen et al. 2015).  Soluble IL1RL1 (IL1RL1 Isoform C, ST2V) (Iwahana et al. 2005, Tominaga et al. 1999) shares the extracellular components of IL1RL1, including the ligand binding domain, but lacks the transmembrane and intracellular components of IL1RL1 (Kakkar et al. 2008, Iwahana et al. 1999). The IL33-IL1RL1 complex recruits a co-receptor, most commonly IL1 receptor accessory protein (IL1RAP, IL-1RAcP) (Schmitz et al. 2005, Lingel et al. 2009, Palmer et al. 2008, Liu et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway44">
 <bp:pathwayOrder rdf:resource="#PathwayStep580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction538" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction537" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 processing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IL-1 family of cytokines that interact with the Type 1 IL-1R include IL-1&#945; (IL1A), IL-1&#946; (IL1B) and the IL-1 receptor antagonist protein (IL1RAP). IL1RAP is synthesized with a signal peptide and secreted as a mature protein via the classical secretory pathway.  IL1A and IL1B are synthesised as cytoplasmic precursors (pro-IL1A and pro-IL1B) in activated cells. They have no signal sequence, precluding secretion via the classical ER-Golgi route (Rubartelli et al. 1990). Processing of pro-IL1B to the active form requires caspase-1 (Thornberry et al. 1992), which is itself activated by a molecular scaffold termed the inflammasome (Martinon et al. 2002). Processing and release of IL1B are thought to be closely linked, because mature IL1B is only seen inside inflammatory cells just prior to release (Brough et al. 2003). It has been reported that in monocytes a fraction of cellular IL1B is released by the regulated secretion of late endosomes and early lysosomes, and that this may represent a cellular compartment where caspase-1 processing of pro-IL1B takes place (Andrei et al. 1999). Shedding of microvesicles from the plasma membrane has also been proposed as a mechanism of secretion (MacKenzie et al. 2001). These proposals superceded previous models in which non-specific release due to cell lysis and passage through a plasma membrane pore were considered. However, there is evidence in the literature that supports all of these mechanisms and there is still controversy over how IL1B exits from cells (Brough    Rothwell 2007). A calpain-like potease has been reported to be important for the processing of  pro-IL1A, but much less is known about how IL1A is released from cells and what specific roles it plays in biology.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway45">
 <bp:pathwayOrder rdf:resource="#PathwayStep590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep595" />
 <bp:pathwayOrder rdf:resource="#PathwayStep617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction587" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction583" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction598" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction571" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction573" />
 <bp:pathwayComponent rdf:resource="#Pathway48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction539" />
 <bp:pathwayComponent rdf:resource="#Pathway46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction579" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin 1 (IL1) signals via Interleukin 1 receptor 1 (IL1R1), the only signaling-capable IL1 receptor. This is a single chain type 1 transmembrane protein comprising an extracellular ligand binding domain and an intracellular  region called the Toll/Interleukin-1 receptor (TIR) domain that is structurally conserved and shared by other members of the two families of receptors (Xu et al. 2000). This domain is also shared by the downstream adapter molecule MyD88. IL1 binding to IL1R1 leads to the recruitment of a second receptor chain termed the IL1 receptor accessory protein (IL1RAP or IL1RAcP) enabling the formation of a high-affinity ligand-receptor complex that is capable of signal transduction. Intracellular signaling is initiated by the recruitment of MyD88 to the IL-1R1/IL1RAP complex. IL1RAP is only recruited to IL1R1 when IL1 is present; it is believed that a TIR domain signaling complex is formed between the receptor and the adapter TIR domains. The recruitment of MyD88 leads to the recruitment of Interleukin-1 receptor-associated kinase (IRAK)-1 and -4, probably via their death domains. IRAK4 then activates IRAK1, allowing IRAK1 to autophosphorylate. Both IRAK1 and IRAK4 then dissociate from MyD88 (Brikos et al. 2007) which remains stably complexed with IL-1R1 and IL1RAP. They in turn interact with Tumor Necrosis Factor Receptor (TNFR)-Associated Factor 6 (TRAF6), which is an E3 ubiquitin ligase (Deng et al. 2000). TRAF6 is then thought to auto-ubiquinate, attaching K63-polyubiquitin to itself with the assistance of the E2 conjugating complex Ubc13/Uev1a. K63-pUb-TRAF6 recruits Transforming Growth Factor (TGF) beta-activated protein kinase 1 (TAK1) in a complex with TAK1-binding protein 2 (TAB2) and TAB3, which both contain nuclear zinc finger motifs that interact with K63-polyubiquitin chains (Ninomiya-Tsuji et al. 1999). This activates TAK1, which then activates  inhibitor of NF-kappaB (IkappaB) kinase 2 (IKK2 or IKKB) within the IKK complex, the kinase responsible for phosphorylation of IkappaB. The IKK complex also contains the scaffold protein NF-kappa B essential modulator (NEMO). TAK1 also couples to the upstream kinases for p38 and c-jun N-terminal kinase (JNK). IRAK1 undergoes K63-linked polyubiquination; Pellino E3 ligases are important in this process. (Butler et al. 2007; Ordureau et al. 2008). The activity of these proteins is greatly enhanced by IRAK phosphorylation (Schauvliege et al. 2006), leading to K63-linked polyubiquitination of IRAK1. This recruits NEMO to IRAK1, with NEMO binding to polyubiquitin (Conze et al. 2008).  TAK1 activates IKKB (and IKK), resulting in phosphorylation of the inhibitory IkB proteins and enabling translocation of NFkB to the nucleus; IKKB also phosphorylates NFkB p105, leading to its degradation and the subsequent release of active TPL2 that triggers the extracellular-signal regulated kinase (ERK)1/2 MAPK cascade. TAK1 can also trigger the p38 and JNK MAPK pathways via activating the upstream MKKs3, 4 and 6. The MAPK pathways activate a number of downstream kinases and transcription factors that co-operate with NFkB to induce the expression of a range of TLR/IL-1R-responsive genes. There are reports suggesting that IL1 stimulation increases nuclear localization of IRAK1 (Bol et al. 2000) and that nuclear IRAK1 binds to the promoter of NFkB-regulated gene and IkBa, enhancing binding of the NFkB p65 subunit to NFkB responsive elements within the IkBa promoter.  IRAK1 is required for IL1-induced Ser-10 phosphorylation of histone H3 in vivo (Liu et al. 2008). However, details of this aspect of IRAK1 signaling mechanisms remain unclear. Interleukin-18 is another Interleukin-1 related cytokine which signals through IL18R and IL18RAP subunit receptors (which share homology with IL1R and IL1RAP in the cytokine signaling cascade). Later it follows a MYD88/IRAK1/TRAF6 cascade signaling until reach the NFKB activation (Moller et al. 2002). Interleukin 33, 36, 37 and 38 are relatively recently discovered Interleukin-1 related citokines which are also able to signal through IL1 receptor subunits or other as IL18R, IL37R (Schmitz et al. 2005, Yi et al. 2016, Lunding et al. 2015, van de Veendorck et al. 2012, Lin et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway42">
 <bp:pathwayOrder rdf:resource="#PathwayStep570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep562" />
 <bp:pathwayOrder rdf:resource="#PathwayStep563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep559" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction521" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction528" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction526" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-37 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukins (IL) are immunomodulatory proteins that elicit a wide array of responses in cells and tissues. Interleukin 37 (IL37), also known as IL 1F7, is a member of the IL 1 family (Sharma et al. 2008). Isoform b of IL37 (referred just as IL37) is synthesized as a precursor that requires processing (primarily by caspase 1) to attain full receptor agonist or antagonist function (Kumar et al. 2002). Both full length and processed IL37 can bind to the IL 18 binding protein (IL 18BP) and the Interleukin 18 receptor 1 (IL 18R1) (Shi et al. 2003). Upon binding to the IL18R1, IL37 recruits Single Ig IL 1 related receptor (SIGIRR) (Nold-Petry et al. 2015). The IL37:IL18R1 complex can activate phosphorylation of Signal transducer and activator of transcription 3 (STAT3), Tyrosine protein kinase Mer and Phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase and dual specificity protein phosphatase PTEN and can also inhibit Nuclear factor NF kappa B p105 subunit (NFKB) (Nold-Petry et al. 2015). Processed IL37 can be secreted from the cytosol to the extracellular space or translocated into the nucleus (Bulau et al. 2014). Full length IL37 can also be secreted from the cytosol to the extracellular space (Bulau et al. 2014). Processed IL37 can bind with Mothers against decapentaplegic homolog 3 (SMAD3) in the cytosol and then translocate to the nucleus, where it facilitates transcription of Tyrosine protein phosphatase non receptors (PTPNs) (Nold et al. 2010, Luo et al. 2017). These events ultimately lead to suppression of cytokine production in several types of immune cells resulting in reduced inflammation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway43">
 <bp:pathwayOrder rdf:resource="#PathwayStep573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction531" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction533" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-36 pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-36 alpha (IL36A), IL36B and IL36G are collectively known as IL36. They are members of the Interlukin-1 family that signal through a receptor composed of Interleukin-1 receptor-like 2 (IL1RL2, IL36R) and Interleukin-1 receptor accessory protein (IL1RAP,  IL-1R/AcP)  to promote inflammatory responses. Interleukin-36 receptor antagonist protein (IL36RN, IL36Ra) is a natural antagonist. IL36 is expressed predominantly by epithelial cells and is implicated strongly through functional and genetic evidence in the pathology of psoriatic disorders.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction503" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway48">
 <bp:pathwayOrder rdf:resource="#PathwayStep637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep643" />
 <bp:pathwayOrder rdf:resource="#PathwayStep644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction590" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction591" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction504" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway49">
 <bp:pathwayOrder rdf:resource="#PathwayStep648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction601" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-18 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-18 (IL18, pro-IL18) is a pleiotropic and pro inflammatory cytokine. It belongs to the Interleukin-1 (IL1 superfamily (Alboni et al. 2010, Krumm et al. 2017, Dinarello 1999). IL18 is synthesized as an inactive 24-kDa precursor protein that is cleaved by extracellular proteases such as caspase-1, protease 3, serine protease, elastase or cathepsin G (Fantuzzi    Dinarello 1999, Gracie et al. 2004, Sugawara et al. 2001), forming an 18-kDa mature protein (Arend et al. 2008, Akita et al. 1997, Fantuzzi et al. 1998, Ghayur et al. 1997, Gu et al. 1997, Ushio et al. 1996).  IL18 also occurs as a short isoform, the result of an alternative splicing event that removes 57 bp/19 aa (IL18alpha) (Conti et al. 1997, Yang et al. 2005). This short isoform has a modest synergistic action with the IL18 canonical active form. The IL18 receptor (IL18R) belongs to the Interleukin-1 receptor/Toll like receptor superfamily. It consists of two subunits, Interleukin-18 receptor 1 (IL18R1, IL-18R&#945;, IL1Rrp1, IL18R1, IL-1R5) and Interleukin-18 receptor accessory protein (IL18RAP, IL18RB, IL-18R&#946;,IL-18RacP, IL-18RII or IL-1R7). Both subunits have three extracellular immunoglobulin-like domains and one intracellular Toll/IL-1 receptor (TIR) domain (O&apos;Neill    Dinarello 2000, Sims 2002). It is believed that IL18 binds first to IL18R1 and later recruits IL18RAP to form a high-affinity heterotrimeric complex (Sims 2002, Sergi    Pentilla 2004, Alboni et al. 2009).  A short isoform of IL18R1 lacks the TIR domain (IL18R1 type II) (Alboni et al. 2009), which is required for signaling, leading to the suggestion that IL18R1 type II is a decoy receptor (Colotta et al. 1994). A truncated form of IL18RAP containing only one of the three immunoglobulin domains stabilizes IL18 binding to IL18R1 but prevents signaling. IL-18 binding protein (IL18BP), a 38-kDa soluble protein, is another negative regulator of IL18 signaling. It has some sequence homology with IL18R1 (Im et al. 2002 , Kim et al. 2002, Novick et al. 1999). IL18BP binds with high affinity to mature IL18, preventing its interaction with IL18R1. Several isoforms IL18BP have been described (Kim et al. 2000). Interleukin-37 (IL37, IL-1F7), another negative regulator of IL18 signaling, is able to bind IL18BP and IL18RAP preventing signaling (Bufler et al.2002, Pan et al. 2001, Kumar et al. 2002). IL18 stimulates Interferon gamma (IFNG, IFN-&#947;) production from T-helper lymphocytes cells (Th1) and macrophages and enhances the cytotoxicity of natural killer (NK) cells. IL18 stimulated IFNG production is synergistically amplified by other Th1-related cytokines such as IL2, IL15, IL12 and IL23 (Boraschi    Dinarello 2006, Park et al. 2007, Dinarello 2007, Dinarello    Fantuzzi 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep543">
 <bp:stepProcess rdf:resource="#BiochemicalReaction505" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway46">
 <bp:pathwayOrder rdf:resource="#PathwayStep615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep599" />
 <bp:pathwayOrder rdf:resource="#PathwayStep600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep614" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction570" />
 <bp:pathwayComponent rdf:resource="#Pathway47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction568" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction506" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway47">
 <bp:pathwayOrder rdf:resource="#PathwayStep604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep607" />
 <bp:pathwayOrder rdf:resource="#PathwayStep608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep610" />
 <bp:pathwayOrder rdf:resource="#PathwayStep611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep603" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction564" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction560" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction559" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction507" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1489">
 <bp:evidence rdf:resource="#Evidence1678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction508" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1488">
 <bp:evidence rdf:resource="#Evidence1677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction509" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1487">
 <bp:evidence rdf:resource="#Evidence1676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction510" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1486">
 <bp:evidence rdf:resource="#Evidence1675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway70">
 <bp:pathwayOrder rdf:resource="#PathwayStep879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep881" />
 <bp:pathwayOrder rdf:resource="#PathwayStep874" />
 <bp:pathwayOrder rdf:resource="#PathwayStep875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep878" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction808" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction811" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction810" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction812" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway73">
 <bp:pathwayOrder rdf:resource="#PathwayStep925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep950" />
 <bp:pathwayOrder rdf:resource="#PathwayStep899" />
 <bp:pathwayComponent rdf:resource="#Pathway74" />
 <bp:pathwayComponent rdf:resource="#Pathway77" />
 <bp:pathwayComponent rdf:resource="#Pathway75" />
 <bp:pathwayComponent rdf:resource="#Pathway76" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCR signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TCR is a multisubunit complex that consists of clonotypic alpha/beta chains noncovalently associated with the invariant CD3 delta/epsilon/gamma and TCR zeta chains. T cell activation by antigen presenting cells (APCs) results in the activation of protein tyrosine kinases (PTKs) that associate with CD3 and TCR zeta subunits and the co-receptor CD4. Members of the Src kinases (Lck), Syk kinases (ZAP-70), Tec (Itk) and Csk families of nonreceptor PTKs play a crucial role in T cell activation. Activation of PTKs following TCR engagement results in the recruitment and tyrosine phosphorylation of enzymes such as phospholipase C gamma1 and Vav as well as critical adaptor proteins such as LAT, SLP-76 and Gads. These proximal activation leads to reorganization of the cytoskeleton as well as transcription activation of multiple genes leading to T lymphocyte proliferation, differentiation and/or effector function. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway74">
 <bp:pathwayOrder rdf:resource="#PathwayStep909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep904" />
 <bp:pathwayOrder rdf:resource="#PathwayStep915" />
 <bp:pathwayOrder rdf:resource="#PathwayStep905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep908" />
 <bp:pathwayOrder rdf:resource="#PathwayStep910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep911" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction830" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction833" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction843" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction834" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Generation of second messenger molecules</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to serving as a scaffold via auto-phosphorylation, ZAP70 also phosphorylates a restricted set of substrates following TCR stimulation - including LAT (step 13) and LCP2. These substrates have been recognized to play pivotal role in TCR signaling by releasing second messengers. When phosphorylated, LAT and SLP-76 act as adaptor proteins which serve as nucleation points for the construction of a higher order signalosome: PLC-gamma1 (step 14) and GRAP2 (step 15) bind to the LAT on the phosphorylated tyrosine residues. LCP2 is then moved to the signalosome by interacting with the SH3 domains of GRAP2 using their proline rich sequences (step 16). Once LCP2 binds to GRAP2, three LCP2 acidic domain N-term tyrosine residues are phosphorylated by ZAP70 (step 17). These phospho-tyrosine residues act as binding sites to the SH2 domains of ITK (steps 18) and PLC-gamma1 (step 19).   PLC-gamma1 is activated by dual phosphorylation on the tyrosine residues at positions 771, 783 and 1254 by ITK (step 20) and ZAP70 (step 21). Phosphorylated PLC-gamma1 subsequently detaches from LAT and LCP2 and translocates to the plasma membrane by binding to phosphatidylinositol-4,5-bisphosphate (PIP2) via its PH domain (step 22). PLC-gamma1 goes on to hydrolyse PIP2 to second messengers DAG and IP3 (step 23). These second messengers are involved in PKC and NF-kB activation and calcium mobilization.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway71">
 <bp:pathwayOrder rdf:resource="#PathwayStep890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep892" />
 <bp:pathwayOrder rdf:resource="#PathwayStep893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep896" />
 <bp:pathwayOrder rdf:resource="#PathwayStep886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep889" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction825" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction822" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction823" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by CSF1 (M-CSF) in myeloid cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Colony stimulating factor-1 (CSF1, CSF-1, also called macrophage colony stimulating factor, M-CSF) is a disulfide-linked dimer that stimulates the proliferation and differentiation of mononuclear phagocytes and the survival, proliferation, motility, and anti-inflammatory activity of macrophages (reviewed in Mouchemore et al. 2012, Stanley and Chitu 2014, Ushach and Zlotnik 2016, Dwyer et al. 2017 and inferred from mouse homologs in Caescu et al. 2015). The unliganded CSF1 receptor, CSF1R (CSF-1R) is either clustered or undergoing rapid dimer-monomer transitions at the cell surface (Li and Stanley 1991). The CSF1 dimer initially binds the D2 and D3 extracellular domains of a monomer of CSF1R (Wang et al. 1993, Chihara et al. 2010, Ma et al. 2012, Felix et al. 2015, and inferred from mouse homologs). A second monomer of CSF1R then binds the CSF1:CSF1R complex and the resulting dimerization of CSF1R activates its kinase activity (Elegheert et al. 2011, Felix et al. 2015, and inferred from mouse homologs). CSF1R initially trans-autophosphorylates tyrosine-561 in the juxtamembrane domain, relieving negative autoinhibition of kinase activity, resulting in the trans-autophosphorylation of 7 more tyrosine residues in its cytoplasmic domain (Rohrschneider et al. 1997, Chihara et al. 2010, and inferred from mouse homologs in Xiong et al. 2011). The PIK3R1 (p85alpha) regulatory subunit of phosphatidylinositol 3-kinase (PI3K) binds phosphotyrosine-723 of CSF1R, phosphorylated SRC binds phosphotyrosine-561 of CSF1R, phosphorylated CBL binds CSF1R associated with SHC, and GRB2:SOS binds CSF1R (Saleem et al. 1995, and inferred from mouse homologs). The resulting activation of the catalytic subunit of PI3K (PIK2CA,B,G) produces phosphatidylinositol 3,4,5-trisphosphate which recruits effectors containing pleckstrin homology domains (PH domains) such as PKB (also called Akt) to the plasma membrane. Pathways activated by PI3K appear to both enhance proliferation, survival, and migration of macrophages (reviewed in Dwyer et al. 2017) and, via induction of miR21, suppress the inflammatory response by targeting mRNAs encoding multiple proinflammatory molecules. Phospholipase C gamma2 (PLCG2) binds phosphotyrosine-723 of CSF1R, hydrolyzes phosphatidylcholine to yield choline phosphate (phosphocholine) and diacylglycerol, and promotes survival and differentiation of macrophages via PKCdelta (PRKCD) (inferred from mouse homologs). GRB2 bound to SOS1 (GRB2:SOS1) transiently interacts with phosphotyrosine-699 of CSF1R. SOS1 promotes the exchange of GDP for GTP by KRAS, activating the RAS-RAF-ERK1,2 pathway that causes proliferation of macrophage precursors (inferred from mouse homologs). CBL transiently associates with and ubiquitinates the CSF1R, then is deubiquitinated and returned to the cytoplasm (inferred from mouse homologs). Phosphorylated CSF1R also recruits STAT1 and STAT3, which are then phosphorylated (inferred from mouse homologs). The role of phosphorylated STAT1,3 in signaling by CSF1R is incompletely characterized.  CSF1R is a target for therapeutics, such as imatinib (reviewed in Kumari et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway72">
 <bp:pathwayOrder rdf:resource="#PathwayStep1060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1088" />
 <bp:pathwayOrder rdf:resource="#PathwayStep963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep955" />
 <bp:pathwayComponent rdf:resource="#Pathway73" />
 <bp:pathwayComponent rdf:resource="#Pathway88" />
 <bp:pathwayComponent rdf:resource="#Pathway78" />
 <bp:pathwayComponent rdf:resource="#Pathway89" />
 <bp:pathwayComponent rdf:resource="#Pathway86" />
 <bp:pathwayComponent rdf:resource="#Pathway97" />
 <bp:pathwayComponent rdf:resource="#Pathway87" />
 <bp:pathwayComponent rdf:resource="#Pathway79" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adaptive Immune System</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adaptive immunity refers to antigen-specific immune response efficiently involved in clearing the pathogens. The adaptive immune system is comprised of B and T lymphocytes that express receptors with remarkable diversity tailored to recognize aspects of particular pathogens or antigens. During infection, dendritic cells (DC) which act as sentinels in the peripheral tissues recognize and pick up the pathogen in the form of antigenic determinants and then process these antigens and present them to T cells. These T cells of appropriate specificity respond to the antigen, and either kill the pathogen directly or secrete cytokines that will stimulate B lymphocyte response. B cells provide humoral immunity by secreting antibodies specific for the pathogen or antigen.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway77">
 <bp:pathwayOrder rdf:resource="#PathwayStep951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction877" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction878" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of ZAP-70 to Immunological synapse</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The dual phosphorylated ITAMs recruit SYK kinase ZAP70 via their tandem SH2 domains (step 8). ZAP70 subsequently undergoes phosphorylation on multiple tyrosine residues for further activation. ZAP70 includes both positive and negative regulatory sites. Tyrosine 493 is a conserved regulatory site found within the activation loop of the kinase domain. This site has shown to be a positive regulatory site required for ZAP70 kinase activity and is phosphorylated by LCK (step 9). This phosphorylation contributes to the active conformation of the catalytic domain. Later ZAP70 undergoes trans-autophosphorylation at Y315 and Y319 (step 10). These sites appear to be positive regulatory sites. ZAP70 achieves its full activation after the trans-autophosphorylation. Activated ZAP70 along with LCK phosphorylates the multiple tyrosine residues in the adaptor protein LAT (step 11). PTPN22 can dephosphorylate and inhibit ZAP70 activity to downregulate TCR signaling (step 12).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway78">
 <bp:pathwayOrder rdf:resource="#PathwayStep956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep959" />
 <bp:pathwayOrder rdf:resource="#PathwayStep960" />
 <bp:pathwayOrder rdf:resource="#PathwayStep961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction879" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rap1 signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rap1 (Ras-proximate-1) is a small G protein in the Ras superfamily. Like all G proteins, Rap1 is activated when bound GDP is exchanged for GTP. Rap1 is targeted to lipid membranes by the covalent attachment of lipid moieties to its carboxyl terminus. Movement of Rap1 from endosomal membranes to the plasma membrane upon activation has been reported in several cell types including Jurkat T cells and megakaryocytes. On activation,  Rap1 undergoes conformational changes that facilitate recruitment of a variety of effectors, triggering it&apos;s participation in integrin signaling, ERK activation, and others.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1419">
 <bp:evidence rdf:resource="#Evidence1594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway75">
 <bp:pathwayOrder rdf:resource="#PathwayStep923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep919" />
 <bp:pathwayOrder rdf:resource="#PathwayStep920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep922" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction845" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CD3 and TCR zeta chains</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prior to T cell receptor (TCR) stimulation, CD4/CD8 associated LCK remains seperated from the TCR and is maintained in an inactive state by the action of CSK. PAG bound CSK phosphorylates the negative regulatory tyrosine of LCK and inactivates the LCK kinase domain (step 1). CSK also inhibits PTPN22 by sequestering it via binding (step 2).  Upon TCR stimulation, CSK dissociates from PAG1 (step 3) and PTPN22 (step4) and is unable to inhibit LCK. Furthermore, LCK becomes activated via PTPRC-mediated dephosphorylation of negative regulatory tyrosine residues (step 5). CD4/CD8 binds MHCII receptor in APC and the associated LCK co-localizes with the TCR.   LCK is further activated by trans-autophosphorylation on the tyrosine residue on its activation loop (step 6). Active LCK further phosphorylates the tyrosine residues on CD3 chains. The signal-transducing CD3 delta/epsilon/gamma and TCR zeta chains contain a critical signaling motif known as the immunoreceptor tyrosine-based activation motif (ITAM). The two critical tyrosines of each ITAM motif are phosphorylated by LCK (step 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1418">
 <bp:evidence rdf:resource="#Evidence1591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA binds the Toll-Like Receptor 3 (TLR3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway76">
 <bp:pathwayOrder rdf:resource="#PathwayStep934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep926" />
 <bp:pathwayOrder rdf:resource="#PathwayStep937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep948" />
 <bp:pathwayOrder rdf:resource="#PathwayStep927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep949" />
 <bp:pathwayOrder rdf:resource="#PathwayStep928" />
 <bp:pathwayOrder rdf:resource="#PathwayStep939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep929" />
 <bp:pathwayOrder rdf:resource="#PathwayStep940" />
 <bp:pathwayOrder rdf:resource="#PathwayStep930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction872" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction858" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction869" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction866" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction867" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream TCR signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Changes in gene expression are required for the T cell to gain full proliferative competence and to produce effector cytokines. Three transcription factors in particular have been found to play a key role in TCR-stimulated changes in gene expression, namely NFkappaB, NFAT and AP-1. A key step in NFkappaB activation is the stimulation and translocation of PRKCQ. The critical element that effects PRKCQ activation is PI3K. PI3K translocates to the plasma membrane by interacting with phospho-tyrosines on CD28 via its two SH2 domains located in p85 subunit (step 24). The p110 subunit of PI3K phosphorylates the inositol ring of PIP2 to generate PIP3 (steps 25). The reverse dephosphorylation process from PIP3 to PIP2 is catalysed by PTEN (step 27). PIP3 may also be dephosphorylated by the phosphatase SHIP to generate PI-3,4-P2 (step 26). PIP3 and PI-3,4-P2 acts as binding sites to the PH domain of PDK1 (step 28) and AKT (step 29). PKB is activated in response to PI3K stimulation by PDK1 (step 30). PDK1 has an essential role in regulating the activation of PRKCQ and recruitment of CBM complex to the immune synapse. PRKCQ is a member of novel class (DAG dependent, Ca++ independent) of PKC and the only member known to translocate to this synapse. Prior to TCR stimulation PRKCQ exists in an inactive closed conformation. TCR signals stimulate PRKCQ (step 31) and release DAG molecules. Subsequently, DAG binds to PRKCQ via the C1 domain and undergoes phosphorylation on tyrosine 90 by LCK to attain an open conformation (step 32). PRKCQ is further phosphorylated by PDK1 on threonine 538 (step 33). This step is critical for PKC activity. CARMA1 translocates to the plasma membrane following the interaction of its SH3 domain with the &apos;PxxP&apos; motif on PDK1 (step 34). CARMA1 is phosphorylated by PKC-theta on residue S552 (step 35), leading to the oligomerization of CARMA1. This complex acts as a scaffold, recruiting BCL10 to the synapse by interacting with their CARD domains (step 36). BCL10 undergoes phosphorylation mediated by the enzyme RIP2 (step 37). Activated BCL10 then mediates the ubiquitination of IKBKG by recruiting MALT1 and TRAF6. MALT1 binds to BCL10 with its Ig-like domains and undergoes oligomerization (step 38). TRAF6 binds to the oligomerized MALT1 and also undergoes oligomerization (step 39). Oligomerized TRAF6 acts as a ubiquitin-protein ligase, catalyzing auto-K63-linked polyubiquitination (step 40). This K-63 ubiquitinated TRAF6 activates MAP3K7 kinase bound to TAB2 (step 41) and also ubiquitinates IKBKG in the IKK complex (step 44). MAP3K7 undergoes autophosphorylation on residues T184 and T187 and gets activated (step 42). Activated MAP3K7 kinase phosphorylates IKBKB on residues S177 and S181 in the activation loop and activates the IKK kinase activity (step 43). IKBKB phosphorylates the NFKBIA bound to the NFkappaB heterodimer, on residues S19 and S23 (step 45) and directs NFKBIA to 26S proteasome degradation (step 47). The NFkappaB heterodimer with a free NTS sequence finally migrates to the nucleus to regulate gene transcription (step 46).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1417">
 <bp:evidence rdf:resource="#Evidence1590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3:TRIF complex recruits RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1416">
 <bp:evidence rdf:resource="#Evidence1589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKG subunit of IKK complex binds K63pUb- RIP1 within the TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1415">
 <bp:evidence rdf:resource="#Evidence1588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63-linked ubiquitination of RIP1 bound to the activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway79">
 <bp:pathwayOrder rdf:resource="#PathwayStep991" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep964" />
 <bp:pathwayComponent rdf:resource="#Pathway85" />
 <bp:pathwayComponent rdf:resource="#Pathway80" />
 <bp:pathwayComponent rdf:resource="#Pathway81" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by the B Cell Receptor (BCR)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature B cells express IgM and IgD immunoglobulins which are complexed at the plasma membrane with Ig-alpha (CD79A, MB-1) and Ig-beta (CD79B, B29) to form the B cell receptor (BCR) (Fu et al. 1974, Fu et al. 1975, Kunkel et al. 1975, Van Noesel et al. 1992, Sanchez et al. 1993, reviewed in Brezski and Monroe 2008). Binding of antigen to the immunoglobulin activates phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic tails of Ig-alpha and Ig-beta by Src family tyrosine kinases, including LYN, FYN, and BLK (Nel et al. 1984, Yamanashi et al. 1991, Flaswinkel and Reth 1994, Saouaf et al. 1994, Hata et al. 1994, Saouaf et al. 1995, reviewed in Gauld and Cambier 2004, reviewed in Harwood and Batista 2010). The protein kinase SYK binds the phosphorylated immunoreceptor tyrosine-activated motifs (ITAMs) on the cytoplasmic tails of Ig-alpha (CD79A, MB-1) and Ig-beta (CD79B, B29) (Wienands et al. 1995, Rowley et al. 1995, Tsang et al. 2008). The binding causes the activation and autophosphorylation of SYK (Law et al. 1994, Baldock et al. 2000, Irish et al. 2006, Tsang et al. 2008, reviewed in Bradshaw 2010). Activated SYK and other kinases phosphorylate BLNK (SLP-65), BCAP, and CD19 which serve as scaffolds for the assembly of large complexes, the signalosomes, by recruiting phosphoinositol 3-kinase (PI3K), phospholipase C gamma (predominantly PLC-gamma2 in B cells, Coggeshall et al. 1992), NCK, BAM32, BTK, VAV1, and SHC. The effectors are phosphorylated by SYK and other kinases. PLC-gamma associated with BLNK hydrolyzes phosphatidylinositol-4,5-bisphosphate to yield inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (Carter et al. 1991, Kim et al. 2004). IP3 binds receptors on the endoplasmic reticulum and causes release of calcium ions from the ER into the cytosol. The depletion of calcium from the ER in turn activates STIM1 to interact with ORAI and TRPC1 channels in the plasma membrane, resulting in an influx of extracellular calcium ions (Muik et al. 2008, Luik et al. 2008, Park et al. 2009, Mori et al. 2002). PI3K associated with BCAP and CD19 phosphorylates phosphatidylinositol 4,5-bisphosphate to yield phosphatidyinositol 3,4,5-trisphosphate. Second messengers (calcium, diacylglycerol,  inositol 1,4,5-trisphosphate, and phosphatidylinositol 3,4,5-trisphosphate) trigger signaling pathways: NF-kappaB is activated via protein kinase C beta, RAS is activated via RasGRP proteins, NF-AT is activated via calcineurin, and AKT (PKB) is activated via PDK1 (reviewed in Shinohara and Kurosaki 2009, Stone 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1414">
 <bp:evidence rdf:resource="#Evidence1586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated TAK1 dissociates from the TLR3 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1413">
 <bp:evidence rdf:resource="#Evidence1585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiqitination of TRAF6 bound to viral dsRNS:TLR3:TICAM1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1412">
 <bp:evidence rdf:resource="#Evidence1584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR3:TRIF:K63pUb-TRAF6 recruits TAK1complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1411">
 <bp:evidence rdf:resource="#Evidence1583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3:TICAM1 complex recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1410">
 <bp:evidence rdf:resource="#Evidence1582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR3 stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway62">
 <bp:pathwayOrder rdf:resource="#PathwayStep851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep845" />
 <bp:pathwayComponent rdf:resource="#Pathway63" />
 <bp:pathwayComponent rdf:resource="#Pathway64" />
 <bp:pathwayComponent rdf:resource="#Pathway65" />
 <bp:pathwayComponent rdf:resource="#Pathway70" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway63">
 <bp:pathwayOrder rdf:resource="#PathwayStep842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction782" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway60">
 <bp:pathwayOrder rdf:resource="#PathwayStep824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep827" />
 <bp:pathwayOrder rdf:resource="#PathwayStep817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep828" />
 <bp:pathwayOrder rdf:resource="#PathwayStep818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep829" />
 <bp:pathwayOrder rdf:resource="#PathwayStep819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep823" />
 <bp:pathwayOrder rdf:resource="#PathwayStep834" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction770" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction761" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction772" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction767" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction768" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-27 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-27 (IL27) is a heterodimeric cytokine that contains Epstein-Barr virus&#8211;induced gene 3 (EBI3) and IL27p28 (IL27). It signals through a receptor composed of Interleukin-6 receptor subunit beta (IL6ST, gp130), which is utilized by many cytokines, and Interleukin-27 receptor subunit alpha (IL27RA, WSX-1, TCCR) (Yoshida    Hunter 2015). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway61">
 <bp:pathwayOrder rdf:resource="#PathwayStep837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep838" />
 <bp:pathwayOrder rdf:resource="#PathwayStep839" />
 <bp:pathwayOrder rdf:resource="#PathwayStep840" />
 <bp:pathwayComponent rdf:resource="#Pathway62" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction778" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction779" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-17 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-17 (IL17) is a family of cytokines (Kawaguchi et al. 2004, Gu et al. 2013). IL17A, the founding member of the family is able to induce the production of other cytokines and chemokines, such as IL6, IL8, and granulocyte colony-stimulating factor (G-CSF) in a variety of cell types, including activated T-cells. It plays a pivotal role in host defenses in response to microbial infection and is involved in the pathogenesis of autoimmune diseases and allergic syndromes. IL17 activates several downstream signaling pathways including NFkB, MAPKs and C/EBPs, inducing the expression of antibacterial peptides, proinflammatory chemokines and cytokines and matrix metalloproteases (MMPs). IL17 can stabilize the mRNA of genes induced by TNF-alpha. IL17 signal transduction is mediated by the cytosolic adaptor molecule ACT1 (also known as CIKS).  The receptor for IL17D is unknown (Gu et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway66">
 <bp:pathwayOrder rdf:resource="#PathwayStep857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction792" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction790" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction789" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction788" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway67">
 <bp:pathwayOrder rdf:resource="#PathwayStep859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep860" />
 <bp:pathwayOrder rdf:resource="#PathwayStep861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction795" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction793" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway64">
 <bp:pathwayOrder rdf:resource="#PathwayStep846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction784" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction783" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1429">
 <bp:evidence rdf:resource="#Evidence1605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway65">
 <bp:pathwayOrder rdf:resource="#PathwayStep858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep852" />
 <bp:pathwayOrder rdf:resource="#PathwayStep863" />
 <bp:pathwayComponent rdf:resource="#Pathway66" />
 <bp:pathwayComponent rdf:resource="#Pathway67" />
 <bp:pathwayComponent rdf:resource="#Pathway68" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1428">
 <bp:evidence rdf:resource="#Evidence1603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds TLR7, TLR8 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1427">
 <bp:evidence rdf:resource="#Evidence1602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds imiquimod</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1426">
 <bp:evidence rdf:resource="#Evidence1601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR8 dimer binds TLR7, TLR8 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway68">
 <bp:pathwayOrder rdf:resource="#PathwayStep868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep870" />
 <bp:pathwayOrder rdf:resource="#PathwayStep871" />
 <bp:pathwayOrder rdf:resource="#PathwayStep872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction803" />
 <bp:pathwayComponent rdf:resource="#Pathway69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction800" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction802" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction801" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1425">
 <bp:evidence rdf:resource="#Evidence1600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds HCQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway69">
 <bp:pathwayOrder rdf:resource="#PathwayStep866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep867" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction798" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction799" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1424">
 <bp:evidence rdf:resource="#Evidence1599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S446-IRF5 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1423">
 <bp:evidence rdf:resource="#Evidence1598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4 binds TASL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1422">
 <bp:evidence rdf:resource="#Evidence1597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated IKBKB phosphorylates IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1421">
 <bp:evidence rdf:resource="#Evidence1596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL recruits IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1420">
 <bp:evidence rdf:resource="#Evidence1595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S446-IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1430">
 <bp:evidence rdf:resource="#Evidence1606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway91">
 <bp:pathwayOrder rdf:resource="#PathwayStep1107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1019" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1018" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1017" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1016" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1014" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1013" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 dependent PI3K/Akt signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28-mediated PI3K signaling plays a crucial role in augmenting T cell activation and survival. Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that can be activated downstream of various receptors, including the T-cell receptor (TCR), co-stimulatory receptors like CD28, and cytokine or chemokine receptors. The role of PI3K signaling differs depending on the upstream receptor involved. CD28, specifically, contains a YMNM consensus motif in its cytoplasmic tail, which serves as a binding site for the p85 regulatory subunit of PI3K.  When CD28 is engaged, it promotes the recruitment of PI3K, complementing PI3K activation downstream of the TCR. This recruitment triggers the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) at the plasma membrane, which serves as a docking site for multiple signaling proteins. Among these, the guanine nucleotide exchange factor VAV and the serine/threonine kinase AKT (also known as protein kinase B, PKB) are key mediators of CD28-induced costimulatory signals. PI3K activation through CD28 promotes cytokine transcription (e.g., IL-2), T cell survival via anti-apoptotic pathways, cell cycle progression, and metabolic changes necessary for T cell growth (Riha and Rudd. 2010, Miller et al. 2009, Han et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway92">
 <bp:pathwayOrder rdf:resource="#PathwayStep1117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1026" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1025" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1024" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 dependent Vav1 pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 binds to several intracellular signaling proteins, including PI3 kinase, Grb2, Gads, and ITK, which are crucial for amplifying the T cell activation signal initiated by the T-cell receptor (TCR). Grb2, in particular, works in tandem with Vav1 to enhance the activation of NFAT and AP-1 transcription factors, critical regulators of gene expression during T cell activation. CD28 costimulation significantly extends the duration and intensity of Vav1 phosphorylation and its localization at the plasma membrane compared to TCR activation alone, indicating that CD28 provides a sustained signal that enhances T cell responsiveness (Hehner et al. 2000). Vav1 plays a pivotal role in transducing signals from both TCR and CD28 to multiple downstream pathways, with a direct impact on cytoskeletal rearrangements. Upon activation, Vav1 triggers the small GTPases Rac1 and Cdc42, which lead to the activation of mitogen-activated protein kinases (MAPKs) like JNK and p38. In the context of CD28 signaling, these pathways are essential for regulating the expression of cytokines and promoting T cell proliferation and survival (Laura In&#233;s Salazar-Fontana et al. 2003). Additionally, Vav1&apos;s involvement in CD28 costimulation is critical for several other cellular processes, including calcium flux, ERK MAPK activation, NF-&#954;B signaling, and the inside-out activation of the integrin LFA-1. This enhances T cell adhesion, clustering, and polarization, ultimately contributing to more effective immune responses. Thus, CD28 costimulation ensures that Vav1-mediated signals are robustly sustained, promoting optimal T cell activation and function (Hehner et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway90">
 <bp:pathwayOrder rdf:resource="#PathwayStep1118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1028" />
 <bp:pathwayComponent rdf:resource="#Pathway91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1027" />
 <bp:pathwayComponent rdf:resource="#Pathway92" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-stimulation by CD28</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 signaling plays a critical role in shaping immune responses by ensuring effective T-cell activation and enhancing T-cell survival and proliferation. When CD28 engages its ligands, B7-1 (CD80) and B7-2 (CD86), on antigen-presenting cells, it provides an essential secondary signal that complements T-cell receptor (TCR) activation. This costimulatory signal leads to the production of interleukin-2 (IL-2), which supports the clonal expansion of T cells, promoting both their proliferation and survival by initiating anti-apoptotic pathways (Ribot et al. 2012, Alegre et al. 2001).   The cytoplasmic tail of CD28, upon ligand binding, undergoes phosphorylation by Src family kinases like LCK and FYN, triggering downstream signaling pathways involving PI3K, VAV-1, Tec family kinases, AKT, and other adaptor proteins (Sharpe    Freeman 2002; Chen    Flies 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence102">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway95">
 <bp:pathwayOrder rdf:resource="#PathwayStep1134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1040" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1039" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-stimulation by ICOS</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ICOS (Inducible T-cell COStimulator) is a critical costimulatory receptor that enhances T cell responses following initial activation. Unlike CD28, which is constitutively expressed on naive T cells, ICOS expression is induced upon T cell activation. Both ICOS and CD28 engage class IA phosphatidylinositol 3-kinase (PI3K), leading to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3) and activation of downstream signaling pathways, including AKT. However, ICOS signaling is distinguished by a stronger induction of PIP3 production and more robust AKT phosphorylation compared to CD28 signaling (Fos et al. 2008). This enhanced signaling through ICOS contributes to its unique role in promoting T cell survival, cytokine production, and differentiation, particularly in the context of T follicular helper (Tfh) cell development and function (Dong et al. 2001). Despite these similarities, detailed knowledge about ICOS-specific downstream signaling pathways remains limited, highlighting a key area for further research to fully understand its distinct and overlapping roles with CD28 in T cell immunity (Wikenheiser    Stumhofer 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence103">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway96">
 <bp:pathwayOrder rdf:resource="#PathwayStep1139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1044" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1041" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-inhibition by BTLA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTLA (B and T Lymphocyte Attenuator) is a co-inhibitory receptor that plays a crucial role in regulating immune responses, maintaining immune homeostasis, and preventing autoimmunity. BTLA interacts with its ligand, HVEM (Herpesvirus Entry Mediator), a member of the tumor necrosis factor receptor (TNFR) family. Upon engagement with HVEM, BTLA recruits the Src homology region 2 domain-containing phosphatases SHP-1 and SHP-2 to its cytoplasmic tail. These phosphatases dephosphorylate key signaling molecules downstream of the T cell receptor (TCR), effectively dampening TCR-mediated signaling and inhibiting T cell activation. This signaling pathway is essential for modulating the immune response, particularly in maintaining peripheral tolerance and preventing the overactivation of T cells that can lead to autoimmune diseases. BTLA is expressed on various immune cells, including T cells, B cells, and dendritic cells, and it functions similarly to other immune checkpoint molecules like CTLA-4 and PD-1, but it has unique structural and functional properties. BTLA&apos;s interaction with HVEM also influences the function of other immune cells. For instance, HVEM is expressed on many cell types, including T cells, B cells, and myeloid cells, and its interaction with BTLA can modulate the immune response in a context-dependent manner. This complex interplay is crucial for fine-tuning immune responses and ensuring that immune activation is appropriately regulated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence104">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway93">
 <bp:pathwayOrder rdf:resource="#PathwayStep1121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1032" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1029" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-inhibition by PD-1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Programmed cell death protein 1 (PD-1) is a crucial inhibitory receptor that regulates T cell receptor (TCR) signaling and plays a vital role in maintaining immune homeostasis. PD-1 exerts its suppressive effects both directly, by inhibiting early activation events that are otherwise enhanced by co-stimulatory signals like CD28, and indirectly, by reducing interleukin-2 (IL-2) production, which is essential for T cell proliferation and survival. Upon ligation, PD-1 inhibits the expression of key survival and differentiation factors, such as Bcl-xL, and downregulates transcription factors that are central to effector T cell function, including GATA-3, T-bet, and Eomes. Mechanistically, PD-1 recruits the tyrosine phosphatases SHP-1 and SHP-2 to the immune synapse, leading to the dephosphorylation of critical signaling molecules like the CD3-zeta chain, PI3K, and AKT, thereby attenuating TCR signaling and inhibiting T cell activation and function (Keir et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence105">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway94">
 <bp:pathwayOrder rdf:resource="#PathwayStep1129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1035" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-inhibition by CTLA4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an immune checkpoint molecule predominantly expressed on the surface of activated T cells and regulatory T (Treg) cells. It plays a critical role in inhibiting T-cell activation and maintaining immune homeostasis (Alegre et al. 2001). After acctivation of T lymphocytes through their antigen receptor (TCR) induces the upregulation of CTLA-4 expression. CTLA-4 engagement alongside TCR activation inhibits T cell responses through two primary mechanisms: competing with CD28 for B7 binding to reduce costimulation, and delivering a negative signal directly into the T cells. It has been reported that phosphotyrosine-dependent recruitment of the SHP-2 phosphatase to CTLA-4 inhibits T cell activation and expansion by dephosphorylation of CD3/TCR chains.  CTLA-4 inhibits T cell activation through several mechanisms, including the reduction of IL-2 production and expression, as well as by arresting T cells in the G1 phase of the cell cycle (Greenwald et al. 2002). This checkpoint molecule not only impacts the T cells that express it but also exerts a dominant regulatory influence on the proliferation of other T cells. This ability to limit the proliferation of surrounding T cells is crucial in preventing autoreactivity and maintaining immune tolerance, ensuring that the immune system does not inadvertently target the body&apos;s own tissues.  Due to its ability to modulate immune responses, CTLA-4 has emerged as a significant therapeutic target for managing conditions such as cancer, autoimmune diseases, and transplant rejection (Tivol et al. 1995, Chambers et al. 1997, Rudd and Schneider 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence106">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway99">
 <bp:pathwayOrder rdf:resource="#PathwayStep1170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1159" />
 <bp:pathwayComponent rdf:resource="#Pathway103" />
 <bp:pathwayComponent rdf:resource="#Pathway101" />
 <bp:pathwayComponent rdf:resource="#Pathway102" />
 <bp:pathwayComponent rdf:resource="#Pathway100" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen processing-Cross presentation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MHC class I molecules generally present peptide antigens derived from proteins synthesized by the cell itself to CD8+ T cells. However, in some circumstances, antigens from extracellular environment can be presented on MHC class I to stimulate CD8+ T cell immunity, a process termed cross-presentation (Rock    Shen. 2005). Cross-presentation/cross-priming is the ability of antigen presenting cells (APCs) to present exogenous antigens on MHC class I molecules to CD8+ T lymphocytes. Among all the APCs, dendritic cells (DC) are the dominant antigen cross presenting cell types in vivo, although macrophages and B cells appear to cross present model antigens in vitro with a low degree of efficiency (Amigorena    Savina. 2010, Ackermann    Peter Cresswell. 2004). Compared to macrophages, DCs have low levels of lysosomal proteases and exhibit limited lysosomal degradation (Delamarre et al. 2005). This limited proteolysis of internalized antigens by DCs might contribute to their high efficiency for cross-presentation (Monua    Trombetta. 2007). APCs acquire the exogenous antigens through endocytic mechanisms, especially phagosomes for particulate/cell-associated antigens and endosomes for soluble protein antigens. There does not seem to be a unique pathway for cross-presentation but rather different potential mechanisms of cross-presentation have been proposed. These proposed pathways can be classified according to the location where two key events occur: 1) processing of the antigenic protein and 2) loading of the processed peptide on to MHC I molecule (Blanchard    Shastri. 2010). Based on the requirement for TAP and cytosolic proteases two mechanisms have been described, a cytosolic pathway (TAP-dependent and proteasome-dependent) or a vacuolar pathway (TAP- and proteasome-independent) (Blanchard    Shastri. 2010, Amigorena    Savina. 2010). Regarding peptide-loading, MHC I could be loaded in the ER or in the phagosome and recycled to cell surface (Blanchard    Shastri. 2010). Exogenous soluble antigens are cross-presented by dendritic cells, albeit with lower efficiency than for particulate substrates. Soluble antigens destined for cross-presentation are taken up by distinct endocytosis mechanisms which route them into stable early endosomes and then to the cytoplasm for proteasomal degradation and peptide loading. The outcome of the cross-presentation can be either tolerance or immunity (Rock    Shen. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence108">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway97">
 <bp:pathwayOrder rdf:resource="#PathwayStep1182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1151" />
 <bp:pathwayComponent rdf:resource="#Pathway104" />
 <bp:pathwayComponent rdf:resource="#Pathway99" />
 <bp:pathwayComponent rdf:resource="#Pathway98" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Class I MHC mediated antigen processing &amp; presentation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Major histocompatibility complex (MHC) class I molecules play an important role in cell mediated immunity by reporting on intracellular events such as viral infection, the presence of intracellular bacteria or tumor-associated antigens. They bind peptide fragments of these proteins and presenting them to CD8+ T cells at the cell surface. This enables cytotoxic T cells to identify and eliminate cells that are synthesizing abnormal or foreign proteins. MHC class I is a trimeric complex composed of a polymorphic heavy chain (HC or alpha chain) and an invariable light chain, known as beta2-microglobulin (B2M) plus an 8-10 residue peptide ligand. Represented here are the events in the biosynthesis of MHC class I molecules, including generation of antigenic peptides by the ubiquitin/26S-proteasome system, delivery of these peptides to the endoplasmic reticulum (ER), loading of peptides to MHC class I molecules and display of MHC class I complexes on the cell surface.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence109">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway98">
 <bp:pathwayOrder rdf:resource="#PathwayStep1150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1053" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1050" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1046" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen processing: Ubiquitination &amp; Proteasome degradation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intracellular foreign or aberrant host proteins are cleaved into peptide fragments of a precise size, such that they can be loaded on to class I MHC molecules and presented externally to cytotoxic T cells. The ubiquitin-26S proteasome system plays a central role in the generation of these class I MHC antigens.  Ubiquitination is the mechanism of adding ubiquitin to lysine residues on substrate protein leading to the formation of a polyubiquitinated substrate. This process involves three classes of enzyme, an E1 ubiquitin-activating enzyme, an E2 ubiquitin-conjugating enzyme, and an E3 ubiquitin ligase. Polyubiquitination through lysine-48 (K48) generally targets the substrate protein for proteasomal destruction. The protease responsible for the degradation of K48-polyubiquitinated proteins is the 26S proteasome. This proteasome is a two subunit protein complex composed of the 20S (catalytic core particle) and 19S (regulatory particle) proteasome complexes. The proteasome eliminates most of the foreign and non-functional proteins from the cell by degrading them into short peptides; only a small fraction of the peptides generated are of the correct length to be presented by the MHC class I system. It has been calculated that between 994 and 3122 protein molecules have to be degraded for the formation of a single, stable MHC class I complex at the cell surface, with an average efficiency of 1 in 2000 (Kloetzel et al. 2004, Princiotta et al. 2003). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1439">
 <bp:evidence rdf:resource="#Evidence1616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 interacts with the activated TLR receptor 7, 8 or 9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1438">
 <bp:evidence rdf:resource="#Evidence1615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 ubiquitinqtes IRF7 within the activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1437">
 <bp:evidence rdf:resource="#Evidence1614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1436">
 <bp:evidence rdf:resource="#Evidence1613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1435">
 <bp:evidence rdf:resource="#Evidence1612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1434">
 <bp:evidence rdf:resource="#Evidence1611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1433">
 <bp:evidence rdf:resource="#Evidence1609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence100">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1432">
 <bp:evidence rdf:resource="#Evidence1608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence101">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1431">
 <bp:evidence rdf:resource="#Evidence1607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR 7/8 or 9 : MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1441">
 <bp:evidence rdf:resource="#Evidence1618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1440">
 <bp:evidence rdf:resource="#Evidence1617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 or 9  </bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway80">
 <bp:pathwayOrder rdf:resource="#PathwayStep990" />
 <bp:pathwayOrder rdf:resource="#PathwayStep978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep971" />
 <bp:pathwayOrder rdf:resource="#PathwayStep972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep973" />
 <bp:pathwayOrder rdf:resource="#PathwayStep974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep980" />
 <bp:pathwayOrder rdf:resource="#PathwayStep967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep969" />
 <bp:pathwayOrder rdf:resource="#PathwayStep981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep988" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction909" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction888" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction901" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction889" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction895" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction897" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction893" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction892" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction899" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction898" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction911" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen activates B Cell Receptor (BCR) leading to generation of second messengers</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature B cells express IgM and IgD immunoglobulins which are complexed with Ig-alpha (CD79A, MB-1) and Ig-beta (CD79B, B29) to form the B cell receptor (BCR) (Fu et al. 1974, Fu et al. 1975, Kunkel et al. 1975, Van Noesal et al. 1992, Sanchez et al. 1993, reviewed in Brezski and Monroe 2008). Binding of antigen to the immunoglobulin activates phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic tails of Ig-alpha and Ig-beta by Src family tyrosine kinases, including LYN, FYN, and BLK (Nel et al. 1984, Yamanashi et al. 1991, Flaswinkel and Reth 1994, Saouaf et al. 1994, Hata et al. 1994, Saouaf et al. 1995, reviewed in Gauld and Cambier 2004, reviewed in Harwood and Batista 2010). The protein kinase SYK may also be involved in phosphorylating the ITAMs. The protein kinase SYK binds the phosphorylated immunoreceptor tyrosine-activated motifs (ITAMs) on the cytoplasmic tails of Ig-alpha (CD79A, MB-1) and Ig-beta (CD79B, B29) (Wienands et al. 1995, Rowley et al. 1995, Tsang et al. 2008). The binding causes the activation and autophosphorylation of SYK (Law et al. 1994, Irish et al. 2006, Baldock et al. 2008, Tsang et al. 2008, reviewed in Bradshaw 2010). Activated SYK and other kinases phosphorylate BLNK (SLP-65, BASH) and BCAP.  LYN and FYN phosphorylate CD19. Phosphorylated BLNK, BCAP, and CD19 serve as scaffolds which recruit effectors to the plasma membrane and assemble large complexes, the signalosomes.  BCAP and CD19 recruit phosphoinositol 3-kinase (PI3K). BLNK recruits phospholipase C gamma (predominantly PLC-gamma2 in B cells, Coggeshall et al. 1992), NCK, BAM32, BTK, VAV1, and SHC. The effectors are phosphorylated by SYK and other kinases. Phosphorylated BCAP recruits PI3K, which is phosphorylated by a SYK-dependent mechanism (Kuwahara et al. 1996) and produces phosphatidylinositol-3,4,5-trisphosphate (PIP3). Phosphorylated CD19 likewise recruits PIP3K. PIP3 recruits BAM32 (Marshall et al. 2000) and BTK (de Weers et al. 1994, Baba et al. 2001) to the plasma membrane via their PH domains. PIP3 also recruits and activates PLC-gamma1 and PLC-gamma2 (Bae et al. 1998). BTK binds phosphorylated BLNK via its SH2 domain (Baba et al. 2001). BTK phosphorylates PLC-gamma2 (Rodriguez et al. 2001), which activates phospholipase activity (Carter et al. 1991, Roifman and Wang 1992, Kim et al. 2004, Sekiya et al. 2004). Phosphorylated BLNK recruits PLC-gamma, VAV, GRB2, and NCK (Fu and Chan 1997, Fu et al. 1998, Chiu et al. 2002). PLC-gamma hydrolyzes phosphatidylinositol-4,5-bisphosphate to yield inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (Carter et al. 1991, Kim et al. 2004). IP3 binds receptors on the endoplasmic reticulum and causes release of Ca2+ ions from the ER into the cytosol. The depletion of calcium from the ER in turn activates STIM1 to interact with ORAI and TRPC1 channels (and possibly other TRP channels) in the plasma membrane, resulting in an influx of extracellular calcium ions (Mori et al. 2002, Muik et al. 2008, Luik et al. 2008, Park et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway81">
 <bp:pathwayOrder rdf:resource="#PathwayStep992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep999" />
 <bp:pathwayComponent rdf:resource="#Pathway84" />
 <bp:pathwayComponent rdf:resource="#Pathway82" />
 <bp:pathwayComponent rdf:resource="#Pathway83" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signaling events of B Cell Receptor (BCR)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second messengers (calcium, diacylglycerol, inositol 1,4,5-trisphosphate, and phosphatidyinositol 3,4,5-trisphosphate) trigger signaling pathways: NF-kappaB is activated via protein kinase C beta, RAS via RasGRP proteins, NF-AT via calcineurin, and AKT via PDK1 (reviewed in Shinohara and Kurosaki 2009, Stone 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway84">
 <bp:pathwayOrder rdf:resource="#PathwayStep1008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1006" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction918" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction924" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction926" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction921" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction920" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction922" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NF-kappaB in B cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG and calcium activate protein kinase C beta (PKC-beta, Kochs et al. 1991) which phosphorylates CARMA1 and other proteins (Sommer et al. 2005). Phosphorylated CARMA1 recruits BCL10 and MALT1 to form the CBM complex (Sommer et al. 2005, Tanner et al. 2007) which, in turn, recruits the kinase TAK1 and the IKK complex (Sommer et al. 2005, Shinohara et al. 2005 using chicken cells). TAK1 phosphorylates the IKK-beta subunit, activating it (Wang et al. 2001). The IKK complex then phosphorylates IkB complexed with NF-kappaB dimers in the cytosol (Zandi et al. 1998, Burke et al. 1999, Heilker et al. 1999), resulting in the degradation of IkB (Miyamoto et al. 1994, Traenckner et al. 1994, Alkalay et al. 1995, DiDonato et al. 1995, Li et al. 1995, Lin et al. 1995, Scherer et al. 1995, Chen et al. 1995). NF-kappaB dimers are thereby released and are translocated to the nucleus where they activate transcription (Baeuerle and Baltimore 1988, Blank et al. 1991, Ghosh et al. 2008, Fagerlund et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway85">
 <bp:pathwayOrder rdf:resource="#PathwayStep1011" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1012" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1014" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction930" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction927" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD22 mediated BCR regulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCR activation is highly regulated and coreceptors like CD22 (SIGLEC2) set a signalling threshold to prevent aberrant immune response and autoimmune disease (Cyster et al. 1997, Han et al. 2005). CD22 is a glycoprotein found on the surface of B cells during restricted stages of development. CD22 is a member of the receptors of the sialic acid-binding Ig-like lectin (Siglec) family which binds specifically to the terminal sequence N-acetylneuraminic acid alpha(2-6) galactose (NeuAc-alpha(2-6)-Gal) present on many B-cell glycoproteins (Powell et al. 1993, Sgroi et al. 1993). CD22 has seven immunoglobulin (Ig)-like extracellular domains and a cytoplasmic tail containing six tyrosines, three of which belong to the inhibitory immunoreceptor tyrosine-based inhibition motifs (ITIMs) sequences. Upon BCR cross-linking CD22 is rapidly tyrosine phosphorylated by the tyrosine kinase Lyn, thereby recruiting and activating tyrosine phosphatase, SHP-1 and inhibiting calcium signalling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway82">
 <bp:pathwayOrder rdf:resource="#PathwayStep993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction913" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction912" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin activates NFAT</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by the B cell receptor and the T cell receptor stimulate transcription by NFAT factors via calcium (reviewed in Gwack et al. 2007). Cytosolic calcium from intracellular stores and extracellular sources binds calmodulin and activates the protein phosphatase calcineurin. Activated calcineurin dephosphorylates NFATs in the cytosol, exposing nuclear localization sequences on the NFATs and causing the NFATs to be imported into the nucleus where they regulate transcription of target genes in complexes with other transcription factors such as AP-1 and JUN. Calcineurin in the target of the immunosuppressive drugs cyclosporin A and FK-506 (reviewed in Lee and Park 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway83">
 <bp:pathwayOrder rdf:resource="#PathwayStep997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction915" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAS in B cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RasGRP1 and RasGRP3 bind diacylglycerol at the plasma membrane (Lorenzo et al. 2001) and are phosphorylated by protein kinase C (Teixeira et al. 2003, Zheng et al. 2005). Phosphorylated RasGRP1 (Roose et al. 2007) and RasGRP3 (Ohba et al. 2000, Yamashita et al. 2000, Rebhun et al. 2000, Lorenzo et al. 2001) then catalyze the exchange of GDP for GTP bound by RAS, thereby activating RAS.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway88">
 <bp:pathwayOrder rdf:resource="#PathwayStep1091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1092" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1009" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1008" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1003" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1002" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Butyrophilin (BTN) family interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Butyrophilins (BTNs) and butyrophilin like (BTNL) molecules are regulators of immune responses that belong to the immunoglobulin (Ig) superfamily of transmembrane proteins. They are structurally related to the B7 family of co-stimulatory molecules and have similar immunomodulatory functions (Afrache et al. 2012, Arnett    Viney 2014). BTNs are implicated in T cell development, activation and inhibition, as well as in the modulation of the interactions of T cells with antigen presenting cells and epithelial cells. Certain BTNsare genetically associated with autoimmune and inflammatory diseases (Abeler Domer et al. 2014).  The human butyrophilin family includes seven members that are subdivided into three subfamilies: BTN1, BTN2 and BTN3. The BTN1 subfamily contains only the prototypic single copy BTN1A1 gene, whereas the BTN2 and BTN3 subfamilies each contain three genes BTN2A1, BTN2A2 and BTN2A3, and BTN3A1, BTN3A2 and BTN3A3, respectively (note that BTN2A3 is a pseudogene). BTN1A1 has a crucial function in the secretion of lipids into milk (Ogg et al. 2004) and collectively, BTN2 and BTN3 proteins are cell surface transmembrane glycoproteins, that act as regulators of immune responses. BTNL proteins share considerable homology to the BTN family members. The human genome contains four BTNL genes: BTNL2, 3, 8 and 9 (Abeler Domer et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway89">
 <bp:pathwayOrder rdf:resource="#PathwayStep1132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1126" />
 <bp:pathwayComponent rdf:resource="#Pathway95" />
 <bp:pathwayComponent rdf:resource="#Pathway96" />
 <bp:pathwayComponent rdf:resource="#Pathway93" />
 <bp:pathwayComponent rdf:resource="#Pathway94" />
 <bp:pathwayComponent rdf:resource="#Pathway90" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of T cell activation by CD28 family</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Optimal activation of T lymphocytes requires a carefully orchestrated interplay between two key signals. The first signal originates from the T cell receptor (TCR) recognizing a specific antigen. However, this initial encounter is insufficient on its own. A crucial &quot;costimulatory&quot; signal is needed for full T cell activation, delivered by the engagement of costimulatory receptors, such as CD28, on the T cell surface with their corresponding ligands on antigen-presenting cells (APCs) (Chen    Flies 2013, Acuto et al. 2003, Slavik et al. 1999).   The CD28 superfamily is central to costimulation, encompassing a diverse group of receptors including CD28, CTLA-4, ICOS, PD-1, and BTLA. These receptors have both positive and negative influences on T cell activation. CD28 and ICOS provide a positive boost, while CTLA-4, PD-1, and BTLA act as inhibitory brakes. CD28 and CTLA-4 bind to B7 family ligands CD80 (B7.1) and CD86 (B7.2), with CD28 delivering stimulatory signals and CTLA-4 providing inhibitory signals. ICOS interacts with ICOS ligand (ICOS-L), enhancing T cell activation and function. PD-1 binds to PD-L1 and PD-L2, mediating inhibitory signals that modulate the immune response. BTLA engages with HVEM (Herpesvirus entry mediator), transmitting inhibitory signals. This balance between stimulatory and inhibitory signals is essential, allowing the immune system to mount effective responses against pathogens while preventing the induction of T cell unresponsiveness and apoptosis (Chen    Flies 2013, Sharpe    Freeman 2002, Carreno    Collins 2002).   The expression of these receptors varies: CD28 is constantly present on naive T cells, whereas CTLA-4 expression depends on prior CD28 engagement. ICOS, PD-1, and BTLA are induced only after initial T cell stimulation. These variations in expression ensure precise regulation of T cell responses at different stages of activation (Sharpe    Freeman 2002).  The receptors themselves also exhibit structural differences. CD28, CTLA-4, and ICOS share a single extracellular domain resembling an immunoglobulin molecule (IgV-like). In contrast, BTLA has a distinct structure with an IgC-like domain. Similarly, the costimulatory ligands, such as B7-1 and B7-2, have unique structural features that enable specific interactions with their partner receptors.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway86">
 <bp:pathwayOrder rdf:resource="#PathwayStep1019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1033" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1055" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1054" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1035" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1034" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1056" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1037" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1036" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1038" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1024" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1046" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1023" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1045" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1027" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1049" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction961" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction960" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction968" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction943" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction964" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction966" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction939" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction970" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction958" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction935" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction957" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction953" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction956" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction933" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction955" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A number of receptors and cell adhesion molecules play a key role in modifying the response of cells of lymphoid origin (such as B-, T- and NK cells) to self and tumor antigens, as well as to pathogenic organisms.  Molecules such as KIRs and LILRs form part of a crucial surveillance system that looks out for any derangement, usually caused by cancer or viral infection, in MHC Class I presentation. Somatic cells are also able to report internal functional impairment by displaying surface stress markers such as MICA. The presence of these molecules on somatic cells is picked up by C-lectin NK immune receptors.  Lymphoid cells are able to regulate their location and movement in accordance to their state of activation, and home in on tissues expressing the appropriate complementary ligands. For example, lymphoid cells may fine tune the presence and concentration of adhesion molecules belonging to the IgSF, Selectin and Integrin class that interact with a number of vascular markers of inflammation.  Furthermore, there are a number of avenues through which lymphoid cells may interact with antigen. This may be presented directly to a specific T-cell receptor in the context of an MHC molecule. Antigen-antibody complexes may anchor to the cell via a small number of lymphoid-specific Fc receptors that may, in turn, influence cell function further. Activated complement factor C3d binds to both antigen and to cell surface receptor CD21. In such cases, the far-reaching influence of CD19 on B-lymphocyte function is tempered by its interaction with CD21.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway87">
 <bp:pathwayOrder rdf:resource="#PathwayStep1077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1078" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1081" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1063" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1085" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1067" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction983" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction982" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction987" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction989" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction988" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1001" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1000" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction993" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction996" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction992" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction979" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction976" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction975" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction978" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction977" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction999" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MHC class II antigen presentation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen presenting cells (APCs) such as B cells, dendritic cells (DCs) and monocytes/macrophages express major histocompatibility complex class II molecules (MHC II) at their surface and present exogenous antigenic peptides to CD4+ T helper cells. CD4+ T cells play a central role in immune protection. On their activation they stimulate differentiation of B cells into antibody-producing B-cell blasts and initiate adaptive immune responses. MHC class II molecules are transmembrane glycoprotein heterodimers of alpha and beta subunits. Newly synthesized MHC II molecules present in the endoplasmic reticulum bind to a chaperone protein called invariant (Ii) chain. The binding of Ii prevents the premature binding of self antigens to the nascent MHC molecules in the ER and also guides MHC molecules to endocytic compartments. In the acidic endosomal environment, Ii is degraded in a stepwise manner, ultimately to free the class II peptide-binding groove for loading of antigenic peptides. Exogenous antigens are internalized by the APC by receptor mediated endocytosis, phagocytosis or pinocytosis into endocytic compartments of MHC class II positive cells, where engulfed antigens are degraded in a low pH environment by multiple acidic proteases, generating MHC class II epitopes. Antigenic peptides are then loaded into the class II ligand-binding groove. The resulting class II peptide complexes then move to the cell surface, where they are scanned by CD4+ T cells for specific recognition (Berger    Roche 2009, Zhou    Blum 2004, Watts 2004, Landsverk et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1449">
 <bp:evidence rdf:resource="#Evidence1630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1448">
 <bp:evidence rdf:resource="#Evidence1629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1447">
 <bp:evidence rdf:resource="#Evidence1628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1446">
 <bp:evidence rdf:resource="#Evidence1626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1445">
 <bp:evidence rdf:resource="#Evidence1625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1444">
 <bp:evidence rdf:resource="#Evidence1624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1443">
 <bp:evidence rdf:resource="#Evidence1620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1442">
 <bp:evidence rdf:resource="#Evidence1619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps within the complex pIRAK4:MyD88:activated TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction546" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep592">
 <bp:stepProcess rdf:resource="#BiochemicalReaction548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction550" />
 <bp:stepProcess rdf:resource="#Catalysis128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction551" />
 <bp:stepProcess rdf:resource="#Catalysis129" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence128">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence129">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep596">
 <bp:stepProcess rdf:resource="#Catalysis130" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction553" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep598">
 <bp:stepProcess rdf:resource="#Pathway46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction554" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence117">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence139">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1409">
 <bp:evidence rdf:resource="#Evidence1581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of recruited TAK1 within the activated TLR3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1408">
 <bp:evidence rdf:resource="#Evidence1579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP3 binds TICAM1 within TLR3 complex to mediate necroptosis </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1407">
 <bp:evidence rdf:resource="#Evidence1578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3-induced ripoptosome assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1406">
 <bp:evidence rdf:resource="#Evidence1577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 processing within TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1405">
 <bp:evidence rdf:resource="#Evidence1575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3 binds to TRIF:activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1404">
 <bp:evidence rdf:resource="#Evidence1574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is phosphorylated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1403">
 <bp:evidence rdf:resource="#Evidence1573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3/IRF7 is transported to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence130">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1402">
 <bp:evidence rdf:resource="#Evidence1572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is ubiquitinated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence131">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1401">
 <bp:evidence rdf:resource="#Evidence1571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds TBK1 within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence132">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1400">
 <bp:evidence rdf:resource="#Evidence1570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is ubiquitinated within TBK1:K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence191">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence193">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis397">
 <bp:controlled rdf:resource="#BiochemicalReaction1308" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence194">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis398">
 <bp:controlled rdf:resource="#BiochemicalReaction1309" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence195">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis399">
 <bp:controlled rdf:resource="#BiochemicalReaction1310" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence199">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1833">
 <bp:stepProcess rdf:resource="#Pathway215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1832">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1619" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1620" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis370">
 <bp:controlled rdf:resource="#BiochemicalReaction1265" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1834">
 <bp:stepProcess rdf:resource="#Pathway216" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis371">
 <bp:controlled rdf:resource="#BiochemicalReaction1268" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1837">
 <bp:stepProcess rdf:resource="#Catalysis539" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1622" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis372">
 <bp:controlled rdf:resource="#BiochemicalReaction1270" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1836">
 <bp:stepProcess rdf:resource="#Catalysis538" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1621" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis373">
 <bp:controlled rdf:resource="#BiochemicalReaction1275" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1839">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1623" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis374">
 <bp:controlled rdf:resource="#BiochemicalReaction1277" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1838">
 <bp:stepProcess rdf:resource="#Pathway217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1831">
 <bp:stepProcess rdf:resource="#Catalysis537" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1618" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1617" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction661" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep715">
 <bp:stepProcess rdf:resource="#BiochemicalReaction662" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep716">
 <bp:stepProcess rdf:resource="#Pathway55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep717">
 <bp:stepProcess rdf:resource="#Pathway56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep719">
 <bp:stepProcess rdf:resource="#BiochemicalReaction664" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis364">
 <bp:controlled rdf:resource="#BiochemicalReaction1238" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis365">
 <bp:controlled rdf:resource="#BiochemicalReaction1246" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis366">
 <bp:controlled rdf:resource="#BiochemicalReaction1249" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis367">
 <bp:controlled rdf:resource="#BiochemicalReaction1252" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction657" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis368">
 <bp:controlled rdf:resource="#BiochemicalReaction1260" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction658" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis369">
 <bp:controlled rdf:resource="#BiochemicalReaction1261" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep712">
 <bp:stepProcess rdf:resource="#Catalysis153" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction659" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction660" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1844">
 <bp:stepProcess rdf:resource="#Pathway218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1843">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1627" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1628" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1845">
 <bp:stepProcess rdf:resource="#Pathway219" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis360">
 <bp:controlled rdf:resource="#BiochemicalReaction1224" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1848">
 <bp:stepProcess rdf:resource="#Catalysis544" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1630" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis361">
 <bp:controlled rdf:resource="#BiochemicalReaction1225" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1629" />
 <bp:stepProcess rdf:resource="#Catalysis543" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis362">
 <bp:controlled rdf:resource="#BiochemicalReaction1228" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis363">
 <bp:controlled rdf:resource="#BiochemicalReaction1232" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1849">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1631" />
 <bp:stepProcess rdf:resource="#Catalysis545" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1840">
 <bp:stepProcess rdf:resource="#Catalysis540" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1842">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1626" />
 <bp:stepProcess rdf:resource="#Catalysis542" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1841">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1625" />
 <bp:stepProcess rdf:resource="#Catalysis541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep725">
 <bp:stepProcess rdf:resource="#BiochemicalReaction670" />
 <bp:stepProcess rdf:resource="#Catalysis155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep726">
 <bp:stepProcess rdf:resource="#BiochemicalReaction671" />
 <bp:stepProcess rdf:resource="#Catalysis156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep727">
 <bp:stepProcess rdf:resource="#BiochemicalReaction672" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction673" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep729">
 <bp:stepProcess rdf:resource="#BiochemicalReaction674" />
 <bp:stepProcess rdf:resource="#Catalysis157" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis353">
 <bp:controlled rdf:resource="#BiochemicalReaction1203" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis354">
 <bp:controlled rdf:resource="#BiochemicalReaction1204" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis355">
 <bp:controlled rdf:resource="#BiochemicalReaction1206" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction665" />
 <bp:stepProcess rdf:resource="#Catalysis154" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis356">
 <bp:controlled rdf:resource="#BiochemicalReaction1212" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction666" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis357">
 <bp:controlled rdf:resource="#BiochemicalReaction1215" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction667" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis358">
 <bp:controlled rdf:resource="#BiochemicalReaction1217" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction668" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis359">
 <bp:controlled rdf:resource="#BiochemicalReaction1222" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep724">
 <bp:stepProcess rdf:resource="#BiochemicalReaction669" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1855">
 <bp:stepProcess rdf:resource="#Catalysis549" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1636" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis390">
 <bp:controlled rdf:resource="#BiochemicalReaction1301" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1854">
 <bp:stepProcess rdf:resource="#Catalysis548" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1635" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis391">
 <bp:controlled rdf:resource="#BiochemicalReaction1302" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1637" />
 <bp:stepProcess rdf:resource="#Catalysis550" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis392">
 <bp:controlled rdf:resource="#BiochemicalReaction1303" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1856">
 <bp:stepProcess rdf:resource="#Pathway221" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis393">
 <bp:controlled rdf:resource="#BiochemicalReaction1304" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1638" />
 <bp:stepProcess rdf:resource="#Catalysis551" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis394">
 <bp:controlled rdf:resource="#BiochemicalReaction1305" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1858">
 <bp:stepProcess rdf:resource="#Pathway222" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis395">
 <bp:controlled rdf:resource="#BiochemicalReaction1306" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis396">
 <bp:controlled rdf:resource="#BiochemicalReaction1307" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1851">
 <bp:stepProcess rdf:resource="#Pathway220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1853">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1634" />
 <bp:stepProcess rdf:resource="#Catalysis547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1633" />
 <bp:stepProcess rdf:resource="#Catalysis546" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep736">
 <bp:stepProcess rdf:resource="#BiochemicalReaction680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep737">
 <bp:stepProcess rdf:resource="#BiochemicalReaction681" />
 <bp:stepProcess rdf:resource="#Catalysis159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep738">
 <bp:stepProcess rdf:resource="#BiochemicalReaction682" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction683" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis386">
 <bp:controlled rdf:resource="#BiochemicalReaction1294" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis387">
 <bp:controlled rdf:resource="#BiochemicalReaction1297" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep730">
 <bp:stepProcess rdf:resource="#Pathway57" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis388">
 <bp:controlled rdf:resource="#BiochemicalReaction1298" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep731">
 <bp:stepProcess rdf:resource="#BiochemicalReaction675" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis389">
 <bp:controlled rdf:resource="#BiochemicalReaction1299" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep733">
 <bp:stepProcess rdf:resource="#BiochemicalReaction677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep734">
 <bp:stepProcess rdf:resource="#Catalysis158" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction678" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction679" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1866">
 <bp:stepProcess rdf:resource="#Pathway223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1865">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1644" />
 <bp:stepProcess rdf:resource="#Catalysis557" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis380">
 <bp:controlled rdf:resource="#BiochemicalReaction1286" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1868">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1646" />
 <bp:stepProcess rdf:resource="#Catalysis558" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis381">
 <bp:controlled rdf:resource="#BiochemicalReaction1287" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1645" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis382">
 <bp:controlled rdf:resource="#BiochemicalReaction1289" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis383">
 <bp:controlled rdf:resource="#BiochemicalReaction1290" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1869">
 <bp:stepProcess rdf:resource="#Catalysis559" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1647" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis384">
 <bp:controlled rdf:resource="#BiochemicalReaction1292" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis385">
 <bp:controlled rdf:resource="#BiochemicalReaction1293" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1639" />
 <bp:stepProcess rdf:resource="#Catalysis552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1862">
 <bp:stepProcess rdf:resource="#Catalysis554" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1641" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1861">
 <bp:stepProcess rdf:resource="#Catalysis553" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1640" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1864">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1643" />
 <bp:stepProcess rdf:resource="#Catalysis556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1863">
 <bp:stepProcess rdf:resource="#Catalysis555" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction691" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction692" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep749">
 <bp:stepProcess rdf:resource="#BiochemicalReaction693" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis375">
 <bp:controlled rdf:resource="#BiochemicalReaction1278" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction684" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis376">
 <bp:controlled rdf:resource="#BiochemicalReaction1280" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep741">
 <bp:stepProcess rdf:resource="#BiochemicalReaction685" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis377">
 <bp:controlled rdf:resource="#BiochemicalReaction1283" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep742">
 <bp:stepProcess rdf:resource="#BiochemicalReaction686" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis378">
 <bp:controlled rdf:resource="#BiochemicalReaction1284" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction687" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis379">
 <bp:controlled rdf:resource="#BiochemicalReaction1285" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep744">
 <bp:stepProcess rdf:resource="#BiochemicalReaction688" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep745">
 <bp:stepProcess rdf:resource="#BiochemicalReaction689" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction690" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis330">
 <bp:controlled rdf:resource="#BiochemicalReaction1172" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis328">
 <bp:controlled rdf:resource="#BiochemicalReaction1168" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis329">
 <bp:controlled rdf:resource="#BiochemicalReaction1171" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis320">
 <bp:controlled rdf:resource="#BiochemicalReaction1154" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis321">
 <bp:controlled rdf:resource="#BiochemicalReaction1155" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis322">
 <bp:controlled rdf:resource="#BiochemicalReaction1156" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis323">
 <bp:controlled rdf:resource="#BiochemicalReaction1158" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis324">
 <bp:controlled rdf:resource="#BiochemicalReaction1159" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis325">
 <bp:controlled rdf:resource="#BiochemicalReaction1160" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis326">
 <bp:controlled rdf:resource="#BiochemicalReaction1162" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis327">
 <bp:controlled rdf:resource="#BiochemicalReaction1166" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1800">
 <bp:stepProcess rdf:resource="#Pathway210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1802">
 <bp:stepProcess rdf:resource="#Pathway212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1801">
 <bp:stepProcess rdf:resource="#Pathway211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1593" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1592" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1595" />
 <bp:stepProcess rdf:resource="#Catalysis528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1594" />
 <bp:stepProcess rdf:resource="#Catalysis527" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis317">
 <bp:controlled rdf:resource="#BiochemicalReaction1151" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis318">
 <bp:controlled rdf:resource="#BiochemicalReaction1152" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis319">
 <bp:controlled rdf:resource="#BiochemicalReaction1153" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1808">
 <bp:stepProcess rdf:resource="#Catalysis529" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1597" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis310">
 <bp:controlled rdf:resource="#BiochemicalReaction1143" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1807">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1596" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis311">
 <bp:controlled rdf:resource="#BiochemicalReaction1145" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis312">
 <bp:controlled rdf:resource="#BiochemicalReaction1146" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1809">
 <bp:stepProcess rdf:resource="#Pathway213" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis313">
 <bp:controlled rdf:resource="#BiochemicalReaction1147" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis314">
 <bp:controlled rdf:resource="#BiochemicalReaction1148" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis315">
 <bp:controlled rdf:resource="#BiochemicalReaction1149" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis316">
 <bp:controlled rdf:resource="#BiochemicalReaction1150" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1811">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1599" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1810">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1598" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1813">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1600" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1812">
 <bp:stepProcess rdf:resource="#Pathway214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1815">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1602" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis350">
 <bp:controlled rdf:resource="#BiochemicalReaction1199" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1814">
 <bp:stepProcess rdf:resource="#Catalysis530" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1601" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis351">
 <bp:controlled rdf:resource="#BiochemicalReaction1200" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1604" />
 <bp:stepProcess rdf:resource="#Catalysis531" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis352">
 <bp:controlled rdf:resource="#BiochemicalReaction1202" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1816">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1603" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis342">
 <bp:controlled rdf:resource="#BiochemicalReaction1191" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1606" />
 <bp:stepProcess rdf:resource="#Catalysis532" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis343">
 <bp:controlled rdf:resource="#BiochemicalReaction1192" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1605" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis344">
 <bp:controlled rdf:resource="#BiochemicalReaction1193" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis345">
 <bp:controlled rdf:resource="#BiochemicalReaction1194" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis346">
 <bp:controlled rdf:resource="#BiochemicalReaction1195" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis347">
 <bp:controlled rdf:resource="#BiochemicalReaction1196" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis348">
 <bp:controlled rdf:resource="#BiochemicalReaction1197" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis349">
 <bp:controlled rdf:resource="#BiochemicalReaction1198" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1608" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1611" />
 <bp:stepProcess rdf:resource="#Catalysis533" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1610" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1613" />
 <bp:stepProcess rdf:resource="#Catalysis534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1825">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1612" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis340">
 <bp:controlled rdf:resource="#BiochemicalReaction1189" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1828">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1615" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis341">
 <bp:controlled rdf:resource="#BiochemicalReaction1190" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1827">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1614" />
 <bp:stepProcess rdf:resource="#Catalysis535" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1820">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1607" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep703">
 <bp:stepProcess rdf:resource="#BiochemicalReaction651" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis339">
 <bp:controlled rdf:resource="#BiochemicalReaction1187" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction652" />
 <bp:stepProcess rdf:resource="#Catalysis151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction653" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction654" />
 <bp:stepProcess rdf:resource="#Catalysis152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep707">
 <bp:stepProcess rdf:resource="#Pathway54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep708">
 <bp:stepProcess rdf:resource="#BiochemicalReaction655" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction656" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis331">
 <bp:controlled rdf:resource="#BiochemicalReaction1173" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis332">
 <bp:controlled rdf:resource="#BiochemicalReaction1177" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1616" />
 <bp:stepProcess rdf:resource="#Catalysis536" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis333">
 <bp:controlled rdf:resource="#BiochemicalReaction1178" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis334">
 <bp:controlled rdf:resource="#BiochemicalReaction1180" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis335">
 <bp:controlled rdf:resource="#BiochemicalReaction1181" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction648" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis336">
 <bp:controlled rdf:resource="#BiochemicalReaction1182" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep701">
 <bp:stepProcess rdf:resource="#Catalysis150" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction649" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis337">
 <bp:controlled rdf:resource="#BiochemicalReaction1185" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction650" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis338">
 <bp:controlled rdf:resource="#BiochemicalReaction1186" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1375">
 <bp:evidence rdf:resource="#Evidence1543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1374">
 <bp:evidence rdf:resource="#Evidence1541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1591" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1373">
 <bp:evidence rdf:resource="#Evidence1540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1372">
 <bp:evidence rdf:resource="#Evidence1538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3 recruits TRIF (TICAM1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1371">
 <bp:evidence rdf:resource="#Evidence1537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction620" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1370">
 <bp:evidence rdf:resource="#Evidence1536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction621" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction622" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1792">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1585" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1584" />
 <bp:stepProcess rdf:resource="#Catalysis523" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1794">
 <bp:stepProcess rdf:resource="#Pathway209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1586" />
 <bp:stepProcess rdf:resource="#Catalysis524" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1796">
 <bp:stepProcess rdf:resource="#Catalysis526" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1588" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1795">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1587" />
 <bp:stepProcess rdf:resource="#Catalysis525" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1590" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep675">
 <bp:stepProcess rdf:resource="#Pathway52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep677">
 <bp:stepProcess rdf:resource="#Pathway53" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1379">
 <bp:evidence rdf:resource="#Evidence1547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction626" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1378">
 <bp:evidence rdf:resource="#Evidence1546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction627" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1377">
 <bp:evidence rdf:resource="#Evidence1545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1376">
 <bp:evidence rdf:resource="#Evidence1544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1386">
 <bp:evidence rdf:resource="#Evidence1554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1385">
 <bp:evidence rdf:resource="#Evidence1553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1384">
 <bp:evidence rdf:resource="#Evidence1552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1383">
 <bp:evidence rdf:resource="#Evidence1551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction628" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1382">
 <bp:evidence rdf:resource="#Evidence1550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction629" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1381">
 <bp:evidence rdf:resource="#Evidence1549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction630" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1380">
 <bp:evidence rdf:resource="#Evidence1548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep683">
 <bp:stepProcess rdf:resource="#BiochemicalReaction631" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction633" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction635" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep688">
 <bp:stepProcess rdf:resource="#BiochemicalReaction636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep689">
 <bp:stepProcess rdf:resource="#BiochemicalReaction637" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1389">
 <bp:evidence rdf:resource="#Evidence1557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1388">
 <bp:evidence rdf:resource="#Evidence1556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1387">
 <bp:evidence rdf:resource="#Evidence1555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1397">
 <bp:evidence rdf:resource="#Evidence1566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK is ubiquitinated within TANK:K63polyUb-TRAF3:TICAM1:TLR3:viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1396">
 <bp:evidence rdf:resource="#Evidence1565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 binds K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1395">
 <bp:evidence rdf:resource="#Evidence1564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction638" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1394">
 <bp:evidence rdf:resource="#Evidence1563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRF-3/IRF7 and their release from the activated TLR3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep691">
 <bp:stepProcess rdf:resource="#BiochemicalReaction639" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1393">
 <bp:evidence rdf:resource="#Evidence1562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction640" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1392">
 <bp:evidence rdf:resource="#Evidence1561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) binds K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction641" />
 <bp:stepProcess rdf:resource="#Catalysis147" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1391">
 <bp:evidence rdf:resource="#Evidence1560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF3 within activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction642" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1390">
 <bp:evidence rdf:resource="#Evidence1558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SARM binds viral dsRNA:TLR3:TICAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis306">
 <bp:controlled rdf:resource="#BiochemicalReaction1137" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis307">
 <bp:controlled rdf:resource="#BiochemicalReaction1138" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis308">
 <bp:controlled rdf:resource="#BiochemicalReaction1141" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis309">
 <bp:controlled rdf:resource="#BiochemicalReaction1142" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction644" />
 <bp:stepProcess rdf:resource="#Catalysis148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction645" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis300">
 <bp:controlled rdf:resource="#BiochemicalReaction1126" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction646" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis301">
 <bp:controlled rdf:resource="#BiochemicalReaction1128" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep699">
 <bp:stepProcess rdf:resource="#Catalysis149" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction647" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis302">
 <bp:controlled rdf:resource="#BiochemicalReaction1130" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis303">
 <bp:controlled rdf:resource="#BiochemicalReaction1133" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis304">
 <bp:controlled rdf:resource="#BiochemicalReaction1134" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1399">
 <bp:evidence rdf:resource="#Evidence1568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of phosphorylated IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis305">
 <bp:controlled rdf:resource="#BiochemicalReaction1136" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1398">
 <bp:evidence rdf:resource="#Evidence1567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK binds K63-poly-Ub-TRAF3:TICAM1:activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1331">
 <bp:evidence rdf:resource="#Evidence1487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1756">
 <bp:stepProcess rdf:resource="#Catalysis510" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1553" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1330">
 <bp:evidence rdf:resource="#Evidence1486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1755">
 <bp:stepProcess rdf:resource="#Catalysis509" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1758">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1555" />
 <bp:stepProcess rdf:resource="#Catalysis512" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1757">
 <bp:stepProcess rdf:resource="#Catalysis511" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1554" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1759">
 <bp:stepProcess rdf:resource="#Pathway205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1750">
 <bp:stepProcess rdf:resource="#Catalysis505" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1752">
 <bp:stepProcess rdf:resource="#Catalysis506" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1751">
 <bp:stepProcess rdf:resource="#Pathway204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1754">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1551" />
 <bp:stepProcess rdf:resource="#Catalysis508" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1550" />
 <bp:stepProcess rdf:resource="#Catalysis507" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction590" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep638">
 <bp:stepProcess rdf:resource="#Catalysis142" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction591" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep639">
 <bp:stepProcess rdf:resource="#Catalysis143" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction592" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1339">
 <bp:evidence rdf:resource="#Evidence1498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep630">
 <bp:stepProcess rdf:resource="#Catalysis140" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction584" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1338">
 <bp:evidence rdf:resource="#Evidence1494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of LBP with LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction585" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1337">
 <bp:evidence rdf:resource="#Evidence1493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis of TRAM (TICAM2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep632">
 <bp:stepProcess rdf:resource="#BiochemicalReaction586" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1336">
 <bp:evidence rdf:resource="#Evidence1492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis of TLR4:LY96:LPS:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep633">
 <bp:stepProcess rdf:resource="#BiochemicalReaction587" />
 <bp:stepProcess rdf:resource="#Catalysis141" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1335">
 <bp:evidence rdf:resource="#Evidence1491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of LPS onto TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction588" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1334">
 <bp:evidence rdf:resource="#Evidence1490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4:LY96:LPS:CD14 recruits TRAM (TICAM2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep635">
 <bp:stepProcess rdf:resource="#BiochemicalReaction589" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1333">
 <bp:evidence rdf:resource="#Evidence1489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep636">
 <bp:stepProcess rdf:resource="#Pathway48" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1332">
 <bp:evidence rdf:resource="#Evidence1488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1342">
 <bp:evidence rdf:resource="#Evidence1502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1563" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1341">
 <bp:evidence rdf:resource="#Evidence1500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1562" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1340">
 <bp:evidence rdf:resource="#Evidence1499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1769">
 <bp:stepProcess rdf:resource="#Pathway206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1564" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1557" />
 <bp:stepProcess rdf:resource="#Catalysis513" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1763">
 <bp:stepProcess rdf:resource="#Catalysis515" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1558" />
 <bp:stepProcess rdf:resource="#Catalysis514" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1765">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1561" />
 <bp:stepProcess rdf:resource="#Catalysis516" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction600" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep649">
 <bp:stepProcess rdf:resource="#BiochemicalReaction601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep640">
 <bp:stepProcess rdf:resource="#BiochemicalReaction593" />
 <bp:stepProcess rdf:resource="#Catalysis144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction594" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1349">
 <bp:evidence rdf:resource="#Evidence1511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction595" />
 <bp:stepProcess rdf:resource="#Catalysis145" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1348">
 <bp:evidence rdf:resource="#Evidence1510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction596" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1347">
 <bp:evidence rdf:resource="#Evidence1509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction597" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1346">
 <bp:evidence rdf:resource="#Evidence1506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction598" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1345">
 <bp:evidence rdf:resource="#Evidence1505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep646">
 <bp:stepProcess rdf:resource="#Pathway49" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1344">
 <bp:evidence rdf:resource="#Evidence1504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction599" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1343">
 <bp:evidence rdf:resource="#Evidence1503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1353">
 <bp:evidence rdf:resource="#Evidence1516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1572" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1352">
 <bp:evidence rdf:resource="#Evidence1515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1777">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1571" />
 <bp:stepProcess rdf:resource="#Catalysis518" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1351">
 <bp:evidence rdf:resource="#Evidence1513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1350">
 <bp:evidence rdf:resource="#Evidence1512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1573" />
 <bp:stepProcess rdf:resource="#Catalysis519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep650">
 <bp:stepProcess rdf:resource="#BiochemicalReaction602" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1565" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1772">
 <bp:stepProcess rdf:resource="#Pathway207" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1774">
 <bp:stepProcess rdf:resource="#Catalysis517" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep651">
 <bp:stepProcess rdf:resource="#Pathway50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep652">
 <bp:stepProcess rdf:resource="#BiochemicalReaction603" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep653">
 <bp:stepProcess rdf:resource="#BiochemicalReaction604" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1359">
 <bp:evidence rdf:resource="#Evidence1524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction605" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1358">
 <bp:evidence rdf:resource="#Evidence1523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction606" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1357">
 <bp:evidence rdf:resource="#Evidence1522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction607" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1356">
 <bp:evidence rdf:resource="#Evidence1520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep657">
 <bp:stepProcess rdf:resource="#Pathway51" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1355">
 <bp:evidence rdf:resource="#Evidence1518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction608" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1354">
 <bp:evidence rdf:resource="#Evidence1517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1364">
 <bp:evidence rdf:resource="#Evidence1530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1582" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1363">
 <bp:evidence rdf:resource="#Evidence1528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1788">
 <bp:stepProcess rdf:resource="#Pathway208" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1362">
 <bp:evidence rdf:resource="#Evidence1527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1361">
 <bp:evidence rdf:resource="#Evidence1526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1360">
 <bp:evidence rdf:resource="#Evidence1525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction610" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction611" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1575" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1574" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1783">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1577" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1576" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1785">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1784">
 <bp:stepProcess rdf:resource="#Catalysis520" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1581" />
 <bp:stepProcess rdf:resource="#Catalysis522" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1580" />
 <bp:stepProcess rdf:resource="#Catalysis521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1790">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1583" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction613" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction614" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep665">
 <bp:stepProcess rdf:resource="#Catalysis146" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction615" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1369">
 <bp:evidence rdf:resource="#Evidence1535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction616" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1368">
 <bp:evidence rdf:resource="#Evidence1534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep667">
 <bp:stepProcess rdf:resource="#BiochemicalReaction617" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1367">
 <bp:evidence rdf:resource="#Evidence1533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction618" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1366">
 <bp:evidence rdf:resource="#Evidence1532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction619" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1365">
 <bp:evidence rdf:resource="#Evidence1531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence204">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence200">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1309">
 <bp:evidence rdf:resource="#Evidence1463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1308">
 <bp:evidence rdf:resource="#Evidence1462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1307">
 <bp:evidence rdf:resource="#Evidence1461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1306">
 <bp:evidence rdf:resource="#Evidence1460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1305">
 <bp:evidence rdf:resource="#Evidence1458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1304">
 <bp:evidence rdf:resource="#Evidence1456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1303">
 <bp:evidence rdf:resource="#Evidence1455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1302">
 <bp:evidence rdf:resource="#Evidence1454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1301">
 <bp:evidence rdf:resource="#Evidence1453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1300">
 <bp:evidence rdf:resource="#Evidence1451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence229">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1319">
 <bp:evidence rdf:resource="#Evidence1474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1318">
 <bp:evidence rdf:resource="#Evidence1473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1317">
 <bp:evidence rdf:resource="#Evidence1472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1316">
 <bp:evidence rdf:resource="#Evidence1471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1315">
 <bp:evidence rdf:resource="#Evidence1470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1314">
 <bp:evidence rdf:resource="#Evidence1469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1313">
 <bp:evidence rdf:resource="#Evidence1468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence220">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1312">
 <bp:evidence rdf:resource="#Evidence1466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence221">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1311">
 <bp:evidence rdf:resource="#Evidence1465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence222">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1310">
 <bp:evidence rdf:resource="#Evidence1464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1320">
 <bp:evidence rdf:resource="#Evidence1475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence219">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1329">
 <bp:evidence rdf:resource="#Evidence1485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1328">
 <bp:evidence rdf:resource="#Evidence1483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1327">
 <bp:evidence rdf:resource="#Evidence1482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1326">
 <bp:evidence rdf:resource="#Evidence1481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1325">
 <bp:evidence rdf:resource="#Evidence1480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1324">
 <bp:evidence rdf:resource="#Evidence1479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1323">
 <bp:evidence rdf:resource="#Evidence1478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence210">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1322">
 <bp:evidence rdf:resource="#Evidence1477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence211">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1321">
 <bp:evidence rdf:resource="#Evidence1476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence255">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1709">
 <bp:evidence rdf:resource="#Evidence1945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1708">
 <bp:evidence rdf:resource="#Evidence1943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1707">
 <bp:evidence rdf:resource="#Evidence1942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1706">
 <bp:evidence rdf:resource="#Evidence1941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1705">
 <bp:evidence rdf:resource="#Evidence1940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1704">
 <bp:evidence rdf:resource="#Evidence1939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1703">
 <bp:evidence rdf:resource="#Evidence1936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1702">
 <bp:evidence rdf:resource="#Evidence1935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1701">
 <bp:evidence rdf:resource="#Evidence1934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1700">
 <bp:evidence rdf:resource="#Evidence1933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1719">
 <bp:evidence rdf:resource="#Evidence1957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1718">
 <bp:evidence rdf:resource="#Evidence1956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1717">
 <bp:evidence rdf:resource="#Evidence1955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1716">
 <bp:evidence rdf:resource="#Evidence1954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1715">
 <bp:evidence rdf:resource="#Evidence1953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1714">
 <bp:evidence rdf:resource="#Evidence1952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1713">
 <bp:evidence rdf:resource="#Evidence1950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1712">
 <bp:evidence rdf:resource="#Evidence1948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1711">
 <bp:evidence rdf:resource="#Evidence1947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1710">
 <bp:evidence rdf:resource="#Evidence1946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1729">
 <bp:evidence rdf:resource="#Evidence1968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1728">
 <bp:evidence rdf:resource="#Evidence1967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1727">
 <bp:evidence rdf:resource="#Evidence1966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1726">
 <bp:evidence rdf:resource="#Evidence1965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1725">
 <bp:evidence rdf:resource="#Evidence1964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1724">
 <bp:evidence rdf:resource="#Evidence1963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1723">
 <bp:evidence rdf:resource="#Evidence1962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1722">
 <bp:evidence rdf:resource="#Evidence1961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1721">
 <bp:evidence rdf:resource="#Evidence1960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1720">
 <bp:evidence rdf:resource="#Evidence1958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1549">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence5">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence6">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence4">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence9">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence7">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence8">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1541">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1523">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis20">
 <bp:controlled rdf:resource="#BiochemicalReaction59" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1527">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis29">
 <bp:controlled rdf:resource="#BiochemicalReaction76" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis24">
 <bp:controlled rdf:resource="#BiochemicalReaction66" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis23">
 <bp:controlled rdf:resource="#BiochemicalReaction65" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis22">
 <bp:controlled rdf:resource="#BiochemicalReaction62" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis21">
 <bp:controlled rdf:resource="#BiochemicalReaction61" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis28">
 <bp:controlled rdf:resource="#BiochemicalReaction75" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1522">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis27">
 <bp:controlled rdf:resource="#BiochemicalReaction73" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1521">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis26">
 <bp:controlled rdf:resource="#BiochemicalReaction71" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1520">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis25">
 <bp:controlled rdf:resource="#BiochemicalReaction70" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1539">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1538">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis19">
 <bp:controlled rdf:resource="#BiochemicalReaction58" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis18">
 <bp:controlled rdf:resource="#BiochemicalReaction56" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis13">
 <bp:controlled rdf:resource="#BiochemicalReaction44" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis12">
 <bp:controlled rdf:resource="#BiochemicalReaction43" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis11">
 <bp:controlled rdf:resource="#BiochemicalReaction41" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis10">
 <bp:controlled rdf:resource="#BiochemicalReaction33" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis17">
 <bp:controlled rdf:resource="#BiochemicalReaction52" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1533">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis16">
 <bp:controlled rdf:resource="#BiochemicalReaction50" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1532">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis15">
 <bp:controlled rdf:resource="#BiochemicalReaction49" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1531">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis14">
 <bp:controlled rdf:resource="#BiochemicalReaction47" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1504">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1694">
 <bp:evidence rdf:resource="#Evidence1924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1503">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1693">
 <bp:evidence rdf:resource="#Evidence1923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1502">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1692">
 <bp:evidence rdf:resource="#Evidence1922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1501">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1691">
 <bp:evidence rdf:resource="#Evidence1921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1508">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1690">
 <bp:evidence rdf:resource="#Evidence1920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1509">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1699">
 <bp:evidence rdf:resource="#Evidence1932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1500">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1698">
 <bp:evidence rdf:resource="#Evidence1930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1697">
 <bp:evidence rdf:resource="#Evidence1929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1696">
 <bp:evidence rdf:resource="#Evidence1928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1695">
 <bp:evidence rdf:resource="#Evidence1925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1519">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1510">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1650">
 <bp:evidence rdf:resource="#Evidence1873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis809">
 <bp:controlled rdf:resource="#BiochemicalReaction2393" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis801">
 <bp:controlled rdf:resource="#BiochemicalReaction2378" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis802">
 <bp:controlled rdf:resource="#BiochemicalReaction2380" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis803">
 <bp:controlled rdf:resource="#BiochemicalReaction2381" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis804">
 <bp:controlled rdf:resource="#BiochemicalReaction2382" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis805">
 <bp:controlled rdf:resource="#BiochemicalReaction2384" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis806">
 <bp:controlled rdf:resource="#BiochemicalReaction2387" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis807">
 <bp:controlled rdf:resource="#BiochemicalReaction2390" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1659">
 <bp:evidence rdf:resource="#Evidence1883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis808">
 <bp:controlled rdf:resource="#BiochemicalReaction2391" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1658">
 <bp:evidence rdf:resource="#Evidence1882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1657">
 <bp:evidence rdf:resource="#Evidence1881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1656">
 <bp:evidence rdf:resource="#Evidence1879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomerl:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1655">
 <bp:evidence rdf:resource="#Evidence1878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1654">
 <bp:evidence rdf:resource="#Evidence1877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation within the complex activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1653">
 <bp:evidence rdf:resource="#Evidence1876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with the activated TLR receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1652">
 <bp:evidence rdf:resource="#Evidence1875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1651">
 <bp:evidence rdf:resource="#Evidence1874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis800">
 <bp:controlled rdf:resource="#BiochemicalReaction2376" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1661">
 <bp:evidence rdf:resource="#Evidence1885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1660">
 <bp:evidence rdf:resource="#Evidence1884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1669">
 <bp:evidence rdf:resource="#Evidence1897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1668">
 <bp:evidence rdf:resource="#Evidence1896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1667">
 <bp:evidence rdf:resource="#Evidence1895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1666">
 <bp:evidence rdf:resource="#Evidence1894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1665">
 <bp:evidence rdf:resource="#Evidence1892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1664">
 <bp:evidence rdf:resource="#Evidence1890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR6:TLR2 is recruited to ligand:CD14:CD36</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1663">
 <bp:evidence rdf:resource="#Evidence1887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ligand binds to TLR10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1662">
 <bp:evidence rdf:resource="#Evidence1886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1 or p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1672">
 <bp:evidence rdf:resource="#Evidence1902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1671">
 <bp:evidence rdf:resource="#Evidence1900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1670">
 <bp:evidence rdf:resource="#Evidence1899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1679">
 <bp:evidence rdf:resource="#Evidence1909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1678">
 <bp:evidence rdf:resource="#Evidence1908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1677">
 <bp:evidence rdf:resource="#Evidence1907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1676">
 <bp:evidence rdf:resource="#Evidence1906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1675">
 <bp:evidence rdf:resource="#Evidence1905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1674">
 <bp:evidence rdf:resource="#Evidence1904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1673">
 <bp:evidence rdf:resource="#Evidence1903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1683">
 <bp:evidence rdf:resource="#Evidence1913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1682">
 <bp:evidence rdf:resource="#Evidence1912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1681">
 <bp:evidence rdf:resource="#Evidence1911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1680">
 <bp:evidence rdf:resource="#Evidence1910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1689">
 <bp:evidence rdf:resource="#Evidence1919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1688">
 <bp:evidence rdf:resource="#Evidence1918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1687">
 <bp:evidence rdf:resource="#Evidence1917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1686">
 <bp:evidence rdf:resource="#Evidence1916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1685">
 <bp:evidence rdf:resource="#Evidence1915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1684">
 <bp:evidence rdf:resource="#Evidence1914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1589">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep91">
 <bp:stepProcess rdf:resource="#BiochemicalReaction84" />
 <bp:stepProcess rdf:resource="#Catalysis34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep92">
 <bp:stepProcess rdf:resource="#Catalysis35" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction85" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep90">
 <bp:stepProcess rdf:resource="#BiochemicalReaction83" />
 <bp:stepProcess rdf:resource="#Catalysis33" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep95">
 <bp:stepProcess rdf:resource="#BiochemicalReaction87" />
 <bp:stepProcess rdf:resource="#Catalysis36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep96">
 <bp:stepProcess rdf:resource="#BiochemicalReaction88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep93">
 <bp:stepProcess rdf:resource="#Pathway9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep94">
 <bp:stepProcess rdf:resource="#BiochemicalReaction86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep88">
 <bp:stepProcess rdf:resource="#BiochemicalReaction81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep89">
 <bp:stepProcess rdf:resource="#BiochemicalReaction82" />
 <bp:stepProcess rdf:resource="#Catalysis32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep86">
 <bp:stepProcess rdf:resource="#BiochemicalReaction79" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep87">
 <bp:stepProcess rdf:resource="#Catalysis31" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction80" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1619">
 <bp:evidence rdf:resource="#Evidence1833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1580">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1618">
 <bp:evidence rdf:resource="#Evidence1832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1617">
 <bp:evidence rdf:resource="#Evidence1831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1616">
 <bp:evidence rdf:resource="#Evidence1830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1615">
 <bp:evidence rdf:resource="#Evidence1829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1584">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1614">
 <bp:evidence rdf:resource="#Evidence1828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1583">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1613">
 <bp:evidence rdf:resource="#Evidence1827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1582">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1612">
 <bp:evidence rdf:resource="#Evidence1826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1581">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1611">
 <bp:evidence rdf:resource="#Evidence1825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1588">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1610">
 <bp:evidence rdf:resource="#Evidence1824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1586">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1585">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep99">
 <bp:stepProcess rdf:resource="#BiochemicalReaction91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep97">
 <bp:stepProcess rdf:resource="#BiochemicalReaction89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep98">
 <bp:stepProcess rdf:resource="#BiochemicalReaction90" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1591">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1629">
 <bp:evidence rdf:resource="#Evidence1848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1590">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1628">
 <bp:evidence rdf:resource="#Evidence1847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1627">
 <bp:evidence rdf:resource="#Evidence1844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1626">
 <bp:evidence rdf:resource="#Evidence1843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1595">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1625">
 <bp:evidence rdf:resource="#Evidence1842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1594">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1624">
 <bp:evidence rdf:resource="#Evidence1841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1593">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1623">
 <bp:evidence rdf:resource="#Evidence1840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1592">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1622">
 <bp:evidence rdf:resource="#Evidence1838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1599">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1621">
 <bp:evidence rdf:resource="#Evidence1837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1598">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1620">
 <bp:evidence rdf:resource="#Evidence1836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1597">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1596">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1569">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1567">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep70">
 <bp:stepProcess rdf:resource="#BiochemicalReaction64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep73">
 <bp:stepProcess rdf:resource="#BiochemicalReaction67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep74">
 <bp:stepProcess rdf:resource="#BiochemicalReaction68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep71">
 <bp:stepProcess rdf:resource="#Catalysis23" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction65" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep72">
 <bp:stepProcess rdf:resource="#Catalysis24" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep66">
 <bp:stepProcess rdf:resource="#BiochemicalReaction60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep67">
 <bp:stepProcess rdf:resource="#BiochemicalReaction61" />
 <bp:stepProcess rdf:resource="#Catalysis21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep64">
 <bp:stepProcess rdf:resource="#BiochemicalReaction58" />
 <bp:stepProcess rdf:resource="#Catalysis19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep65">
 <bp:stepProcess rdf:resource="#BiochemicalReaction59" />
 <bp:stepProcess rdf:resource="#Catalysis20" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1639">
 <bp:evidence rdf:resource="#Evidence1861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep68">
 <bp:stepProcess rdf:resource="#BiochemicalReaction62" />
 <bp:stepProcess rdf:resource="#Catalysis22" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1638">
 <bp:evidence rdf:resource="#Evidence1860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep69">
 <bp:stepProcess rdf:resource="#BiochemicalReaction63" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1637">
 <bp:evidence rdf:resource="#Evidence1858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1562">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1636">
 <bp:evidence rdf:resource="#Evidence1856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1561">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1635">
 <bp:evidence rdf:resource="#Evidence1855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1560">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1634">
 <bp:evidence rdf:resource="#Evidence1854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1633">
 <bp:evidence rdf:resource="#Evidence1853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1566">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1632">
 <bp:evidence rdf:resource="#Evidence1851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1565">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1631">
 <bp:evidence rdf:resource="#Evidence1850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1564">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1630">
 <bp:evidence rdf:resource="#Evidence1849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1579">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1578">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep80">
 <bp:stepProcess rdf:resource="#BiochemicalReaction73" />
 <bp:stepProcess rdf:resource="#Catalysis27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep81">
 <bp:stepProcess rdf:resource="#BiochemicalReaction74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep84">
 <bp:stepProcess rdf:resource="#BiochemicalReaction77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep85">
 <bp:stepProcess rdf:resource="#BiochemicalReaction78" />
 <bp:stepProcess rdf:resource="#Catalysis30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep82">
 <bp:stepProcess rdf:resource="#Catalysis28" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep83">
 <bp:stepProcess rdf:resource="#Catalysis29" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep77">
 <bp:stepProcess rdf:resource="#BiochemicalReaction70" />
 <bp:stepProcess rdf:resource="#Catalysis25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep78">
 <bp:stepProcess rdf:resource="#BiochemicalReaction71" />
 <bp:stepProcess rdf:resource="#Catalysis26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep75">
 <bp:stepProcess rdf:resource="#BiochemicalReaction69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep76">
 <bp:stepProcess rdf:resource="#Pathway8" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep79">
 <bp:stepProcess rdf:resource="#BiochemicalReaction72" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1649">
 <bp:evidence rdf:resource="#Evidence1872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1648">
 <bp:evidence rdf:resource="#Evidence1871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1573">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1647">
 <bp:evidence rdf:resource="#Evidence1870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1572">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1646">
 <bp:evidence rdf:resource="#Evidence1869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1571">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1645">
 <bp:evidence rdf:resource="#Evidence1868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1570">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1644">
 <bp:evidence rdf:resource="#Evidence1866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1577">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1643">
 <bp:evidence rdf:resource="#Evidence1865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1576">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1642">
 <bp:evidence rdf:resource="#Evidence1864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1575">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1641">
 <bp:evidence rdf:resource="#Evidence1863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1574">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1640">
 <bp:evidence rdf:resource="#Evidence1862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep51">
 <bp:stepProcess rdf:resource="#BiochemicalReaction46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep52">
 <bp:stepProcess rdf:resource="#BiochemicalReaction47" />
 <bp:stepProcess rdf:resource="#Catalysis14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep50">
 <bp:stepProcess rdf:resource="#BiochemicalReaction45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep44">
 <bp:stepProcess rdf:resource="#BiochemicalReaction39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep45">
 <bp:stepProcess rdf:resource="#BiochemicalReaction40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep42">
 <bp:stepProcess rdf:resource="#BiochemicalReaction37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep43">
 <bp:stepProcess rdf:resource="#BiochemicalReaction38" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep48">
 <bp:stepProcess rdf:resource="#Catalysis12" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep49">
 <bp:stepProcess rdf:resource="#Catalysis13" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep46">
 <bp:stepProcess rdf:resource="#Catalysis11" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep47">
 <bp:stepProcess rdf:resource="#BiochemicalReaction42" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep62">
 <bp:stepProcess rdf:resource="#BiochemicalReaction56" />
 <bp:stepProcess rdf:resource="#Catalysis18" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep63">
 <bp:stepProcess rdf:resource="#BiochemicalReaction57" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep60">
 <bp:stepProcess rdf:resource="#Pathway7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep61">
 <bp:stepProcess rdf:resource="#BiochemicalReaction55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep55">
 <bp:stepProcess rdf:resource="#BiochemicalReaction50" />
 <bp:stepProcess rdf:resource="#Catalysis16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep56">
 <bp:stepProcess rdf:resource="#BiochemicalReaction51" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep53">
 <bp:stepProcess rdf:resource="#BiochemicalReaction48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep54">
 <bp:stepProcess rdf:resource="#BiochemicalReaction49" />
 <bp:stepProcess rdf:resource="#Catalysis15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep59">
 <bp:stepProcess rdf:resource="#BiochemicalReaction54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep57">
 <bp:stepProcess rdf:resource="#Catalysis17" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep58">
 <bp:stepProcess rdf:resource="#BiochemicalReaction53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep30">
 <bp:stepProcess rdf:resource="#BiochemicalReaction25" />
 <bp:stepProcess rdf:resource="#Catalysis6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep22">
 <bp:stepProcess rdf:resource="#BiochemicalReaction17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep23">
 <bp:stepProcess rdf:resource="#Catalysis3" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction18" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep20">
 <bp:stepProcess rdf:resource="#BiochemicalReaction15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep21">
 <bp:stepProcess rdf:resource="#BiochemicalReaction16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep26">
 <bp:stepProcess rdf:resource="#Catalysis4" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep27">
 <bp:stepProcess rdf:resource="#Catalysis5" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction22" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep24">
 <bp:stepProcess rdf:resource="#BiochemicalReaction19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep25">
 <bp:stepProcess rdf:resource="#BiochemicalReaction20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep28">
 <bp:stepProcess rdf:resource="#BiochemicalReaction23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep29">
 <bp:stepProcess rdf:resource="#BiochemicalReaction24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep40">
 <bp:stepProcess rdf:resource="#BiochemicalReaction35" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep41">
 <bp:stepProcess rdf:resource="#BiochemicalReaction36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep33">
 <bp:stepProcess rdf:resource="#BiochemicalReaction28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep34">
 <bp:stepProcess rdf:resource="#BiochemicalReaction29" />
 <bp:stepProcess rdf:resource="#Catalysis7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep31">
 <bp:stepProcess rdf:resource="#BiochemicalReaction26" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1609">
 <bp:evidence rdf:resource="#Evidence1823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep32">
 <bp:stepProcess rdf:resource="#BiochemicalReaction27" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1608">
 <bp:evidence rdf:resource="#Evidence1822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep37">
 <bp:stepProcess rdf:resource="#Catalysis9" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction32" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1607">
 <bp:evidence rdf:resource="#Evidence1821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep38">
 <bp:stepProcess rdf:resource="#Catalysis10" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1606">
 <bp:evidence rdf:resource="#Evidence1820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep35">
 <bp:stepProcess rdf:resource="#Catalysis8" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction30" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1605">
 <bp:evidence rdf:resource="#Evidence1819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep36">
 <bp:stepProcess rdf:resource="#BiochemicalReaction31" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1604">
 <bp:evidence rdf:resource="#Evidence1818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1603">
 <bp:evidence rdf:resource="#Evidence1817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1602">
 <bp:evidence rdf:resource="#Evidence1816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep39">
 <bp:stepProcess rdf:resource="#BiochemicalReaction34" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1601">
 <bp:evidence rdf:resource="#Evidence1815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1600">
 <bp:evidence rdf:resource="#Evidence1814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep11">
 <bp:stepProcess rdf:resource="#BiochemicalReaction9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep12">
 <bp:stepProcess rdf:resource="#BiochemicalReaction10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep10">
 <bp:stepProcess rdf:resource="#Catalysis1" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction8" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep15">
 <bp:stepProcess rdf:resource="#BiochemicalReaction13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep16">
 <bp:stepProcess rdf:resource="#BiochemicalReaction14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep13">
 <bp:stepProcess rdf:resource="#Catalysis2" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep14">
 <bp:stepProcess rdf:resource="#BiochemicalReaction12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep19">
 <bp:stepProcess rdf:resource="#Pathway6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep17">
 <bp:stepProcess rdf:resource="#Pathway4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep18">
 <bp:stepProcess rdf:resource="#Pathway5" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis82">
 <bp:controlled rdf:resource="#BiochemicalReaction256" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis81">
 <bp:controlled rdf:resource="#BiochemicalReaction255" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis80">
 <bp:controlled rdf:resource="#BiochemicalReaction254" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis86">
 <bp:controlled rdf:resource="#BiochemicalReaction280" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis85">
 <bp:controlled rdf:resource="#BiochemicalReaction275" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis84">
 <bp:controlled rdf:resource="#BiochemicalReaction260" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis83">
 <bp:controlled rdf:resource="#BiochemicalReaction258" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis89">
 <bp:controlled rdf:resource="#BiochemicalReaction298" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis88">
 <bp:controlled rdf:resource="#BiochemicalReaction290" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis87">
 <bp:controlled rdf:resource="#BiochemicalReaction289" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis71">
 <bp:controlled rdf:resource="#BiochemicalReaction212" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis70">
 <bp:controlled rdf:resource="#BiochemicalReaction209" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis75">
 <bp:controlled rdf:resource="#BiochemicalReaction230" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis74">
 <bp:controlled rdf:resource="#BiochemicalReaction226" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis73">
 <bp:controlled rdf:resource="#BiochemicalReaction225" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis72">
 <bp:controlled rdf:resource="#BiochemicalReaction216" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis79">
 <bp:controlled rdf:resource="#BiochemicalReaction253" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis78">
 <bp:controlled rdf:resource="#BiochemicalReaction251" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis77">
 <bp:controlled rdf:resource="#BiochemicalReaction247" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis76">
 <bp:controlled rdf:resource="#BiochemicalReaction232" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis93">
 <bp:controlled rdf:resource="#BiochemicalReaction328" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis92">
 <bp:controlled rdf:resource="#BiochemicalReaction307" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis91">
 <bp:controlled rdf:resource="#BiochemicalReaction305" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis90">
 <bp:controlled rdf:resource="#BiochemicalReaction302" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis97">
 <bp:controlled rdf:resource="#BiochemicalReaction345" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis96">
 <bp:controlled rdf:resource="#BiochemicalReaction343" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis95">
 <bp:controlled rdf:resource="#BiochemicalReaction336" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis94">
 <bp:controlled rdf:resource="#BiochemicalReaction330" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis99">
 <bp:controlled rdf:resource="#BiochemicalReaction378" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis98">
 <bp:controlled rdf:resource="#BiochemicalReaction372" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis42">
 <bp:controlled rdf:resource="#BiochemicalReaction111" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis41">
 <bp:controlled rdf:resource="#BiochemicalReaction109" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis40">
 <bp:controlled rdf:resource="#BiochemicalReaction102" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis46">
 <bp:controlled rdf:resource="#BiochemicalReaction119" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis45">
 <bp:controlled rdf:resource="#BiochemicalReaction118" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis44">
 <bp:controlled rdf:resource="#BiochemicalReaction114" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis43">
 <bp:controlled rdf:resource="#BiochemicalReaction113" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis49">
 <bp:controlled rdf:resource="#BiochemicalReaction130" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis48">
 <bp:controlled rdf:resource="#BiochemicalReaction123" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis47">
 <bp:controlled rdf:resource="#BiochemicalReaction122" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis31">
 <bp:controlled rdf:resource="#BiochemicalReaction80" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis30">
 <bp:controlled rdf:resource="#BiochemicalReaction78" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis35">
 <bp:controlled rdf:resource="#BiochemicalReaction85" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis34">
 <bp:controlled rdf:resource="#BiochemicalReaction84" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis33">
 <bp:controlled rdf:resource="#BiochemicalReaction83" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis32">
 <bp:controlled rdf:resource="#BiochemicalReaction82" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis39">
 <bp:controlled rdf:resource="#BiochemicalReaction99" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis38">
 <bp:controlled rdf:resource="#BiochemicalReaction98" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis37">
 <bp:controlled rdf:resource="#BiochemicalReaction97" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis36">
 <bp:controlled rdf:resource="#BiochemicalReaction87" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis60">
 <bp:controlled rdf:resource="#BiochemicalReaction169" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis64">
 <bp:controlled rdf:resource="#BiochemicalReaction178" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis63">
 <bp:controlled rdf:resource="#BiochemicalReaction176" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis62">
 <bp:controlled rdf:resource="#BiochemicalReaction172" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis61">
 <bp:controlled rdf:resource="#BiochemicalReaction171" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis68">
 <bp:controlled rdf:resource="#BiochemicalReaction193" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis67">
 <bp:controlled rdf:resource="#BiochemicalReaction186" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis66">
 <bp:controlled rdf:resource="#BiochemicalReaction183" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis65">
 <bp:controlled rdf:resource="#BiochemicalReaction181" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis69">
 <bp:controlled rdf:resource="#BiochemicalReaction208" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis53">
 <bp:controlled rdf:resource="#BiochemicalReaction138" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis52">
 <bp:controlled rdf:resource="#BiochemicalReaction137" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis51">
 <bp:controlled rdf:resource="#BiochemicalReaction133" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis50">
 <bp:controlled rdf:resource="#BiochemicalReaction131" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis57">
 <bp:controlled rdf:resource="#BiochemicalReaction156" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis56">
 <bp:controlled rdf:resource="#BiochemicalReaction153" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis55">
 <bp:controlled rdf:resource="#BiochemicalReaction143" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis54">
 <bp:controlled rdf:resource="#BiochemicalReaction139" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis59">
 <bp:controlled rdf:resource="#BiochemicalReaction168" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis58">
 <bp:controlled rdf:resource="#BiochemicalReaction158" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1426">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1429">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1415">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1410">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1573">
 <bp:evidence rdf:resource="#Evidence1780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1754" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1572">
 <bp:evidence rdf:resource="#Evidence1779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1997">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1753" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1571">
 <bp:evidence rdf:resource="#Evidence1778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2712">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1570">
 <bp:evidence rdf:resource="#Evidence1777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1999">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1755" />
 <bp:stepProcess rdf:resource="#Catalysis611" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2711">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1748" />
 <bp:stepProcess rdf:resource="#Catalysis609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1992">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1749" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1991">
 <bp:stepProcess rdf:resource="#Pathway244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1994">
 <bp:stepProcess rdf:resource="#Pathway245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1750" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1996">
 <bp:stepProcess rdf:resource="#Catalysis610" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1752" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1751" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1579">
 <bp:evidence rdf:resource="#Evidence1786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1578">
 <bp:evidence rdf:resource="#Evidence1785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1577">
 <bp:evidence rdf:resource="#Evidence1784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2710">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1576">
 <bp:evidence rdf:resource="#Evidence1783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1575">
 <bp:evidence rdf:resource="#Evidence1782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1574">
 <bp:evidence rdf:resource="#Evidence1781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1584">
 <bp:evidence rdf:resource="#Evidence1792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1583">
 <bp:evidence rdf:resource="#Evidence1791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1582">
 <bp:evidence rdf:resource="#Evidence1790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization initiated from endosomal compartments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1581">
 <bp:evidence rdf:resource="#Evidence1788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1580">
 <bp:evidence rdf:resource="#Evidence1787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1589">
 <bp:evidence rdf:resource="#Evidence1798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1588">
 <bp:evidence rdf:resource="#Evidence1797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation&lt;br&gt;</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1587">
 <bp:evidence rdf:resource="#Evidence1796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1586">
 <bp:evidence rdf:resource="#Evidence1794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1585">
 <bp:evidence rdf:resource="#Evidence1793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3  upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1595">
 <bp:evidence rdf:resource="#Evidence1807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1594">
 <bp:evidence rdf:resource="#Evidence1806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1593">
 <bp:evidence rdf:resource="#Evidence1805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1592">
 <bp:evidence rdf:resource="#Evidence1804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1591">
 <bp:evidence rdf:resource="#Evidence1800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1590">
 <bp:evidence rdf:resource="#Evidence1799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1 upon stimulation of TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1599">
 <bp:evidence rdf:resource="#Evidence1812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1598">
 <bp:evidence rdf:resource="#Evidence1811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1597">
 <bp:evidence rdf:resource="#Evidence1809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1596">
 <bp:evidence rdf:resource="#Evidence1808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2701">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2700">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2707">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2706">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2705">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2709">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2708">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1539">
 <bp:evidence rdf:resource="#Evidence1740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1538">
 <bp:evidence rdf:resource="#Evidence1737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1537">
 <bp:evidence rdf:resource="#Evidence1736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1536">
 <bp:evidence rdf:resource="#Evidence1735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1535">
 <bp:evidence rdf:resource="#Evidence1734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1534">
 <bp:evidence rdf:resource="#Evidence1733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1533">
 <bp:evidence rdf:resource="#Evidence1731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1532">
 <bp:evidence rdf:resource="#Evidence1730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1531">
 <bp:evidence rdf:resource="#Evidence1729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1530">
 <bp:evidence rdf:resource="#Evidence1725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1540">
 <bp:evidence rdf:resource="#Evidence1741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1549">
 <bp:evidence rdf:resource="#Evidence1753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1548">
 <bp:evidence rdf:resource="#Evidence1751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1547">
 <bp:evidence rdf:resource="#Evidence1749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1546">
 <bp:evidence rdf:resource="#Evidence1748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1545">
 <bp:evidence rdf:resource="#Evidence1747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1544">
 <bp:evidence rdf:resource="#Evidence1746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1543">
 <bp:evidence rdf:resource="#Evidence1744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1542">
 <bp:evidence rdf:resource="#Evidence1743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1541">
 <bp:evidence rdf:resource="#Evidence1742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1551">
 <bp:evidence rdf:resource="#Evidence1755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1550">
 <bp:evidence rdf:resource="#Evidence1754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1480">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1485">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1559">
 <bp:evidence rdf:resource="#Evidence1764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1484">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1558">
 <bp:evidence rdf:resource="#Evidence1763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1483">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1557">
 <bp:evidence rdf:resource="#Evidence1762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1482">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1556">
 <bp:evidence rdf:resource="#Evidence1761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1489">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1555">
 <bp:evidence rdf:resource="#Evidence1759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1488">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1554">
 <bp:evidence rdf:resource="#Evidence1758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1487">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1553">
 <bp:evidence rdf:resource="#Evidence1757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1486">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1552">
 <bp:evidence rdf:resource="#Evidence1756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1562">
 <bp:evidence rdf:resource="#Evidence1767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1561">
 <bp:evidence rdf:resource="#Evidence1766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1560">
 <bp:evidence rdf:resource="#Evidence1765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1490">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1495">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1569">
 <bp:evidence rdf:resource="#Evidence1776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1494">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1568">
 <bp:evidence rdf:resource="#Evidence1775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1493">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1567">
 <bp:evidence rdf:resource="#Evidence1774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1566">
 <bp:evidence rdf:resource="#Evidence1772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1499">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1565">
 <bp:evidence rdf:resource="#Evidence1771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1498">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1564">
 <bp:evidence rdf:resource="#Evidence1769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 :oligo-Myd88:activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1497">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1563">
 <bp:evidence rdf:resource="#Evidence1768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1469">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1479">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1509">
 <bp:evidence rdf:resource="#Evidence1702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated IKBKB phosphorylates IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1470">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1508">
 <bp:evidence rdf:resource="#Evidence1701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL recruits IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1507">
 <bp:evidence rdf:resource="#Evidence1700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S446-IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1506">
 <bp:evidence rdf:resource="#Evidence1699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1505">
 <bp:evidence rdf:resource="#Evidence1697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rab5-mediated recruitment of class III PI3K to TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1474">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1504">
 <bp:evidence rdf:resource="#Evidence1695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1473">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1503">
 <bp:evidence rdf:resource="#Evidence1694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1 upon stimulation of TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1472">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1502">
 <bp:evidence rdf:resource="#Evidence1693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1471">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1501">
 <bp:evidence rdf:resource="#Evidence1692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation&lt;br&gt;</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1478">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1500">
 <bp:evidence rdf:resource="#Evidence1691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1449">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1447">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1446">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1519">
 <bp:evidence rdf:resource="#Evidence1713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1518">
 <bp:evidence rdf:resource="#Evidence1712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR 7/8 or 9 : MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1517">
 <bp:evidence rdf:resource="#Evidence1711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1516">
 <bp:evidence rdf:resource="#Evidence1710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1441">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1515">
 <bp:evidence rdf:resource="#Evidence1708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal full-length TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1440">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1514">
 <bp:evidence rdf:resource="#Evidence1707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR9 dimer binds HCQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1513">
 <bp:evidence rdf:resource="#Evidence1706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal C-ter TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1512">
 <bp:evidence rdf:resource="#Evidence1705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal N-ter TLR9 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1445">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1511">
 <bp:evidence rdf:resource="#Evidence1704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S446-IRF5 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1444">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1510">
 <bp:evidence rdf:resource="#Evidence1703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4 binds TASL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1458">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1457">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1529">
 <bp:evidence rdf:resource="#Evidence1724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps within the complex pIRAK4:MyD88:activated TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1528">
 <bp:evidence rdf:resource="#Evidence1723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1527">
 <bp:evidence rdf:resource="#Evidence1722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 or 9  </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1452">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1526">
 <bp:evidence rdf:resource="#Evidence1721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 interacts with the activated TLR receptor 7, 8 or 9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1451">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1525">
 <bp:evidence rdf:resource="#Evidence1720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 ubiquitinqtes IRF7 within the activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1450">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1524">
 <bp:evidence rdf:resource="#Evidence1719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1523">
 <bp:evidence rdf:resource="#Evidence1718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1456">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1522">
 <bp:evidence rdf:resource="#Evidence1717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1455">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1521">
 <bp:evidence rdf:resource="#Evidence1716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1454">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1520">
 <bp:evidence rdf:resource="#Evidence1714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1453">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1939">
 <bp:evidence rdf:resource="#Evidence2211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bcl-2 and Bcl-XL bind NLRP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1938">
 <bp:evidence rdf:resource="#Evidence2209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">dsDNA:AIM2 clusters bind ASC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1937">
 <bp:evidence rdf:resource="#Evidence2208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1936">
 <bp:evidence rdf:resource="#Evidence2207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">dsDNA:AIM2:ASC cluster binds procaspase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1935">
 <bp:evidence rdf:resource="#Evidence2206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1934">
 <bp:evidence rdf:resource="#Evidence2203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 phosphorylates MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1933">
 <bp:evidence rdf:resource="#Evidence2202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 induces K63-linked ubiquitination of NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1932">
 <bp:evidence rdf:resource="#Evidence2201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFAIP3 (A20) deubiquitinates RIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1931">
 <bp:evidence rdf:resource="#Evidence2200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 is K63 polyubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1930">
 <bp:evidence rdf:resource="#Evidence2199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1949">
 <bp:evidence rdf:resource="#Evidence2222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 recruits PYCARD (ASC) via a PYD-PYD interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1948">
 <bp:evidence rdf:resource="#Evidence2221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 mediates loss of intracellular K+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1947">
 <bp:evidence rdf:resource="#Evidence2220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP binds reduced thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1946">
 <bp:evidence rdf:resource="#Evidence2219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 forms oligomeric non-selective cation channels</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1945">
 <bp:evidence rdf:resource="#Evidence2218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGT1 binds HSP90</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1944">
 <bp:evidence rdf:resource="#Evidence2217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PYCARD recruits procaspase-1 via CARD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1943">
 <bp:evidence rdf:resource="#Evidence2216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 mediates membrane pores that include pannexin-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1942">
 <bp:evidence rdf:resource="#Evidence2214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 senses MDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1941">
 <bp:evidence rdf:resource="#Evidence2213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1940">
 <bp:evidence rdf:resource="#Evidence2212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDP:NLRP1 binds ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1959">
 <bp:evidence rdf:resource="#Evidence2232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pyrin binds ASC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1958">
 <bp:evidence rdf:resource="#Evidence2231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROS oxidize thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1957">
 <bp:evidence rdf:resource="#Evidence2230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PSTPIP1 binds Pyrin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1956">
 <bp:evidence rdf:resource="#Evidence2229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP binds to P2X7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1955">
 <bp:evidence rdf:resource="#Evidence2228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 oligomerizes via NACHT domains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1954">
 <bp:evidence rdf:resource="#Evidence2227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 activation by elicitor proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1953">
 <bp:evidence rdf:resource="#Evidence2226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP binds NLRP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1952">
 <bp:evidence rdf:resource="#Evidence2225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of NLRP3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1951">
 <bp:evidence rdf:resource="#Evidence2224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGT1:HSP90 binds inactive NLRP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1950">
 <bp:evidence rdf:resource="#Evidence2223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 activation by small molecules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1969">
 <bp:evidence rdf:resource="#Evidence2245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 interacts with DDX58/IFIH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1968">
 <bp:evidence rdf:resource="#Evidence2244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PCBP2 with MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1967">
 <bp:evidence rdf:resource="#Evidence2243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD mediated deubiquitination of DDX58 (RIG-I)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1966">
 <bp:evidence rdf:resource="#Evidence2242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIN1 mediated IRF3 degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1965">
 <bp:evidence rdf:resource="#Evidence2240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA binds DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1964">
 <bp:evidence rdf:resource="#Evidence2239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP90 binds TBK1 and IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1963">
 <bp:evidence rdf:resource="#Evidence2238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA binds IFIH1:TKFC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1962">
 <bp:evidence rdf:resource="#Evidence2236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IPAF binds procaspase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1961">
 <bp:evidence rdf:resource="#Evidence2235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IPAF is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1960">
 <bp:evidence rdf:resource="#Evidence2233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP is released from oxidized thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1908">
 <bp:evidence rdf:resource="#Evidence2175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of ficolin-rich granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1907">
 <bp:evidence rdf:resource="#Evidence2174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of tertiary granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1906">
 <bp:evidence rdf:resource="#Evidence2172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1905">
 <bp:evidence rdf:resource="#Evidence2171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of C3 by C3 convertases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1904">
 <bp:evidence rdf:resource="#Evidence2170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of classic pathway C5 convertase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1903">
 <bp:evidence rdf:resource="#Evidence2169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5 binds C5 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1902">
 <bp:evidence rdf:resource="#Evidence2167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MBL binds to repetitive carbohydrate structures on the surfaces of viruses, bacteria, fungi, and protozoa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1901">
 <bp:evidence rdf:resource="#Evidence2166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of MASPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1900">
 <bp:evidence rdf:resource="#Evidence2165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-2 binds to molecular patterns on the target cell surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1909">
 <bp:evidence rdf:resource="#Evidence2176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of tertiary granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1919">
 <bp:evidence rdf:resource="#Evidence2188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1918">
 <bp:evidence rdf:resource="#Evidence2187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1 induced apoptosis is mediated by RIP2 and CARD8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1917">
 <bp:evidence rdf:resource="#Evidence2186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDP elicits a NOD2 response</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1916">
 <bp:evidence rdf:resource="#Evidence2183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of secretory granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1915">
 <bp:evidence rdf:resource="#Evidence2182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of specific granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1914">
 <bp:evidence rdf:resource="#Evidence2181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of azurophil granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1913">
 <bp:evidence rdf:resource="#Evidence2180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of ficolin-rich granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1912">
 <bp:evidence rdf:resource="#Evidence2179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of azurophil granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1911">
 <bp:evidence rdf:resource="#Evidence2178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of specific granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1910">
 <bp:evidence rdf:resource="#Evidence2177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of secretory granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1929">
 <bp:evidence rdf:resource="#Evidence2198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 binds NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1928">
 <bp:evidence rdf:resource="#Evidence2197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD deubiquitinates NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1927">
 <bp:evidence rdf:resource="#Evidence2196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of p38 MAPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1926">
 <bp:evidence rdf:resource="#Evidence2195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1925">
 <bp:evidence rdf:resource="#Evidence2194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">iE-DAP elicits a NOD1 response</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1924">
 <bp:evidence rdf:resource="#Evidence2193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63 polyubiquitinated RIP2 associates with the TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1923">
 <bp:evidence rdf:resource="#Evidence2192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AAMP binds NOD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1922">
 <bp:evidence rdf:resource="#Evidence2191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD2 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1921">
 <bp:evidence rdf:resource="#Evidence2190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD oligomer recruites RIP2 (RICK)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1920">
 <bp:evidence rdf:resource="#Evidence2189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARD9 binds RIP2 (and NOD2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1822">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1821">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1820">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1826">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1829">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1828">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction983">
 <bp:evidence rdf:resource="#Evidence1070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGN-lysosome vesicle uncoating and release of nonameric complex to lysosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction982">
 <bp:evidence rdf:resource="#Evidence1069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trafficking of nonameric complex in the endocytic pathway</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction985">
 <bp:evidence rdf:resource="#Evidence1072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Uncoating of clathrin-coated vesicles and fusion with endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction984">
 <bp:evidence rdf:resource="#Evidence1071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of MHC II alpha beta heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction981">
 <bp:evidence rdf:resource="#Evidence1068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of invariant chain trimer and MHC II alpha beta dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction980">
 <bp:evidence rdf:resource="#Evidence1067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Generation of CLIP from lip10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction987">
 <bp:evidence rdf:resource="#Evidence1074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reduction of disulphide bonds in MHC II antigens</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction986">
 <bp:evidence rdf:resource="#Evidence1073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of nonameric complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction989">
 <bp:evidence rdf:resource="#Evidence1076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LAG3 (CD233) binds MHC II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction988">
 <bp:evidence rdf:resource="#Evidence1075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fusion of COPII vesicle with Golgi complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1834">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1833">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1832">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1831">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1837">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1836">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1835">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1839">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction994">
 <bp:evidence rdf:resource="#Evidence1081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MHC class II antigen internalization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction993">
 <bp:evidence rdf:resource="#Evidence1080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of antigen loaded MHC II molecules to surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction996">
 <bp:evidence rdf:resource="#Evidence1083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of lip22 to lip10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction995">
 <bp:evidence rdf:resource="#Evidence1082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insertion of MHC II:Ii complex in to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction990">
 <bp:evidence rdf:resource="#Evidence1077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGN-lysosomal vesicle coat assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction992">
 <bp:evidence rdf:resource="#Evidence1079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassociation of CLIP from MHC II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction991">
 <bp:evidence rdf:resource="#Evidence1078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Loading of antigenic peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction998">
 <bp:evidence rdf:resource="#Evidence1085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of clathrin coated vesicle by Ii</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1830">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction997">
 <bp:evidence rdf:resource="#Evidence1084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of MHC II:Ii complex to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction999">
 <bp:evidence rdf:resource="#Evidence1086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of TGN-lysosome vesicle to lysosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1800">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1805">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1804">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1802">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1808">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1807">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1806">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1811">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1810">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1818">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1817">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis690">
 <bp:controlled rdf:resource="#BiochemicalReaction2025" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis691">
 <bp:controlled rdf:resource="#BiochemicalReaction2027" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis692">
 <bp:controlled rdf:resource="#BiochemicalReaction2028" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis693">
 <bp:controlled rdf:resource="#BiochemicalReaction2042" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis683">
 <bp:controlled rdf:resource="#BiochemicalReaction2000" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis684">
 <bp:controlled rdf:resource="#BiochemicalReaction2001" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis685">
 <bp:controlled rdf:resource="#BiochemicalReaction2004" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis686">
 <bp:controlled rdf:resource="#BiochemicalReaction2014" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis687">
 <bp:controlled rdf:resource="#BiochemicalReaction2018" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis688">
 <bp:controlled rdf:resource="#BiochemicalReaction2022" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis689">
 <bp:controlled rdf:resource="#BiochemicalReaction2024" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis680">
 <bp:controlled rdf:resource="#BiochemicalReaction1985" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis681">
 <bp:controlled rdf:resource="#BiochemicalReaction1991" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis682">
 <bp:controlled rdf:resource="#BiochemicalReaction1994" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis672">
 <bp:controlled rdf:resource="#BiochemicalReaction1948" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis673">
 <bp:controlled rdf:resource="#BiochemicalReaction1966" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis674">
 <bp:controlled rdf:resource="#BiochemicalReaction1967" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis675">
 <bp:controlled rdf:resource="#BiochemicalReaction1970" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis676">
 <bp:controlled rdf:resource="#BiochemicalReaction1971" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis677">
 <bp:controlled rdf:resource="#BiochemicalReaction1973" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis678">
 <bp:controlled rdf:resource="#BiochemicalReaction1975" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis679">
 <bp:controlled rdf:resource="#BiochemicalReaction1984" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis694">
 <bp:controlled rdf:resource="#BiochemicalReaction2046" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis695">
 <bp:controlled rdf:resource="#BiochemicalReaction2047" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis696">
 <bp:controlled rdf:resource="#BiochemicalReaction2056" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis697">
 <bp:controlled rdf:resource="#BiochemicalReaction2059" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis698">
 <bp:controlled rdf:resource="#BiochemicalReaction2062" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis699">
 <bp:controlled rdf:resource="#BiochemicalReaction2063" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1789">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1788">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1787">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction907">
 <bp:evidence rdf:resource="#Evidence987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STIM1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction906">
 <bp:evidence rdf:resource="#Evidence986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRAC translocates calcium from the extracellular region to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction909">
 <bp:evidence rdf:resource="#Evidence989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CD19:VAV binds PI3K and GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction908">
 <bp:evidence rdf:resource="#Evidence988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD19 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis647">
 <bp:controlled rdf:resource="#BiochemicalReaction1819" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis648">
 <bp:controlled rdf:resource="#BiochemicalReaction1820" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis649">
 <bp:controlled rdf:resource="#BiochemicalReaction1841" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction903">
 <bp:evidence rdf:resource="#Evidence983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTK autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1782">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction902">
 <bp:evidence rdf:resource="#Evidence982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds the activated BCR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1781">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis640">
 <bp:controlled rdf:resource="#BiochemicalReaction1798" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction905">
 <bp:evidence rdf:resource="#Evidence985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD19 Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1780">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis641">
 <bp:controlled rdf:resource="#BiochemicalReaction1799" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction904">
 <bp:evidence rdf:resource="#Evidence984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Immunoglobulin of the BCR binds antigen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis642">
 <bp:controlled rdf:resource="#BiochemicalReaction1801" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1786">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis643">
 <bp:controlled rdf:resource="#BiochemicalReaction1802" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1785">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis644">
 <bp:controlled rdf:resource="#BiochemicalReaction1803" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction901">
 <bp:evidence rdf:resource="#Evidence981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STIM1 binds TRPC1 forming STIM1:TRPC1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1784">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis645">
 <bp:controlled rdf:resource="#BiochemicalReaction1805" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction900">
 <bp:evidence rdf:resource="#Evidence980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-SYK phosphorylates BLNK (SLP65)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1783">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis646">
 <bp:controlled rdf:resource="#BiochemicalReaction1818" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1798">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction918">
 <bp:evidence rdf:resource="#Evidence1002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated IkB is degraded</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction917">
 <bp:evidence rdf:resource="#Evidence1001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 associated with the CBM complex phosphorylates IKKbeta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction919">
 <bp:evidence rdf:resource="#Evidence1003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TrCP ubiquitinylates IkB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis636">
 <bp:controlled rdf:resource="#BiochemicalReaction1794" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis637">
 <bp:controlled rdf:resource="#BiochemicalReaction1795" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis638">
 <bp:controlled rdf:resource="#BiochemicalReaction1796" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis639">
 <bp:controlled rdf:resource="#BiochemicalReaction1797" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction914">
 <bp:evidence rdf:resource="#Evidence996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin dephosphorylates NFATC1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1793">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction913">
 <bp:evidence rdf:resource="#Evidence995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds NFATC1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1792">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction916">
 <bp:evidence rdf:resource="#Evidence999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RasGRP1 and RasGRP3 binds diacylglycerol and is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1791">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis630">
 <bp:controlled rdf:resource="#BiochemicalReaction1788" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction915">
 <bp:evidence rdf:resource="#Evidence998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-RasGRP1,3:DAG cause RAS to exchange GDP for GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1790">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis631">
 <bp:controlled rdf:resource="#BiochemicalReaction1789" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction910">
 <bp:evidence rdf:resource="#Evidence990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI(3,4,5)P3 (PIP3) binds DAPP1 (BAM32) and DAPP1 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1797">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis632">
 <bp:controlled rdf:resource="#BiochemicalReaction1790" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1796">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis633">
 <bp:controlled rdf:resource="#BiochemicalReaction1791" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction912">
 <bp:evidence rdf:resource="#Evidence994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FKBP1A binds tacrolimus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1795">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis634">
 <bp:controlled rdf:resource="#BiochemicalReaction1792" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction911">
 <bp:evidence rdf:resource="#Evidence991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-DAPP1 (p-BAM32) binds PLCG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1794">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis635">
 <bp:controlled rdf:resource="#BiochemicalReaction1793" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1766">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1765">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction929">
 <bp:evidence rdf:resource="#Evidence1014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN phosphorylates CD22</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction928">
 <bp:evidence rdf:resource="#Evidence1013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD22 binds itself to form homo-oligomers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis670">
 <bp:controlled rdf:resource="#BiochemicalReaction1933" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1769">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis671">
 <bp:controlled rdf:resource="#BiochemicalReaction1934" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis669">
 <bp:controlled rdf:resource="#BiochemicalReaction1932" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction925">
 <bp:evidence rdf:resource="#Evidence1009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARMA1:BCL10:MALT1 complex recruits TAK1 and IKK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1760">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis661">
 <bp:controlled rdf:resource="#BiochemicalReaction1895" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction924">
 <bp:evidence rdf:resource="#Evidence1008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCB (PKC-beta) phosphorylates CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis662">
 <bp:controlled rdf:resource="#BiochemicalReaction1896" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction927">
 <bp:evidence rdf:resource="#Evidence1012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP1 binds p-CD22</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis663">
 <bp:controlled rdf:resource="#BiochemicalReaction1905" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction926">
 <bp:evidence rdf:resource="#Evidence1010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated IKK phosphorylates I-kappaB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis664">
 <bp:controlled rdf:resource="#BiochemicalReaction1906" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction921">
 <bp:evidence rdf:resource="#Evidence1005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCB (Protein kinase C beta, PKC-beta) binds diacylglycerol and phosphatidylserine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1764">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis665">
 <bp:controlled rdf:resource="#BiochemicalReaction1919" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction920">
 <bp:evidence rdf:resource="#Evidence1004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF with beta-TrCP1 or beta-TrCP2 binds NF-kappaB:phospho-IkB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1763">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis666">
 <bp:controlled rdf:resource="#BiochemicalReaction1927" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction923">
 <bp:evidence rdf:resource="#Evidence1007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappaB translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1762">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis667">
 <bp:controlled rdf:resource="#BiochemicalReaction1928" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction922">
 <bp:evidence rdf:resource="#Evidence1006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARMA1 recruits MALT1 and BCL10 forming CBM Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1761">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis668">
 <bp:controlled rdf:resource="#BiochemicalReaction1931" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1779">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1777">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1776">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction939">
 <bp:evidence rdf:resource="#Evidence1025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR3DL1 interacting with HLA Bw4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis660">
 <bp:controlled rdf:resource="#BiochemicalReaction1894" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis658">
 <bp:controlled rdf:resource="#BiochemicalReaction1891" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis659">
 <bp:controlled rdf:resource="#BiochemicalReaction1892" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction930">
 <bp:evidence rdf:resource="#Evidence1015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD22 binds B-cell receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction936">
 <bp:evidence rdf:resource="#Evidence1022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR2DL1 interacting with HLA-C group 2 (Cw3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1771">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis650">
 <bp:controlled rdf:resource="#BiochemicalReaction1847" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction935">
 <bp:evidence rdf:resource="#Evidence1021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ligands bind L-selectin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1770">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis651">
 <bp:controlled rdf:resource="#BiochemicalReaction1851" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction938">
 <bp:evidence rdf:resource="#Evidence1024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRTAM binds to NECL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis652">
 <bp:controlled rdf:resource="#BiochemicalReaction1857" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction937">
 <bp:evidence rdf:resource="#Evidence1023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ICAM1-5 bind Integrin alphaLbeta2 (LFA-1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis653">
 <bp:controlled rdf:resource="#BiochemicalReaction1867" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction932">
 <bp:evidence rdf:resource="#Evidence1018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MHC Class I interacts with CD160</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1775">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis654">
 <bp:controlled rdf:resource="#BiochemicalReaction1870" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction931">
 <bp:evidence rdf:resource="#Evidence1017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LILRs interact with MHC Class I</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1774">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis655">
 <bp:controlled rdf:resource="#BiochemicalReaction1887" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction934">
 <bp:evidence rdf:resource="#Evidence1020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NKG2D homodimer interacting with ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1773">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis656">
 <bp:controlled rdf:resource="#BiochemicalReaction1888" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction933">
 <bp:evidence rdf:resource="#Evidence1019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PILRA,PILRB bind CD99</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1772">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis657">
 <bp:controlled rdf:resource="#BiochemicalReaction1890" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1744">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1749">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction911" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1748">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep991">
 <bp:stepProcess rdf:resource="#Pathway81" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1747">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis603">
 <bp:controlled rdf:resource="#BiochemicalReaction1724" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis604">
 <bp:controlled rdf:resource="#BiochemicalReaction1726" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction941">
 <bp:evidence rdf:resource="#Evidence1027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCR binds self-lipid-based antigen via CD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis605">
 <bp:controlled rdf:resource="#BiochemicalReaction1739" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction940">
 <bp:evidence rdf:resource="#Evidence1026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PILRA binds PIANP, COLLEC12 trimer, NPDC1, CLEC4G</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis606">
 <bp:controlled rdf:resource="#BiochemicalReaction1740" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis607">
 <bp:controlled rdf:resource="#BiochemicalReaction1741" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis608">
 <bp:controlled rdf:resource="#BiochemicalReaction1747" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis609">
 <bp:controlled rdf:resource="#BiochemicalReaction1748" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep992">
 <bp:stepProcess rdf:resource="#Pathway82" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction947">
 <bp:evidence rdf:resource="#Evidence1033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CMVPP65 binds NCR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction912" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction946">
 <bp:evidence rdf:resource="#Evidence1032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR2DS2 interacting with HLA-C group 1 (Cw3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction913" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction949">
 <bp:evidence rdf:resource="#Evidence1035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VCAM1 binds Integrin alpha4beta1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction914" />
 <bp:stepProcess rdf:resource="#Catalysis243" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction948">
 <bp:evidence rdf:resource="#Evidence1034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3d-complexed antigen binds to complement receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep996">
 <bp:stepProcess rdf:resource="#Pathway83" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction943">
 <bp:evidence rdf:resource="#Evidence1029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PVR binds CD226</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1742">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep997">
 <bp:stepProcess rdf:resource="#Catalysis244" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction915" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction942">
 <bp:evidence rdf:resource="#Evidence1028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KLRC1:KLRD1 heterodimer interacts with HLA-E</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1741">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis600">
 <bp:controlled rdf:resource="#BiochemicalReaction1720" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction916" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction945">
 <bp:evidence rdf:resource="#Evidence1031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR3DL2 interacting with HLA-A3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1740">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis601">
 <bp:controlled rdf:resource="#BiochemicalReaction1722" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep999">
 <bp:stepProcess rdf:resource="#Pathway84" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction944">
 <bp:evidence rdf:resource="#Evidence1030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR2DL4 interacting with HLA-G</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis602">
 <bp:controlled rdf:resource="#BiochemicalReaction1723" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1755">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1759">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1758">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction950">
 <bp:evidence rdf:resource="#Evidence1036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR2DS1 interacting with HLA-C group 2 (Cw4)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction952">
 <bp:evidence rdf:resource="#Evidence1038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD96 binds PVR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction951">
 <bp:evidence rdf:resource="#Evidence1037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epithelial cadherin binds to KLRG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction958">
 <bp:evidence rdf:resource="#Evidence1044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC2D binds KLRB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction957">
 <bp:evidence rdf:resource="#Evidence1043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD40L binds CD40</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction959">
 <bp:evidence rdf:resource="#Evidence1045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TREM,CD300 binds lipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction954">
 <bp:evidence rdf:resource="#Evidence1040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nectin 2 binds CD226</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1753">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction953">
 <bp:evidence rdf:resource="#Evidence1039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCR complex interacts with peptide antigen-presenting MHC Class I</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1752">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction956">
 <bp:evidence rdf:resource="#Evidence1042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGA4:ITGB1 binds natalizumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1751">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction955">
 <bp:evidence rdf:resource="#Evidence1041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIR2DL2/3 interacting with HLA-C group 1 (Cw4)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1750">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1723">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1722">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1721">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1726">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1729">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction961">
 <bp:evidence rdf:resource="#Evidence1047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sialic acid binds SIGLEC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis625">
 <bp:controlled rdf:resource="#BiochemicalReaction1780" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction960">
 <bp:evidence rdf:resource="#Evidence1046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD200 binds to CD200R</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis626">
 <bp:controlled rdf:resource="#BiochemicalReaction1781" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction963">
 <bp:evidence rdf:resource="#Evidence1049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OSCAR binds collagen and SP-D</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis627">
 <bp:controlled rdf:resource="#BiochemicalReaction1784" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction962">
 <bp:evidence rdf:resource="#Evidence1048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLAMF6 binds SLAMF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis628">
 <bp:controlled rdf:resource="#BiochemicalReaction1785" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis629">
 <bp:controlled rdf:resource="#BiochemicalReaction1786" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction969">
 <bp:evidence rdf:resource="#Evidence1055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXADR binds to AMICA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction968">
 <bp:evidence rdf:resource="#Evidence1054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SAP and EAT2 binds SLAMF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis620">
 <bp:controlled rdf:resource="#BiochemicalReaction1773" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction965">
 <bp:evidence rdf:resource="#Evidence1051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LAIR2 binds collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1720">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis621">
 <bp:controlled rdf:resource="#BiochemicalReaction1774" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction964">
 <bp:evidence rdf:resource="#Evidence1050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLAMF7 binds SLAMF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis622">
 <bp:controlled rdf:resource="#BiochemicalReaction1776" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction967">
 <bp:evidence rdf:resource="#Evidence1053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCR3LG1 binds NCR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis623">
 <bp:controlled rdf:resource="#BiochemicalReaction1777" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction966">
 <bp:evidence rdf:resource="#Evidence1052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCR binds microbial lipid-based antigen via CD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis624">
 <bp:controlled rdf:resource="#BiochemicalReaction1779" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1733">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1739">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1736">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction972">
 <bp:evidence rdf:resource="#Evidence1058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fc gamma receptors interact with antigen-bound IgG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis614">
 <bp:controlled rdf:resource="#BiochemicalReaction1764" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction971">
 <bp:evidence rdf:resource="#Evidence1057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LAIR1 binds collagen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis615">
 <bp:controlled rdf:resource="#BiochemicalReaction1765" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction974">
 <bp:evidence rdf:resource="#Evidence1060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC2B binds KLRF1 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis616">
 <bp:controlled rdf:resource="#BiochemicalReaction1767" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction973">
 <bp:evidence rdf:resource="#Evidence1059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MADCAM1-1 binds Integrin alpha4beta7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis617">
 <bp:controlled rdf:resource="#BiochemicalReaction1770" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis618">
 <bp:controlled rdf:resource="#BiochemicalReaction1771" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis619">
 <bp:controlled rdf:resource="#BiochemicalReaction1772" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction970">
 <bp:evidence rdf:resource="#Evidence1056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral HA binds NCRI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction979">
 <bp:evidence rdf:resource="#Evidence1066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of COPII vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction976">
 <bp:evidence rdf:resource="#Evidence1063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of Arf1:GDP, AP-1 Clathrin coated nonameric complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1731">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis610">
 <bp:controlled rdf:resource="#BiochemicalReaction1752" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction975">
 <bp:evidence rdf:resource="#Evidence1062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Initial proteolyis of Ii by aspartic proteases to lip22</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1730">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis611">
 <bp:controlled rdf:resource="#BiochemicalReaction1755" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction978">
 <bp:evidence rdf:resource="#Evidence1065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Internalization of MHC II:Ii clathrin coated vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis612">
 <bp:controlled rdf:resource="#BiochemicalReaction1757" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction977">
 <bp:evidence rdf:resource="#Evidence1064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of CANX from nonameric complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis613">
 <bp:controlled rdf:resource="#BiochemicalReaction1762" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1892">
 <bp:evidence rdf:resource="#Evidence2153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of C2 into C2a and C2b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1891">
 <bp:evidence rdf:resource="#Evidence2152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor D cleaves C3b-bound Factor B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1890">
 <bp:evidence rdf:resource="#Evidence2151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor D cleaves C3(H2O)-bound Factor B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1899">
 <bp:evidence rdf:resource="#Evidence2164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-1 binds to molecular patterns on the target cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1898">
 <bp:evidence rdf:resource="#Evidence2163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-3 binds to molecular patterns on the target cell surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1897">
 <bp:evidence rdf:resource="#Evidence2161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CL-LK binds carbohydrates on target cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1896">
 <bp:evidence rdf:resource="#Evidence2159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C1r</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1895">
 <bp:evidence rdf:resource="#Evidence2158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1894">
 <bp:evidence rdf:resource="#Evidence2155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of C4 into C4a and C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1893">
 <bp:evidence rdf:resource="#Evidence2154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Classical C3 convertase (C4b:C2a complex)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1859">
 <bp:evidence rdf:resource="#Evidence2118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of soluble VTN:C5b-C9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1858">
 <bp:evidence rdf:resource="#Evidence2117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds host cell surface markers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1857">
 <bp:evidence rdf:resource="#Evidence2116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates Factor H-boundC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1856">
 <bp:evidence rdf:resource="#Evidence2115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds C4BP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1855">
 <bp:evidence rdf:resource="#Evidence2114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b-binding protein binds C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1854">
 <bp:evidence rdf:resource="#Evidence2113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Displacement of C2a/Bb by CR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1853">
 <bp:evidence rdf:resource="#Evidence2112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD55 (DAF) binds C3bBb, C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1852">
 <bp:evidence rdf:resource="#Evidence2111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR1 binds C3bBb/C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1851">
 <bp:evidence rdf:resource="#Evidence2110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CPN, CPB2 cleave C3a, C5a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1850">
 <bp:evidence rdf:resource="#Evidence2109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1869">
 <bp:evidence rdf:resource="#Evidence2128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD59 inhibits MAC formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1868">
 <bp:evidence rdf:resource="#Evidence2127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CFHR dimers bind C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1867">
 <bp:evidence rdf:resource="#Evidence2126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates plasma Factor H-bound C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1866">
 <bp:evidence rdf:resource="#Evidence2125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5a receptor binds C5a anaphylatoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1865">
 <bp:evidence rdf:resource="#Evidence2124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to extracellular Factor H:C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1864">
 <bp:evidence rdf:resource="#Evidence2123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Clusterin binds C5b-C7, C8, C9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1863">
 <bp:evidence rdf:resource="#Evidence2122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3a receptor binds anaphylatoxin C3a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1862">
 <bp:evidence rdf:resource="#Evidence2121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein binds C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1861">
 <bp:evidence rdf:resource="#Evidence2120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD55 (DAF) promotes C3bBb/C4bC2a dissociation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1860">
 <bp:evidence rdf:resource="#Evidence2119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to C3bBb</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1870">
 <bp:evidence rdf:resource="#Evidence2129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin, ELANE cleave C5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1879">
 <bp:evidence rdf:resource="#Evidence2138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD46 binds C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1878">
 <bp:evidence rdf:resource="#Evidence2137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1-Inh binds and inactivates C1r, C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1877">
 <bp:evidence rdf:resource="#Evidence2136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Vitronectin (VTN) binds to C5b:C6:C7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1876">
 <bp:evidence rdf:resource="#Evidence2135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD46 binds C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1875">
 <bp:evidence rdf:resource="#Evidence2134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein binds Protein S</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1874">
 <bp:evidence rdf:resource="#Evidence2133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I complex formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1873">
 <bp:evidence rdf:resource="#Evidence2132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to membrane-associated C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1872">
 <bp:evidence rdf:resource="#Evidence2131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1-Inh binds Antigen: antibody: C1 complex activated C1r, C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1871">
 <bp:evidence rdf:resource="#Evidence2130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of internal thioester in C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1881">
 <bp:evidence rdf:resource="#Evidence2140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein displaces C2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1880">
 <bp:evidence rdf:resource="#Evidence2139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3 convertases spontaneously dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1889">
 <bp:evidence rdf:resource="#Evidence2150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor B binds to surface-associated C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1888">
 <bp:evidence rdf:resource="#Evidence2149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of alternative pathway C5 convertase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1887">
 <bp:evidence rdf:resource="#Evidence2148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3(H2O):Factor Bb cleaves C3 to C3b and C3a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1886">
 <bp:evidence rdf:resource="#Evidence2147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Properdin stabilizes C3b:Bb bound to cell surfaces</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1885">
 <bp:evidence rdf:resource="#Evidence2146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spontaneous hydrolysis of C3 thioester</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1884">
 <bp:evidence rdf:resource="#Evidence2145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3b binds to cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1883">
 <bp:evidence rdf:resource="#Evidence2144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor B binds to C3(H2O)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1882">
 <bp:evidence rdf:resource="#Evidence2142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binds to cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence38">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence39">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1819">
 <bp:evidence rdf:resource="#Evidence2074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1818">
 <bp:evidence rdf:resource="#Evidence2073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1817">
 <bp:evidence rdf:resource="#Evidence2072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1816">
 <bp:evidence rdf:resource="#Evidence2071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1815">
 <bp:evidence rdf:resource="#Evidence2069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1814">
 <bp:evidence rdf:resource="#Evidence2068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1813">
 <bp:evidence rdf:resource="#Evidence2067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence34">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1812">
 <bp:evidence rdf:resource="#Evidence2066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence35">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1811">
 <bp:evidence rdf:resource="#Evidence2065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence36">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1810">
 <bp:evidence rdf:resource="#Evidence2064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence37">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence30">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence31">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence32">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence33">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence49">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1829">
 <bp:evidence rdf:resource="#Evidence2085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A1 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence40">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1828">
 <bp:evidence rdf:resource="#Evidence2084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1827">
 <bp:evidence rdf:resource="#Evidence2083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G or G analog binds C-ter TLR7 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1826">
 <bp:evidence rdf:resource="#Evidence2082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFTPA/SFTPD binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1825">
 <bp:evidence rdf:resource="#Evidence2081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxLDL:CD36 binds TLR4:TLR6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1824">
 <bp:evidence rdf:resource="#Evidence2080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds LTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence45">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1823">
 <bp:evidence rdf:resource="#Evidence2079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence46">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1822">
 <bp:evidence rdf:resource="#Evidence2078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence47">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1821">
 <bp:evidence rdf:resource="#Evidence2076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1/2 ligand binds to CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence48">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1820">
 <bp:evidence rdf:resource="#Evidence2075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence41">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence42">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence43">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence44">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence16">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence17">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence18">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence19">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1839">
 <bp:evidence rdf:resource="#Evidence2097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C8 binds C5b:C6:C7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1838">
 <bp:evidence rdf:resource="#Evidence2096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5b:C6:C7 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1837">
 <bp:evidence rdf:resource="#Evidence2095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5b binds C6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1836">
 <bp:evidence rdf:resource="#Evidence2094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C7 binds C5b:C6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1835">
 <bp:evidence rdf:resource="#Evidence2093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C9 binds C5b:C6:C7:C8</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence12">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1834">
 <bp:evidence rdf:resource="#Evidence2090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFTPA/SFTPD binds TLR2:TLR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence13">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1833">
 <bp:evidence rdf:resource="#Evidence2089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 release from cells</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence14">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1832">
 <bp:evidence rdf:resource="#Evidence2088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxPL binds CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence15">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1831">
 <bp:evidence rdf:resource="#Evidence2087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxPL binds LBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1830">
 <bp:evidence rdf:resource="#Evidence2086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleaved fibrinogen products bind TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence10">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence11">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence27">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence28">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence29">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1849">
 <bp:evidence rdf:resource="#Evidence2108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR2 binds C3d, C3dg, iC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1848">
 <bp:evidence rdf:resource="#Evidence2107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to MCP, CR1:C4b, C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1847">
 <bp:evidence rdf:resource="#Evidence2106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I cleaves iC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1846">
 <bp:evidence rdf:resource="#Evidence2105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I inactivates C4BP-bound C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence23">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1845">
 <bp:evidence rdf:resource="#Evidence2104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H displaces Bb</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence24">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1844">
 <bp:evidence rdf:resource="#Evidence2103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen:IgG:C1Q:2xActivated C1R:SERPING1:2xActivated C1S:SERPING1 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence25">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1843">
 <bp:evidence rdf:resource="#Evidence2102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5AR2 binds anaphylatoxins and thier desArginated derivatives</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence26">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1842">
 <bp:evidence rdf:resource="#Evidence2101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR2:C3d,C3dg,iC3b binds CD19:CD81</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1841">
 <bp:evidence rdf:resource="#Evidence2100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates MCP/CR1-bound C4b/C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence20">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1840">
 <bp:evidence rdf:resource="#Evidence2099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to membrane-associated Factor H:C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence21">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence22">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence70">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence71">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence72">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence73">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence78">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence79">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence74">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence75">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence76">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence77">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence81">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence82">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence83">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence84">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence80">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence89">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence85">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence86">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence87">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence88">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence50">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence51">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence56">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence57">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence58">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence59">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence52">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence53">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence54">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence55">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1809">
 <bp:evidence rdf:resource="#Evidence2063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence60">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1808">
 <bp:evidence rdf:resource="#Evidence2062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence61">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1807">
 <bp:evidence rdf:resource="#Evidence2061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence62">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1806">
 <bp:evidence rdf:resource="#Evidence2060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1805">
 <bp:evidence rdf:resource="#Evidence2059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1804">
 <bp:evidence rdf:resource="#Evidence2058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1803">
 <bp:evidence rdf:resource="#Evidence2057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1802">
 <bp:evidence rdf:resource="#Evidence2056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence67">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1801">
 <bp:evidence rdf:resource="#Evidence2055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence68">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1800">
 <bp:evidence rdf:resource="#Evidence2054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence69">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence63">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence64">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence65">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence66">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1701">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1700">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1706">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1705">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1703">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep6">
 <bp:stepProcess rdf:resource="#BiochemicalReaction4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep7">
 <bp:stepProcess rdf:resource="#BiochemicalReaction5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1709">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep8">
 <bp:stepProcess rdf:resource="#BiochemicalReaction6" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1708">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep9">
 <bp:stepProcess rdf:resource="#BiochemicalReaction7" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1707">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2">
 <bp:stepProcess rdf:resource="#Pathway3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep4">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep5">
 <bp:stepProcess rdf:resource="#BiochemicalReaction3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1">
 <bp:stepProcess rdf:resource="#Pathway2" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1712">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1711">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1710">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1717">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1716">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1715">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1719">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence92">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence93">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence94">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence95">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence90">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence91">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence96">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence97">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence98">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence99">
</bp:Evidence>

<bp:Provenance rdf:ID="Provenance1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reactome</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.reactome.org</bp:comment>
</bp:Provenance>

<bp:Catalysis rdf:ID="Catalysis793">
 <bp:controlled rdf:resource="#BiochemicalReaction2365" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis794">
 <bp:controlled rdf:resource="#BiochemicalReaction2366" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis795">
 <bp:controlled rdf:resource="#BiochemicalReaction2367" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis796">
 <bp:controlled rdf:resource="#BiochemicalReaction2368" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis797">
 <bp:controlled rdf:resource="#BiochemicalReaction2372" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis798">
 <bp:controlled rdf:resource="#BiochemicalReaction2373" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis799">
 <bp:controlled rdf:resource="#BiochemicalReaction2375" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1669">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1667">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1666">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis770">
 <bp:controlled rdf:resource="#BiochemicalReaction2310" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis768">
 <bp:controlled rdf:resource="#BiochemicalReaction2308" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis769">
 <bp:controlled rdf:resource="#BiochemicalReaction2309" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1661">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis760">
 <bp:controlled rdf:resource="#BiochemicalReaction2247" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1660">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis761">
 <bp:controlled rdf:resource="#BiochemicalReaction2250" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis762">
 <bp:controlled rdf:resource="#BiochemicalReaction2263" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis763">
 <bp:controlled rdf:resource="#BiochemicalReaction2266" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1665">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis764">
 <bp:controlled rdf:resource="#BiochemicalReaction2271" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1664">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis765">
 <bp:controlled rdf:resource="#BiochemicalReaction2284" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1663">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis766">
 <bp:controlled rdf:resource="#BiochemicalReaction2294" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1662">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis767">
 <bp:controlled rdf:resource="#BiochemicalReaction2306" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1679">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1678">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1677">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis757">
 <bp:controlled rdf:resource="#BiochemicalReaction2243" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis758">
 <bp:controlled rdf:resource="#BiochemicalReaction2245" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis759">
 <bp:controlled rdf:resource="#BiochemicalReaction2246" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1671">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis750">
 <bp:controlled rdf:resource="#BiochemicalReaction2229" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1670">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis751">
 <bp:controlled rdf:resource="#BiochemicalReaction2230" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis752">
 <bp:controlled rdf:resource="#BiochemicalReaction2232" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1676">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis753">
 <bp:controlled rdf:resource="#BiochemicalReaction2235" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1675">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis754">
 <bp:controlled rdf:resource="#BiochemicalReaction2237" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1674">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis755">
 <bp:controlled rdf:resource="#BiochemicalReaction2240" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1673">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis756">
 <bp:controlled rdf:resource="#BiochemicalReaction2242" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1644">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis790">
 <bp:controlled rdf:resource="#BiochemicalReaction2356" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1649">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis791">
 <bp:controlled rdf:resource="#BiochemicalReaction2360" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1648">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis792">
 <bp:controlled rdf:resource="#BiochemicalReaction2362" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis782">
 <bp:controlled rdf:resource="#BiochemicalReaction2342" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis783">
 <bp:controlled rdf:resource="#BiochemicalReaction2343" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis784">
 <bp:controlled rdf:resource="#BiochemicalReaction2344" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis785">
 <bp:controlled rdf:resource="#BiochemicalReaction2346" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1643">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis786">
 <bp:controlled rdf:resource="#BiochemicalReaction2347" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1642">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis787">
 <bp:controlled rdf:resource="#BiochemicalReaction2348" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1641">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis788">
 <bp:controlled rdf:resource="#BiochemicalReaction2349" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1640">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis789">
 <bp:controlled rdf:resource="#BiochemicalReaction2351" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1656">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1655">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis780">
 <bp:controlled rdf:resource="#BiochemicalReaction2337" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1659">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis781">
 <bp:controlled rdf:resource="#BiochemicalReaction2339" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis779">
 <bp:controlled rdf:resource="#BiochemicalReaction2334" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1650">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis771">
 <bp:controlled rdf:resource="#BiochemicalReaction2313" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis772">
 <bp:controlled rdf:resource="#BiochemicalReaction2314" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis773">
 <bp:controlled rdf:resource="#BiochemicalReaction2318" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis774">
 <bp:controlled rdf:resource="#BiochemicalReaction2319" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1654">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis775">
 <bp:controlled rdf:resource="#BiochemicalReaction2320" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1653">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis776">
 <bp:controlled rdf:resource="#BiochemicalReaction2322" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1652">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis777">
 <bp:controlled rdf:resource="#BiochemicalReaction2329" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1651">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis778">
 <bp:controlled rdf:resource="#BiochemicalReaction2330" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1624">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1626">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis724">
 <bp:controlled rdf:resource="#BiochemicalReaction2160" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis725">
 <bp:controlled rdf:resource="#BiochemicalReaction2161" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis726">
 <bp:controlled rdf:resource="#BiochemicalReaction2162" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis727">
 <bp:controlled rdf:resource="#BiochemicalReaction2166" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis728">
 <bp:controlled rdf:resource="#BiochemicalReaction2167" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis729">
 <bp:controlled rdf:resource="#BiochemicalReaction2169" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1621">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis720">
 <bp:controlled rdf:resource="#BiochemicalReaction2150" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1620">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis721">
 <bp:controlled rdf:resource="#BiochemicalReaction2152" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis722">
 <bp:controlled rdf:resource="#BiochemicalReaction2154" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis723">
 <bp:controlled rdf:resource="#BiochemicalReaction2159" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1637">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis713">
 <bp:controlled rdf:resource="#BiochemicalReaction2139" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis714">
 <bp:controlled rdf:resource="#BiochemicalReaction2142" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis715">
 <bp:controlled rdf:resource="#BiochemicalReaction2143" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis716">
 <bp:controlled rdf:resource="#BiochemicalReaction2144" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis717">
 <bp:controlled rdf:resource="#BiochemicalReaction2147" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis718">
 <bp:controlled rdf:resource="#BiochemicalReaction2148" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis719">
 <bp:controlled rdf:resource="#BiochemicalReaction2149" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1631">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis710">
 <bp:controlled rdf:resource="#BiochemicalReaction2132" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1630">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis711">
 <bp:controlled rdf:resource="#BiochemicalReaction2136" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis712">
 <bp:controlled rdf:resource="#BiochemicalReaction2137" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1607">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1606">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1609">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1608">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis746">
 <bp:controlled rdf:resource="#BiochemicalReaction2219" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis747">
 <bp:controlled rdf:resource="#BiochemicalReaction2220" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis748">
 <bp:controlled rdf:resource="#BiochemicalReaction2226" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis749">
 <bp:controlled rdf:resource="#BiochemicalReaction2227" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis740">
 <bp:controlled rdf:resource="#BiochemicalReaction2204" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis741">
 <bp:controlled rdf:resource="#BiochemicalReaction2205" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis742">
 <bp:controlled rdf:resource="#BiochemicalReaction2208" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis743">
 <bp:controlled rdf:resource="#BiochemicalReaction2212" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis744">
 <bp:controlled rdf:resource="#BiochemicalReaction2214" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis745">
 <bp:controlled rdf:resource="#BiochemicalReaction2215" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1614">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1613">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1612">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1611">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1618">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1617">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1616">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1615">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1619">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis735">
 <bp:controlled rdf:resource="#BiochemicalReaction2191" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis736">
 <bp:controlled rdf:resource="#BiochemicalReaction2193" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis737">
 <bp:controlled rdf:resource="#BiochemicalReaction2196" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis738">
 <bp:controlled rdf:resource="#BiochemicalReaction2198" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis739">
 <bp:controlled rdf:resource="#BiochemicalReaction2202" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis730">
 <bp:controlled rdf:resource="#BiochemicalReaction2170" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1610">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis731">
 <bp:controlled rdf:resource="#BiochemicalReaction2175" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis732">
 <bp:controlled rdf:resource="#BiochemicalReaction2177" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis733">
 <bp:controlled rdf:resource="#BiochemicalReaction2183" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis734">
 <bp:controlled rdf:resource="#BiochemicalReaction2188" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1771">
 <bp:evidence rdf:resource="#Evidence2016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1770">
 <bp:evidence rdf:resource="#Evidence2015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1779">
 <bp:evidence rdf:resource="#Evidence2027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1778">
 <bp:evidence rdf:resource="#Evidence2026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1777">
 <bp:evidence rdf:resource="#Evidence2024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1776">
 <bp:evidence rdf:resource="#Evidence2023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1775">
 <bp:evidence rdf:resource="#Evidence2022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1774">
 <bp:evidence rdf:resource="#Evidence2019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1773">
 <bp:evidence rdf:resource="#Evidence2018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1772">
 <bp:evidence rdf:resource="#Evidence2017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1782">
 <bp:evidence rdf:resource="#Evidence2030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1781">
 <bp:evidence rdf:resource="#Evidence2029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1780">
 <bp:evidence rdf:resource="#Evidence2028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1789">
 <bp:evidence rdf:resource="#Evidence2040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1788">
 <bp:evidence rdf:resource="#Evidence2039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1787">
 <bp:evidence rdf:resource="#Evidence2037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1786">
 <bp:evidence rdf:resource="#Evidence2036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1785">
 <bp:evidence rdf:resource="#Evidence2035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1784">
 <bp:evidence rdf:resource="#Evidence2034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1783">
 <bp:evidence rdf:resource="#Evidence2033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1793">
 <bp:evidence rdf:resource="#Evidence2046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1792">
 <bp:evidence rdf:resource="#Evidence2044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1791">
 <bp:evidence rdf:resource="#Evidence2042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1790">
 <bp:evidence rdf:resource="#Evidence2041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis702">
 <bp:controlled rdf:resource="#BiochemicalReaction2081" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis703">
 <bp:controlled rdf:resource="#BiochemicalReaction2098" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis704">
 <bp:controlled rdf:resource="#BiochemicalReaction2109" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis705">
 <bp:controlled rdf:resource="#BiochemicalReaction2116" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis706">
 <bp:controlled rdf:resource="#BiochemicalReaction2123" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis707">
 <bp:controlled rdf:resource="#BiochemicalReaction2127" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis708">
 <bp:controlled rdf:resource="#BiochemicalReaction2128" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis709">
 <bp:controlled rdf:resource="#BiochemicalReaction2130" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1799">
 <bp:evidence rdf:resource="#Evidence2052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1798">
 <bp:evidence rdf:resource="#Evidence2051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1797">
 <bp:evidence rdf:resource="#Evidence2050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1796">
 <bp:evidence rdf:resource="#Evidence2049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1795">
 <bp:evidence rdf:resource="#Evidence2048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis700">
 <bp:controlled rdf:resource="#BiochemicalReaction2072" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1794">
 <bp:evidence rdf:resource="#Evidence2047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis701">
 <bp:controlled rdf:resource="#BiochemicalReaction2080" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1739">
 <bp:evidence rdf:resource="#Evidence1979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1738">
 <bp:evidence rdf:resource="#Evidence1978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1737">
 <bp:evidence rdf:resource="#Evidence1977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1736">
 <bp:evidence rdf:resource="#Evidence1975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1735">
 <bp:evidence rdf:resource="#Evidence1974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1734">
 <bp:evidence rdf:resource="#Evidence1973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1733">
 <bp:evidence rdf:resource="#Evidence1972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1732">
 <bp:evidence rdf:resource="#Evidence1971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1731">
 <bp:evidence rdf:resource="#Evidence1970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1730">
 <bp:evidence rdf:resource="#Evidence1969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1749">
 <bp:evidence rdf:resource="#Evidence1993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1748">
 <bp:evidence rdf:resource="#Evidence1991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1747">
 <bp:evidence rdf:resource="#Evidence1990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1746">
 <bp:evidence rdf:resource="#Evidence1989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1745">
 <bp:evidence rdf:resource="#Evidence1988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1744">
 <bp:evidence rdf:resource="#Evidence1986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1743">
 <bp:evidence rdf:resource="#Evidence1984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1:TLR2 is recruited to ligand:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1742">
 <bp:evidence rdf:resource="#Evidence1982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR6/2 ligand associates with CD14 and CD36 within lipid rafts</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1741">
 <bp:evidence rdf:resource="#Evidence1981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1740">
 <bp:evidence rdf:resource="#Evidence1980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1689">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1688">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1759">
 <bp:evidence rdf:resource="#Evidence2004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1758">
 <bp:evidence rdf:resource="#Evidence2003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1683">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1757">
 <bp:evidence rdf:resource="#Evidence2002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1682">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1756">
 <bp:evidence rdf:resource="#Evidence2001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1681">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1755">
 <bp:evidence rdf:resource="#Evidence2000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1680">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1754">
 <bp:evidence rdf:resource="#Evidence1999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1687">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1753">
 <bp:evidence rdf:resource="#Evidence1998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1686">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1752">
 <bp:evidence rdf:resource="#Evidence1997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1685">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1751">
 <bp:evidence rdf:resource="#Evidence1996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1684">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1750">
 <bp:evidence rdf:resource="#Evidence1994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1760">
 <bp:evidence rdf:resource="#Evidence2005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1699">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1690">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1769">
 <bp:evidence rdf:resource="#Evidence2014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1694">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1768">
 <bp:evidence rdf:resource="#Evidence2013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1693">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1767">
 <bp:evidence rdf:resource="#Evidence2012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1692">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1766">
 <bp:evidence rdf:resource="#Evidence2011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1691">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1765">
 <bp:evidence rdf:resource="#Evidence2010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1698">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1764">
 <bp:evidence rdf:resource="#Evidence2009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1697">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1763">
 <bp:evidence rdf:resource="#Evidence2008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1696">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1762">
 <bp:evidence rdf:resource="#Evidence2007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1695">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1761">
 <bp:evidence rdf:resource="#Evidence2006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2167">
 <bp:stepProcess rdf:resource="#Pathway266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1903" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1904" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1180">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1905" />
 <bp:stepProcess rdf:resource="#Catalysis663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1906" />
 <bp:stepProcess rdf:resource="#Catalysis664" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1184">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1908" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1183">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1909" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1182">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2172">
 <bp:stepProcess rdf:resource="#Pathway267" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1181">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1907" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1189">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1912" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1913" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1910" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1911" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1191">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1915" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1190">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1916" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1914" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1195">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1917" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1194">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1918" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1193">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2183">
 <bp:stepProcess rdf:resource="#Pathway268" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1192">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2184">
 <bp:stepProcess rdf:resource="#Pathway269" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1196">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1921" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1919" />
 <bp:stepProcess rdf:resource="#Catalysis665" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1920" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1924" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1925" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1922" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1923" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1162">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1928" />
 <bp:stepProcess rdf:resource="#Catalysis667" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2493">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1161">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1929" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1160">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1926" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2491">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1927" />
 <bp:stepProcess rdf:resource="#Catalysis666" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2490">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2495">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2494">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2499">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2498">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1930" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1931" />
 <bp:stepProcess rdf:resource="#Catalysis668" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1178">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction741">
 <bp:evidence rdf:resource="#Evidence800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Carbonic anhydrase 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction740">
 <bp:evidence rdf:resource="#Evidence799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Glutathione S-transferase omega-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction743">
 <bp:evidence rdf:resource="#Evidence802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of S-methyl-5&apos;-thioadenosine phosphorylase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction742">
 <bp:evidence rdf:resource="#Evidence801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IFNG gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction749">
 <bp:evidence rdf:resource="#Evidence808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Phosphatidylinositol transfer protein alpha isoform</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction748">
 <bp:evidence rdf:resource="#Evidence807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Ras-related protein Ral-A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction745">
 <bp:evidence rdf:resource="#Evidence804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Heterogeneous nuclear ribonucleoprotein D-like</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction744">
 <bp:evidence rdf:resource="#Evidence803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ADP-ribosylation factor 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction747">
 <bp:evidence rdf:resource="#Evidence806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Lamin-B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction746">
 <bp:evidence rdf:resource="#Evidence805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of lymphocyte cytosolic protein 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction752">
 <bp:evidence rdf:resource="#Evidence811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of superoxide dismutase 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction751">
 <bp:evidence rdf:resource="#Evidence810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of heterogeneous nuclear ribonucleoprotein F</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction754">
 <bp:evidence rdf:resource="#Evidence813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Moesin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction753">
 <bp:evidence rdf:resource="#Evidence812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Macrophage migration inhibitory factor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction750">
 <bp:evidence rdf:resource="#Evidence809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Programmed cell death protein 4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction759">
 <bp:evidence rdf:resource="#Evidence819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CANX binds EBI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction756">
 <bp:evidence rdf:resource="#Evidence815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12RB1 binds TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction755">
 <bp:evidence rdf:resource="#Evidence814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of BolA-like protein 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction758">
 <bp:evidence rdf:resource="#Evidence818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 and STAT1 are phosphorylated by JAKs after IL27:IL27R interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction757">
 <bp:evidence rdf:resource="#Evidence817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1, STAT3 bind p-Y611-IL27RA from Interleukin-27:Interleukin-27 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction763">
 <bp:evidence rdf:resource="#Evidence823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CANX dissociates from IL27:EBI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction762">
 <bp:evidence rdf:resource="#Evidence822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 binds p-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction765">
 <bp:evidence rdf:resource="#Evidence825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1,JAK2,(TYK2) bind IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction764">
 <bp:evidence rdf:resource="#Evidence824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL27RA binds JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction761">
 <bp:evidence rdf:resource="#Evidence821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">sIL27RA translocates from the cytoplasm to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction760">
 <bp:evidence rdf:resource="#Evidence820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL27 translocates from the cytosol to the extracellular space</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction767">
 <bp:evidence rdf:resource="#Evidence827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-27 binds Interleukin-27 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction766">
 <bp:evidence rdf:resource="#Evidence826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EBI3:CANX binds IL27</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction769">
 <bp:evidence rdf:resource="#Evidence829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-27 dissociates from Interleukin-27 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction768">
 <bp:evidence rdf:resource="#Evidence828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL27RA and IL6ST are phosphorylated after IL27:IL27 receptor interaction and JAK&apos;s phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction774">
 <bp:evidence rdf:resource="#Evidence834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1 and p-Y705-STAT3 dissociate from IL27:IL27 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction773">
 <bp:evidence rdf:resource="#Evidence833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-27 translocates from the ER lumen to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction776">
 <bp:evidence rdf:resource="#Evidence836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL27 binds CRLF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction775">
 <bp:evidence rdf:resource="#Evidence835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1, JAK2, TYK2 in IL27:EBI3:IL27RA:JAK1:IL6ST:(JAK1,JAK2,TYK2) are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction770">
 <bp:evidence rdf:resource="#Evidence830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL27RA dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction772">
 <bp:evidence rdf:resource="#Evidence832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRLF1:IL27 translocates to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction771">
 <bp:evidence rdf:resource="#Evidence831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1:p-Y705-STAT3 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction778">
 <bp:evidence rdf:resource="#Evidence839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL17RA:IL17RE binds IL17C dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction777">
 <bp:evidence rdf:resource="#Evidence838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL17RA and IL17RC bind IL17A dimer,IL17F dimer,IL17A:IL17F</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction779">
 <bp:evidence rdf:resource="#Evidence840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL17RA and IL17RB bind IL25 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction790">
 <bp:evidence rdf:resource="#Evidence856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction785">
 <bp:evidence rdf:resource="#Evidence849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction784">
 <bp:evidence rdf:resource="#Evidence848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction787">
 <bp:evidence rdf:resource="#Evidence851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction786">
 <bp:evidence rdf:resource="#Evidence850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction781">
 <bp:evidence rdf:resource="#Evidence844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction780">
 <bp:evidence rdf:resource="#Evidence843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction783">
 <bp:evidence rdf:resource="#Evidence847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction782">
 <bp:evidence rdf:resource="#Evidence845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction789">
 <bp:evidence rdf:resource="#Evidence855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction788">
 <bp:evidence rdf:resource="#Evidence854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction796">
 <bp:evidence rdf:resource="#Evidence863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction795">
 <bp:evidence rdf:resource="#Evidence862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction798">
 <bp:evidence rdf:resource="#Evidence867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction797">
 <bp:evidence rdf:resource="#Evidence865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction792">
 <bp:evidence rdf:resource="#Evidence858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction791">
 <bp:evidence rdf:resource="#Evidence857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction794">
 <bp:evidence rdf:resource="#Evidence861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction793">
 <bp:evidence rdf:resource="#Evidence860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction799">
 <bp:evidence rdf:resource="#Evidence868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence705">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence706">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence707">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence708">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence709">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence700">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence701">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence726">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence729">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence720">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence721">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence722">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence723">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence715">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence716">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence717">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence719">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence710">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence711">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence712">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence749">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence740">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence741">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence742">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence744">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence739">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence730">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence731">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence733">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence736">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction709">
 <bp:evidence rdf:resource="#Evidence767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y693-STAT4 dissociates after IL12:IL12R interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction708">
 <bp:evidence rdf:resource="#Evidence766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12B dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence763">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence764">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence765">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence766">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence769">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction705">
 <bp:evidence rdf:resource="#Evidence763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-12 dissociates from Interleukin-12 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction704">
 <bp:evidence rdf:resource="#Evidence762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT4 binds to IL12RB2 in Interleukin-12 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction707">
 <bp:evidence rdf:resource="#Evidence765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12RB1:TYK2 binds IL12RB2:JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction706">
 <bp:evidence rdf:resource="#Evidence764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y693-STAT4 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction701">
 <bp:evidence rdf:resource="#Evidence759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2, TYK2 in IL12A:IL12RB1:TYK2:IL12B:IL12RB2:JAK2 are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction700">
 <bp:evidence rdf:resource="#Evidence757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1/JAK2 bound to IL12RB2:IL6ST receptor phosphorylates STAT1 and STAT4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence760">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction703">
 <bp:evidence rdf:resource="#Evidence761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT4 is phosphorylated by p-JAK2 and/or p-Y-TYK2 after IL12:IL12R interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction702">
 <bp:evidence rdf:resource="#Evidence760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-12 binds Interleukin-12 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence761">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction719">
 <bp:evidence rdf:resource="#Evidence777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12B:IL12B translocates from ER lumen to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence759">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence752">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence753">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction710">
 <bp:evidence rdf:resource="#Evidence768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Y693-STAT4 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence755">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence758">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction716">
 <bp:evidence rdf:resource="#Evidence774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12RB2 binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction715">
 <bp:evidence rdf:resource="#Evidence773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12A:IL12B translocates from Golgi lumen to late endosome lumen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction718">
 <bp:evidence rdf:resource="#Evidence776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12A:IL12B translocates from late endosome lumen to extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction717">
 <bp:evidence rdf:resource="#Evidence775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12A:IL12B translocates from ER lumen to Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction712">
 <bp:evidence rdf:resource="#Evidence770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12 bound to IL12R internalises</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction711">
 <bp:evidence rdf:resource="#Evidence769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12RB2 in IL12A:IL12RB1:p-Y-TYK2:IL12B:IL12RB2:p-JAK2 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction714">
 <bp:evidence rdf:resource="#Evidence772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12A binds IL12B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence750">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction713">
 <bp:evidence rdf:resource="#Evidence771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12B translocates from the cytosol to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence785">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction721">
 <bp:evidence rdf:resource="#Evidence780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Cofilin-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence786">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction720">
 <bp:evidence rdf:resource="#Evidence779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Stress-70 protein, mitochondrial</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence788">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence789">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction727">
 <bp:evidence rdf:resource="#Evidence786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Aryl Hydrocarbon receptor-interacting protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction726">
 <bp:evidence rdf:resource="#Evidence785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of glutathione S-transferase alpha 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction729">
 <bp:evidence rdf:resource="#Evidence788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Plasminogen activator inhibitor 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction728">
 <bp:evidence rdf:resource="#Evidence787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Peptidyl-prolyl cis-trans isomerase A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence780">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction723">
 <bp:evidence rdf:resource="#Evidence782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of SOD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction722">
 <bp:evidence rdf:resource="#Evidence781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Proteasome activator complex subunit 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence781">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence782">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction725">
 <bp:evidence rdf:resource="#Evidence784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of TCP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction724">
 <bp:evidence rdf:resource="#Evidence783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ribosomal protein lateral stalk subunit P0</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence773">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction730">
 <bp:evidence rdf:resource="#Evidence789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence774">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence775">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction732">
 <bp:evidence rdf:resource="#Evidence791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of calponin-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence776">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction731">
 <bp:evidence rdf:resource="#Evidence790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of cell division cycle 42</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence777">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence779">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction738">
 <bp:evidence rdf:resource="#Evidence797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression U2 small nuclear ribonucleoprotein A&apos;</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction737">
 <bp:evidence rdf:resource="#Evidence796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of annexin A2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction739">
 <bp:evidence rdf:resource="#Evidence798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of transaldolase 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction734">
 <bp:evidence rdf:resource="#Evidence793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Heterogeneous nuclear ribonucleoproteins A2/B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence770">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction733">
 <bp:evidence rdf:resource="#Evidence792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of capping actin protein of muscle Z-line alpha subunit 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence771">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction736">
 <bp:evidence rdf:resource="#Evidence795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Interleukin-10</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence772">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction735">
 <bp:evidence rdf:resource="#Evidence794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Ras-related protein Rap-1b</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1871" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1149">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1865" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1866" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1863" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1864" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1870" />
 <bp:stepProcess rdf:resource="#Catalysis654" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1867" />
 <bp:stepProcess rdf:resource="#Catalysis653" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1868" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1140">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1872" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2471">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1873" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2470">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2479">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2476">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1876" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1877" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2132">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1874" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1875" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1880" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1881" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1879" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence796">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1151">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1882" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2482">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1150">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2142">
 <bp:stepProcess rdf:resource="#Pathway261" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2480">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2140">
 <bp:stepProcess rdf:resource="#Pathway260" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence790">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence791">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence792">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1128">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2458">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1885" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1886" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1883" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1884" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1889" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1887" />
 <bp:stepProcess rdf:resource="#Catalysis655" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1888" />
 <bp:stepProcess rdf:resource="#Catalysis656" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1892" />
 <bp:stepProcess rdf:resource="#Catalysis659" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1893" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1890" />
 <bp:stepProcess rdf:resource="#Catalysis657" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2151">
 <bp:stepProcess rdf:resource="#Catalysis658" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1891" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2469">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2156">
 <bp:stepProcess rdf:resource="#Pathway263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2157">
 <bp:stepProcess rdf:resource="#Catalysis661" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1895" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2154">
 <bp:stepProcess rdf:resource="#Catalysis660" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1894" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2155">
 <bp:stepProcess rdf:resource="#Pathway262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2158">
 <bp:stepProcess rdf:resource="#Catalysis662" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1896" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2159">
 <bp:stepProcess rdf:resource="#Pathway264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1897" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1899" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2460">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2161">
 <bp:stepProcess rdf:resource="#Pathway265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1898" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2449">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1117">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2447">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2440">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2444">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2443">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2109">
 <bp:stepProcess rdf:resource="#Catalysis651" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1851" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2416">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1849" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2415">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1850" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2418">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1843" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1844" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1842" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1847" />
 <bp:stepProcess rdf:resource="#Catalysis650" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1848" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1845" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1846" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2410">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2427">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1860" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2426">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1861" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2429">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1854" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1855" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1852" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1853" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1859" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1856" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1857" />
 <bp:stepProcess rdf:resource="#Catalysis652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1862" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2421">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2088">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1833" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2089">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1834" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1836" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1837" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2091">
 <bp:stepProcess rdf:resource="#Pathway258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1835" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2097">
 <bp:stepProcess rdf:resource="#Pathway259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1838" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2096">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2090">
 <bp:stepProcess rdf:resource="#Pathway257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2099">
 <bp:stepProcess rdf:resource="#Catalysis649" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1841" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1085">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1084">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1089">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1088">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1087">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1086">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1096">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1095">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1093">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1099">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1098">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1097">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2046">
 <bp:stepProcess rdf:resource="#Catalysis636" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2047">
 <bp:stepProcess rdf:resource="#Catalysis637" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1795" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2044">
 <bp:stepProcess rdf:resource="#Pathway253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2045">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1793" />
 <bp:stepProcess rdf:resource="#Catalysis635" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2048">
 <bp:stepProcess rdf:resource="#Catalysis638" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1796" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2049">
 <bp:stepProcess rdf:resource="#Catalysis639" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1797" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2390">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2050">
 <bp:stepProcess rdf:resource="#Catalysis640" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1798" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1063">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1800" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1062">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1801" />
 <bp:stepProcess rdf:resource="#Catalysis642" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1061">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1799" />
 <bp:stepProcess rdf:resource="#Catalysis641" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1060">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2052">
 <bp:stepProcess rdf:resource="#Pathway254" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2391">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2398">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1066">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1065">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1064">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1069">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1068">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2399">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1804" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2058">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1805" />
 <bp:stepProcess rdf:resource="#Catalysis645" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2055">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1802" />
 <bp:stepProcess rdf:resource="#Catalysis643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2056">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1803" />
 <bp:stepProcess rdf:resource="#Catalysis644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1806" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1070">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2060">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1807" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2061">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1808" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1074">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2064">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1811" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1073">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1812" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1072">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1809" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1071">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1810" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1076">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1075">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1079">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2068">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1815" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2069">
 <bp:stepProcess rdf:resource="#Pathway255" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2066">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1813" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1814" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1817" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1818" />
 <bp:stepProcess rdf:resource="#Catalysis646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1816" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1041">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2075">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1821" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1040">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2076">
 <bp:stepProcess rdf:resource="#Pathway256" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2371">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2073">
 <bp:stepProcess rdf:resource="#Catalysis647" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1819" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2370">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2074">
 <bp:stepProcess rdf:resource="#Catalysis648" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1820" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1045">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1044">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1043">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1042">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1049">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1048">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1047">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1046">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2377">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1824" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1822" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1823" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1827" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2083">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1828" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1825" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1826" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1052">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1831" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1051">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1832" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1050">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1829" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2381">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2085">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1830" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1055">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1054">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1053">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1059">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1058">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1057">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2388">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction862">
 <bp:evidence rdf:resource="#Evidence938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction and oligomerization of MALT1 to Bcl10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction861">
 <bp:evidence rdf:resource="#Evidence937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PKC theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction864">
 <bp:evidence rdf:resource="#Evidence940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S177,S181-IKKB:IKKA:pUb-NEMO phosphorylates IkB-alpha:NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction863">
 <bp:evidence rdf:resource="#Evidence939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TAK1-TAB2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction860">
 <bp:evidence rdf:resource="#Evidence936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of TRAF6 to CBM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction869">
 <bp:evidence rdf:resource="#Evidence945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of CARMA1 to Plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction866">
 <bp:evidence rdf:resource="#Evidence942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PDK1 to Plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction865">
 <bp:evidence rdf:resource="#Evidence941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction868">
 <bp:evidence rdf:resource="#Evidence944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Bcl10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction867">
 <bp:evidence rdf:resource="#Evidence943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PI3K to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction873">
 <bp:evidence rdf:resource="#Evidence949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K bound to TRAT1 phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction872">
 <bp:evidence rdf:resource="#Evidence948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PKC theta to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction875">
 <bp:evidence rdf:resource="#Evidence952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of ZAP-70</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction874">
 <bp:evidence rdf:resource="#Evidence950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of PIP3 to PI(3,4)P2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction871">
 <bp:evidence rdf:resource="#Evidence947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of Bcl10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction870">
 <bp:evidence rdf:resource="#Evidence946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex to form NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction877">
 <bp:evidence rdf:resource="#Evidence954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of ZAP-70 to phosphorylated ITAMs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction876">
 <bp:evidence rdf:resource="#Evidence953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of ZAP-70 by Lck</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction879">
 <bp:evidence rdf:resource="#Evidence957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by membrane-associated GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction878">
 <bp:evidence rdf:resource="#Evidence955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN22 dephosphorylates ZAP70</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction884">
 <bp:evidence rdf:resource="#Evidence962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3 proteins beta and zeta bind and inhibit Rap1Gap2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction883">
 <bp:evidence rdf:resource="#Evidence961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rap1 signal termination by Rap1GAPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction886">
 <bp:evidence rdf:resource="#Evidence966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated BTK phosphorylates PLCG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction885">
 <bp:evidence rdf:resource="#Evidence963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA/PKG phosphorylate Rap1GAP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction880">
 <bp:evidence rdf:resource="#Evidence958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by cytosolic GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction882">
 <bp:evidence rdf:resource="#Evidence960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rap1 sequesters Raf1 to inhibit ERK cascade</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction881">
 <bp:evidence rdf:resource="#Evidence959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of EPACs by cAMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction888">
 <bp:evidence rdf:resource="#Evidence968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PIK3AP1 (p-BCAP) binds PIK3CD:PIK3R1 (PI3K delta)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction887">
 <bp:evidence rdf:resource="#Evidence967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SYK and LYN phosphorylate BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction889">
 <bp:evidence rdf:resource="#Evidence969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCAP Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction895">
 <bp:evidence rdf:resource="#Evidence975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction894">
 <bp:evidence rdf:resource="#Evidence974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction897">
 <bp:evidence rdf:resource="#Evidence977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction896">
 <bp:evidence rdf:resource="#Evidence976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN, FYN, BLK phosphorylate ITAMs of Ig-alpha (CD79A) and Ig-beta (CD79B)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction891">
 <bp:evidence rdf:resource="#Evidence971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BLNK (SLP-65) Signalosome hydrolyzes phosphatidyinositol bisphosphate forming diacylglycerol and inositol-1,4,5-trisphosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction890">
 <bp:evidence rdf:resource="#Evidence970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRPC1 translocates calcium from the extracellular region to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction893">
 <bp:evidence rdf:resource="#Evidence973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTK binds BTK inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction892">
 <bp:evidence rdf:resource="#Evidence972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STIM1 activation of CRAC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction899">
 <bp:evidence rdf:resource="#Evidence979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated BLNK (SLP65, in Antigen:p-BCR:p-SYK:p-BLNK:CIN85:GRB2:SOS1) binds BTK, PLCG2, VAV1, NCK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction898">
 <bp:evidence rdf:resource="#Evidence978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK autophosphorylates at the activated BCR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence804">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence805">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence806">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence807">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence808">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence800">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence802">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence826">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence828">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence829">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence820">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence821">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence822">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence817">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence818">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence810">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence811">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence847">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence849">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence840">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence841">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence842">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence843">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence844">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence845">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence846">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence836">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence837">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence839">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence830">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence831">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence832">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence833">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence834">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence835">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction808">
 <bp:evidence rdf:resource="#Evidence878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction807">
 <bp:evidence rdf:resource="#Evidence877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction809">
 <bp:evidence rdf:resource="#Evidence879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence869">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence861">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence862">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence863">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence864">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence865">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence866">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence867">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence868">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction804">
 <bp:evidence rdf:resource="#Evidence873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction803">
 <bp:evidence rdf:resource="#Evidence872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction806">
 <bp:evidence rdf:resource="#Evidence876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction805">
 <bp:evidence rdf:resource="#Evidence875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction800">
 <bp:evidence rdf:resource="#Evidence869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction802">
 <bp:evidence rdf:resource="#Evidence871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence860">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction801">
 <bp:evidence rdf:resource="#Evidence870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction819">
 <bp:evidence rdf:resource="#Evidence890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIK3R1:PIK3CA,B,D (PI3K), PLCG2 (PLCgamma2), SHC1 (SHC), PTPN11 (SHP2), GRB2:GAB2, GRB2:GAB3, GRAP2 (MONA), CBL:GRB2, INPP5D (SHIP1), INPPL1 (SHIP2) bind PolyUb,p-8Y-CSF1R and are activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction818">
 <bp:evidence rdf:resource="#Evidence889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-CBL autoubiquitinates and multiubiquitinates p-Y561-CSF1R in CSF1 dimer:p-Y561-CSF1R dimer:p-Y-CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence859">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence850">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence851">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence852">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence854">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence855">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence856">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence857">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction815">
 <bp:evidence rdf:resource="#Evidence886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R-associated phosphatidylinositol 3-kinase (PI3K) phosphorylates PI(4,5)P2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction814">
 <bp:evidence rdf:resource="#Evidence885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R-associated PLCG2 hydrolyzes phosphatidylcholine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction817">
 <bp:evidence rdf:resource="#Evidence888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R-associated SOS1 mediates exchange of GTP for GDP bound to RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction816">
 <bp:evidence rdf:resource="#Evidence887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R trans-autophosphorylates on tyrosine-561</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction811">
 <bp:evidence rdf:resource="#Evidence881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction810">
 <bp:evidence rdf:resource="#Evidence880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction813">
 <bp:evidence rdf:resource="#Evidence884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src family kinases phosphorylate CBL in CSF1 dimer:p-Y561-CSF1R dimer:CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction812">
 <bp:evidence rdf:resource="#Evidence882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction829">
 <bp:evidence rdf:resource="#Evidence903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCK recruits WASP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence883">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence884">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence885">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction820">
 <bp:evidence rdf:resource="#Evidence891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1 dimer,IL34 dimer:p-Y561-CSF1R dimer binds SRC family kinases FYN,HCK,SRC,YES1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence886">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence887">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence888">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence889">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction826">
 <bp:evidence rdf:resource="#Evidence897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1 dimer binds CSF1R or IL34</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction825">
 <bp:evidence rdf:resource="#Evidence896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R trans-autophosphorylates on multiple tyrosine and serine residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction828">
 <bp:evidence rdf:resource="#Evidence902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SLP-76 to Gads</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction827">
 <bp:evidence rdf:resource="#Evidence901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCK binds PAK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction822">
 <bp:evidence rdf:resource="#Evidence893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1 dimer,IL34 dimer:p-Y561-CSF1R dimer:SFK binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence880">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction821">
 <bp:evidence rdf:resource="#Evidence892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1R dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence881">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction824">
 <bp:evidence rdf:resource="#Evidence895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1 dimer,IL34 dimer:p-Y561-CSF1R dimer:SFK binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence882">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction823">
 <bp:evidence rdf:resource="#Evidence894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF1 dimer,IL34 dimer:p-Y561-CSF1R:GRB2:SOS1 dissociates yielding CSF1 dimer,IL34 dimer:p-Y561-CSF1R:SFK and GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence872">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence873">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence874">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction831">
 <bp:evidence rdf:resource="#Evidence905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC-gamma1 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence875">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction830">
 <bp:evidence rdf:resource="#Evidence904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of ITK to SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence876">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence877">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence879">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction837">
 <bp:evidence rdf:resource="#Evidence911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PLC-gamma1 to PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction836">
 <bp:evidence rdf:resource="#Evidence910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLC-gamma1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction839">
 <bp:evidence rdf:resource="#Evidence913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of Gads to LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction838">
 <bp:evidence rdf:resource="#Evidence912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SLP-76 binds ADAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction833">
 <bp:evidence rdf:resource="#Evidence907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma1 to LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction832">
 <bp:evidence rdf:resource="#Evidence906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TBSMs in LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence870">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction835">
 <bp:evidence rdf:resource="#Evidence909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence871">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction834">
 <bp:evidence rdf:resource="#Evidence908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SLP-76 binds NCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction840">
 <bp:evidence rdf:resource="#Evidence914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma1 to SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction842">
 <bp:evidence rdf:resource="#Evidence916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassociation of PLC-gamma1 from LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction841">
 <bp:evidence rdf:resource="#Evidence915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassociation of PLC-gamma1 from SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction848">
 <bp:evidence rdf:resource="#Evidence923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of ITAM motifs in CD3 complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction847">
 <bp:evidence rdf:resource="#Evidence922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN22 dissociates from CSK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction849">
 <bp:evidence rdf:resource="#Evidence924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of Lck-pY505 by CD45</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction844">
 <bp:evidence rdf:resource="#Evidence919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of LCK by PTPN22</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction843">
 <bp:evidence rdf:resource="#Evidence917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SLP-76:ADAP binds Ena/VASP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction846">
 <bp:evidence rdf:resource="#Evidence921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of Lck by Csk</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction845">
 <bp:evidence rdf:resource="#Evidence920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Csk with PAG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence894">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction851">
 <bp:evidence rdf:resource="#Evidence927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Change of PKC theta conformation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence895">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction850">
 <bp:evidence rdf:resource="#Evidence925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Lck</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence896">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction853">
 <bp:evidence rdf:resource="#Evidence929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN dephosphorylates PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence897">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction852">
 <bp:evidence rdf:resource="#Evidence928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Bcl10 to CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence898">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence899">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction859">
 <bp:evidence rdf:resource="#Evidence935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction858">
 <bp:evidence rdf:resource="#Evidence934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence890">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction855">
 <bp:evidence rdf:resource="#Evidence931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-TRCP ubiquitinates IkB-alpha in p-S32,33-IkB-alpha:NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence891">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction854">
 <bp:evidence rdf:resource="#Evidence930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NEMO by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence892">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction857">
 <bp:evidence rdf:resource="#Evidence933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence893">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction856">
 <bp:evidence rdf:resource="#Evidence932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1029">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2008">
 <bp:stepProcess rdf:resource="#Catalysis614" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1764" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1028">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2009">
 <bp:stepProcess rdf:resource="#Catalysis615" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1765" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2359">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1758" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1759" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1756" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1757" />
 <bp:stepProcess rdf:resource="#Catalysis612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1762" />
 <bp:stepProcess rdf:resource="#Catalysis613" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1763" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2004">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1760" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2005">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1761" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2350">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2010">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1766" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1023">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1022">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1021">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1020">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2351">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1027">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1025">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1024">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2355">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2019">
 <bp:stepProcess rdf:resource="#Pathway246" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1039">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2013">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1769" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2014">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1770" />
 <bp:stepProcess rdf:resource="#Catalysis617" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2011">
 <bp:stepProcess rdf:resource="#Catalysis616" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2012">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1768" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2017">
 <bp:stepProcess rdf:resource="#Catalysis620" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1773" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2018">
 <bp:stepProcess rdf:resource="#Catalysis621" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1774" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2015">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1771" />
 <bp:stepProcess rdf:resource="#Catalysis618" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2016">
 <bp:stepProcess rdf:resource="#Catalysis619" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1772" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1030">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2020">
 <bp:stepProcess rdf:resource="#Pathway247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2361">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1775" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2360">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1034">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1033">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1032">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1031">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1038">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1037">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1036">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1035">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1009">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1008">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1007">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1006">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2337">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2024">
 <bp:stepProcess rdf:resource="#Pathway248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2025">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2022">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1776" />
 <bp:stepProcess rdf:resource="#Catalysis622" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1777" />
 <bp:stepProcess rdf:resource="#Catalysis623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1781" />
 <bp:stepProcess rdf:resource="#Catalysis626" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1782" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2026">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1779" />
 <bp:stepProcess rdf:resource="#Catalysis624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2027">
 <bp:stepProcess rdf:resource="#Catalysis625" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1780" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2031">
 <bp:stepProcess rdf:resource="#Pathway250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1783" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2030">
 <bp:stepProcess rdf:resource="#Pathway249" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1000">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1005">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1003">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1002">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1019">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1018">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1017">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2348">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2035">
 <bp:stepProcess rdf:resource="#Catalysis629" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1786" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2033">
 <bp:stepProcess rdf:resource="#Catalysis627" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1784" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2034">
 <bp:stepProcess rdf:resource="#Catalysis628" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1785" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1789" />
 <bp:stepProcess rdf:resource="#Catalysis631" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2037">
 <bp:stepProcess rdf:resource="#Pathway251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2038">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1788" />
 <bp:stepProcess rdf:resource="#Catalysis630" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2042">
 <bp:stepProcess rdf:resource="#Pathway252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1792" />
 <bp:stepProcess rdf:resource="#Catalysis634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1790" />
 <bp:stepProcess rdf:resource="#Catalysis632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2041">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1791" />
 <bp:stepProcess rdf:resource="#Catalysis633" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1012">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1011">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1010">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1016">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1014">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1013">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2315">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2319">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1979">
 <bp:evidence rdf:resource="#Evidence2255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS binds TOMM70</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1978">
 <bp:evidence rdf:resource="#Evidence2254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1977">
 <bp:evidence rdf:resource="#Evidence2253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 inhibits MAVS-DDX58 interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2310">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1976">
 <bp:evidence rdf:resource="#Evidence2252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAX1BP1:A20 inhibit TBK1/IKKi K63-polyubiquitination</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1975">
 <bp:evidence rdf:resource="#Evidence2251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of DDX58/IFIH1 signaling by RNF216</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1974">
 <bp:evidence rdf:resource="#Evidence2250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibition of DDX58/IFIH1 signaling by ATG5:ATG12:MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1973">
 <bp:evidence rdf:resource="#Evidence2249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OTUD5 deubiquitinates TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2314">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1972">
 <bp:evidence rdf:resource="#Evidence2248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PIN1 with p-IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2313">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1971">
 <bp:evidence rdf:resource="#Evidence2247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF125 mediated ubiquitination of DDX58, IFIH1 and MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2312">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1970">
 <bp:evidence rdf:resource="#Evidence2246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of ITCH and K48 ubiquitination of MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2311">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1980">
 <bp:evidence rdf:resource="#Evidence2257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of phosphorylated IRF3,IRF7 dimers into nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2326">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1989">
 <bp:evidence rdf:resource="#Evidence2266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of interferon-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1988">
 <bp:evidence rdf:resource="#Evidence2265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 or IKBKE forms homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2321">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1987">
 <bp:evidence rdf:resource="#Evidence2264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF3,IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2320">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1986">
 <bp:evidence rdf:resource="#Evidence2263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of Phospho IRF3 or phospho IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1985">
 <bp:evidence rdf:resource="#Evidence2262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1984">
 <bp:evidence rdf:resource="#Evidence2261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE are autophosphorylated at Ser172</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2325">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1983">
 <bp:evidence rdf:resource="#Evidence2260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF3 to MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2324">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1982">
 <bp:evidence rdf:resource="#Evidence2259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREBBP, EP300 binds p-T,4S-IRF3:p-T,4S-IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2323">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1981">
 <bp:evidence rdf:resource="#Evidence2258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1/IKK epsilon complex interacts with MAVS bound TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2322">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1991">
 <bp:evidence rdf:resource="#Evidence2269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKK Complex phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1990">
 <bp:evidence rdf:resource="#Evidence2267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3:p-T,4S-IRF3:CREBBP, EP300 binds promoters of Interferon-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1999">
 <bp:evidence rdf:resource="#Evidence2278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS interacts with RIPK1 and FADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1998">
 <bp:evidence rdf:resource="#Evidence2277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of caspase-8 and -10 to FADD complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1997">
 <bp:evidence rdf:resource="#Evidence2276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerzation of procaspase-8, procaspase-10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1996">
 <bp:evidence rdf:resource="#Evidence2275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1995">
 <bp:evidence rdf:resource="#Evidence2273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS:TOMM70 recruits HSP90:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1994">
 <bp:evidence rdf:resource="#Evidence2272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of IKK by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1993">
 <bp:evidence rdf:resource="#Evidence2271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1992">
 <bp:evidence rdf:resource="#Evidence2270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of MEKK1 with TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2309">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2300">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction590">
 <bp:evidence rdf:resource="#Evidence638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction592">
 <bp:evidence rdf:resource="#Evidence640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction591">
 <bp:evidence rdf:resource="#Evidence639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction587">
 <bp:evidence rdf:resource="#Evidence634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBA is phosphorylated by Phospho IKKB kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction586">
 <bp:evidence rdf:resource="#Evidence633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 induces oligomerisation of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction589">
 <bp:evidence rdf:resource="#Evidence636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1R1:IL1:IL1RAP:MYD88 homodimer binds IRAK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction588">
 <bp:evidence rdf:resource="#Evidence635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 receptor type 1: Interleukin 1 binds Interleukin-1 receptor accessory protein, membrane associated isoform</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction583">
 <bp:evidence rdf:resource="#Evidence630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UBE2N:UBE2V1 dissociates from hp-IRAK1:3xK63-polyUb-TRAF6:3xUBE2N:UBE2V1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction582">
 <bp:evidence rdf:resource="#Evidence629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 receptor type 2 binds Interleukin 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction585">
 <bp:evidence rdf:resource="#Evidence632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1 receptor antagonist protein binds Interleukin 1 receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction584">
 <bp:evidence rdf:resource="#Evidence631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway318">
 <bp:pathwayOrder rdf:resource="#PathwayStep2680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2366" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated Ca+2 mobilization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Increase of intracellular calcium in mast cells is most crucial for mast cell degranulation. Elevation of intracellular calcium is achieved by activation of PLC-gamma. Mast cells express both PLC-gamma1 and PLC-gamma2 isoforms and activation of these enzymes leads to conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol triphosphate (IP3) and diacylglycerol (DAG). The production of IP3 leads to mobilization of intracellular Ca+2, which later results in a sustained Ca+2 flux response that is maintained by an influx of extracellular Ca+2. In addition to degranulation, an increase in intracellular calcium concentration also activates the Ca2+/calmodulin-dependent serine phosphatase calcineurin. Calcineurin dephosphorylates the nuclear factor for T cell activation (NFAT) which exposes nuclear-localization signal sequence triggering translocation of the dephosphorylated NFAT-CaN complex to the nucleus. Once in the nucleus, NFAT regulates the transcription of several cytokine genes (Kambayashi et al. 2007, Hoth    Penner 1992, Ebinu et al. 2000, Siraganian et al).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway319">
 <bp:pathwayOrder rdf:resource="#PathwayStep2703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2694" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2390" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2388" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the LAT signaling complex leads to activation of MAPK and production of cytokines. The sequence of events that leads from LAT to cytokine production has not been as clearly defined as the sequence that leads to degranulation. However, the pathways that lead to cytokine production require the guanine-nucleotide-exchange factors SOS and VAV that regulate GDP-GTP exchange of RAS. After its activation, RAS positively regulates the RAF-dependent pathway that leads to phosphorylation and, in part, activation of the mitogen-activated protein kinases (MAPKs) extracellular-signal-regulated kinase 1 (ERK1) and  ERK2 (Gilfillan    Tkaczyk 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway316">
 <bp:pathwayOrder rdf:resource="#PathwayStep2648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2333" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of LAT2/NTAL/LAB on calcium mobilization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The lipid raft resident adaptor molecules LAT1 and Non-T cell activation linker (NTAL), also known as linker for activation of B cells (LAB)/LAT2 are known participants in the regulation of mast cell calcium responses. Both LAT and NTAL are expressed and phosphorylated following engagement of FCERI on mast cells. NTAL is functionally and topographically different from LAT. There is a considerable debate on the role of NTAL in mast cell. Depending on the circumstances, NTAL appears to have a dual role as positive and negative regulator of MC responses elicited via FCERI. Studies conducted in bone marrow-derived mast cells (BMMCs) of mice lacking NTAL displayed enhanced FCERI-mediated tyrosine phosphorylation of several substrates, calcium response, degranulation, and cytokine production. This indicated that NTAL negatively regulates FCERI-mediated degranulation. However, in mice lacking both LAT and NTAL showed severe block in FCERI-mediated signaling than BMMCs deficient in LAT alone, suggesting that NTAL also shares a redundant function with LAT to play a positive role (Draberova et al. 2007, Orr    McVicar. 2011, Zhu et al. 2004, Volna et al. 2004). The major steps in NTAL mediated Ca+2 influx involves  NTAL--&gt; GAB2--&gt; PI3K</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway317">
 <bp:pathwayOrder rdf:resource="#PathwayStep2659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2349" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2355" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated NF-kB activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The increase in intracellular Ca+2 in conjunction with DAG also activates PKC and RasGRP, which inturn contributes to cytokine production by mast cells (Kambayashi et al. 2007). Activation of the FCERI engages CARMA1, BCL10 and MALT1 complex to activate NF-kB through PKC-theta (Klemm et al. 2006, Chen et al. 2007). FCERI stimulation leads to phosphorylation, and degradation of IkB which allows the release and nuclear translocation of the NF-kB proteins. Activation of the NF-kB transcription factors then results in the synthesis of several cytokines. NF-kB activation by FCERI is critical for proinflammatory cytokine production during mast cell activation and is crucial for allergic inflammatory diseases (Klemm et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway314">
 <bp:pathwayOrder rdf:resource="#PathwayStep2626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2625" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2322" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In response to receptor ligation, the tyrosine residues in DAP12&apos;s immunoreceptor tyrosine-based activation motif (ITAM) are phosphorylated by Src family kinases. These phosphotyrosines form the docking site for the protein tyrosine kinase SYK in myeloid cells and SYK and ZAP70 in NK cells. DAP12-bound SYK autophosphorylates and phosphorylates the scaffolding molecule LAT, recruiting the proximal signaling molecules phosphatidylinositol-3-OH kinase (PI3K), phospholipase-C gamma (PLC-gamma), GADS (GRB2-related adapter downstream of SHC), SLP76 (SH2 domain-containing leukocyte protein of 76 kDa), GRB2:SOS (Growth factor receptor-bound protein 2:Son of sevenless homolog 1) and VAV. All of these intermediate signalling molecules result in the recruitment and activation of kinases AKT, CBL (Casitas B-lineage lymphoma) and ERK (extracellular signal-regulated kinase), and rearrangement of the actin cytoskeleton (actin polymerization) finally leading to cellular activation. PLC-gamma generates the secondary messengers diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (InsP3), leading to activation of protein kinase C (PKC) and calcium mobilization, respectively (Turnbull    Colonna 2007, Klesney-Tait et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway315">
 <bp:pathwayOrder rdf:resource="#PathwayStep2679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2652" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2643" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2339" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2338" />
 <bp:pathwayComponent rdf:resource="#Pathway318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2337" />
 <bp:pathwayComponent rdf:resource="#Pathway319" />
 <bp:pathwayComponent rdf:resource="#Pathway316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2336" />
 <bp:pathwayComponent rdf:resource="#Pathway317" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fc epsilon receptor (FCERI) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mast cells (MC) are distributed in tissues throughout the human body and have long been recognized as key cells of type I hypersensitivity reactions. They also play important roles in inflammatory and immediate allergic reactions. Activation through FCERI-bound antigen-specific IgE causes release of potent inflammatory mediators, such as histamine, proteases, chemotactic factors, cytokines and metabolites of arachidonic acid that act on the vasculature, smooth muscle, connective tissue, mucous glands and inflammatory cells (Borish    Joseph 1992, Amin 2012, Metcalfe et al. 1993). FCERI is a multimeric cell-surface receptor that binds the Fc fragment of IgE with high affinity. On mast cells and basophils FCERI exists as a tetrameric complex consisting of one alpha-chain, one beta-chain, and two disulfide-bonded gamma-chains, and on dendritic cells, Langerhans cells, macrophages, and eosinophils it exists as a trimeric complex with one alpha-chain and two disulfide-bonded gamma-chains (Wu 2011, Kraft    Kinet 2007). FCERI signaling in mast cells includes a network of signaling molecules and adaptor proteins. These molecules coordinate ultimately leading to effects on degranulation, eicosanoid production, and cytokine and chemokine production and cell migration and adhesion, growth and survival. The first step in FCERI signaling is the phosphorylation of the tyrosine residues in the ITAM of both the beta and the gamma subunits of the FCERI by LYN, which is bound to the FCERI beta-chain. The phosphorylated ITAM then recruits the protein tyrosine kinase SYK (spleen tyrosine kinase) which then phosphorylates the adaptor protein LAT. Phosphorylated LAT (linker for activation of T cells) acts as a scaffolding protein and recruits other cytosolic adaptor molecules GRB2 (growth-factor-receptor-bound protein 2), GADS (GRB2-related adaptor protein), SHC (SRC homology 2 (SH2)-domain-containing transforming protein C) and SLP76 (SH2-domain-containing leukocyte protein of 76 kDa), as well as the exchange factors and adaptor molecules VAV and SOS (son of sevenless homologue), and the signalling enzyme phospholipase C gamma1 (PLC-gamma1). Tyrosoine phosphorylation of enzymes and adaptors, including VAV, SHC GRB2 and SOS stimulate small GTPases such as RAC, RAS and RAF. These pathways lead to activation of the ERK, JNK and p38 MAP kinases, histamine release and cytokine production. FCERI activation also triggers the phosphorylation of PLC-gamma which upon membrane localisation hydrolyse PIP2 to form IP3 and 1,2-diacylglycerol (DAG) - second messengers that release Ca2+ from internal stores and activate PKC, respectively. Degranulation or histamine release follows the activation of PLC-gamma and protein kinase C (PKC) and the increased mobilization of calcium (Ca2+). Receptor aggregation also results in the phosphorylation of adaptor protein NTAL/LAT2 which then recruits GAB2. PI3K associates with phosphorylated GAB2 and catalyses the formation of PIP3 in the membrane, which attracts many PH domain proteins like BTK, PLC-gamma, AKT and PDK. PI3K mediated activation of AKT then regulate the mast cell proliferation, development and survival (Gu et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction598">
 <bp:evidence rdf:resource="#Evidence646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1B,Myr82K-Myr83K-IL1A:IL1R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction597">
 <bp:evidence rdf:resource="#Evidence645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction599">
 <bp:evidence rdf:resource="#Evidence648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL18BP binds IL18</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction594">
 <bp:evidence rdf:resource="#Evidence642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction593">
 <bp:evidence rdf:resource="#Evidence641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction596">
 <bp:evidence rdf:resource="#Evidence644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction595">
 <bp:evidence rdf:resource="#Evidence643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction991" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1076">
 <bp:stepProcess rdf:resource="#BiochemicalReaction990" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction993" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction992" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction994" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction996" />
 <bp:stepProcess rdf:resource="#Catalysis254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction995" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction998" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1083">
 <bp:stepProcess rdf:resource="#BiochemicalReaction997" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1000" />
 <bp:stepProcess rdf:resource="#Catalysis256" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1085">
 <bp:stepProcess rdf:resource="#Catalysis255" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction999" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1088">
 <bp:stepProcess rdf:resource="#Pathway88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1001" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1089">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1002" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1004" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1003" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1006" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1005" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1007" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1097">
 <bp:stepProcess rdf:resource="#Pathway89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1096">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1099">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1010" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1098">
 <bp:stepProcess rdf:resource="#Pathway90" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction501">
 <bp:evidence rdf:resource="#Evidence540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of MAOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction500">
 <bp:evidence rdf:resource="#Evidence539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of NDN,TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction507">
 <bp:evidence rdf:resource="#Evidence546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STATs dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction506">
 <bp:evidence rdf:resource="#Evidence545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT3-upregulated nuclear proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway1">
 <bp:pathwayOrder rdf:resource="#PathwayStep1" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep897" />
 <bp:pathwayComponent rdf:resource="#Pathway72" />
 <bp:pathwayComponent rdf:resource="#Pathway2" />
 <bp:pathwayComponent rdf:resource="#Pathway105" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Immune System</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans are exposed to millions of potential pathogens daily, through contact, ingestion, and inhalation. Our ability to avoid infection depends on the adaptive immune system and during the first critical hours and days of exposure to a new pathogen, our innate immune system.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction509">
 <bp:evidence rdf:resource="#Evidence548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL4,IL13-downregulated extracellular genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction508">
 <bp:evidence rdf:resource="#Evidence547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of HMOX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway3">
 <bp:pathwayOrder rdf:resource="#PathwayStep6" />
 <bp:pathwayOrder rdf:resource="#PathwayStep7" />
 <bp:pathwayOrder rdf:resource="#PathwayStep8" />
 <bp:pathwayOrder rdf:resource="#PathwayStep9" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3" />
 <bp:pathwayOrder rdf:resource="#PathwayStep4" />
 <bp:pathwayOrder rdf:resource="#PathwayStep5" />
 <bp:pathwayOrder rdf:resource="#PathwayStep11" />
 <bp:pathwayOrder rdf:resource="#PathwayStep12" />
 <bp:pathwayOrder rdf:resource="#PathwayStep10" />
 <bp:pathwayOrder rdf:resource="#PathwayStep15" />
 <bp:pathwayOrder rdf:resource="#PathwayStep16" />
 <bp:pathwayOrder rdf:resource="#PathwayStep13" />
 <bp:pathwayOrder rdf:resource="#PathwayStep14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction12" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction8" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction9" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction4" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction10" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolactin receptor signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolactin (PRL) is a hormone secreted mainly by the anterior pituitary gland. It was originally identified by its ability to stimulate the development of the mammary gland and lactation, but is now known to have numerous and varied functions (Bole-Feysot et al. 1998). Despite this, few pathologies have been associated with abnormalities in prolactin receptor (PRLR) signaling, though roles in various forms of cancer and certain autoimmune disorders have been suggested (Goffin et al. 2002). A vast body of literature suggests effects of PRL in immune cells (Matera 1996) but PRLR KO mice have unaltered immune system development and function (Bouchard et al. 1999). In addition to the pituitary, numerous other tissues produce PRL, including the decidua and myometrium, certain cells of the immune system, brain, skin and exocrine glands such as the mammary, sweat and lacrimal glands (Ben-Jonathan et al. 1996). Pituitary PRL secretion is negatively regulated by inhibitory factors originating from the hypothalamus, the most important of which is dopamine, acting through the D2 subclass of dopamine receptors present in lactotrophs (Freeman et al. 2000). PRL-binding sites or receptors have been identified in numerous cells and tissues of adult mammals. Various forms of PRLR, generated by alternative splicing, have been reported in several species including humans (Kelly et al. 1991, Clevenger et al. 2003).  PRLR is a member of the cytokine receptor superfamily. Like many other members of this family, the first step in receptor activation was generally believed to be ligand-induced dimerization whereby one molecule of PRL bound to two molecules of receptor (Elkins et al. 2000). Recent reports suggest that PRLR pre-assembles at the plasma membrane in the absence of ligand (Gadd    Clevenger 2006, Tallet et al. 2011), suggesting that ligand-induced activation involves conformational changes in preformed PRLR dimers (Broutin et al. 2010).   PRLR has no intrinsic kinase activity but associates (Lebrun et al. 1994, 1995) with Janus kinase 2 (JAK2) which is activated following receptor activation (Campbell et al. 1994, Rui et al. 1994, Carter-Su et al. 2000, Barua et al. 2009). JAK2-dependent activation of JAK1 has also been reported (Neilson et al. 2007). It is generally accepted that activation of JAK2 occurs by transphosphorylation upon ligand-induced receptor activation, based on JAK activation by chimeric receptors in which various extracellular domains of cytokine or tyrosine kinase receptors were fused to the IL-2 receptor beta chain (see Ihle et al. 1994). This activation step involves the tyrosine phosphorylation of JAK2, which in turn phosphorylates PRLR on specific intracellular tyrosine residues leading to STAT5 recruitment and signaling, considered to be the most important signaling cascade for PRLR. STAT1 and STAT3 activation have also been reported (DaSilva et al. 1996) as have many other signaling pathways; signaling through MAP kinases (Shc/SOS/Grb2/Ras/Raf/MAPK) has been reported as a consequence of PRL stimuilation in many different cellular systems (see Bole-Feysot et al. 1998) though it is not clear how this signal is propagated. Other cascades non exhaustively include Src kinases, Focal adhesion kinase, phospholipase C gamma, PI3 kinase/Akt and Nek3 (Clevenger et al. 2003, Miller et al. 2007). The protein tyrosine phosphatase SHP2 is recruited to the C terminal tyrosine of PRLR and may have a regulatory role (Ali    Ali 2000). PRLR phosphotyrosines can recruit insulin receptor substrates (IRS) and other adaptor proteins to the receptor complex (Bole-Feysot et al. 1998).  Female homozygous PRLR knockout mice are completely infertile and show a lack of mammary development (Ormandy et al. 1997). Hemizogotes are unable to lactate following their first pregnancy and depending on the genetic background, this phenotype can persist through subsequent pregnancies (Kelly et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction503">
 <bp:evidence rdf:resource="#Evidence542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4:IL4R:JAK2 binds IL13RA1:TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway2">
 <bp:pathwayOrder rdf:resource="#PathwayStep153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep17" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2" />
 <bp:pathwayOrder rdf:resource="#PathwayStep205" />
 <bp:pathwayComponent rdf:resource="#Pathway71" />
 <bp:pathwayComponent rdf:resource="#Pathway22" />
 <bp:pathwayComponent rdf:resource="#Pathway15" />
 <bp:pathwayComponent rdf:resource="#Pathway26" />
 <bp:pathwayComponent rdf:resource="#Pathway3" />
 <bp:pathwayComponent rdf:resource="#Pathway17" />
 <bp:pathwayComponent rdf:resource="#Pathway4" />
 <bp:pathwayComponent rdf:resource="#Pathway18" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytokine Signaling in Immune system</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytokines are small proteins that regulate and mediate immunity, inflammation, and hematopoiesis. They are secreted in response to immune stimuli, and usually act briefly, locally, at very low concentrations. Cytokines bind to specific membrane receptors, which then signal the cell via second messengers, to regulate cellular activity.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction502">
 <bp:evidence rdf:resource="#Evidence541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RG binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway5">
 <bp:pathwayOrder rdf:resource="#PathwayStep76" />
 <bp:pathwayOrder rdf:resource="#PathwayStep19" />
 <bp:pathwayOrder rdf:resource="#PathwayStep60" />
 <bp:pathwayComponent rdf:resource="#Pathway7" />
 <bp:pathwayComponent rdf:resource="#Pathway6" />
 <bp:pathwayComponent rdf:resource="#Pathway8" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence19" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antiviral mechanism by IFN-stimulated genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferons activate JAK&#8211;STAT signaling, which leads to the transcriptional induction of hundreds of IFN-stimulated genes (ISGs). The ISG-encoded proteins include direct effectors which inhibit viral infection through diverse mechanisms as well as factors that promote adaptive immune responses. The ISG proteins generated by IFN pathways plays key roles in the induction of innate and adaptive immune responses.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction505">
 <bp:evidence rdf:resource="#Evidence544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of HSPA8, ALOX15</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway4">
 <bp:pathwayOrder rdf:resource="#PathwayStep100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep18" />
 <bp:pathwayOrder rdf:resource="#PathwayStep127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep93" />
 <bp:pathwayComponent rdf:resource="#Pathway9" />
 <bp:pathwayComponent rdf:resource="#Pathway12" />
 <bp:pathwayComponent rdf:resource="#Pathway10" />
 <bp:pathwayComponent rdf:resource="#Pathway5" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence18" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferons (IFNs) are cytokines that play a central role in initiating immune responses, especially antiviral and antitumor effects. There are three types of IFNs:Type I (IFN-alpha, -beta and others, such as omega, epsilon, and kappa), Type II (IFN-gamma) and Type III (IFN-lamda). In this module we are mainly focusing on type I IFNs alpha and beta and type II IFN-gamma. Both type I and type II IFNs exert their actions through cognate receptor complexes, IFNAR and IFNGR respectively, present on cell surface membranes. Type I IFNs are broadly expressed heterodimeric receptors composed of the IFNAR1 and IFNAR2 subunits, while the type II IFN receptor consists of IFNGR1 and IFNGR2. Type III interferon lambda has three members: lamda1 (IL-29), lambda2 (IL-28A), and lambda3 (IL-28B) respectively. IFN-lambda signaling is initiated through unique heterodimeric receptor composed of IFN-LR1/IF-28Ralpha and IL10R2 chains.  Type I IFNs typically recruit JAK1 and TYK2 proteins to transduce their signals to STAT1 and 2; in combination with IRF9 (IFN-regulatory factor 9), these proteins form the heterotrimeric complex ISGF3. In nucleus ISGF3 binds to IFN-stimulated response elements (ISRE) to promote gene induction.  Type II IFNs in turn rely upon the activation of JAKs 1 and 2 and STAT1. Once activated, STAT1 dimerizes to form the transcriptional regulator GAF (IFNG activated factor) and this binds to the IFNG activated sequence (GAS) elements and initiate the transcription of IFNG-responsive genes.  Like type I IFNs, IFN-lambda recruits TYK2 and JAK1 kinases and then promote the phosphorylation of STAT1/2, and induce the ISRE3 complex formation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction504">
 <bp:evidence rdf:resource="#Evidence543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of HSP90B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway7">
 <bp:pathwayOrder rdf:resource="#PathwayStep70" />
 <bp:pathwayOrder rdf:resource="#PathwayStep62" />
 <bp:pathwayOrder rdf:resource="#PathwayStep73" />
 <bp:pathwayOrder rdf:resource="#PathwayStep63" />
 <bp:pathwayOrder rdf:resource="#PathwayStep74" />
 <bp:pathwayOrder rdf:resource="#PathwayStep71" />
 <bp:pathwayOrder rdf:resource="#PathwayStep61" />
 <bp:pathwayOrder rdf:resource="#PathwayStep72" />
 <bp:pathwayOrder rdf:resource="#PathwayStep66" />
 <bp:pathwayOrder rdf:resource="#PathwayStep67" />
 <bp:pathwayOrder rdf:resource="#PathwayStep64" />
 <bp:pathwayOrder rdf:resource="#PathwayStep75" />
 <bp:pathwayOrder rdf:resource="#PathwayStep65" />
 <bp:pathwayOrder rdf:resource="#PathwayStep68" />
 <bp:pathwayOrder rdf:resource="#PathwayStep69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction58" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction56" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction61" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction62" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction55" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction63" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction64" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence61" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS antiviral response</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The human oligoadenylate synthetase (OAS) family consists of four proteins whose production is stimulated by interferon, OAS1, OAS2, OAS3, and OASL. The first three members have the 2&apos;-5&apos;-oligoadenylate synthetase activity for which the family is named (Sadler AJ    Williams BR 2008), whereas OASL is devoid of this activity despite sharing significant sequence similarity with the other OAS proteins (Zhu J et al. 2015). OAS1, 2, and 3 are activated by double-stranded RNA to synthesize 5&apos;-triphosphorylated 2&apos;-5&apos;-oligoadenylates (2-5A) from ATP (Kerr IM    Brown RE 1978). The 2-5A serve as chemically unique second messengers that induce regulated RNA decay by activating ribonuclease L (RNase L), thus mediating antiviral innate immunity (Zhou A et al. 1993; Lin RJ et al. 2009; Huang H et al. 2014; Han Y et al. 2014). RNase L has also been implicated in antibacterial innate immunity (Li XL et al. 2008). RNase L cleaves single-stranded RNA (ssRNA) in U-rich sequences, typically after UU or UA dinucleotides leaving a 5&apos;-OH and 2&apos;,3&apos;-cyclic phosphate (Floyd-Smith G et al. 1981; Wreschner DH et al.1981; Cooper DA et al. 2014). Some OAS proteins have additional or alternative antiviral functions that are independent of RNase L activity (Perelygin AA et al., 2002; Kristiansen H et al. 2011). The precise mechanisms of RNase L-independent OAS antiviral activities remain to be fully elucidated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway6">
 <bp:pathwayOrder rdf:resource="#PathwayStep51" />
 <bp:pathwayOrder rdf:resource="#PathwayStep30" />
 <bp:pathwayOrder rdf:resource="#PathwayStep52" />
 <bp:pathwayOrder rdf:resource="#PathwayStep50" />
 <bp:pathwayOrder rdf:resource="#PathwayStep22" />
 <bp:pathwayOrder rdf:resource="#PathwayStep44" />
 <bp:pathwayOrder rdf:resource="#PathwayStep23" />
 <bp:pathwayOrder rdf:resource="#PathwayStep45" />
 <bp:pathwayOrder rdf:resource="#PathwayStep20" />
 <bp:pathwayOrder rdf:resource="#PathwayStep42" />
 <bp:pathwayOrder rdf:resource="#PathwayStep21" />
 <bp:pathwayOrder rdf:resource="#PathwayStep43" />
 <bp:pathwayOrder rdf:resource="#PathwayStep26" />
 <bp:pathwayOrder rdf:resource="#PathwayStep48" />
 <bp:pathwayOrder rdf:resource="#PathwayStep27" />
 <bp:pathwayOrder rdf:resource="#PathwayStep49" />
 <bp:pathwayOrder rdf:resource="#PathwayStep24" />
 <bp:pathwayOrder rdf:resource="#PathwayStep46" />
 <bp:pathwayOrder rdf:resource="#PathwayStep25" />
 <bp:pathwayOrder rdf:resource="#PathwayStep47" />
 <bp:pathwayOrder rdf:resource="#PathwayStep28" />
 <bp:pathwayOrder rdf:resource="#PathwayStep29" />
 <bp:pathwayOrder rdf:resource="#PathwayStep40" />
 <bp:pathwayOrder rdf:resource="#PathwayStep41" />
 <bp:pathwayOrder rdf:resource="#PathwayStep33" />
 <bp:pathwayOrder rdf:resource="#PathwayStep55" />
 <bp:pathwayOrder rdf:resource="#PathwayStep34" />
 <bp:pathwayOrder rdf:resource="#PathwayStep56" />
 <bp:pathwayOrder rdf:resource="#PathwayStep31" />
 <bp:pathwayOrder rdf:resource="#PathwayStep53" />
 <bp:pathwayOrder rdf:resource="#PathwayStep32" />
 <bp:pathwayOrder rdf:resource="#PathwayStep54" />
 <bp:pathwayOrder rdf:resource="#PathwayStep37" />
 <bp:pathwayOrder rdf:resource="#PathwayStep59" />
 <bp:pathwayOrder rdf:resource="#PathwayStep38" />
 <bp:pathwayOrder rdf:resource="#PathwayStep35" />
 <bp:pathwayOrder rdf:resource="#PathwayStep57" />
 <bp:pathwayOrder rdf:resource="#PathwayStep36" />
 <bp:pathwayOrder rdf:resource="#PathwayStep58" />
 <bp:pathwayOrder rdf:resource="#PathwayStep39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction36" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction37" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction34" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction18" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction38" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction51" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction30" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction45" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction29" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction27" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction49" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction40" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction43" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction41" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction42" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence20" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR-mediated signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon-induced, double-stranded RNA-activated protein kinase PKR (EIF2AK2) mainly halts cellular protein translation by phosphorylating eIF2&#945;, which blocks the recycling of GDP-eIF2 to GTP-eIF2 required for cap-dependent translation initiation. PKR is constitutively expressed at low level, and its expression is up-regulated by interferon alpha/beta signaling. PKR is mainly localized in the cytoplasm with a small fraction in the nucleus (Tian    Mathews 2001).  PKR was identified in the 1970s (Friedman et al, 1972; Kerr et al., 1977). Its activation is characterized by the shifting of its monomer/dimer equilibrium towards the dimer, with subsequent autophosphorylation (reviewed by Sadler    Williams, 2007; Bou-Nader et al, 2019). Possible activating factors include binding of viral dsRNA to the PKR dsRNA binding domain (reviewed by Nallagatla et al, 2011), as well as cellular proteins (ISG15, PACT, DCP1A) and heparin (Patel    Sen, 1998; Dougherty et al., 2014; George et al., 1996; Fasciano et al., 2005; reviewed by Zhang et al, 2021). General translation shutdown by PKR can therefore be promoted by both viral infection and the integrated response of the cell to stress stimuli (reviewed by Pizzinga et al, 2019; Costa-Mattioli    Walter, 2020). Several cellular inhibitors of PKR activation and eIF2&#945; phosphorylation by PKR have been identified and binding of PKR to viral proteins from RNA viruses (e.g. HIV, influenza A, RSV) has also been shown to contribute to inhibition (reviewed by Cesaro    Michiels, 2021). In addition to its role in translation shutdown via eIF2&#945;, PKR affects translation through NFAR protein phosphorylation; it can also phosphorylate RNA helicase A, CDC2, and MKK6, thus modulating RNA metabolism, G2 arrest, and p38 MAPK activation. Finally, PKR can bind to TRAF proteins, the IkappaB kinase complex, GSK-3beta, and several inflammasome components leading to NF-kappa B activation, tau phosphorylation, apoptosis, and inflammasome activation (reviewed by Gil    Esteban, 2000; Garcia et al, 2007; Pindel    Sadler, 2011; Marchal et al, 2014; Yim    Williams, 2014; McKey et al, 2021).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway9">
 <bp:pathwayOrder rdf:resource="#PathwayStep99" />
 <bp:pathwayOrder rdf:resource="#PathwayStep97" />
 <bp:pathwayOrder rdf:resource="#PathwayStep98" />
 <bp:pathwayOrder rdf:resource="#PathwayStep95" />
 <bp:pathwayOrder rdf:resource="#PathwayStep96" />
 <bp:pathwayOrder rdf:resource="#PathwayStep94" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction89" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction90" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction88" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction86" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence94" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Modulation of host responses by IFN-stimulated genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Excessive or long-lasting innate immune responses can be harmful to the host, so negative feedback mechanisms are essential. This Reactome pathway describes regulatory functions of selected interferon (IFN)-stimulated genes (ISGs) such as IFI44, IFI44L, IFI6 and IFI27 that suppress the IFN-mediated innate immune responses triggered by viral infections (DeDiego ML et al., 2019a, b; Villamayor L, L&#243;pez-Garc&#237;a D et al., 2023; Villamayor L, Rivero V et al., 2023).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway8">
 <bp:pathwayOrder rdf:resource="#PathwayStep80" />
 <bp:pathwayOrder rdf:resource="#PathwayStep91" />
 <bp:pathwayOrder rdf:resource="#PathwayStep81" />
 <bp:pathwayOrder rdf:resource="#PathwayStep92" />
 <bp:pathwayOrder rdf:resource="#PathwayStep90" />
 <bp:pathwayOrder rdf:resource="#PathwayStep84" />
 <bp:pathwayOrder rdf:resource="#PathwayStep85" />
 <bp:pathwayOrder rdf:resource="#PathwayStep82" />
 <bp:pathwayOrder rdf:resource="#PathwayStep83" />
 <bp:pathwayOrder rdf:resource="#PathwayStep77" />
 <bp:pathwayOrder rdf:resource="#PathwayStep88" />
 <bp:pathwayOrder rdf:resource="#PathwayStep78" />
 <bp:pathwayOrder rdf:resource="#PathwayStep89" />
 <bp:pathwayOrder rdf:resource="#PathwayStep86" />
 <bp:pathwayOrder rdf:resource="#PathwayStep87" />
 <bp:pathwayOrder rdf:resource="#PathwayStep79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction78" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction80" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction72" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction83" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction84" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction81" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction71" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction76" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction77" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction74" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction75" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence77" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISG15 antiviral mechanism</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon-stimulated gene 15 (ISG15) is a member of the ubiquitin-like (Ubl) family. It is strongly induced upon exposure to type I Interferons (IFNs), viruses, bacterial LPS, and other stresses. Once released the mature ISG15 conjugates with an array of target proteins, a process termed ISGylation. ISGylation utilizes a mechanism similar to ubiquitination, requiring a three-step enzymatic cascade. UBE1L is the ISG15 E1 activating enzyme which specifically activates ISG15 at the expense of ATP. ISG15 is then transfered from E1 to the E2 conjugating enzyme UBCH8 and then to the target protein with the aid of an ISG15 E3 ligase, such as HERC5 and EFP. Hundreds of target proteins for ISGylation have been identified. Several proteins that are part of antiviral signaling pathways, such as RIG-I, MDA5, Mx1, PKR, filamin B, STAT1, IRF3 and JAK1, have been identified as targets for ISGylation. ISG15 also conjugates some viral proteins, inhibiting viral budding and release. ISGylation appears to act either by disrupting the activity of a target protein and/or by altering its localization within the cell.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction510">
 <bp:evidence rdf:resource="#Evidence549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CD36</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction512">
 <bp:evidence rdf:resource="#Evidence551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1,STAT3,STAT6 bind IL13:IL13R type II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction511">
 <bp:evidence rdf:resource="#Evidence550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS5,(SOCS1) bind IL4RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction518">
 <bp:evidence rdf:resource="#Evidence560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37(?-218) binds p-S423,S425-SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction517">
 <bp:evidence rdf:resource="#Evidence559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37, IL37(?-218) translocates from cytosol to extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction519">
 <bp:evidence rdf:resource="#Evidence561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37(?-218) binds SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction514">
 <bp:evidence rdf:resource="#Evidence553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3,p-Y641-STAT6 dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction513">
 <bp:evidence rdf:resource="#Evidence552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT3-upregulated cytosolic proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction516">
 <bp:evidence rdf:resource="#Evidence557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL33 binds IL1RL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction515">
 <bp:evidence rdf:resource="#Evidence556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL33:IL1RL1 binds IL1RAP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence902">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence903">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence904">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence905">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence906">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence907">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence908">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence909">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction521">
 <bp:evidence rdf:resource="#Evidence563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37(1-?) and IL37 (?-) dissocates from IL37(1-?):IL37(?-218):CASP1(120-197):CASP1(317-404)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction520">
 <bp:evidence rdf:resource="#Evidence562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction523">
 <bp:evidence rdf:resource="#Evidence565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37 binds 2x(CASP1(120-197):CASP1(317-404))</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction522">
 <bp:evidence rdf:resource="#Evidence564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPNs gene transcription and translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence900">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence901">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction529">
 <bp:evidence rdf:resource="#Evidence571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37:2x(CASP1(120-197):CASP1(317-404)) cleaves IL37</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction528">
 <bp:evidence rdf:resource="#Evidence570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction525">
 <bp:evidence rdf:resource="#Evidence567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37(?-218):p-S423,S425-SMAD3 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction524">
 <bp:evidence rdf:resource="#Evidence566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37(?-218) translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction527">
 <bp:evidence rdf:resource="#Evidence569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37 binds  IL18R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction526">
 <bp:evidence rdf:resource="#Evidence568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37:IL18R1 binds SIGIRR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction532">
 <bp:evidence rdf:resource="#Evidence575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL36:IL1RL2 binds IL1RAP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction531">
 <bp:evidence rdf:resource="#Evidence574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL36RN, IL1F10 bind IL1RL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction534">
 <bp:evidence rdf:resource="#Evidence578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 family precursors are cleaved by caspase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction533">
 <bp:evidence rdf:resource="#Evidence576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL36 binds IL1RL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction530">
 <bp:evidence rdf:resource="#Evidence572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL37, IL37(?-218) binds IL18BP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction539">
 <bp:evidence rdf:resource="#Evidence584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p62:MEKK3 binds to TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction536">
 <bp:evidence rdf:resource="#Evidence580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of caspase-1 p10/p20 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction535">
 <bp:evidence rdf:resource="#Evidence579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-1 active tetramer formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction538">
 <bp:evidence rdf:resource="#Evidence582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTSG cleaves CASP1(1-404)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction537">
 <bp:evidence rdf:resource="#Evidence581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-1 family are secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence924">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence925">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence926">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence927">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence928">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence929">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction543">
 <bp:evidence rdf:resource="#Evidence588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 is activated within the TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction542">
 <bp:evidence rdf:resource="#Evidence587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hyperphosphorylated IRAK1 associates with TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction545">
 <bp:evidence rdf:resource="#Evidence590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitinated TRAF6 binds the TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction544">
 <bp:evidence rdf:resource="#Evidence589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hp-IRAK1, hp-IRAK4 4 phosphorylate Pellino-1 and 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence920">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence921">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction541">
 <bp:evidence rdf:resource="#Evidence586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hp-IRAK1,hp-IRAK4 bind Pellino1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence922">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction540">
 <bp:evidence rdf:resource="#Evidence585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 phosphorylates MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence923">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction547">
 <bp:evidence rdf:resource="#Evidence592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1R1:IL1:IL1RAP binds MYD88 homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction546">
 <bp:evidence rdf:resource="#Evidence591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Interleukin 1 receptor complex binds Tollip</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction549">
 <bp:evidence rdf:resource="#Evidence594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 is phosphorylated downstream of IRAK4 following IL1 receptor activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction548">
 <bp:evidence rdf:resource="#Evidence593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hp-IRAK1:p-Pellino, IRAK4:p-Pellino bind UBE2N:UBE2V1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence913">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence914">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence916">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence917">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence919">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction554">
 <bp:evidence rdf:resource="#Evidence600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction553">
 <bp:evidence rdf:resource="#Evidence598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 binds to MYD88 within the IL1R complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction556">
 <bp:evidence rdf:resource="#Evidence603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction555">
 <bp:evidence rdf:resource="#Evidence601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction550">
 <bp:evidence rdf:resource="#Evidence595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 is K63 poly-ubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence910">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction552">
 <bp:evidence rdf:resource="#Evidence597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 phosphorylates IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence911">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction551">
 <bp:evidence rdf:resource="#Evidence596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence912">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction558">
 <bp:evidence rdf:resource="#Evidence605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction557">
 <bp:evidence rdf:resource="#Evidence604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction559">
 <bp:evidence rdf:resource="#Evidence606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence947">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction570">
 <bp:evidence rdf:resource="#Evidence617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence948">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence949">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction565">
 <bp:evidence rdf:resource="#Evidence612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction564">
 <bp:evidence rdf:resource="#Evidence611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction567">
 <bp:evidence rdf:resource="#Evidence614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence940">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction566">
 <bp:evidence rdf:resource="#Evidence613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence941">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction561">
 <bp:evidence rdf:resource="#Evidence608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence942">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction560">
 <bp:evidence rdf:resource="#Evidence607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence943">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction563">
 <bp:evidence rdf:resource="#Evidence610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence944">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction562">
 <bp:evidence rdf:resource="#Evidence609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence945">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction569">
 <bp:evidence rdf:resource="#Evidence616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction568">
 <bp:evidence rdf:resource="#Evidence615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence935">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence936">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction581">
 <bp:evidence rdf:resource="#Evidence628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1R1 binds IL1R1 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence937">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction580">
 <bp:evidence rdf:resource="#Evidence627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO binds polyubiquitinated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence938">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence939">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction576">
 <bp:evidence rdf:resource="#Evidence623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binding leads to IRAK1:TRAF6 release</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction575">
 <bp:evidence rdf:resource="#Evidence622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction578">
 <bp:evidence rdf:resource="#Evidence625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4-activated IRAK1 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction577">
 <bp:evidence rdf:resource="#Evidence624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-IRAK1 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence930">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction572">
 <bp:evidence rdf:resource="#Evidence619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF Beta-TrCP complex binds to NFKB p50:p65: phospho IKBA complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence931">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction571">
 <bp:evidence rdf:resource="#Evidence618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-TrCP ubiquitinates NFKB p50:p65:phospho IKBA complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence932">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction574">
 <bp:evidence rdf:resource="#Evidence621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hp-IRAK1:3xTRAF6 binds UBE2N:UBE2V1:K63-polyUb</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence933">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction573">
 <bp:evidence rdf:resource="#Evidence620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated and phosphorylated IKBA binds to and is degraded by the proteasome complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence934">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction579">
 <bp:evidence rdf:resource="#Evidence626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 is activated by autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2637">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1309">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence968">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence969">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence960">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence961">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence962">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence963">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence964">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence965">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence966">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2630">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1315">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1314">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1319">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2649">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence957">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence958">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence959">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence950">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence951">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence952">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence953">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence954">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence955">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence956">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2640">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1313">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1312">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2643">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2642">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2641">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2026" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2615">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2308">
 <bp:stepProcess rdf:resource="#Catalysis691" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2027" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2614">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2305">
 <bp:stepProcess rdf:resource="#Catalysis690" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2025" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2613">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2306">
 <bp:stepProcess rdf:resource="#Pathway282" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2612">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2619">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2618">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2309">
 <bp:stepProcess rdf:resource="#Catalysis692" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2028" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2617">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2616">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2020" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2023" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2024" />
 <bp:stepProcess rdf:resource="#Catalysis689" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2021" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2022" />
 <bp:stepProcess rdf:resource="#Catalysis688" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence982">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence983">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence984">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence985">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence986">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence987">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence988">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence989">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2611">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2610">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence980">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence981">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2037" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2626">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2038" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2625">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2035" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2624">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2036" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence979">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2029" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2311">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2030" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2033" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2034" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2031" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2032" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence971">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence972">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence973">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence974">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence975">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence976">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence977">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2621">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence970">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2607">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2606">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2609">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence993">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence994">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence995">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence996">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence997">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence998">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence999">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence990">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence991">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence992">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction948" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2365">
 <bp:stepProcess rdf:resource="#Pathway287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction947" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2080" />
 <bp:stepProcess rdf:resource="#Catalysis701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1035">
 <bp:stepProcess rdf:resource="#BiochemicalReaction950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2078" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1034">
 <bp:stepProcess rdf:resource="#BiochemicalReaction949" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2079" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1037">
 <bp:stepProcess rdf:resource="#BiochemicalReaction952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2083" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction951" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction954" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2367">
 <bp:stepProcess rdf:resource="#Catalysis702" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2081" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1038">
 <bp:stepProcess rdf:resource="#BiochemicalReaction953" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2082" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction955" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1382">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2086" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1381">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2087" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1042">
 <bp:stepProcess rdf:resource="#BiochemicalReaction957" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1380">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2084" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1041">
 <bp:stepProcess rdf:resource="#BiochemicalReaction956" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2085" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1387">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1044">
 <bp:stepProcess rdf:resource="#BiochemicalReaction959" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2090" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction958" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2091" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1046">
 <bp:stepProcess rdf:resource="#BiochemicalReaction961" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2088" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1045">
 <bp:stepProcess rdf:resource="#BiochemicalReaction960" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2089" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1048">
 <bp:stepProcess rdf:resource="#BiochemicalReaction963" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1047">
 <bp:stepProcess rdf:resource="#BiochemicalReaction962" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2092" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1049">
 <bp:stepProcess rdf:resource="#BiochemicalReaction964" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2093" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2094" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction966" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1393">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2097" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1050">
 <bp:stepProcess rdf:resource="#BiochemicalReaction965" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1392">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2384">
 <bp:stepProcess rdf:resource="#Catalysis703" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction968" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1391">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2095" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1052">
 <bp:stepProcess rdf:resource="#BiochemicalReaction967" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1390">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2096" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1399">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1398">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1369">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1055">
 <bp:stepProcess rdf:resource="#BiochemicalReaction970" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction969" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction972" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2099" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1056">
 <bp:stepProcess rdf:resource="#BiochemicalReaction971" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction974" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1058">
 <bp:stepProcess rdf:resource="#BiochemicalReaction973" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2390">
 <bp:stepProcess rdf:resource="#Pathway288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1060">
 <bp:stepProcess rdf:resource="#Pathway87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction976" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1360">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2394">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2107" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2691">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1061">
 <bp:stepProcess rdf:resource="#Catalysis250" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction975" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2108" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2690">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1064">
 <bp:stepProcess rdf:resource="#Catalysis251" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction977" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2106" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2695">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2693">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1361">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2692">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2699">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2696">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1066">
 <bp:stepProcess rdf:resource="#Catalysis252" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction980" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction979" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1068">
 <bp:stepProcess rdf:resource="#BiochemicalReaction982" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2396">
 <bp:stepProcess rdf:resource="#Catalysis704" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction981" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1069">
 <bp:stepProcess rdf:resource="#BiochemicalReaction983" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction985" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction984" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1073">
 <bp:stepProcess rdf:resource="#Catalysis253" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction987" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1371">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction986" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1370">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1075">
 <bp:stepProcess rdf:resource="#BiochemicalReaction989" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1074">
 <bp:stepProcess rdf:resource="#BiochemicalReaction988" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1376">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2048" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1348">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2046" />
 <bp:stepProcess rdf:resource="#Catalysis694" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2679">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1347">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2328">
 <bp:stepProcess rdf:resource="#Catalysis695" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2047" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2678">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2040" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2041" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2039" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2044" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2045" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2042" />
 <bp:stepProcess rdf:resource="#Catalysis693" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2043" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2673">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2671">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2670">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2677">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2676">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2674">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1008">
 <bp:stepProcess rdf:resource="#BiochemicalReaction925" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction924" />
 <bp:stepProcess rdf:resource="#Catalysis247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1359">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2056" />
 <bp:stepProcess rdf:resource="#Catalysis696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1009">
 <bp:stepProcess rdf:resource="#BiochemicalReaction926" />
 <bp:stepProcess rdf:resource="#Catalysis248" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1358">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2057" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2689">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction917" />
 <bp:stepProcess rdf:resource="#Catalysis245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2050" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2051" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction919" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2049" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction918" />
 <bp:stepProcess rdf:resource="#Catalysis246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2331">
 <bp:stepProcess rdf:resource="#Pathway283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1004">
 <bp:stepProcess rdf:resource="#BiochemicalReaction921" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2054" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction920" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2055" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction923" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2052" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1005">
 <bp:stepProcess rdf:resource="#BiochemicalReaction922" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2053" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2680">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2058" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2684">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2683">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1351">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2682">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1350">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2681">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2688">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2685">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1019">
 <bp:stepProcess rdf:resource="#BiochemicalReaction934" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2659">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1018">
 <bp:stepProcess rdf:resource="#BiochemicalReaction933" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1326">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2067" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2656">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1329">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1011">
 <bp:stepProcess rdf:resource="#BiochemicalReaction927" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2061" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1010">
 <bp:stepProcess rdf:resource="#Pathway85" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2062" />
 <bp:stepProcess rdf:resource="#Catalysis698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1013">
 <bp:stepProcess rdf:resource="#BiochemicalReaction929" />
 <bp:stepProcess rdf:resource="#Catalysis249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2341">
 <bp:stepProcess rdf:resource="#Catalysis697" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2059" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1012">
 <bp:stepProcess rdf:resource="#BiochemicalReaction928" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2060" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1015">
 <bp:stepProcess rdf:resource="#Pathway86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2065" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1014">
 <bp:stepProcess rdf:resource="#BiochemicalReaction930" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2066" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1017">
 <bp:stepProcess rdf:resource="#BiochemicalReaction932" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2063" />
 <bp:stepProcess rdf:resource="#Catalysis699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1016">
 <bp:stepProcess rdf:resource="#BiochemicalReaction931" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2064" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2068" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction935" />
</bp:PathwayStep>

<bp:BioSource rdf:ID="BioSource1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homo sapiens</bp:name>
</bp:BioSource>

<bp:Evidence rdf:ID="Evidence1320">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2651">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2650">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1324">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2654">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2653">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2652">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1339">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction944" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2669">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2667">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1022">
 <bp:stepProcess rdf:resource="#BiochemicalReaction937" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2071" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction936" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2072" />
 <bp:stepProcess rdf:resource="#Catalysis700" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1024">
 <bp:stepProcess rdf:resource="#BiochemicalReaction939" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2070" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction938" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2353">
 <bp:stepProcess rdf:resource="#Pathway284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1026">
 <bp:stepProcess rdf:resource="#BiochemicalReaction941" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2358">
 <bp:stepProcess rdf:resource="#Pathway286" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1025">
 <bp:stepProcess rdf:resource="#BiochemicalReaction940" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2074" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2356">
 <bp:stepProcess rdf:resource="#Pathway285" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1027">
 <bp:stepProcess rdf:resource="#BiochemicalReaction942" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2073" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2076" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2077" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1031">
 <bp:stepProcess rdf:resource="#BiochemicalReaction946" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1030">
 <bp:stepProcess rdf:resource="#BiochemicalReaction945" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2075" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2662">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2661">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2660">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2666">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2665">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2664">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2663">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2010" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2007" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2012" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2013" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2011" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2295">
 <bp:stepProcess rdf:resource="#Pathway281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2016" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2293">
 <bp:stepProcess rdf:resource="#Catalysis686" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2014" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2015" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2019" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2017" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2018" />
 <bp:stepProcess rdf:resource="#Catalysis687" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1289">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1290">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1296">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1295">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1299">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction620">
 <bp:evidence rdf:resource="#Evidence671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 dimer binds PTPRZ1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction622">
 <bp:evidence rdf:resource="#Evidence673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 dimer binds CSF1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction621">
 <bp:evidence rdf:resource="#Evidence672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXLNA (IL14) binds syntaxin3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction628">
 <bp:evidence rdf:resource="#Evidence681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC1 recruits SHIP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction627">
 <bp:evidence rdf:resource="#Evidence680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC1 recruits GRB2:GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction629">
 <bp:evidence rdf:resource="#Evidence682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 mediates cytokine-induced phosphorylation of GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction624">
 <bp:evidence rdf:resource="#Evidence675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34:CSF1 binds CSF1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction623">
 <bp:evidence rdf:resource="#Evidence674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-32 binds proteinase-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction626">
 <bp:evidence rdf:resource="#Evidence679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SHC1:SHIP1 complex is stabilized by GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction625">
 <bp:evidence rdf:resource="#Evidence677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction631">
 <bp:evidence rdf:resource="#Evidence684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gab2 binds the p85 subunit of Class 1A PI3 kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction630">
 <bp:evidence rdf:resource="#Evidence683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC recruits GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction633">
 <bp:evidence rdf:resource="#Evidence686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3 zeta binding allows recruitment of PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction632">
 <bp:evidence rdf:resource="#Evidence685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The receptor is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction639">
 <bp:evidence rdf:resource="#Evidence692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GM-CSF receptor alpha subunit binds GM-CSF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction638">
 <bp:evidence rdf:resource="#Evidence691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-3 receptor alpha subunit binds Interleukin-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction635">
 <bp:evidence rdf:resource="#Evidence688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dissociates from the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction634">
 <bp:evidence rdf:resource="#Evidence687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The common beta chain IL3RB binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction637">
 <bp:evidence rdf:resource="#Evidence690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-5:Interleukin-5 receptor alpha binds IL3RB:JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction636">
 <bp:evidence rdf:resource="#Evidence689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GM-CSF receptor alpha:GM-CSF binds Bc</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction642">
 <bp:evidence rdf:resource="#Evidence695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL3 stimulation induces Vav binding to Tec kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction641">
 <bp:evidence rdf:resource="#Evidence694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL3RB is phosphorylated on Ser-585</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction644">
 <bp:evidence rdf:resource="#Evidence697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of STAT5a/b by JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction643">
 <bp:evidence rdf:resource="#Evidence696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP1 and SHP2 bind the common beta chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction640">
 <bp:evidence rdf:resource="#Evidence693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction649">
 <bp:evidence rdf:resource="#Evidence702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyrosine kinases phosphorylate the receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction646">
 <bp:evidence rdf:resource="#Evidence699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-5 is a homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction645">
 <bp:evidence rdf:resource="#Evidence698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-3 receptor alpha: Interleukin-3 binds IL3RB:JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction648">
 <bp:evidence rdf:resource="#Evidence701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 can recruit GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction647">
 <bp:evidence rdf:resource="#Evidence700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 is phosphorylated, activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction653">
 <bp:evidence rdf:resource="#Evidence706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S585-IL3RB binds 14-3-3 proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction652">
 <bp:evidence rdf:resource="#Evidence705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 bound to the common beta chain becomes tyrosine phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction655">
 <bp:evidence rdf:resource="#Evidence709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction654">
 <bp:evidence rdf:resource="#Evidence707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP1 and SHP2 dephosphorylate Y628 of IL3RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction651">
 <bp:evidence rdf:resource="#Evidence704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 is recruited by JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction650">
 <bp:evidence rdf:resource="#Evidence703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SHC1 is mediated by Y593 of the common beta chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction657">
 <bp:evidence rdf:resource="#Evidence711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction656">
 <bp:evidence rdf:resource="#Evidence710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds CRK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction659">
 <bp:evidence rdf:resource="#Evidence713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL is tyrosine phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction658">
 <bp:evidence rdf:resource="#Evidence712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds B-cell linker protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction664">
 <bp:evidence rdf:resource="#Evidence720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 binds to p-Y-IL23R in IL23:IL23 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction663">
 <bp:evidence rdf:resource="#Evidence719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y693-STAT4, p-Y705-STAT3 dissociate from IL23:IL23 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction666">
 <bp:evidence rdf:resource="#Evidence722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12B:IL23A translocates from ER lumen to extracellular space</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction665">
 <bp:evidence rdf:resource="#Evidence721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12B binds IL23A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction660">
 <bp:evidence rdf:resource="#Evidence714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL:CRKL binds RAPGEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction662">
 <bp:evidence rdf:resource="#Evidence716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-5 receptor alpha subunit binds Interleukin-5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction661">
 <bp:evidence rdf:resource="#Evidence715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL, GRB2, FYN and PI3K p85 subunit are constitutively associated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction668">
 <bp:evidence rdf:resource="#Evidence724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-23 binds interleukin-23 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction667">
 <bp:evidence rdf:resource="#Evidence723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3:p-Y693-STAT4 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction669">
 <bp:evidence rdf:resource="#Evidence725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL23R binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction680">
 <bp:evidence rdf:resource="#Evidence737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT4 binds IL12RB2:IL12RB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction675">
 <bp:evidence rdf:resource="#Evidence732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1,JAK2 bound to IL27RA:IL12RB2 receptor are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction674">
 <bp:evidence rdf:resource="#Evidence730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL23R in IL23:IL23 receptor complex is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction677">
 <bp:evidence rdf:resource="#Evidence734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL35 binds IL27RA:IL12RB2 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction676">
 <bp:evidence rdf:resource="#Evidence733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1,JAK2 bound to IL27RA:IL12RB2 receptor phosphorylate STAT1,STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction671">
 <bp:evidence rdf:resource="#Evidence727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3, STAT4 are phosphorylated by p-JAK2, p-TYK2 in IL23:IL23 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction670">
 <bp:evidence rdf:resource="#Evidence726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2, TYK2 in IL23A:IL12B:IL23R:JAK2:IL12RB1:TYK2 are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction673">
 <bp:evidence rdf:resource="#Evidence729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 binds p-Y693-STAT4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction672">
 <bp:evidence rdf:resource="#Evidence728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT4 binds p-Y-IL23R in IL23:IL23 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction679">
 <bp:evidence rdf:resource="#Evidence736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EBI3 gene transcription and translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction678">
 <bp:evidence rdf:resource="#Evidence735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 bound to IL12RB2:IL12RB2 phosphorylate STAT4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction691">
 <bp:evidence rdf:resource="#Evidence748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1,STAT3 associate with IL27RA:IL12RB2 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction690">
 <bp:evidence rdf:resource="#Evidence747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CANX dissociates from IL12A:EBI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction686">
 <bp:evidence rdf:resource="#Evidence743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1/JAK2/TYK2 bound to IL6ST:IL6ST are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction685">
 <bp:evidence rdf:resource="#Evidence742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1/JAK2/TYK2 bound to IL6ST:IL6ST phosphorylate STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction688">
 <bp:evidence rdf:resource="#Evidence745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL35 binds IL12RB2:IL12RB2 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction687">
 <bp:evidence rdf:resource="#Evidence744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL35 binds IL-12RB2:IL6ST receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction682">
 <bp:evidence rdf:resource="#Evidence739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL12A gene transcription and translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction681">
 <bp:evidence rdf:resource="#Evidence738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1/JAK2 bound to IL35:IL6ST:IL12RB2 receptor are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction684">
 <bp:evidence rdf:resource="#Evidence741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EBI3:CANX binds IL12A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction683">
 <bp:evidence rdf:resource="#Evidence740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT4 dissociates from IL12RB2:IL12RB2 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction689">
 <bp:evidence rdf:resource="#Evidence746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL35 binds IL6ST:IL6ST receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction697">
 <bp:evidence rdf:resource="#Evidence754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-35 translocates from the ER lumen to the extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction696">
 <bp:evidence rdf:resource="#Evidence753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1:p-STAT4 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction699">
 <bp:evidence rdf:resource="#Evidence756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 in IL12RB2:IL12RB2 receptor is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction698">
 <bp:evidence rdf:resource="#Evidence755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 and STAT4 associate with IL12RB2:IL6ST receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction693">
 <bp:evidence rdf:resource="#Evidence750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 and p-STAT4 dissociate from IL12RB2:IL6ST receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction692">
 <bp:evidence rdf:resource="#Evidence749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1, p-STAT3 dissociate from IL27RA:IL12RB2 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction695">
 <bp:evidence rdf:resource="#Evidence752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 dissociates from IL6ST:IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction694">
 <bp:evidence rdf:resource="#Evidence751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 associates with IL6ST:IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2519">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2509">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2508">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2500">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction609">
 <bp:evidence rdf:resource="#Evidence660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3R binds CSF3 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction600">
 <bp:evidence rdf:resource="#Evidence649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL18:IL18R1 binds IL18RAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction606">
 <bp:evidence rdf:resource="#Evidence656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1F10 is cleaved</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction605">
 <bp:evidence rdf:resource="#Evidence655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1F10 binds IL1RL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction608">
 <bp:evidence rdf:resource="#Evidence659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 dimer binds SDC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction607">
 <bp:evidence rdf:resource="#Evidence657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK8 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction602">
 <bp:evidence rdf:resource="#Evidence651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL18 binds IL18R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction601">
 <bp:evidence rdf:resource="#Evidence650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL18, ALOX5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction604">
 <bp:evidence rdf:resource="#Evidence654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1F10(?-152) binds IL1RAPL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction603">
 <bp:evidence rdf:resource="#Evidence653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1F10 binds IL1RAPL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction611">
 <bp:evidence rdf:resource="#Evidence662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXLNA (IL14) binds syntaxin1A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction610">
 <bp:evidence rdf:resource="#Evidence661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction617">
 <bp:evidence rdf:resource="#Evidence668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXLNA (IL14) binds syntaxin4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction616">
 <bp:evidence rdf:resource="#Evidence667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:CSFR binds CSFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction619">
 <bp:evidence rdf:resource="#Evidence670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-16 is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction618">
 <bp:evidence rdf:resource="#Evidence669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1 binds IL10RB:TYK2 and IFNLR1:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction613">
 <bp:evidence rdf:resource="#Evidence664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 binds CSF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction612">
 <bp:evidence rdf:resource="#Evidence663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL34 dimer:SDC1 binds CSF1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction615">
 <bp:evidence rdf:resource="#Evidence666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-3 cleaves pro-interleukin-16</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction614">
 <bp:evidence rdf:resource="#Evidence665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD4 binds Interleukin-16</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1969" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2245">
 <bp:stepProcess rdf:resource="#Catalysis675" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1970" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1967" />
 <bp:stepProcess rdf:resource="#Catalysis674" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1968" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1973" />
 <bp:stepProcess rdf:resource="#Catalysis677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1974" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2246">
 <bp:stepProcess rdf:resource="#Catalysis676" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1971" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1972" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1261">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1976" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2592">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1260">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1977" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2591">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2590">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1975" />
 <bp:stepProcess rdf:resource="#Catalysis678" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2596">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2595">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2594">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2593">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2599">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2598">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2597">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2255">
 <bp:stepProcess rdf:resource="#Pathway277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1980" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2254">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1979" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1983" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1981" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1982" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1272">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1986" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1271">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1987" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1270">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1984" />
 <bp:stepProcess rdf:resource="#Catalysis679" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2261">
 <bp:stepProcess rdf:resource="#Catalysis680" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1985" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2579">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1990" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2267">
 <bp:stepProcess rdf:resource="#Pathway278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1988" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1989" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1991" />
 <bp:stepProcess rdf:resource="#Catalysis681" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1992" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1993" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2273">
 <bp:stepProcess rdf:resource="#Pathway279" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2570">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1996" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2271">
 <bp:stepProcess rdf:resource="#Catalysis682" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1994" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1995" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2571">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1259">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1999" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2000" />
 <bp:stepProcess rdf:resource="#Catalysis683" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1997" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1998" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2279">
 <bp:stepProcess rdf:resource="#Pathway280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2001" />
 <bp:stepProcess rdf:resource="#Catalysis684" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2002" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1250">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2005" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2581">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2006" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2580">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2003" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2283">
 <bp:stepProcess rdf:resource="#Catalysis685" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2004" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2585">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2584">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2583">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2582">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2589">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2588">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2586">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1229">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1938" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1228">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2209">
 <bp:stepProcess rdf:resource="#Pathway272" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1227">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1936" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1226">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2207">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1937" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2557">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2200">
 <bp:stepProcess rdf:resource="#Catalysis669" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1932" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2201">
 <bp:stepProcess rdf:resource="#Catalysis670" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1933" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2204">
 <bp:stepProcess rdf:resource="#Pathway271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1935" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1934" />
 <bp:stepProcess rdf:resource="#Catalysis671" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2203">
 <bp:stepProcess rdf:resource="#Pathway270" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1221">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1220">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2553">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1947" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1238">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1945" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2569">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1237">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1946" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2568">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1940" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1941" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1939" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1944" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1942" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2214">
 <bp:stepProcess rdf:resource="#Pathway273" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2538">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1205">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1956" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1204">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1957" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2539">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1951" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1948" />
 <bp:stepProcess rdf:resource="#Catalysis672" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1949" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1954" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1955" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1953" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2230">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1958" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1200">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2549">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1216">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1965" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1219">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2233">
 <bp:stepProcess rdf:resource="#Pathway274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1961" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1959" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1960" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1963" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1964" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1962" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2236">
 <bp:stepProcess rdf:resource="#Pathway275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2240">
 <bp:stepProcess rdf:resource="#Pathway276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1966" />
 <bp:stepProcess rdf:resource="#Catalysis673" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2541">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1211">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2542">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction36">
 <bp:evidence rdf:resource="#Evidence42" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR binds activating host RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction37">
 <bp:evidence rdf:resource="#Evidence43" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Heparin binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction34">
 <bp:evidence rdf:resource="#Evidence40" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCK1 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction35">
 <bp:evidence rdf:resource="#Evidence41" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1,STAT3 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction38">
 <bp:evidence rdf:resource="#Evidence44" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIV TAR RNA binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence290">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction39">
 <bp:evidence rdf:resource="#Evidence45" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNAJC3 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence291">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction350">
 <bp:evidence rdf:resource="#Evidence383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL21 binds IL21R:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence289">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction345">
 <bp:evidence rdf:resource="#Evidence377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Within the IL-2R complex JAK3 phosphorylates JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2071">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction344">
 <bp:evidence rdf:resource="#Evidence376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2070">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction347">
 <bp:evidence rdf:resource="#Evidence380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL21 receptor STAT phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction346">
 <bp:evidence rdf:resource="#Evidence378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2 receptor alpha binds interleukin-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction341">
 <bp:evidence rdf:resource="#Evidence373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds IL2RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2075">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction340">
 <bp:evidence rdf:resource="#Evidence372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2B is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2074">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction343">
 <bp:evidence rdf:resource="#Evidence375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 bound to IL2 receptor is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2073">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction342">
 <bp:evidence rdf:resource="#Evidence374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT5 is released</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2072">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2079">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2076">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction32">
 <bp:evidence rdf:resource="#Evidence38" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates MAPT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence285">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction349">
 <bp:evidence rdf:resource="#Evidence382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL21:IL21R:JAK1 binds IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction33">
 <bp:evidence rdf:resource="#Evidence39" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence286">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction348">
 <bp:evidence rdf:resource="#Evidence381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL21 receptor JAK phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction30">
 <bp:evidence rdf:resource="#Evidence36" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates SPHK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence287">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction31">
 <bp:evidence rdf:resource="#Evidence37" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ILF3 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence288">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction25">
 <bp:evidence rdf:resource="#Evidence31" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates CDK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction26">
 <bp:evidence rdf:resource="#Evidence32" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PRKRA dimer binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction23">
 <bp:evidence rdf:resource="#Evidence29" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSV N binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction24">
 <bp:evidence rdf:resource="#Evidence30" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VTRNA2-1 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction29">
 <bp:evidence rdf:resource="#Evidence35" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates TP53 tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction27">
 <bp:evidence rdf:resource="#Evidence33" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPM binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction28">
 <bp:evidence rdf:resource="#Evidence34" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S225-SPHK1 localizes to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence280">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction361">
 <bp:evidence rdf:resource="#Evidence396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OSM binds LIFR:JAKs,OSMR:JAKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction360">
 <bp:evidence rdf:resource="#Evidence395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAKs bind OSMR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence278">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction356">
 <bp:evidence rdf:resource="#Evidence391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTF1 binds LIFR:JAKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence279">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction355">
 <bp:evidence rdf:resource="#Evidence390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAKs bind LIFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2081">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction358">
 <bp:evidence rdf:resource="#Evidence393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRLF1 binds CLCF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2080">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction357">
 <bp:evidence rdf:resource="#Evidence392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL31:IL31RA:JAK1 binds OSMR:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction352">
 <bp:evidence rdf:resource="#Evidence387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL11:IL11RA binds IL6ST:JAK1,JAK2,(TYK2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2086">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction351">
 <bp:evidence rdf:resource="#Evidence384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL21 receptor STAT binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2085">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction354">
 <bp:evidence rdf:resource="#Evidence389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRLF1:CLCF1 binds CNTRF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2084">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction353">
 <bp:evidence rdf:resource="#Evidence388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CNTF binds CNTFR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2089">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2088">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2087">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction21">
 <bp:evidence rdf:resource="#Evidence27" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates ILF3:ILF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence274">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction22">
 <bp:evidence rdf:resource="#Evidence28" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR dimer autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence275">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction359">
 <bp:evidence rdf:resource="#Evidence394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">gp130:JAKs bind CNTFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence276">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction20">
 <bp:evidence rdf:resource="#Evidence26" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR inhibitors bind PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence277">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction58">
 <bp:evidence rdf:resource="#Evidence65" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEL cleaves cellular ssRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction59">
 <bp:evidence rdf:resource="#Evidence66" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS2 produces oligoadenylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction56">
 <bp:evidence rdf:resource="#Evidence63" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEL cleaves viral ssRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction57">
 <bp:evidence rdf:resource="#Evidence64" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS2 binds viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction370">
 <bp:evidence rdf:resource="#Evidence406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serine phosphorylation of STATs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction372">
 <bp:evidence rdf:resource="#Evidence408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyrosine phosphorylation of STAT1, STAT3 by IL6 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway109">
 <bp:pathwayOrder rdf:resource="#PathwayStep1217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1174" />
 <bp:pathwayComponent rdf:resource="#Pathway113" />
 <bp:pathwayComponent rdf:resource="#Pathway110" />
 <bp:pathwayComponent rdf:resource="#Pathway111" />
 <bp:pathwayComponent rdf:resource="#Pathway122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1167" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian myeloid differentiation factor 88 (MyD88) is Toll/interleukin (IL)-1 (TIR)-domain containing adapter  protein which plays crucial role in TLR signaling. All TLRs, with only one exception of TLR3, can initiate downstream  signaling trough MyD88. In the MyD88 - dependent pathway, once the adaptor is bound to TLR  it leads to recruitment of IL1 receptor associated kinase family  IRAK which is followed by activation of tumour necrosis factor receptor-associated factor 6 (TRAF6) . TRAF6 is an ubiquitin E3 ligase which in turn induces TGF-beta activating kinase 1 (TAK1) auto phosphorylation. Once activated TAK1 can ultimately mediate the induction of the transcription factor NF-kB or the mitogen-activated protein kinases  (MAPK), such as JNK, p38 and ERK. This results in the translocation of the activated NF-kB and MAPKs to the nucleus and the initiation of appropriate gene transcription leading to the production of many proinflammatory cytokines and antimicrobial peptides.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction371">
 <bp:evidence rdf:resource="#Evidence407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6 binds IL6R-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway107">
 <bp:pathwayOrder rdf:resource="#PathwayStep1206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1099" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1101" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trafficking and processing of endosomal TLR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian TLR3, TLR7, TLR8, TLR9 are endosomal receptors that sense nucleic acids that have been released from endocytosed/phagocytosed bacteria, viruses or parasites. These TLRs have a ligand-recognition domain that faces the lumen of the endosome (which is topologically equivalent to the outside of the cell), a transmembrane domain, and a signaling domain that faces the cytosol. Under normal conditions, self nucleic acids are not recognized by TLRs due to multiple levels of regulation including receptor compartmentalization, trafficking and proteolytic processing (Barton GM et al 2006, Ewald SE et al 2008). At steady state TLR3, TLR7, TLR8, TLR9 reside primarily in the endoplasmic reticulum (ER), however, their activation by specific ligands only occurs within acidified endolysosomal compartments (Hacker H et al 1998, Funami K et al 2004, Gibbard RJ et al 2006). Several chaperon proteins associate with TLRs in the ER to provide efficient translocation to endolysosome. Upon reaching endolysosomal compartments the ectodomains of TLR7 and TLR9 are proteolytically cleaved by cysteine endoproteases. Both full-length and cleaved C-terminus of TLR9 bind CpG-oligodeoxynucleotides, however it has been proposed that only the processed receptor is functional.  Although similar cleavage of TLR3 has been reported by Ewald et al 2011, other studies demonstrated that the N-terminal region of TLR3 ectodomain was implicated in ligand binding, thus TLR3 may function as a full-length receptor (Liu L et al 2008, Tokisue T et al 2008).  There are no data on TLR8 processing, although the cell biology of TLR8 is probably similar to TLR9 and TLR7 (Gibbard RJ et al 2006, Wei T et al 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway108">
 <bp:pathwayOrder rdf:resource="#PathwayStep1211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1210" />
 <bp:pathwayComponent rdf:resource="#Pathway109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 5 (TLR5) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR5 is the receptor for flagellin, the protein that forms bacterial flagella. Unlike most other Pathogen-Associated Molecular Patterns (PAMPs), flagellin does not undergo any posttranslational modifications that would distinguish it from cellular proteins. However, flagellin is extremely conserved at its amino- and carboxyl-termini, which presumably explains why it was selected as a ligand for innate immune recognition. TLR5 is expressed on epithelial cells as well as on macrophages and dendritic cells. Expression of TLR5 on intestinal epithelium is polarized such that TLR5 is expressed only on the basolateral side of the cell, as pathogenic but not commensal microbes cross the epithelial barrier. This ensures that innate immune responses are confined to pathogenic but not commensal microbes (Paul 2004; Hayashi et al. 2001; Gewirtz et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway105">
 <bp:pathwayOrder rdf:resource="#PathwayStep2417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2607" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2236" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2090" />
 <bp:pathwayComponent rdf:resource="#Pathway106" />
 <bp:pathwayComponent rdf:resource="#Pathway315" />
 <bp:pathwayComponent rdf:resource="#Pathway257" />
 <bp:pathwayComponent rdf:resource="#Pathway268" />
 <bp:pathwayComponent rdf:resource="#Pathway302" />
 <bp:pathwayComponent rdf:resource="#Pathway313" />
 <bp:pathwayComponent rdf:resource="#Pathway267" />
 <bp:pathwayComponent rdf:resource="#Pathway275" />
 <bp:pathwayComponent rdf:resource="#Pathway284" />
 <bp:pathwayComponent rdf:resource="#Pathway295" />
 <bp:pathwayComponent rdf:resource="#Pathway282" />
 <bp:pathwayComponent rdf:resource="#Pathway294" />
 <bp:pathwayComponent rdf:resource="#Pathway281" />
 <bp:pathwayComponent rdf:resource="#Pathway290" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate Immune System</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate immunity encompases the nonspecific part of immunity tha are part of an individual&apos;s natural biologic makeup</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway106">
 <bp:pathwayOrder rdf:resource="#PathwayStep1800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1201" />
 <bp:pathwayComponent rdf:resource="#Pathway225" />
 <bp:pathwayComponent rdf:resource="#Pathway123" />
 <bp:pathwayComponent rdf:resource="#Pathway157" />
 <bp:pathwayComponent rdf:resource="#Pathway256" />
 <bp:pathwayComponent rdf:resource="#Pathway210" />
 <bp:pathwayComponent rdf:resource="#Pathway174" />
 <bp:pathwayComponent rdf:resource="#Pathway192" />
 <bp:pathwayComponent rdf:resource="#Pathway107" />
 <bp:pathwayComponent rdf:resource="#Pathway108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll-like Receptor Cascades</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, ten members of the Toll-like receptor (TLR) family (TLR1-TLR10) have been identified (TLR11 has been found in mouse, but not in human). All TLRs have a similar Toll/IL-1 receptor (TIR) domain in their cytoplasmic region and an Ig-like domain in the extracellular region, where each is enriched with a varying number of leucine-rich repeats (LRRs). Each TLR can recognize specific microbial pathogen components. The binding pathogenic component to TLR initializes signaling pathways that lead to induction of Interferon alpha/beta and inflammatory cytokines. There are two main signaling pathways. The first is a MyD88-dependent pathway that is common to all TLRs, except TLR3; the second is a TRIF(TICAM1)-dependent pathway that is peculiar to TLR3 and TLR4. TLR4-mediated signaling pathway via TRIF requires adapter molecule TRAM (TRIF-related adapter molecule or TICAM2). TRAM is thought to bridge between the activated TLR4 complex and TRIF.(Takeda    Akira 2004; Akira 2003; Takeda    Akira 2005; Kawai 2005; Heine    Ulmer 2005). This pathway is organized as trafficking and processing of TLR, various TLR cascades (TLR10,TLR3,TLR5,TLR7/8,TLR9,TLR4,TLR2) and their regulation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction367">
 <bp:evidence rdf:resource="#Evidence403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6 binds IL6R</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway114">
 <bp:pathwayOrder rdf:resource="#PathwayStep1246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1134" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction366">
 <bp:evidence rdf:resource="#Evidence402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway115">
 <bp:pathwayOrder rdf:resource="#PathwayStep1249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1135" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction369">
 <bp:evidence rdf:resource="#Evidence405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyrosine phosphorylated IL6ST binds STAT1,STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway112">
 <bp:pathwayOrder rdf:resource="#PathwayStep1228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1112" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction368">
 <bp:evidence rdf:resource="#Evidence404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS3 binds IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway113">
 <bp:pathwayOrder rdf:resource="#PathwayStep1244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1248" />
 <bp:pathwayComponent rdf:resource="#Pathway114" />
 <bp:pathwayComponent rdf:resource="#Pathway115" />
 <bp:pathwayComponent rdf:resource="#Pathway121" />
 <bp:pathwayComponent rdf:resource="#Pathway116" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction363">
 <bp:evidence rdf:resource="#Evidence398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OSM,LIF,CTF1 receptor complex binds gp130</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway110">
 <bp:pathwayOrder rdf:resource="#PathwayStep1216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1104" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2053">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction362">
 <bp:evidence rdf:resource="#Evidence397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIF binds LIFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway111">
 <bp:pathwayOrder rdf:resource="#PathwayStep1220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1110" />
 <bp:pathwayComponent rdf:resource="#Pathway112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1123" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2052">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction365">
 <bp:evidence rdf:resource="#Evidence400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIFR:JAKs bind gp130:JAKs:CNTFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2051">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction364">
 <bp:evidence rdf:resource="#Evidence399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL11 binds IL11RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2050">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction50">
 <bp:evidence rdf:resource="#Evidence56" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates HIV tat</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2057">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction51">
 <bp:evidence rdf:resource="#Evidence57" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIV Tat72 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2055">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2054">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction54">
 <bp:evidence rdf:resource="#Evidence60" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADAR1 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction55">
 <bp:evidence rdf:resource="#Evidence62" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS1 binds viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction52">
 <bp:evidence rdf:resource="#Evidence58" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates eIF2-alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2059">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction53">
 <bp:evidence rdf:resource="#Evidence59" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR binds viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2058">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction47">
 <bp:evidence rdf:resource="#Evidence53" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction48">
 <bp:evidence rdf:resource="#Evidence54" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer localizes to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction45">
 <bp:evidence rdf:resource="#Evidence51" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DUS2 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction46">
 <bp:evidence rdf:resource="#Evidence52" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCMV TRS1 binds PKR dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction49">
 <bp:evidence rdf:resource="#Evidence55" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates PTPN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction381">
 <bp:evidence rdf:resource="#Evidence417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 binds p-Y759-IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction380">
 <bp:evidence rdf:resource="#Evidence416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6:IL6R-2 binds IL6ST:JAK1, JAK2, (TYK2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction383">
 <bp:evidence rdf:resource="#Evidence419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Assembly of hexameric IL-6 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction382">
 <bp:evidence rdf:resource="#Evidence418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6:IL6R binds IL6ST:JAK1,JAK2,(TYK2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction378">
 <bp:evidence rdf:resource="#Evidence414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway103">
 <bp:pathwayOrder rdf:resource="#PathwayStep1181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1076" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1079" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-presentation of soluble exogenous antigens (endosomes)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exogenous soluble antigens are cross-presented by dendritic cells, albeit with lower efficiency than for particulate substrates. Soluble antigens destined for cross-presentation are taken up by distinct endocytosis mechanisms which route them into stable early endosomes and then to the cytoplasm for proteasomal degradation and peptide loading.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2060">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction377">
 <bp:evidence rdf:resource="#Evidence413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6ST is tyrosine phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway104">
 <bp:pathwayOrder rdf:resource="#PathwayStep1187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1086" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1095" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1083" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1082" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1091" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1090" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen Presentation: Folding, assembly and peptide loading of class I MHC</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unlike other glycoproteins, correct folding of MHC class I molecules is not sufficient to trigger their exit from the ER, they exit only after peptide loading. Described here is the process of antigen presentation which consists of the folding, assembly, and peptide loading of MHC class I molecules. The newly synthesized MHC class I Heavy Chain (HC) is initially folded with the help of several chaperones (calnexin, BiP, ERp57) and then binds with Beta-2-microglobulin (B2M). This MHC:B2M heterodimer enters the peptide loading complex (PLC), a multiprotein complex that includes calreticulin, endoplasmic reticulum resident protein 57 (ERp57), transporter associated with antigen processing (TAP) and tapasin. Peptides generated from Ub-proteolysis are transported into the ER through TAP. These peptides are further trimmed by ER-associated aminopeptidase (ERAP) and loaded on to MHC class I molecules. Stable MHC class I trimers with high-affinity peptide are transported from the ER to the cell surface by the Golgi apparatus.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway101">
 <bp:pathwayOrder rdf:resource="#PathwayStep1161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1062" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1068" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ER-Phagosome pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The other TAP-dependent cross-presentation mechanism in phagocytes is the endoplasmic reticulum (ER)-phagosome model. Desjardins proposed that ER is recruited to the cell surface, where it fuses with the plasma membrane, underneath phagocytic cups, to supply membrane for the formation of nascent phagosomes (Gagnon et al. 2002). Three independent studies simultaneously showed that ER contributes to the vast majority of phagosome membrane (Guermonprez et al. 2003, Houde et al. 2003, Ackerman et al. 2003). The composition of early phagosome membrane contains ER-resident proteins, the components required for cross-presentation. This model is similar to the phagosome-to-cytosol model in that Ag is translocated to cytosol for proteasomal degradation, but differs in that antigenic peptides are translocated back into the phagosome (instead of ER) for peptide:MHC-I complexes. ER fusion with phagosome introduces molecules that are involved in Ag transport to cytosol (Sec61) and proteasome-generated peptides back into the phagosome (TAP) for loading onto MHC-I.  Although the ER-phagosome pathway is controversial, the concept remains attractive as it explains how peptide-receptive MHC-I molecules could intersect with a relatively high concentration of exogenous antigens, presumably a crucial prerequisite for efficient cross-presentation (Basha et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction379">
 <bp:evidence rdf:resource="#Evidence415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway102">
 <bp:pathwayOrder rdf:resource="#PathwayStep1172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1073" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1071" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1070" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endosomal/Vacuolar pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Some antigens are cross-presented through a vacuolar mechanism that involves generation of antigenic peptides and their loading on to MHC-I molecules within the endosomal compartment in a proteasome and TAP-independent manner. Antigens within the endosome are processed by cathepsin S and other proteases into antigenic peptides. Loading of these peptides onto MHC-I molecules occurs directly within early and late endosomal compartments. Why certain antigens are cross-presented exclusively by the cytosolic pathway while others use the vacuolar pathway is unknown. It may be because some epitopes cannot be generated by endosomal proteolysis, or are completely destroyed. Alternatively, the physical form of the antigen may influence its accessibility to the endosomal or vacuolar pathways (Shen et al. 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction374">
 <bp:evidence rdf:resource="#Evidence410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6:IL6R-2 binds IL6ST-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2064">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction373">
 <bp:evidence rdf:resource="#Evidence409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT1, STAT3 form dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway100">
 <bp:pathwayOrder rdf:resource="#PathwayStep1154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1058" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1057" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-presentation of particulate exogenous antigens (phagosomes)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dendritic cells (DCs) take up and process exogenous particulate or cell-associated antigens such as microbes or tumor cells for MHC-I cross-presentation. Particulate antigens have been reported to be more efficiently cross-presented than soluble antigens by DCs (Khor et al. 2008). Particulate antigens are internalized by phagosomes. There are two established models that explain the mechanism by which exogenous particulate antigens are presented through MHC I; the cytosolic pathway where internalized antigens are somehow translocated from phagosomes into cytosol for proteasomal degradation and the vacuolar pathway (Lin et al. 2008, Amigorena et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2063">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction376">
 <bp:evidence rdf:resource="#Evidence412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1,JAK2,(TYK2) bind IL6ST</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2062">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction375">
 <bp:evidence rdf:resource="#Evidence411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STATs are released</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2061">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2068">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction40">
 <bp:evidence rdf:resource="#Evidence46" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPHK1 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2066">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence295">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2065">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction43">
 <bp:evidence rdf:resource="#Evidence49" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates PPP2R5A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence296">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction44">
 <bp:evidence rdf:resource="#Evidence50" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMOylation of PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence297">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction41">
 <bp:evidence rdf:resource="#Evidence47" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates DHX9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence298">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction42">
 <bp:evidence rdf:resource="#Evidence48" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKR forms a dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2069">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction78">
 <bp:evidence rdf:resource="#Evidence86" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of host protein filamin B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction79">
 <bp:evidence rdf:resource="#Evidence87" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of E3 ligase with ISG15:E2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction392">
 <bp:evidence rdf:resource="#Evidence429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 binds IL7R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction391">
 <bp:evidence rdf:resource="#Evidence428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3:PI3K-regulatory subunits binds IRS1,IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction394">
 <bp:evidence rdf:resource="#Evidence431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 is phosphorylated by TSLP:IL7R:CRLF2:STAT3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction393">
 <bp:evidence rdf:resource="#Evidence430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRWD1 gene expression is repressed by STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway129">
 <bp:pathwayOrder rdf:resource="#PathwayStep1318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1323" />
 <bp:pathwayComponent rdf:resource="#Pathway132" />
 <bp:pathwayComponent rdf:resource="#Pathway130" />
 <bp:pathwayComponent rdf:resource="#Pathway131" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction390">
 <bp:evidence rdf:resource="#Evidence427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3 binds PI3K regulatory subunits</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway127">
 <bp:pathwayOrder rdf:resource="#PathwayStep1304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1178" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway128">
 <bp:pathwayOrder rdf:resource="#PathwayStep1307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1179" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction389">
 <bp:evidence rdf:resource="#Evidence426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7R is phosphorylated on Y499</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway136">
 <bp:pathwayOrder rdf:resource="#PathwayStep1349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1211" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction388">
 <bp:evidence rdf:resource="#Evidence425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRWD1 binds AcK(9,14,18,79)-p(S10,T11)-histone H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway137">
 <bp:pathwayOrder rdf:resource="#PathwayStep1363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1226" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF-mediated programmed cell death</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3 and -4 trigger TRIF-dependent programmed cell death in various human and mouse cells (Kalai M et al. 2002; Han KJ et al. 2004; Kaiser WJ and Offermann MK 2005; Estornes Y et al. 2012; He S et al. 2011). Apoptosis is a prevalent form of programmed cell death and is mediated by the activation of a set of caspases. In addition to apoptosis, TLR3/TLR4 activation induces RIP3-dependent necroptosis. These two programmed cell-death pathways may suppress each other. When the caspase activity is impaired or inhibited, certain cell types switch the apoptotic death program to necroptosis in response to various stimuli (TNF, Fas, viral infection and other stress stimuli) (Kalai M et al. 2002; Weber A et al. 2010; Feoktistova M et al. 2011, Tenev et al 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway134">
 <bp:pathwayOrder rdf:resource="#PathwayStep1338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1201" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway135">
 <bp:pathwayOrder rdf:resource="#PathwayStep1359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1210" />
 <bp:pathwayComponent rdf:resource="#Pathway136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1222" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction385">
 <bp:evidence rdf:resource="#Evidence421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL6R binds IL6R inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway132">
 <bp:pathwayOrder rdf:resource="#PathwayStep1329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1196" />
 <bp:pathwayComponent rdf:resource="#Pathway133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1200" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2031">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction384">
 <bp:evidence rdf:resource="#Evidence420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 and STAT3 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway133">
 <bp:pathwayOrder rdf:resource="#PathwayStep1327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1194" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2030">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction387">
 <bp:evidence rdf:resource="#Evidence424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRWD1 binds SMARCA4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway130">
 <bp:pathwayOrder rdf:resource="#PathwayStep1316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1184" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction386">
 <bp:evidence rdf:resource="#Evidence423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway131">
 <bp:pathwayOrder rdf:resource="#PathwayStep1319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1189" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction72">
 <bp:evidence rdf:resource="#Evidence80" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of protein translation regulator 4EHP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2035">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction73">
 <bp:evidence rdf:resource="#Evidence81" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of viral protein NS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2034">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction70">
 <bp:evidence rdf:resource="#Evidence78" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIN1 mediated IRF3 degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2033">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction71">
 <bp:evidence rdf:resource="#Evidence79" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of protein ISGylation by ISG15 deconjugating enzyme USP18</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2032">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction76">
 <bp:evidence rdf:resource="#Evidence84" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of ISG15 by UBA7 E1 ligase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2039">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction77">
 <bp:evidence rdf:resource="#Evidence85" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of ISG15 with NEDD4 and inhibition of Ebola virus budding</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2038">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction74">
 <bp:evidence rdf:resource="#Evidence82" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Competitive inhibition of translation initiation by ISGylated 4EHP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2037">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction75">
 <bp:evidence rdf:resource="#Evidence83" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2036">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction69">
 <bp:evidence rdf:resource="#Evidence76" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS2 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction67">
 <bp:evidence rdf:resource="#Evidence74" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OASL binds DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction68">
 <bp:evidence rdf:resource="#Evidence75" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway118">
 <bp:pathwayOrder rdf:resource="#PathwayStep1262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1145" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway119">
 <bp:pathwayOrder rdf:resource="#PathwayStep1271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1152" />
 <bp:pathwayComponent rdf:resource="#Pathway120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1156" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway116">
 <bp:pathwayOrder rdf:resource="#PathwayStep1261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1266" />
 <bp:pathwayComponent rdf:resource="#Pathway118" />
 <bp:pathwayComponent rdf:resource="#Pathway119" />
 <bp:pathwayComponent rdf:resource="#Pathway117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway117">
 <bp:pathwayOrder rdf:resource="#PathwayStep1260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1140" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway125">
 <bp:pathwayOrder rdf:resource="#PathwayStep1361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1342" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1300" />
 <bp:pathwayComponent rdf:resource="#Pathway126" />
 <bp:pathwayComponent rdf:resource="#Pathway137" />
 <bp:pathwayComponent rdf:resource="#Pathway135" />
 <bp:pathwayComponent rdf:resource="#Pathway141" />
 <bp:pathwayComponent rdf:resource="#Pathway140" />
 <bp:pathwayComponent rdf:resource="#Pathway138" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF (TICAM1)-mediated TLR4 signaling </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF (TICAM1) was shown to induce IRF3/7 and NF-kappa-B activation as well as apoptosis through distinct intracellular signaling pathways (Yamamoto M et al., 2003; Fitzgerald KA et al., 2003; Han KJ et al., 2004; Kaiser WJ    Offermann MK 2005).  TRIF consists of an N-terminal domain (NTD) (1-153), an intermediate disordered proline-rich region, a TIR domain, and a C-terminal region (Mahita J    Sowdhamin R 2017). The disordered proline-rich region between NTD domain and the TIR domain of TICAM1 contains binding sites for TRAF (TNF receptor associated factor) family proteins, which, in turn, recruit protein kinases to promote activation of IRF3 and/or NF-kappa-B (Sato S et al., 2003; Fitzgerald KA et al., 2003). The C-terminal region of TICAM1 (TRIF) can recruit receptor-interacting serine/threonine-protein kinase 1 (RIPK1), and this event is followed by the activation of the IKK complex or the induction of programmed cell death (Han KJ et al., 2004; Kaiser WJ    Offermann MK 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction399">
 <bp:evidence rdf:resource="#Evidence436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway126">
 <bp:pathwayOrder rdf:resource="#PathwayStep1305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1333" />
 <bp:pathwayComponent rdf:resource="#Pathway134" />
 <bp:pathwayComponent rdf:resource="#Pathway129" />
 <bp:pathwayComponent rdf:resource="#Pathway127" />
 <bp:pathwayComponent rdf:resource="#Pathway128" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway123">
 <bp:pathwayOrder rdf:resource="#PathwayStep1491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1397" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1489" />
 <bp:pathwayComponent rdf:resource="#Pathway124" />
 <bp:pathwayComponent rdf:resource="#Pathway143" />
 <bp:pathwayComponent rdf:resource="#Pathway142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1256" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 4 (TLR4) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4 is unique among the TLR family in its ability to recruit four adapters to activate two distinct signaling pathways. One pathway is activated by the pair of the adapters  Mal or TIRAP (Toll/interleukin-1-receptor (TIR)-domain-containing adapter protein) and MyD88, which leads to the NFkB activation and the induction of pro-inflammatory cytokines. The second pathway is activated by the adapters TRIF (TIR-domain-containing adapter protein inducing interferon-beta) and TRAM (TRIF-related adapter molecule). The combined use of TRIF and TRAM adapters is specific for TLR4 signaling pathway and leads to the induction of type I interferons  and delayed activation of NFkB. The previous model of TLR4 signaling pathway described the simultaneous activation of these two signaling pathways at the plasma membrane, however the later studies suggested that upon activation TLR4 first induces TIRAP-MyD88 signaling at the plasma membrane and is then endocytosed and activates TRAM-TRIF signaling from the early endosome [Kagan JC et al 2008; Tanimura N et al 2008; Zanoni I et al 2011].
Toll-like Receptor 4 is a microbe associated molecular pattern receptor well known for it&apos;s sensitivity to bacterial lipopolysaccharides (LPS). LPS is assembled within diverse Gram-negative bacteria, many of which are human or plant pathogens. It is a component of the outer membrane of Gram-negative bacteria and consists of lipid A, a core polysaccharide and an O-polysaccharide of variable length (often more than 50 monosaccharide units). LPS is a potent activator of the innate immune response in humans, causing reactions including fever, headache, nausea, diarrhoea, changes in leukocyte and platelet counts, disseminated intravascular coagulation, multiorgan failure, shock and death. All these reactions are induced by cytokines and other endogenous mediators which are produced after interaction of LPS with the humoral and cellular targets of the host. In macrophages and dendritic cells, LPS-mediated activation of TLR4 triggers the biosynthesis of diverse mediators of inflammation, such as TNF-alpha and IL6, and activates the production of co-stimulatory molecules required for the adaptive immune response. In mononuclear and endothelial cells, LPS also stimulates tissue factor production. These events are desirable for clearing local infections, but when these various mediators and clotting factors are overproduced, they can damage small blood vessels and precipitate shock accompanied by disseminated intravascular coagulation and multiple organ failure.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway124">
 <bp:pathwayOrder rdf:resource="#PathwayStep1393" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1298" />
 <bp:pathwayComponent rdf:resource="#Pathway125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1175" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88-independent TLR4 cascade </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The MyD88-independent signaling pathway is shared by TLR3 and TLR4 cascades. TIR-domain-containing adapter-inducing interferon-beta (TRIF or TICAM1) is a key adapter molecule in transducing signals from TLR3 and TLR4 in a MyD88-independent manner (Yamamoto M et al. 2003a). TRIF is recruited to the ligand-stimulated TLR3 or 4 complex via its TIR domain. TLR3 directly binds TRIF (Oshiumi H et al 2003). In contrast, the TLR4-mediated signaling pathway requires two adapter molecules, TRAM (TRIF-related adapter molecule or TICAM2) and TRIF. TRAM(TICAM2) is thought to bridge the activated TLR4 complex and TRIF (Yamamoto M et al. 2003b, Tanimura N et al. 2008, Kagan LC et al. 2008). TRIF recruitment to the TLR complex stimulates distinct pathways leading to the production of type I interferons (IFNs) and pro-inflammatory cytokines and to the induction of programmed cell death.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction396">
 <bp:evidence rdf:resource="#Evidence433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimers bind the BRWD1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway121">
 <bp:pathwayOrder rdf:resource="#PathwayStep1280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1157" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2042">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction395">
 <bp:evidence rdf:resource="#Evidence432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TSLP binds CRLF2:IL7R</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway122">
 <bp:pathwayOrder rdf:resource="#PathwayStep1291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1169" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2041">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction398">
 <bp:evidence rdf:resource="#Evidence435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7:IL7R:JAK1 binds IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2040">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction397">
 <bp:evidence rdf:resource="#Evidence434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK3 in IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway120">
 <bp:pathwayOrder rdf:resource="#PathwayStep1270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction61">
 <bp:evidence rdf:resource="#Evidence68" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE12 cleaves 2&apos;-5&apos; oligoadenylates </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2046">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction62">
 <bp:evidence rdf:resource="#Evidence69" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral 2&apos;,5&apos;-PDE cleaves 2&apos;-5&apos; oligoadenylates </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2045">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2044">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction60">
 <bp:evidence rdf:resource="#Evidence67" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCE1 binds RNASEL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2043">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction65">
 <bp:evidence rdf:resource="#Evidence72" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS3 produces oligoadenylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction66">
 <bp:evidence rdf:resource="#Evidence73" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS1 produces oligoadenylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2049">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction63">
 <bp:evidence rdf:resource="#Evidence70" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OAS3 binds viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2048">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction64">
 <bp:evidence rdf:resource="#Evidence71" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEL binds 2&apos;-5&apos; oligoadenylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2047">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2019">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2018">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway149">
 <bp:pathwayOrder rdf:resource="#PathwayStep1439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1441" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1291" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway158">
 <bp:pathwayOrder rdf:resource="#PathwayStep1506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1500" />
 <bp:pathwayComponent rdf:resource="#Pathway159" />
 <bp:pathwayComponent rdf:resource="#Pathway166" />
 <bp:pathwayComponent rdf:resource="#Pathway161" />
 <bp:pathwayComponent rdf:resource="#Pathway160" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway159">
 <bp:pathwayOrder rdf:resource="#PathwayStep1497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1339" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway156">
 <bp:pathwayOrder rdf:resource="#PathwayStep1484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1332" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway157">
 <bp:pathwayOrder rdf:resource="#PathwayStep1558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1586" />
 <bp:pathwayComponent rdf:resource="#Pathway158" />
 <bp:pathwayComponent rdf:resource="#Pathway169" />
 <bp:pathwayComponent rdf:resource="#Pathway167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1418" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1390" />
 <bp:pathwayComponent rdf:resource="#Pathway172" />
 <bp:pathwayComponent rdf:resource="#Pathway173" />
 <bp:pathwayComponent rdf:resource="#Pathway171" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 3 (TLR3) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll-like receptor 3 (TLR3) as was shown for mammals is expressed in various tissues and cells, including myeloid dendritic cells, macrophages, respiratory and intestinal epithelium, neurons and microglial cells to induce antiviral and inflammatory responses of the innate immunity in combating viral infections. TLR3 recognizes dsRNA in the endosome and that triggers the receptor dimerization. TLR3 recruits the adaptor TRIF (TICAM1), leading to the activation of NF-kappa-B and the production of type I interferons (IFNs). dsRNA-stimulated phosphorylation of two specific TLR3 tyrosine residues (Tyr759 and Tyr858) is essential for initiating TLR3 signaling pathways.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction90">
 <bp:evidence rdf:resource="#Evidence99" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI6, IFI27 binds DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway154">
 <bp:pathwayOrder rdf:resource="#PathwayStep1459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1306" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction91">
 <bp:evidence rdf:resource="#Evidence100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FKBP5 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway155">
 <bp:pathwayOrder rdf:resource="#PathwayStep1469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1313" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway152">
 <bp:pathwayOrder rdf:resource="#PathwayStep1453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1301" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway153">
 <bp:pathwayOrder rdf:resource="#PathwayStep1458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1457" />
 <bp:pathwayComponent rdf:resource="#Pathway154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1310" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction94">
 <bp:evidence rdf:resource="#Evidence104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNAR2:JAK1:STAT2 binds JAK1,2 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway150">
 <bp:pathwayOrder rdf:resource="#PathwayStep1451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1445" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1456" />
 <bp:pathwayComponent rdf:resource="#Pathway152" />
 <bp:pathwayComponent rdf:resource="#Pathway153" />
 <bp:pathwayComponent rdf:resource="#Pathway151" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2013">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction95">
 <bp:evidence rdf:resource="#Evidence105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCE1 binds RNASEL, inhibiting it</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway151">
 <bp:pathwayOrder rdf:resource="#PathwayStep1448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1299" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2012">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction92">
 <bp:evidence rdf:resource="#Evidence102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNAR2:JAK1:STAT2 binds type 1 interferon analogs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2011">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction93">
 <bp:evidence rdf:resource="#Evidence103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNAR1:TYK2 binds TYK2 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2010">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction98">
 <bp:evidence rdf:resource="#Evidence108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of JAK kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2017">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction99">
 <bp:evidence rdf:resource="#Evidence109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of INFAR1 by TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2016">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction96">
 <bp:evidence rdf:resource="#Evidence106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1dimer:KPNA1 binds KPNB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2015">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction97">
 <bp:evidence rdf:resource="#Evidence107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STAT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2014">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction89">
 <bp:evidence rdf:resource="#Evidence98" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI44, IFI44L binds FKBP5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2029">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway138">
 <bp:pathwayOrder rdf:resource="#PathwayStep1374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1230" />
 <bp:pathwayComponent rdf:resource="#Pathway139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1233" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of IRF3, IRF7 mediated by TBK1, IKK&#949; (IKBKE)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell stimulation with viral double-stranded (ds) RNA and bacterial lipopolysaccharide (LPS) activate Toll-like receptors 3 (TLR3) and TLR4, respectively, triggering the activation the activation of two IKK-related serine/threonine kinases, TANK-binding kinase 1 (TBK1) and I&#954;B kinase &#949; (IKK&#949;, IKBKE) which directly phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 promoting their dimerization and translocation into the nucleus. Although both kinases show structural and functional similarities, it seems that TBK1 and IKBKE differ in their regulation of downstream signaling events of TLR3/TLR4.  IRF3 activation and interferon &#946; (IFN&#946;) production by poly(I:C), a synthetic analog of dsRNA, are decreased in TBK1-deficient mouse fibroblasts, whereas normal activation was observed in the IKBKE-deficient fibroblasts. However, in double-deficient mouse fibroblasts, the activation of IRF3 is completely abolished, suggesting a partially redundant functions of TBK1 and IKK&#949; (IKBKE) (Hemmi H et al., 2004).  The poly(I:C)-induced phosphorylation of TBK1 and IRF3 was abolished in TRIF (TICAM1)-knockout human keratinocyte HACAT cells (Bakshi S et al., 2017). TICAM1 is utilized as an adaptor protein by TLR3 and TLR4 (Yamamoto M et al., 2003).  TLR3 recruits and activates PI3 kinase (PI3K), which activates the downstream kinase, Akt, leading to full phosphorylation and activation of IRF3 (Sarkar SN et al., 2004). When PI3K is not recruited to TLR3 or its activity is blocked, IRF3 is only partially phosphorylated and fails to bind the promoter of the target gene (Sarkar SN et al., 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway139">
 <bp:pathwayOrder rdf:resource="#PathwayStep1380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1240" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TBK1, IKK&#949; (IKBKE)-mediated activation of IRF3, IRF7 </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of type I IFN genes in response to Toll-like receptor 3 (TLR3) and TLR4 ligands is mediated by TANK-binding kinase 1 (TBK1) or I-kappa-B kinase epsilon (IKK&#949;, IKBKE), which phosphorylate IFN regulatory factor 3 (IRF3) and IRF7. The activity of TBK1 and/or IRF3, IRF7 is regulated by multiple mechanisms including post-translational modifications, protein-protein interactions, and protein degradation (Zhao W et al., 2013; Runde AP et al., 2022).  This Reactome module describes regulation of TBK1, IKK&#949; activity by K63-linked ubiquitination of TBK1 and IKK&#949;, and TBK1 interaction with OPTN.  .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway147">
 <bp:pathwayOrder rdf:resource="#PathwayStep1438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1434" />
 <bp:pathwayComponent rdf:resource="#Pathway148" />
 <bp:pathwayComponent rdf:resource="#Pathway155" />
 <bp:pathwayComponent rdf:resource="#Pathway150" />
 <bp:pathwayComponent rdf:resource="#Pathway149" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway148">
 <bp:pathwayOrder rdf:resource="#PathwayStep1437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1288" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway145">
 <bp:pathwayOrder rdf:resource="#PathwayStep1406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1262" />
 <bp:pathwayComponent rdf:resource="#Pathway146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1277" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway146">
 <bp:pathwayOrder rdf:resource="#PathwayStep1415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1266" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway143">
 <bp:pathwayOrder rdf:resource="#PathwayStep1426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1280" />
 <bp:pathwayComponent rdf:resource="#Pathway147" />
 <bp:pathwayComponent rdf:resource="#Pathway145" />
 <bp:pathwayComponent rdf:resource="#Pathway156" />
 <bp:pathwayComponent rdf:resource="#Pathway144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1321" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2020">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction80">
 <bp:evidence rdf:resource="#Evidence88" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of Influenza A virus nonstructural protein 1 (NS1A) into the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway144">
 <bp:pathwayOrder rdf:resource="#PathwayStep1404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1258" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway141">
 <bp:pathwayOrder rdf:resource="#PathwayStep1390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1250" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK complex recruitment mediated by RIP1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor-interacting protein 1 (RIP1) mediates the activation of proinflammatory cytokines via intermediate induction of IKK complex in NFkB pathways [Ea et al. 2006]. Poly(I-C) treatment stimulated the recruitment of RIP1, TRAF6, and TAK1 to the TLR3 receptor complex in human embryonic kidney HEK293 transfected with FLAG-tagged TLR3 [Cusson-Hermance et al. 2005]. RIP1 was shown to be dispensable for TRIF-dependent activation of IRF3, which occurs in a TRIF/TBK1/IKKi-dependent manner [Cusson-Hermance et al. 2005, Sato et al. 2003]</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway142">
 <bp:pathwayOrder rdf:resource="#PathwayStep1396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1255" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of LPS from LBP carrier to CD14</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LBP delivers LPS from bacteria (or bacterial membrane fragments) to CD14 on the surfaces of phagocytes, where it is recognised by the MD2:TLR4 complex . Thus, LBP is an opsonin and CD14 is an opsonic receptor for complexes of LPS (or LPS-containing particles such as bacteria) and LBP. CD14 exists as two isoforms. CD14 can be either secreted into the extracellular compartment, or it can be anchored to the plasma membrane via its GPI module.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction83">
 <bp:evidence rdf:resource="#Evidence91" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of protein phosphatase 1 beta (PP2CB)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2024">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction84">
 <bp:evidence rdf:resource="#Evidence92" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of ISG15 from E1 to E2 (UBCH8)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway140">
 <bp:pathwayOrder rdf:resource="#PathwayStep1383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1249" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1244" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6-mediated induction of TAK1 complex within TLR4 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, together with ubiquitin-conjugating E2-type enzymes UBC13 and UEV1A (also known as UBE2V1), TRAF6 catalyses Lys63-linked ubiquitination. It is believed that auto polyubiquitination  and oligomerization of TRAF6 is followed by binding the ubiquitin receptors of TAB2 or TAB3 (TAK1 binding protein 2 and 3), which stimulates phosphorylation and activation of TGF beta-activated kinase 1(TAK1). TAK1 phosphorylates IKK alpha and IKK beta, which in turn phosphorylate NF-kB inhibitors - IkB  and eventually results in IkB degradation and NF-kB translocation to the nucleus. Also TAK1 mediates JNK and p38 MAP kinases activation by phosphorylating MKK4/7 and MKK3/6 respectivly resulting in the activation of many transcription factors.  The role of TRAF6 is somewhat controversial and probably cell type specific. TRAF6 autoubiquitination was found to be dispensable for TRAF6 function to activate TAK1 pathway. These findings are consistent with the new mechanism of TRAF6-mediated NF-kB activation that was suggested by Xia et al. (2009). TRAF6 generates unanchored Lys63-linked polyubiquitin chains that bind to the regulatory subunits of TAK1 (TAB2 or TAB3) and IKK(NEMO), leading to the activation of the kinases.  Xia et al. (2009) demonstrated in vitro that unlike polyubiquitin chains covalently attached to TRAF6 or IRAK, TAB2 and NEMO-associated ubiquitin chains were found to be unanchored and susceptible to N-terminal ubiquitin cleavage. Only K63-linked polyubiquitin chains, but not monomeric ubiquitin, activated TAK1 in a dose-dependent manner. Optimal activation of the IKK complex was achieved using ubiquitin polymers containing both K48 and K63 linkages. Furthermore, the authors proposed that the TAK1 complexes might be brougt in close proximity by binding several TAB2/3 to a single polyubiquitin chain to facilitate TAK1 kinase trans-phosphorylation. Alternativly, the possibility that polyUb binding promotes allosteric activation of TAK1 complex should  be considered (Walsh et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2023">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction81">
 <bp:evidence rdf:resource="#Evidence89" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Monoubiquitination of N-myristoyl GAG (P12493) protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2022">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction82">
 <bp:evidence rdf:resource="#Evidence90" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of E2 conjugating enzymes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2021">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction87">
 <bp:evidence rdf:resource="#Evidence96" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of DDX58 (RIG-I)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2028">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction88">
 <bp:evidence rdf:resource="#Evidence97" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI27 binds IFIH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2027">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction85">
 <bp:evidence rdf:resource="#Evidence93" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of host proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2026">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction86">
 <bp:evidence rdf:resource="#Evidence95" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI6 binds HSPA5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2025">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2189">
 <bp:evidence rdf:resource="#Evidence2486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF1 binds p21 RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2188">
 <bp:evidence rdf:resource="#Evidence2485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein kinase A (PKA) and RPS6KA5 (MSK1) phosphorylates p65 (RELA) subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2187">
 <bp:evidence rdf:resource="#Evidence2484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBP and p300 binds NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2186">
 <bp:evidence rdf:resource="#Evidence2482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4A binds HIV and HCV glycoproteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2185">
 <bp:evidence rdf:resource="#Evidence2481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC10A binds Tn-MUC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2184">
 <bp:evidence rdf:resource="#Evidence2480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds to p-Y65,Y76-FCER1G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2183">
 <bp:evidence rdf:resource="#Evidence2479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK phosphorylates PLCG2 in p-6Y-SYK:p-Y65,Y76-FCER1G:PLCG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2182">
 <bp:evidence rdf:resource="#Evidence2478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG2 translocates from cytosol to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2181">
 <bp:evidence rdf:resource="#Evidence2477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 binds p-6Y-SYK:p-Y65,Y76-FCER1G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2180">
 <bp:evidence rdf:resource="#Evidence2476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4D binds mycobacterial trehalose-6,6&apos;-dimycolate (TDM)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway178">
 <bp:pathwayOrder rdf:resource="#PathwayStep1689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1694" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1621" />
 <bp:pathwayComponent rdf:resource="#Pathway179" />
 <bp:pathwayComponent rdf:resource="#Pathway188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1504" />
 <bp:pathwayComponent rdf:resource="#Pathway190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1477" />
 <bp:pathwayComponent rdf:resource="#Pathway191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediates NFkB activation via canonical phosphorylation of IKK complex by TAK1. TRAF6 and TAK1 also regulate MAPK cascades leading to the activation of AP-1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway179">
 <bp:pathwayOrder rdf:resource="#PathwayStep1626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1654" />
 <bp:pathwayComponent rdf:resource="#Pathway187" />
 <bp:pathwayComponent rdf:resource="#Pathway181" />
 <bp:pathwayComponent rdf:resource="#Pathway182" />
 <bp:pathwayComponent rdf:resource="#Pathway180" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway176">
 <bp:pathwayOrder rdf:resource="#PathwayStep1604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1607" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1440" />
 <bp:pathwayComponent rdf:resource="#Pathway178" />
 <bp:pathwayComponent rdf:resource="#Pathway177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1442" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 dependent cascade initiated on endosome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon binding of their ligands, TLR7/8 and TLR9 recruit a cytoplasmic adaptor MyD88 and IRAKs, downstream of which the signaling pathways are divided to induce either inflammatory cytokines or type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway177">
 <bp:pathwayOrder rdf:resource="#PathwayStep1613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1438" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1434" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In plasmacytoid dendritic cell induction of type I IFNs critically depends on IFN regulatory factor 7 in TLR7 and 9 signaling (Honda et al 2005). IRF-7, but not IRF3, interacts with MyD88, TRAF6, and IRAKs and translocates to the nucleus upon phosphorylation (Kawai et al 2004; Uematsu et al 2005).  TLR7/8 signaling was shown to induce IRF5 activation along with IRF7 [Schoenemeyer et al 2005], while IRF8 [Tsujimura H et al 2004] and IRF1 were reported to be implicated in TLR9 signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway174">
 <bp:pathwayOrder rdf:resource="#PathwayStep1602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1599" />
 <bp:pathwayComponent rdf:resource="#Pathway176" />
 <bp:pathwayComponent rdf:resource="#Pathway175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1427" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1425" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 7/8 (TLR7/8) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA can serve as a danger signal, both in its double-stranded form as well as single-stranded RNA (ssRNA). Toll like receptor 7 (TLR7) and TLR8 are endosomal receptors that sense ssRNA oligonucleotides containing guanosine (G)- and uridine (U)-rich sequences from RNA viruses (Jurk M et al. 2002; Heil F et al. 2004; Diebold SS et al. 2004; Li Y et al. 2013; reviewed in Lester SN    Li K 2014). TLR7 is primarily expressed in plasmacytoid dendritic cells (pDCs) and, to some extent, in B cells, monocytes and macrophages, whereas TLR8 is mostly expressed in monocytes, macrophages and myeloid DCs. Upon engagement of ssRNAs in endosomes, TLR7/8 initiate the myeloid differentiation factor 88 (MyD88)-dependent pathway, culminating in synthesis of type I and type III IFNs and proinflammatory mediators via activation of IFN regulatory factors (IRF7, IRF5) and NF-kappaB, respectively, depending on the cell type (Takaoka A et al., 2005; Heinz LX et al., 2020; reviewed in Lester SN    Li K 2014). TLR7 and TLR8 are able to detect GU-rich ssRNA sequences from the viral genomes of influenza, human immunodeficiency virus-1 (HIV-1), vesicular stomatitis virus (VSV), coxsackie B virus, coronavirus and flaviviruses (hepatitis C virus, HCV and West Nile virus, WNV; reviewed in Lester SN    Li K 2014). Specifically, GU-rich ssRNA oligonucleotides derived from HIV-1, for example, stimulate dendritic cells (DC) and macrophages to secrete interferon-alpha and proinflammatory, as well as regulatory, cytokines (Heil F et al. 2004). This has been found to be mediated by TLR7, as well as TLR8. Similarly, severe acute respiratory syndrome-associated coronavirus type 1 (SARS-CoV-1) GU-rich ssRNAs had powerful immunostimulatory activities in mononuclear phagocytes to induce considerable level of pro-inflammatory cytokine TNF-a, IL-6 and IL-12 release via the TLR7 and TLR8 (Li Y et al. 2013). Further, mice deficient in either Tlr7 or the TLR adaptor protein Myd88 demonstrated reduced responses to in vivo infection with VSV (Lund JM et al. 2004),  mouse-adapted SARS-CoV-1 (Sheahan et al. 2008; Totura et al., 2015). Upon Middle East respiratory syndrome-related coronavirus (MERS-CoV) infection, lack of MyD88 signaling resulted in delayed viral clearance and increased lung pathology in mice (Zhao et al. 2014). Consistently, another study showed that Tlr7-/- mice have reduced IFN expression compared with wild-type mice (Channappanavar et al. 2019). In addition, loss of function TLR7 variants identified in the patients with SARS-CoV-2 (COVID-19) resulted in defective upregulation of type I IFN&#8211;related genes in the TLR7 pathway (Figure 3) in response to the TLR7 agonist imiquimod as compared with controls (Van der Made CI et al. 2020). Separate studies showed that synthetic imidazoquinoline compounds (e.g. imiquimod and R-848, low-molecular-weight immune response modifiers that can induce the synthesis of interferon-alpha) also exert their effects in a MyD88-dependent fashion through TLR7 or TLR8 (Hemmi H et al. 2002; Jurk M et al. 2002; Diebold SS et al. 2004). Some viruses utilize multiple strategies to evade antiviral innate immune signaling, as is seen with influenza or SARS coronaviruses. TLR7-mediated innate immunity, for example, was associated with the negative regulation through removing Lys63-linked polyubiquitin chains of TRAF3/TRAF6 by papin-like protease (PLpro) catalytic domain of nsp3 from SARS-CoV-1 (Li SW et al. 2016). Thus, TLR7 and TLR8 play a critical role in sensing of viral ssRNA in the endosome.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway175">
 <bp:pathwayOrder rdf:resource="#PathwayStep1594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1595" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1420" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4:TASL-dependent IRF5 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This Reactome module describes the Toll-like receptor 7 (TLR7), TLR8, or TLR9 &#8211; induced activation of interferon regulatory factor 5 (IRF5) via the SLC15A4:TASL axis.  Solute carrier family 15, member 4 (SLC15A4, also known as PHT1) is a proton-coupled L-histidine/oligopeptide transporter. In addition to its function as a transporter, SLC15A4 regulates TLR7-9 signaling pathways in late endosomes/lysosomes (Heinz LX. et al., 2020; Kobayashi T et al., 2021). SLC15A4 acts as a signaling scaffold, recruiting the protein TLR adaptor interacting with SLC15A4 on the lysosome (TASL) to the cytosolic surface of endolysosomes (Heinz LX. et al., 2020; Custodio TF et al., 2023; Chen X et al., 2023). Upon activation of endosomal TLR signaling, TASL undergoes phosphorylation and recruits IRF5 to its pLxIS motif (Heinz LX. et al., 2020). The SLC15A4:TASL complex facilitates IRF5 phosphorylation by IKBKB (IKK&#946;) and subsequent IRF5 homodimerization downstream of TLR7-TLR9 (Heinz LX. et al., 2020; Zhang H et al., 2023; Chen X et al., 2023; Boeszoermeny A et al., 2023). Once activated, IRF5 translocates to the nucleus to induce the transcription of genes encoding type I interferons (IFNs) and pro-inflammatory cytokines. Hyperactivation of the SLC15A4:TASL:IRF5 pathway, often caused by the detection of endogenous nucleic acids, leads to increased production of type I IFNs and is associated with pathogenesis of inflammatory diseases such as systemic lupus erythematosus (SLE) (Odhams CA et al., 2019; Heinz LX. et al., 2020; Kobayashi T et al., 2021). .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway172">
 <bp:pathwayOrder rdf:resource="#PathwayStep1581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1409" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1410" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1,TRAF6-dependent induction of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, together with ubiquitin-conjugating E2-type enzymes UBC13 and UEV1A (also known as UBE2V1), TRAF6 catalyses Lys63-linked ubiquitination. It is believed that auto polyubiquitination  and oligomerization of TRAF6 is followed by binding the ubiquitin receptors of TAB2 or TAB3 (TAK1 binding protein 2 and 3), which stimulates phosphorylation and activation of TGF beta-activated kinase 1(TAK1). TAK1 phosphorylates IKK alpha and IKK beta, which in turn phosphorylate NF-kB inhibitors - IkB  and eventually results in IkB degradation and NF-kB translocation to the nucleus. Also TAK1 mediates JNK and p38 MAP kinases activation by phosphorylating MKK4/7 and MKK3/6 respectivly resulting in the activation of many transcription factors.  The role of TRAF6 is somewhat controversial and probably cell type specific. TRAF6 autoubiquitination was found to be dispensable for TRAF6 function to activate TAK1 pathway. These findings are consistent with the new mechanism of TRAF6-mediated NF-kB activation that was suggested by Xia et al. (2009). TRAF6 generates unanchored Lys63-linked polyubiquitin chains that bind to the regulatory subunits of TAK1 (TAB2 or TAB3) and IKK(NEMO), leading to the activation of the kinases.  Xia et al. (2009) demonstrated in vitro that unlike polyubiquitin chains covalently attached to TRAF6 or IRAK, TAB2 and NEMO-associated ubiquitin chains were found to be unanchored and susceptible to N-terminal ubiquitin cleavage. Only K63-linked polyubiquitin chains, but not monomeric ubiquitin, activated TAK1 in a dose-dependent manner. Optimal activation of the IKK complex was achieved using ubiquitin polymers containing both K48 and K63 linkages. Furthermore, the authors proposed that the TAK1 complexes might be brougt in close proximity by binding several TAB2/3 to a single polyubiquitin chain to facilitate TAK1 kinase trans-phosphorylation. Alternativly, the possibility that polyUb binding promotes allosteric activation of TAK1 complex should  be considered (Walsh et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway173">
 <bp:pathwayOrder rdf:resource="#PathwayStep1587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1416" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1415" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1, RIP1-mediated IKK complex recruitment</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor-interacting protein 1 (RIP1) mediates the activation of interferon-alpha/beta via intermediate activation of IKK/TBK1 or NFkB pathways.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway170">
 <bp:pathwayOrder rdf:resource="#PathwayStep1569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1571" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1400" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TBK1, IKK&#949;-mediated activation of IRF3, IRF7 upon TLR3 ligation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of type I IFN genes in response to Toll-like receptor 3 (TLR3) and TLR4 ligands is mediated by TANK-binding kinase 1 (TBK1) or I-kappa-B kinase epsilon (IKK&#949;, IKBKE), which phosphorylate IFN regulatory factor 3 (IRF3) and IRF7. The activity of TBK1 and/or IRF3, IRF7 is regulated by multiple mechanisms including post-translational modifications, protein-protein interactions, and protein degradation (Zhao W et al., 2013; Runde AP et al., 2022).  This Reactome module describes regulation of TBK1, IKK&#949; activity by K63-linked ubiquitination of TBK1 and IKK&#949;, and TBK1 interaction with OPTN.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway171">
 <bp:pathwayOrder rdf:resource="#PathwayStep1576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1406" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3-mediated TICAM1-dependent programmed cell death</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3 and TLR4 trigger TRIF(TICAM1)-dependent programmed cell death in various human and mouse cells (Kalai M et al. 2002; Han KJ et al. 2004; Kaiser WJ and Offermann MK 2005; Estornes Y et al. 2012; He S et al. 2011). Apoptosis is a prevalent form of programmed cell death and is mediated by the activation of a set of caspases. In addition to apoptosis, TLR3/TLR4 activation induces RIP3-dependent necroptosis. These two programmed cell-death pathways may suppress each other. When the caspase activity is impaired or inhibited, certain cell types switch the apoptotic death program to necroptosis in response to various stimuli (TNF, Fas, viral infection and other stress stimuli) (Kalai M et al. 2002; Weber A et al. 2010; Feoktistova M et al. 2011, Tenev et al 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2199">
 <bp:evidence rdf:resource="#Evidence2498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP binds p-7S-p100 in active NIK:p-S176,180-IKKA dimer:p-7S-p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2198">
 <bp:evidence rdf:resource="#Evidence2497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK phosphorylates IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2197">
 <bp:evidence rdf:resource="#Evidence2494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 activate GTPase RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2196">
 <bp:evidence rdf:resource="#Evidence2493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p300 acetylates RELA subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2195">
 <bp:evidence rdf:resource="#Evidence2492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S276-RELA binds RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2194">
 <bp:evidence rdf:resource="#Evidence2491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ManLAM</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2193">
 <bp:evidence rdf:resource="#Evidence2490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFKs phosphorylates RAF1 on Y340,Y341</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2192">
 <bp:evidence rdf:resource="#Evidence2489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ICAM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2191">
 <bp:evidence rdf:resource="#Evidence2488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK phosphorylates p21 RAF1 on S338</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2190">
 <bp:evidence rdf:resource="#Evidence2487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ICAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway169">
 <bp:pathwayOrder rdf:resource="#PathwayStep1568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1562" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1405" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1404" />
 <bp:pathwayComponent rdf:resource="#Pathway170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1399" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1398" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1-dependent activation of IRF3/IRF7</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell stimulation with viral double-stranded (ds) RNA and bacterial lipopolysaccharide (LPS) activate Toll-like receptors 3 (TLR3) and TLR4, respectively, triggering the activation the activation of two IKK-related serine/threonine kinases, TANK-binding kinase 1 (TBK1) and I&#954;B kinase &#949; (IKK&#949;, IKBKE) which directly phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 promoting their dimerization and translocation into the nucleus. Although both kinases show structural and functional similarities, it seems that TBK1 and IKBKE differ in their regulation of downstream signaling events of TLR3/TLR4.  IRF3 activation and interferon &#946; (IFN&#946;) production by poly(I:C), a synthetic analog of dsRNA, are decreased in TBK1-deficient mouse fibroblasts, whereas normal activation was observed in the IKBKE-deficient fibroblasts. However, in double-deficient mouse fibroblasts, the activation of IRF3 is completely abolished, suggesting a partially redundant functions of TBK1 and IKK&#949; (IKBKE) (Hemmi H et al., 2004).  The poly(I:C)-induced phosphorylation of TBK1 and IRF3 was abolished in TRIF (TICAM1)-knockout human keratinocyte HACAT cells (Bakshi S et al., 2017). TICAM1 is utilized as an adaptor protein by TLR3 and TLR4 (Yamamoto M et al., 2003).  TLR3 recruits and activates PI3 kinase (PI3K), which activates the downstream kinase, Akt, leading to full phosphorylation and activation of IRF3 (Sarkar SN et al., 2004). When PI3K is not recruited to TLR3 or its activity is blocked, IRF3 is only partially phosphorylated and fails to bind the promoter of the target gene (Sarkar SN et al., 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway167">
 <bp:pathwayOrder rdf:resource="#PathwayStep1539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1540" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1373" />
 <bp:pathwayComponent rdf:resource="#Pathway168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1387" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway168">
 <bp:pathwayOrder rdf:resource="#PathwayStep1547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1548" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1551" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1376" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway165">
 <bp:pathwayOrder rdf:resource="#PathwayStep1521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1357" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway166">
 <bp:pathwayOrder rdf:resource="#PathwayStep1536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1365" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway163">
 <bp:pathwayOrder rdf:resource="#PathwayStep1514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1354" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway164">
 <bp:pathwayOrder rdf:resource="#PathwayStep1525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1520" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1361" />
 <bp:pathwayComponent rdf:resource="#Pathway165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1356" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway161">
 <bp:pathwayOrder rdf:resource="#PathwayStep1513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1518" />
 <bp:pathwayComponent rdf:resource="#Pathway163" />
 <bp:pathwayComponent rdf:resource="#Pathway164" />
 <bp:pathwayComponent rdf:resource="#Pathway162" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway162">
 <bp:pathwayOrder rdf:resource="#PathwayStep1509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1349" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1347" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway160">
 <bp:pathwayOrder rdf:resource="#PathwayStep1503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1343" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway198">
 <bp:pathwayOrder rdf:resource="#PathwayStep1729" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1728" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1531" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway199">
 <bp:pathwayOrder rdf:resource="#PathwayStep1734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1735" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1538" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1537" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1534" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway196">
 <bp:pathwayOrder rdf:resource="#PathwayStep1788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1768" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1591" />
 <bp:pathwayComponent rdf:resource="#Pathway197" />
 <bp:pathwayComponent rdf:resource="#Pathway208" />
 <bp:pathwayComponent rdf:resource="#Pathway209" />
 <bp:pathwayComponent rdf:resource="#Pathway206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1564" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediates NFkB activation via canonical phosphorylation of IKK complex by TAK1. TRAF6 and TAK1 also regulate MAPK cascades leading to the activation of AP-1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway197">
 <bp:pathwayOrder rdf:resource="#PathwayStep1727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1759" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1731" />
 <bp:pathwayComponent rdf:resource="#Pathway200" />
 <bp:pathwayComponent rdf:resource="#Pathway198" />
 <bp:pathwayComponent rdf:resource="#Pathway199" />
 <bp:pathwayComponent rdf:resource="#Pathway205" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway194">
 <bp:pathwayOrder rdf:resource="#PathwayStep1712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1713" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1724" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1709" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1528" />
 <bp:pathwayComponent rdf:resource="#Pathway196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1526" />
 <bp:pathwayComponent rdf:resource="#Pathway195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1530" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 dependent cascade initiated on endosome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon binding of their ligands, TLR7/8 and TLR9 recruit a cytoplasmic adaptor MyD88 and IRAKs, downstream of which the signaling pathways are divided to induce either inflammatory cytokines or type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway195">
 <bp:pathwayOrder rdf:resource="#PathwayStep1716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1717" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1521" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In plasmacytoid dendritic cell induction of type I IFNs critically depends on IFN regulatory factor 7 in TLR7 and 9 signaling (Honda et al 2005). IRF-7, but not IRF3, interacts with MyD88, TRAF6, and IRAKs and translocates to the nucleus upon phosphorylation (Kawai et al 2004; Uematsu et al 2005).  TLR7/8 signaling was shown to induce IRF5 activation along with IRF7 [Schoenemeyer et al 2005], while IRF8 [Tsujimura H et al 2004] and IRF1 were reported to be implicated in TLR9 signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway192">
 <bp:pathwayOrder rdf:resource="#PathwayStep1705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1515" />
 <bp:pathwayComponent rdf:resource="#Pathway194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1513" />
 <bp:pathwayComponent rdf:resource="#Pathway193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1512" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 9 (TLR9) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CpG DNA is an unusual Pathogen-Associated Molecular Pattern (PAMP). Cytosine methylation exists in mammalian but not bacterial cells, and most (but not all) CpG in the mammalian genome is methylated. Therefore, unmethylated CpG DNA may signal the presence of microbial infection. Evidence of CpG recognition by TLR9 was demonstrated both in human and  mouse, and this type of signaling requires its internalization into late endosomal/lysosomal compartments. TLR9 has been reported to be able to discern different types of CpG motifs, and therefore that it presumably recognizes CpG DNA directly. It appears that over evolutionary periods, TLR9 molecules expressed by different species have diverged. This has led to differences in the precise sequence motif (CpG dinucleotide plus flanking regions) that optimally stimulate the innate immune system of different animals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway193">
 <bp:pathwayOrder rdf:resource="#PathwayStep1701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1510" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4:TASL-dependent IRF5 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This Reactome module describes the Toll-like receptor 7 (TLR7), TLR8, or TLR9 &#8211; induced activation of interferon regulatory factor 5 (IRF5) via the SLC15A4:TASL axis.  Solute carrier family 15, member 4 (SLC15A4, also known as PHT1) is a proton-coupled L-histidine/oligopeptide transporter. In addition to its function as a transporter, SLC15A4 regulates TLR7-9 signaling pathways in late endosomes/lysosomes (Heinz LX. et al., 2020; Kobayashi T et al., 2021). SLC15A4 acts as a signaling scaffold, recruiting the protein TLR adaptor interacting with SLC15A4 on the lysosome (TASL) to the cytosolic surface of endolysosomes (Heinz LX. et al., 2020; Custodio TF et al., 2023; Chen X et al., 2023). Upon activation of endosomal TLR signaling, TASL undergoes phosphorylation and recruits IRF5 to its pLxIS motif (Heinz LX. et al., 2020). The SLC15A4:TASL complex facilitates IRF5 phosphorylation by IKBKB (IKK&#946;) and subsequent IRF5 homodimerization downstream of TLR7-TLR9 (Heinz LX. et al., 2020; Zhang H et al., 2023; Chen X et al., 2023; Boeszoermeny A et al., 2023). Once activated, IRF5 translocates to the nucleus to induce the transcription of genes encoding type I interferons (IFNs) and pro-inflammatory cytokines. Hyperactivation of the SLC15A4:TASL:IRF5 pathway, often caused by the detection of endogenous nucleic acids, leads to increased production of type I IFNs and is associated with pathogenesis of inflammatory diseases such as systemic lupus erythematosus (SLE) (Odhams CA et al., 2019; Heinz LX. et al., 2020; Kobayashi T et al., 2021). .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway190">
 <bp:pathwayOrder rdf:resource="#PathwayStep1684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1496" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1497" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway191">
 <bp:pathwayOrder rdf:resource="#PathwayStep1691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1500" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway189">
 <bp:pathwayOrder rdf:resource="#PathwayStep1668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1486" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway187">
 <bp:pathwayOrder rdf:resource="#PathwayStep1657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1469" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1475" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway188">
 <bp:pathwayOrder rdf:resource="#PathwayStep1679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1665" />
 <bp:pathwayComponent rdf:resource="#Pathway189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1478" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway185">
 <bp:pathwayOrder rdf:resource="#PathwayStep1646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1461" />
 <bp:pathwayComponent rdf:resource="#Pathway186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1464" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway186">
 <bp:pathwayOrder rdf:resource="#PathwayStep1648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1462" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway183">
 <bp:pathwayOrder rdf:resource="#PathwayStep1635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1453" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway184">
 <bp:pathwayOrder rdf:resource="#PathwayStep1640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1458" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1457" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway181">
 <bp:pathwayOrder rdf:resource="#PathwayStep1628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1449" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1447" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway182">
 <bp:pathwayOrder rdf:resource="#PathwayStep1639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1644" />
 <bp:pathwayComponent rdf:resource="#Pathway185" />
 <bp:pathwayComponent rdf:resource="#Pathway183" />
 <bp:pathwayComponent rdf:resource="#Pathway184" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway180">
 <bp:pathwayOrder rdf:resource="#PathwayStep1624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1444" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2145">
 <bp:evidence rdf:resource="#Evidence2437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV1 to p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2144">
 <bp:evidence rdf:resource="#Evidence2436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 phosphorylates LIMK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2143">
 <bp:evidence rdf:resource="#Evidence2435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of cofilin by LIMK-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2142">
 <bp:evidence rdf:resource="#Evidence2434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extension of pseudopodia by myosin-X in a PI3K dependent manner</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2141">
 <bp:evidence rdf:resource="#Evidence2433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP and PIP3 bind WAVE Regulatory Complex (WRC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2140">
 <bp:evidence rdf:resource="#Evidence2432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WASPs or WAVEs activate the ARP2/3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction301">
 <bp:evidence rdf:resource="#Evidence330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction300">
 <bp:evidence rdf:resource="#Evidence329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15 binds IL2RB:JAK1 and IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction303">
 <bp:evidence rdf:resource="#Evidence332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:IL2RB:JAK1:IL2RG:p-JAK3:p-Y-SHC1:GRB2 binds GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction302">
 <bp:evidence rdf:resource="#Evidence331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3:p-Y-SHC1:GRB2:GAB2 phosphorylates GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction309">
 <bp:evidence rdf:resource="#Evidence339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction308">
 <bp:evidence rdf:resource="#Evidence337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15 binds IL15RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction305">
 <bp:evidence rdf:resource="#Evidence334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2149">
 <bp:evidence rdf:resource="#Evidence2441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction304">
 <bp:evidence rdf:resource="#Evidence333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT3 and p-STAT5 dissociates from IL15:IL15RA:IL2RB:p-JAK1:IL2RG:p-JAK3:p-Y-STAT3:p-STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2148">
 <bp:evidence rdf:resource="#Evidence2440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL phosphorylates WAVEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction307">
 <bp:evidence rdf:resource="#Evidence336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3 phosphorylates STAT3 and STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2147">
 <bp:evidence rdf:resource="#Evidence2439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction306">
 <bp:evidence rdf:resource="#Evidence335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT3 binds p-STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2146">
 <bp:evidence rdf:resource="#Evidence2438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 and CDC42 activate PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2156">
 <bp:evidence rdf:resource="#Evidence2448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of LIMK1 by Hsp90</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2155">
 <bp:evidence rdf:resource="#Evidence2447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Detachment of WASP/WAVE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2154">
 <bp:evidence rdf:resource="#Evidence2446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An unknown GEF exchanges GTP for GDP on CDC42:GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2153">
 <bp:evidence rdf:resource="#Evidence2445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of myosins in phagosome formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2152">
 <bp:evidence rdf:resource="#Evidence2444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transphosphorylation of pLIMK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2151">
 <bp:evidence rdf:resource="#Evidence2443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WIP binds WASP,N-WASP, activating them</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2150">
 <bp:evidence rdf:resource="#Evidence2442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction312">
 <bp:evidence rdf:resource="#Evidence342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y694-STAT5A, p-STAT5B dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction311">
 <bp:evidence rdf:resource="#Evidence341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9R is phosphorylated by IL9:IL9R:JAK1:IL2RG:p-Y904,939-JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction314">
 <bp:evidence rdf:resource="#Evidence344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9:IL9R:JAK1:IL2RG:JAK3 phosphorylates JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction313">
 <bp:evidence rdf:resource="#Evidence343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1:p-Y705-STAT3 translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction310">
 <bp:evidence rdf:resource="#Evidence340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9 binds IL9R:JAK1 and IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction319">
 <bp:evidence rdf:resource="#Evidence349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK3 binds JAK3 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction316">
 <bp:evidence rdf:resource="#Evidence346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9:p-Y116-IL9R:JAK1:IL2RG:p-904,939-JAK3:STAT3 phosphorylates STAT1, STAT3 or STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction315">
 <bp:evidence rdf:resource="#Evidence345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RG binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2159">
 <bp:evidence rdf:resource="#Evidence2452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of AA by iPLA2 upon FCGR activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction318">
 <bp:evidence rdf:resource="#Evidence348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1 binds p-Y705-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2158">
 <bp:evidence rdf:resource="#Evidence2450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Branching and elongation of mother and daughter filaments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction317">
 <bp:evidence rdf:resource="#Evidence347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9R binds JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2157">
 <bp:evidence rdf:resource="#Evidence2449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of WASP and N-WASP by CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction14">
 <bp:evidence rdf:resource="#Evidence17" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SH2B binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2167">
 <bp:evidence rdf:resource="#Evidence2460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of PA into DAG by PAP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction15">
 <bp:evidence rdf:resource="#Evidence21" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NS1 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2166">
 <bp:evidence rdf:resource="#Evidence2459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLCG1 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction12">
 <bp:evidence rdf:resource="#Evidence15" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR binds SHP2 (PTPN11)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2165">
 <bp:evidence rdf:resource="#Evidence2458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of PLCG from FCGR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction13">
 <bp:evidence rdf:resource="#Evidence16" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR binds STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2164">
 <bp:evidence rdf:resource="#Evidence2457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds to p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction18">
 <bp:evidence rdf:resource="#Evidence24" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-PKR dimer phosphorylates SNCA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2163">
 <bp:evidence rdf:resource="#Evidence2456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLCgamma to membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction19">
 <bp:evidence rdf:resource="#Evidence25" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-TARBP2 binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2162">
 <bp:evidence rdf:resource="#Evidence2455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction16">
 <bp:evidence rdf:resource="#Evidence22" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK complex is activated by PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2161">
 <bp:evidence rdf:resource="#Evidence2454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG stimulates protein kinase C-delta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction17">
 <bp:evidence rdf:resource="#Evidence23" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FA core complex:HSP70s binds PKR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2160">
 <bp:evidence rdf:resource="#Evidence2453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction323">
 <bp:evidence rdf:resource="#Evidence354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC1 recruits GRB2:GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2093">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction322">
 <bp:evidence rdf:resource="#Evidence353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SHC1:SHIP1 complex is stabilized by GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2092">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction325">
 <bp:evidence rdf:resource="#Evidence356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 mediates cytokine-induced phosphorylation of GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2091">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction324">
 <bp:evidence rdf:resource="#Evidence355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC1 recruits SHIP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2097">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2096">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction321">
 <bp:evidence rdf:resource="#Evidence351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL9:p-Y407-IL9R:JAK1:IL2RG:p-904,939-JAK3 binds STAT1, STAT3, STAT5A or STAT5B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2095">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction320">
 <bp:evidence rdf:resource="#Evidence350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y701-STAT1, p-Y705-STAT3, p-Y649-STAT5 dissociates from IL9:p-Y407-IL9R:JAK1:IL2RG:p-904,939-JAK3:p-Y705-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2099">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2098">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction10">
 <bp:evidence rdf:resource="#Evidence13" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR binds SCF beta-TrCP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction327">
 <bp:evidence rdf:resource="#Evidence358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gab2 binds the p85 subunit of Class 1A PI3 kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction11">
 <bp:evidence rdf:resource="#Evidence14" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction326">
 <bp:evidence rdf:resource="#Evidence357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SHC recruits GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction329">
 <bp:evidence rdf:resource="#Evidence361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IL2RB Y338 enables SHC recruitment</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2169">
 <bp:evidence rdf:resource="#Evidence2462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of PC to PA by PLD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction328">
 <bp:evidence rdf:resource="#Evidence360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK is a substrate for JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2168">
 <bp:evidence rdf:resource="#Evidence2461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2178">
 <bp:evidence rdf:resource="#Evidence2474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4C binds HIV and HCV glycoproteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2177">
 <bp:evidence rdf:resource="#Evidence2473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN and FYN phosphorylate FCER1G in CLEC6A:FCERG and CLEC4E:FCERG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2176">
 <bp:evidence rdf:resource="#Evidence2472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4E binds alpha-mannan and trehalose-6-6&apos;-dimycolate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2175">
 <bp:evidence rdf:resource="#Evidence2471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2174">
 <bp:evidence rdf:resource="#Evidence2468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGER-1,2,3 bind AGEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2173">
 <bp:evidence rdf:resource="#Evidence2467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TRTK-12 fragment of F-actin capping protein alpha binds the AGER ligand S100B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2172">
 <bp:evidence rdf:resource="#Evidence2466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced glycosylation end product-specific receptor (AGER/RAGE) is a multiligand receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2171">
 <bp:evidence rdf:resource="#Evidence2465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGER binds ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2170">
 <bp:evidence rdf:resource="#Evidence2463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction334">
 <bp:evidence rdf:resource="#Evidence366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IL2RB Y338, Y392 or Y510 enables STAT recruitment</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction333">
 <bp:evidence rdf:resource="#Evidence365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2 receptor alpha:IL2 binds Interleukin-2 receptor beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction336">
 <bp:evidence rdf:resource="#Evidence368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruited STAT5 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction335">
 <bp:evidence rdf:resource="#Evidence367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interleukin-2: IL2 receptor alpha:beta binds IL2 receptor gamma subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction330">
 <bp:evidence rdf:resource="#Evidence362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 phosphorylates Y338, Y392 and Y510 of IL2RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction332">
 <bp:evidence rdf:resource="#Evidence364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RG binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction331">
 <bp:evidence rdf:resource="#Evidence363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RB binds JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction338">
 <bp:evidence rdf:resource="#Evidence370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2B binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction337">
 <bp:evidence rdf:resource="#Evidence369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK3 binds JAK3 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction339">
 <bp:evidence rdf:resource="#Evidence371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2179">
 <bp:evidence rdf:resource="#Evidence2475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC6A binds alpha-mannan in fungal cell walls</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2101">
 <bp:evidence rdf:resource="#Evidence2388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD is processed into DCD(63-110)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2228" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2100">
 <bp:evidence rdf:resource="#Evidence2387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTN1,HTN3 or HTN5 binds the bacterial anionic surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2528">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2229" />
 <bp:stepProcess rdf:resource="#Catalysis750" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2525">
 <bp:stepProcess rdf:resource="#Catalysis748" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2526">
 <bp:stepProcess rdf:resource="#Catalysis749" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2230" />
 <bp:stepProcess rdf:resource="#Catalysis751" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2520">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2524">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep319">
 <bp:stepProcess rdf:resource="#Pathway29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction284" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2109">
 <bp:evidence rdf:resource="#Evidence2397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD(63-110) is processed to DCD(63-109)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep311">
 <bp:stepProcess rdf:resource="#BiochemicalReaction285" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2108">
 <bp:evidence rdf:resource="#Evidence2396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LCN2:2,5DHBA binds Fe3+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction286" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2107">
 <bp:evidence rdf:resource="#Evidence2395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds Mn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction287" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2106">
 <bp:evidence rdf:resource="#Evidence2394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lactoferrin scavenges iron ions</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction288" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2105">
 <bp:evidence rdf:resource="#Evidence2393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds Zn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction289" />
 <bp:stepProcess rdf:resource="#Catalysis87" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2104">
 <bp:evidence rdf:resource="#Evidence2392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A7 or S100A7A binds Zn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep316">
 <bp:stepProcess rdf:resource="#Catalysis88" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction290" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2103">
 <bp:evidence rdf:resource="#Evidence2390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHGA-derived peptide binds the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep317">
 <bp:stepProcess rdf:resource="#Pathway28" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2102">
 <bp:evidence rdf:resource="#Evidence2389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEs bind bacterial LPS, PGN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1100" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2112">
 <bp:evidence rdf:resource="#Evidence2400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYZ binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1099" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2111">
 <bp:evidence rdf:resource="#Evidence2399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A binds bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1102" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2110">
 <bp:evidence rdf:resource="#Evidence2398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BPIF binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1207">
 <bp:stepProcess rdf:resource="#Catalysis291" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2237" />
 <bp:stepProcess rdf:resource="#Catalysis754" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1209">
 <bp:stepProcess rdf:resource="#Pathway108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2530">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2531">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2232" />
 <bp:stepProcess rdf:resource="#Catalysis752" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1200">
 <bp:stepProcess rdf:resource="#Pathway106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1096" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1201">
 <bp:stepProcess rdf:resource="#Pathway107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2535">
 <bp:stepProcess rdf:resource="#Catalysis753" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2532">
 <bp:stepProcess rdf:resource="#Pathway301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1203">
 <bp:stepProcess rdf:resource="#Catalysis290" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1097" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction294" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2119">
 <bp:evidence rdf:resource="#Evidence2407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPPIN protein complex binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction295" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2118">
 <bp:evidence rdf:resource="#Evidence2406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEs bind bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction296" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2117">
 <bp:evidence rdf:resource="#Evidence2405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP3,4 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction297" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2116">
 <bp:evidence rdf:resource="#Evidence2404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRTN3 cleaves CAMP(31-170) to generate CAMP(134-170)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction298" />
 <bp:stepProcess rdf:resource="#Catalysis89" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2115">
 <bp:evidence rdf:resource="#Evidence2403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY binds the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction299" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2114">
 <bp:evidence rdf:resource="#Evidence2402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY is transferred to the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction300" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2113">
 <bp:evidence rdf:resource="#Evidence2401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEAP2 binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1108" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2123">
 <bp:evidence rdf:resource="#Evidence2411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYZ hydrolyzes peptidoglycans in the bacterial cell wall</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2549">
 <bp:stepProcess rdf:resource="#Catalysis760" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1216">
 <bp:stepProcess rdf:resource="#Catalysis293" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2122">
 <bp:evidence rdf:resource="#Evidence2410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A,REG3G binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1219">
 <bp:stepProcess rdf:resource="#Pathway111" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2121">
 <bp:evidence rdf:resource="#Evidence2409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP1 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2547">
 <bp:stepProcess rdf:resource="#Catalysis758" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1218">
 <bp:stepProcess rdf:resource="#Catalysis294" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1109" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2120">
 <bp:evidence rdf:resource="#Evidence2408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLA2G2A binds bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2548">
 <bp:stepProcess rdf:resource="#Catalysis759" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction302" />
 <bp:stepProcess rdf:resource="#Catalysis90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2242" />
 <bp:stepProcess rdf:resource="#Catalysis756" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1211">
 <bp:stepProcess rdf:resource="#Pathway109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2240" />
 <bp:stepProcess rdf:resource="#Catalysis755" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2545">
 <bp:stepProcess rdf:resource="#Catalysis757" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1212">
 <bp:stepProcess rdf:resource="#Pathway110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1215">
 <bp:stepProcess rdf:resource="#Catalysis292" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2543">
 <bp:stepProcess rdf:resource="#Pathway302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2544">
 <bp:stepProcess rdf:resource="#Pathway303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep333">
 <bp:stepProcess rdf:resource="#Catalysis91" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction306" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2129">
 <bp:evidence rdf:resource="#Evidence2420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIIIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep335">
 <bp:stepProcess rdf:resource="#Catalysis92" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction307" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2128">
 <bp:evidence rdf:resource="#Evidence2417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction308" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2127">
 <bp:evidence rdf:resource="#Evidence2416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP7A transports cytosolic Cu2+ to phagosomal lumen</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep337">
 <bp:stepProcess rdf:resource="#Pathway30" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2126">
 <bp:evidence rdf:resource="#Evidence2414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY binds the bacterial cell surface in the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction309" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2125">
 <bp:evidence rdf:resource="#Evidence2413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELANE, CTSG or PRTN3 binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction310" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2124">
 <bp:evidence rdf:resource="#Evidence2412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTN5, (HTN1, HTN3) binds fungal SSA1/SSA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1117" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2134">
 <bp:evidence rdf:resource="#Evidence2425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1227">
 <bp:stepProcess rdf:resource="#Catalysis296" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1116" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2133">
 <bp:evidence rdf:resource="#Evidence2424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to phosphorylated ITAMs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2132">
 <bp:evidence rdf:resource="#Evidence2423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK by Src kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2558">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1229">
 <bp:stepProcess rdf:resource="#Catalysis297" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1118" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2131">
 <bp:evidence rdf:resource="#Evidence2422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2255" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2130">
 <bp:evidence rdf:resource="#Evidence2421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sequestering and phosphorylation Fc gamma receptors in the lipid rafts</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2553">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2250" />
 <bp:stepProcess rdf:resource="#Catalysis761" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1222">
 <bp:stepProcess rdf:resource="#Pathway112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2551">
 <bp:stepProcess rdf:resource="#Pathway304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1224">
 <bp:stepProcess rdf:resource="#Catalysis295" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2557">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2554">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2555">
 <bp:stepProcess rdf:resource="#Pathway305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2560">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2256" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction317" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2139">
 <bp:evidence rdf:resource="#Evidence2431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by CRKII:DOCK180:ELMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction318" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2138">
 <bp:evidence rdf:resource="#Evidence2430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(WASPs, WAVE):G-actin:ARP2/3 binds F-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction319" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2137">
 <bp:evidence rdf:resource="#Evidence2429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src phosphorylate WASP,N-WASP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction320" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2136">
 <bp:evidence rdf:resource="#Evidence2428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-ERK phosphorylates WAVEs and ABI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2135">
 <bp:evidence rdf:resource="#Evidence2427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of CRKII:DOCK180:ELMO complex to FCGR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2505">
 <bp:stepProcess rdf:resource="#Pathway300" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2207" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2205" />
 <bp:stepProcess rdf:resource="#Catalysis741" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2208" />
 <bp:stepProcess rdf:resource="#Catalysis742" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2209" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence309">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2502">
 <bp:stepProcess rdf:resource="#Catalysis740" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2500">
 <bp:stepProcess rdf:resource="#Catalysis739" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2202" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence307">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2215" />
 <bp:stepProcess rdf:resource="#Catalysis745" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2515">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2518">
 <bp:stepProcess rdf:resource="#Catalysis746" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2519">
 <bp:stepProcess rdf:resource="#Catalysis747" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2214" />
 <bp:stepProcess rdf:resource="#Catalysis744" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2511">
 <bp:stepProcess rdf:resource="#Catalysis743" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep308">
 <bp:stepProcess rdf:resource="#BiochemicalReaction282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep300">
 <bp:stepProcess rdf:resource="#Pathway26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep301">
 <bp:stepProcess rdf:resource="#Pathway27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep306">
 <bp:stepProcess rdf:resource="#Catalysis86" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction356" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction359" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep394">
 <bp:stepProcess rdf:resource="#BiochemicalReaction360" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep396">
 <bp:stepProcess rdf:resource="#BiochemicalReaction362" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction363" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1275">
 <bp:stepProcess rdf:resource="#Catalysis322" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1155" />
 <bp:stepProcess rdf:resource="#Catalysis321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1276">
 <bp:stepProcess rdf:resource="#Pathway121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1159" />
 <bp:stepProcess rdf:resource="#Catalysis324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1278">
 <bp:stepProcess rdf:resource="#Catalysis323" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1158" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence324">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1160" />
 <bp:stepProcess rdf:resource="#Catalysis325" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence326">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1162" />
 <bp:stepProcess rdf:resource="#Catalysis326" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence327">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1161" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence328">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1164" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence329">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1163" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction364" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction365" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence320">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2009">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2008">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2007">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence319">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1166" />
 <bp:stepProcess rdf:resource="#Catalysis327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1288">
 <bp:stepProcess rdf:resource="#Catalysis328" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1167" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1289">
 <bp:stepProcess rdf:resource="#Pathway122" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence312">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence313">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1170" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence314">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1169" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence315">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1172" />
 <bp:stepProcess rdf:resource="#Catalysis330" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence316">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1292">
 <bp:stepProcess rdf:resource="#Catalysis329" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1171" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence317">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1174" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence318">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1173" />
 <bp:stepProcess rdf:resource="#Catalysis331" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2002">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2000">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2006">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2005">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2003">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1297">
 <bp:stepProcess rdf:resource="#Pathway124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1296">
 <bp:stepProcess rdf:resource="#Pathway123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1299">
 <bp:stepProcess rdf:resource="#Pathway125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1175" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence332">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1128" />
 <bp:stepProcess rdf:resource="#Catalysis301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2263" />
 <bp:stepProcess rdf:resource="#Catalysis762" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep351">
 <bp:stepProcess rdf:resource="#Pathway31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1230">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2561">
 <bp:stepProcess rdf:resource="#Pathway306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2261" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1234">
 <bp:stepProcess rdf:resource="#Catalysis298" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1237">
 <bp:stepProcess rdf:resource="#Catalysis300" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2565">
 <bp:stepProcess rdf:resource="#Pathway307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1236">
 <bp:stepProcess rdf:resource="#Catalysis299" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2260" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence369">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2570">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction326" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence360">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction327" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence361">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep358">
 <bp:stepProcess rdf:resource="#Pathway32" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence362">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep359">
 <bp:stepProcess rdf:resource="#Catalysis93" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction328" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence365">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction330" />
 <bp:stepProcess rdf:resource="#Catalysis94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2574">
 <bp:stepProcess rdf:resource="#Pathway308" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1130" />
 <bp:stepProcess rdf:resource="#Catalysis302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1244">
 <bp:stepProcess rdf:resource="#Pathway114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2266" />
 <bp:stepProcess rdf:resource="#Catalysis763" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1243">
 <bp:stepProcess rdf:resource="#Pathway113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1133" />
 <bp:stepProcess rdf:resource="#Catalysis303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2271" />
 <bp:stepProcess rdf:resource="#Catalysis764" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1248">
 <bp:stepProcess rdf:resource="#Pathway115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1247">
 <bp:stepProcess rdf:resource="#Catalysis304" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2270" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence359">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2581">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1251">
 <bp:stepProcess rdf:resource="#Catalysis306" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1136" />
 <bp:stepProcess rdf:resource="#Catalysis305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction336" />
 <bp:stepProcess rdf:resource="#Catalysis95" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence350">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction337" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence351">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction338" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence354">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction339" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction340" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep374">
 <bp:stepProcess rdf:resource="#Catalysis96" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction344" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence390">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2585">
 <bp:stepProcess rdf:resource="#Pathway310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1252">
 <bp:stepProcess rdf:resource="#Catalysis307" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1255">
 <bp:stepProcess rdf:resource="#Pathway117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1254">
 <bp:stepProcess rdf:resource="#Pathway116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2584">
 <bp:stepProcess rdf:resource="#Pathway309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1257">
 <bp:stepProcess rdf:resource="#Catalysis308" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1143" />
 <bp:stepProcess rdf:resource="#Catalysis310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1142" />
 <bp:stepProcess rdf:resource="#Catalysis309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2279" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence389">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2592">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2593">
 <bp:stepProcess rdf:resource="#Pathway311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1262">
 <bp:stepProcess rdf:resource="#Catalysis311" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1261">
 <bp:stepProcess rdf:resource="#Pathway118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction345" />
 <bp:stepProcess rdf:resource="#Catalysis97" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence380">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction346" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence381">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep378">
 <bp:stepProcess rdf:resource="#Pathway33" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence382">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction347" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence387">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction348" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction349" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction351" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep384">
 <bp:stepProcess rdf:resource="#Pathway34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep385">
 <bp:stepProcess rdf:resource="#Pathway35" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1264">
 <bp:stepProcess rdf:resource="#Catalysis313" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2596">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2286" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1263">
 <bp:stepProcess rdf:resource="#Catalysis312" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1266">
 <bp:stepProcess rdf:resource="#Pathway119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2284" />
 <bp:stepProcess rdf:resource="#Catalysis765" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1148" />
 <bp:stepProcess rdf:resource="#Catalysis314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2285" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1268">
 <bp:stepProcess rdf:resource="#Pathway120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1149" />
 <bp:stepProcess rdf:resource="#Catalysis315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2598">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1150" />
 <bp:stepProcess rdf:resource="#Catalysis316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2599">
 <bp:stepProcess rdf:resource="#Pathway312" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence379">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1271">
 <bp:stepProcess rdf:resource="#Catalysis318" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1270">
 <bp:stepProcess rdf:resource="#Catalysis317" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1154" />
 <bp:stepProcess rdf:resource="#Catalysis320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1153" />
 <bp:stepProcess rdf:resource="#Catalysis319" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction353" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence370">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction354" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence371">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction355" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence376">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction471">
 <bp:evidence rdf:resource="#Evidence510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL13RA1 binds TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway208">
 <bp:pathwayOrder rdf:resource="#PathwayStep1789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1791" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1583" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1585" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction470">
 <bp:evidence rdf:resource="#Evidence509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1,STAT3,STAT6 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway209">
 <bp:pathwayOrder rdf:resource="#PathwayStep1796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1590" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1587" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway206">
 <bp:pathwayOrder rdf:resource="#PathwayStep1770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1771" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1565" />
 <bp:pathwayComponent rdf:resource="#Pathway207" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway207">
 <bp:pathwayOrder rdf:resource="#PathwayStep1778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1782" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1573" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1571" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1570" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1568" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1574" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway204">
 <bp:pathwayOrder rdf:resource="#PathwayStep1752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1549" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway205">
 <bp:pathwayOrder rdf:resource="#PathwayStep1767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1760" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1560" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1559" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1563" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction466">
 <bp:evidence rdf:resource="#Evidence504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:IL22RA1:JAK1 binds IL10RB:TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway213">
 <bp:pathwayOrder rdf:resource="#PathwayStep1811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1827" />
 <bp:pathwayComponent rdf:resource="#Pathway214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1614" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1612" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1598" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction465">
 <bp:evidence rdf:resource="#Evidence503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 in IL24:IL20RA:JAK1:IL20RB is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway214">
 <bp:pathwayOrder rdf:resource="#PathwayStep1822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1823" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1606" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1605" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1603" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1610" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction468">
 <bp:evidence rdf:resource="#Evidence507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL4, IL13-upregulated extracellular proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway211">
 <bp:pathwayOrder rdf:resource="#PathwayStep1833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1828" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1829" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1809" />
 <bp:pathwayComponent rdf:resource="#Pathway215" />
 <bp:pathwayComponent rdf:resource="#Pathway213" />
 <bp:pathwayComponent rdf:resource="#Pathway224" />
 <bp:pathwayComponent rdf:resource="#Pathway212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1618" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1662" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian myeloid differentiation factor 88 (MyD88) is Toll/interleukin (IL)-1 (TIR)-domain containing adapter  protein which plays crucial role in TLR signaling. All TLRs, with only one exception of TLR3, can initiate downstream  signaling trough MyD88. In the MyD88 - dependent pathway, once the adaptor is bound to TLR  it leads to recruitment of IL1 receptor associated kinase family  IRAK which is followed by activation of tumour necrosis factor receptor-associated factor 6 (TRAF6) . TRAF6 is an ubiquitin E3 ligase which in turn induces TGF-beta activating kinase 1 (TAK1) auto phosphorylation. Once activated TAK1 can ultimately mediate the induction of the transcription factor NF-kB or the mitogen-activated protein kinases  (MAPK), such as JNK, p38 and ERK. This results in the translocation of the activated NF-kB and MAPKs to the nucleus and the initiation of appropriate gene transcription leading to the production of many proinflammatory cytokines and antimicrobial peptides.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction467">
 <bp:evidence rdf:resource="#Evidence505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:p&#8209;Y251,p&#8209;Y301&#8209;IL22RA1:p&#8209;JAK1:PTPN11:IL10RB:p&#8209;TYK2 binds PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway212">
 <bp:pathwayOrder rdf:resource="#PathwayStep1804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1806" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1592" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction462">
 <bp:evidence rdf:resource="#Evidence500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20:IL20RA:JAK1:IL20RB:p&#8209;JAK2,p&#8209;JAK3 binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction461">
 <bp:evidence rdf:resource="#Evidence499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL2,IFNL3 bind IL10RB:TYK2 and IFNLR1:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway210">
 <bp:pathwayOrder rdf:resource="#PathwayStep1801" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1886" />
 <bp:pathwayComponent rdf:resource="#Pathway211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1663" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 10 (TLR10) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Little is known about TLR10 ligands. It has been established that the receptor homodimerizes upon binding and signals in an MyD88-dependent manner (Hasan U et al 2005; Nyman T et al 2008). It may also heterodimerize with TLRs 1 and 2. It is expressed in a restricted fashion as a highly N-glycosylated protein detectable in B cells and dendritic cells.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction464">
 <bp:evidence rdf:resource="#Evidence502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20RA binds IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction463">
 <bp:evidence rdf:resource="#Evidence501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dissociates from  IL22:p-Y251,p-Y301-IL22RA1:p-JAK1:IL10RB:p-TYK2:p-Y705-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction469">
 <bp:evidence rdf:resource="#Evidence508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT6-upregulated plasma membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction480">
 <bp:evidence rdf:resource="#Evidence519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3, p-Y641-STAT6 dimerise</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction482">
 <bp:evidence rdf:resource="#Evidence521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 binds IL4R in IL13-bound IL13R type II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction481">
 <bp:evidence rdf:resource="#Evidence520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4R, IL2RG, JAK1 in IL4-bound IL4R1:JAK1 are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence399">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction477">
 <bp:evidence rdf:resource="#Evidence516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of GATA3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway202">
 <bp:pathwayOrder rdf:resource="#PathwayStep1745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1746" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1748" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1544" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction476">
 <bp:evidence rdf:resource="#Evidence515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4R binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway203">
 <bp:pathwayOrder rdf:resource="#PathwayStep1756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1757" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1750" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1554" />
 <bp:pathwayComponent rdf:resource="#Pathway204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1552" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction479">
 <bp:evidence rdf:resource="#Evidence518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dimer, p-Y641-STAT6 dimer translocate to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway200">
 <bp:pathwayOrder rdf:resource="#PathwayStep1744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1749" />
 <bp:pathwayComponent rdf:resource="#Pathway202" />
 <bp:pathwayComponent rdf:resource="#Pathway203" />
 <bp:pathwayComponent rdf:resource="#Pathway201" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction478">
 <bp:evidence rdf:resource="#Evidence517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4 binds IL4R:JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway201">
 <bp:pathwayOrder rdf:resource="#PathwayStep1739" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1539" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1541" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction473">
 <bp:evidence rdf:resource="#Evidence512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT3-upregulated extracellular proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction472">
 <bp:evidence rdf:resource="#Evidence511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 phosphorylates STAT3,STAT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction475">
 <bp:evidence rdf:resource="#Evidence514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4:IL4R:JAK2 binds IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction474">
 <bp:evidence rdf:resource="#Evidence513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL18, ALOX5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence391">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis199">
 <bp:controlled rdf:resource="#BiochemicalReaction825" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence398">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction491">
 <bp:evidence rdf:resource="#Evidence530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL4R, IL13RA, JAK2 and TYK2 are tyrosine phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction490">
 <bp:evidence rdf:resource="#Evidence529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL13:IL13RA:TYK2 binds IL4R:JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction493">
 <bp:evidence rdf:resource="#Evidence532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STATs translocate to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction492">
 <bp:evidence rdf:resource="#Evidence531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK3 binds JAK3 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway228">
 <bp:pathwayOrder rdf:resource="#PathwayStep1893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1669" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1666" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway229">
 <bp:pathwayOrder rdf:resource="#PathwayStep1899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1670" />
 <bp:pathwayComponent rdf:resource="#Pathway230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1684" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway226">
 <bp:pathwayOrder rdf:resource="#PathwayStep1889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1664" />
 <bp:pathwayComponent rdf:resource="#Pathway227" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor TLR6:TLR2 Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR2 and TLR4 recognize different bacterial cell wall components. While TLR4 is trained onto Gram-negative lipopolysaccharide components, TLR2 - in combination with TLR6 - plays a major role in recognizing peptidoglycan wall products from Gram-positive bacteria, as well as Mycobacterial diacylated lipopeptides. In particular, TLR6 appears to participate in discriminating the subtle differences between dipalmitoyl and tripalmitoyl cysteinyl residues (Okusawa et al. 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway227">
 <bp:pathwayOrder rdf:resource="#PathwayStep1921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1969" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1892" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1971" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1973" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1690" />
 <bp:pathwayComponent rdf:resource="#Pathway228" />
 <bp:pathwayComponent rdf:resource="#Pathway229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1729" />
 <bp:pathwayComponent rdf:resource="#Pathway231" />
 <bp:pathwayComponent rdf:resource="#Pathway240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1735" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1734" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1695" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction488">
 <bp:evidence rdf:resource="#Evidence527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL13 binds IL13RA:TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway235">
 <bp:pathwayOrder rdf:resource="#PathwayStep1942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1704" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction487">
 <bp:evidence rdf:resource="#Evidence526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT3-upregulated plasma membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway236">
 <bp:pathwayOrder rdf:resource="#PathwayStep1945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1710" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway233">
 <bp:pathwayOrder rdf:resource="#PathwayStep1932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1935" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1699" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction489">
 <bp:evidence rdf:resource="#Evidence528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of SOCS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway234">
 <bp:pathwayOrder rdf:resource="#PathwayStep1943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1948" />
 <bp:pathwayComponent rdf:resource="#Pathway235" />
 <bp:pathwayComponent rdf:resource="#Pathway236" />
 <bp:pathwayComponent rdf:resource="#Pathway237" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction484">
 <bp:evidence rdf:resource="#Evidence523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL13 binds IL13RA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway231">
 <bp:pathwayOrder rdf:resource="#PathwayStep1936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1926" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1930" />
 <bp:pathwayComponent rdf:resource="#Pathway233" />
 <bp:pathwayComponent rdf:resource="#Pathway234" />
 <bp:pathwayComponent rdf:resource="#Pathway232" />
 <bp:pathwayComponent rdf:resource="#Pathway239" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction483">
 <bp:evidence rdf:resource="#Evidence522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of FASLG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway232">
 <bp:pathwayOrder rdf:resource="#PathwayStep1927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1929" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1696" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction486">
 <bp:evidence rdf:resource="#Evidence525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL13-upregulated plasma membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction485">
 <bp:evidence rdf:resource="#Evidence524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT6-upregulated extracellular proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway230">
 <bp:pathwayOrder rdf:resource="#PathwayStep1910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1904" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1678" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1675" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1673" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway219">
 <bp:pathwayOrder rdf:resource="#PathwayStep1846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1630" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway217">
 <bp:pathwayOrder rdf:resource="#PathwayStep1843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1839" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1840" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1626" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1623" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway218">
 <bp:pathwayOrder rdf:resource="#PathwayStep1845" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1851" />
 <bp:pathwayComponent rdf:resource="#Pathway220" />
 <bp:pathwayComponent rdf:resource="#Pathway221" />
 <bp:pathwayComponent rdf:resource="#Pathway219" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway215">
 <bp:pathwayOrder rdf:resource="#PathwayStep1844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1834" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1838" />
 <bp:pathwayComponent rdf:resource="#Pathway223" />
 <bp:pathwayComponent rdf:resource="#Pathway217" />
 <bp:pathwayComponent rdf:resource="#Pathway218" />
 <bp:pathwayComponent rdf:resource="#Pathway216" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway216">
 <bp:pathwayOrder rdf:resource="#PathwayStep1835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1620" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction499">
 <bp:evidence rdf:resource="#Evidence538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of BCL2, BCL2L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway224">
 <bp:pathwayOrder rdf:resource="#PathwayStep1880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1881" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1658" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1657" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction498">
 <bp:evidence rdf:resource="#Evidence537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 binds IL4R in IL4-bound IL4R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway225">
 <bp:pathwayOrder rdf:resource="#PathwayStep1888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1982" />
 <bp:pathwayComponent rdf:resource="#Pathway241" />
 <bp:pathwayComponent rdf:resource="#Pathway226" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 2 (TLR2) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR2 is involved in recognition of peptidoglycan from gram-positive bacteria, bacterial lipoproteins, mycoplasma lipoprotein and mycobacterial products. It is quite possible that recognition of at least some other TLR2 ligands may be assisted by additional accessory proteins, particularly in association with TLR1 or TLR6. TLR2 is expressed constitutively on macrophages, dendritic cells, and B cells, and can be induced in some other cell types, including epithelial cells. TLR1 and TLR6, on the other hand, are expressed almost ubiquitously (Muzio et al. 2000). TLR2 may be a sensor and inductor of specific defense processes, including oxidative stress and cellular necrosis initially spurred by microbial compounds.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway222">
 <bp:pathwayOrder rdf:resource="#PathwayStep1859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1638" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway223">
 <bp:pathwayOrder rdf:resource="#PathwayStep1868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1867" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1871" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1870" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1648" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1651" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction495">
 <bp:evidence rdf:resource="#Evidence534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PTGS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway220">
 <bp:pathwayOrder rdf:resource="#PathwayStep1855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1636" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1633" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction494">
 <bp:evidence rdf:resource="#Evidence533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STATs dimerize</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway221">
 <bp:pathwayOrder rdf:resource="#PathwayStep1865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1862" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1863" />
 <bp:pathwayComponent rdf:resource="#Pathway222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1640" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction497">
 <bp:evidence rdf:resource="#Evidence536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3,STAT6 bind p-Y-IL4R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction496">
 <bp:evidence rdf:resource="#Evidence535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IL13-downregulated extracellular proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis170">
 <bp:controlled rdf:resource="#BiochemicalReaction782" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis171">
 <bp:controlled rdf:resource="#BiochemicalReaction784" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis172">
 <bp:controlled rdf:resource="#BiochemicalReaction785" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis173">
 <bp:controlled rdf:resource="#BiochemicalReaction786" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis174">
 <bp:controlled rdf:resource="#BiochemicalReaction789" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis175">
 <bp:controlled rdf:resource="#BiochemicalReaction790" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis176">
 <bp:controlled rdf:resource="#BiochemicalReaction791" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1095" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1094" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1199">
 <bp:stepProcess rdf:resource="#Pathway105" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway248">
 <bp:pathwayOrder rdf:resource="#PathwayStep2025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1779" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1778" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway249">
 <bp:pathwayOrder rdf:resource="#PathwayStep2031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2037" />
 <bp:pathwayComponent rdf:resource="#Pathway251" />
 <bp:pathwayComponent rdf:resource="#Pathway252" />
 <bp:pathwayComponent rdf:resource="#Pathway250" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway257">
 <bp:pathwayOrder rdf:resource="#PathwayStep2091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2167" />
 <bp:pathwayComponent rdf:resource="#Pathway258" />
 <bp:pathwayComponent rdf:resource="#Pathway266" />
 <bp:pathwayComponent rdf:resource="#Pathway260" />
 <bp:pathwayComponent rdf:resource="#Pathway259" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the complement cascade, a panel of soluble molecules rapidly and effectively senses a danger or damage and triggers reactions to provide a response that discriminates among foreign intruders, cellular debris, healthy and altered host cells (Ricklin D et al. 2010). Complement proteins circulate in the blood stream in functionally inactive states. When triggered the complement cascade generates enzymatically active molecules (such as C3/C5 convertases) and biological effectors: opsonins (C3b, C3d and C4b), anaphylatoxins (C3a and C5a), and C5b, which initiates assembly of the lytic membrane attack complex (MAC). Three branches lead to complement activation: the classical, lectin and alternative pathways (Kang YH et al. 2009; Ricklin D et al. 2010). The classical pathway is initiated by C1 complex binding to immune complexes, pentraxins or other targets such as apoptotic cells leading to cleavage of C4 and C2 components and formation of the classical C3 convertase, C4bC2a. The lectin pathway is activated by binding of mannan-binding lectin (MBL) to repetitive carbohydrate residues, or by binding of ficolins to carbohydrate or acetylated groups on target surfaces. MBL and ficolins interact with MBL-associated serine proteases (MASP) leading to cleavage of C4 and C2 and formation of the classical C3 convertase, C4bC2a. The alternative pathway is spontaneously activated by the hydrolysis of the internal thioester group of C3 to give C3(H2O). Alternative pathway activation involves interaction of C3(H2O) and/or previously generated C3b with factor B, which is cleaved by factor D to generate the alternative C3 convertases C3(H2O)Bb and/or C3bBb. All three pathways merge at the proteolytic cleavage of component C3 by C3 convertases to form opsonin C3b and anaphylatoxin C3a. C3b covalently binds to glycoproteins scattered across the target cell surface. This is followed by an amplification reaction that generates additional C3 convertases and deposits more C3b at the local site. C3b can also bind to C3 convertases switching them to C5 convertases, which mediate C5 cleavage leading to MAC formation. Thus, the activation of the complement system leads to several important outcomes:  opsonization of target cells to enhance phagocytosis, lysis of target cells via membrane attack complex (MAC) assembly on the cell surface, production of anaphylatoxins C3a/C5a involved in the host inflammatory response, C5a-mediated leukocyte chemotaxis, and clearance of antibody-antigen complexes. The complement system is able to distinguish between pathological and physiological challenges, i.e. the outcomes of complement activation are predetermined by the trigger and are tightly tuned by a combination of initiation events with several regulatory mechanisms. These regulatory mechanisms use soluble (e.g., C4BP, CFI and CFH) and membrane-bound regulators (e.g., CR1, CD46(MCP), CD55(DAF) and CD59) and are coordinated by complement receptors such as CR1, CR2, etc. In response to microbial infection complement activation results in flagging microorganisms with opsonins for facilitated phagocytosis, formation of MAC on cells such as Gram-negative bacteria leading to cell lysis, and release of C3a and C5a to stimulate downstream immune responses and to attract leukocytes. Most pathogens can be eliminated by these complement-mediated host responses, though some pathogenic microorganisms have developed ways of avoiding complement recognition or blocking host complement attack resulting in greater virulence (Lambris JD et al. 2008; Serruto D et al. 2010). All three complement pathways (classical, lectin and alternative) have been implicated in clearance of dying cells (Mevorach D et al. 1998; Ogden CA et al. 2001; Gullstrand B et al.2009; Kemper C et al. 2008). Altered surfaces of apoptotic cells are recognized by complement proteins leading to opsonization and subsequent phagocytosis. In contrast to pathogens, apoptotic cells are believed to induce only a limited complement activation by allowing opsonization of altered surfaces but restricting the terminal pathway of MAC formation (Gershov D et al. 2000; Braunschweig A and Jozsi M 2011). Thus, opsonization facilitates clearance of dying cells and cell debris without triggering danger signals and further inflammatory responses (Fraser DA et al. 2007, 2009; Benoit ME et al. 2012). C1q-mediated complement activation by apoptotic cells has been shown in a variety of human cells: keratinocytes, human umbilical vein endothelial cells (HUVEC), Jurkat T lymphoblastoid cells, lung adenocarcinoma cells (Korb LC and Ahearn JM 1997; Mold C and Morris CA 2001; Navratil JS et al. 2001; Nauta AJ et al. 2004). In addition to C1q the opsonization of apoptotic Jurkat T cells with MBL also facilitated clearance of these cells by both dendritic cells (DC) and macrophages (Nauta AJ et al. 2004). Also C3b, iC3b and C4b deposition on apoptotic cells as a consequence of activation of the complement cascade may promote complement-mediated phagocytosis. C1q, MBL and cleavage fragments of C3/C4 can bind to several receptors expressed on macrophages (e.g. cC1qR (calreticulin), CR1, CR3, CR4) suggesting a potential clearance mechanism through this interaction (Mevorach D et al. 1998; Ogden CA et al. 2001). Apoptosis is also associated with an altered expression of complement regulators on the surface of apoptotic cells. CD46 (MCP) bound to the plasma membrane of a healthy cell protects it from complement-mediated attack by preventing deposition of C3b and C4b, and reduced expression of CD46 on dying cells may lead to enhanced opsonization (Elward K et al. 2005). Upregulation of CD55 (DAF) and CD59 on apoptotic cell surfaces may protect damaged cells against complement mediated lysis (Pedersen ED et al. 2007; Iborra A et al. 2003; Hensel F et al. 2001). In addition, fluid-phase complement regulators such as C4BP, CFH may also inhibit lysis of apoptotic cells by limiting complement activation (Trouw LA et al 2007; Braunschweig A and Jozsi M. 2011). Complement facilitates the clearance of immune complexes (IC) from the circulation (Chevalier J and Kazatchkine MD 1989; Nielsen CH et al. 1997). Erythrocytes bear clusters of complement receptor 1 (CR1 or CD35), which serves as an immune adherence receptor for C3 and/or C4 fragments deposited on IC that are shuttled to liver and spleen, where IC are transferred and processed by tissue macrophages through an Fc receptor-mediated process. Complement proteins are always present in the blood and a small percentage spontaneously activate. Inappropriate activation leads to host cell damage, so on healthy human cells any complement activation or amplification is strictly regulated by surface-bound regulators that accelerate decay of the convertases (CR1, CD55), act as a cofactor for the factor I (CFI)-mediated degradation of C3b and C4b (CR1, CD46), or prevent the formation of MAC (CD59). Soluble regulators such as C4BP, CFH and FHL1 recognize self surface pattern-like glycosaminoglycans and further impair activation. Complement components interact with other biological systems. Upon microbial infection complement acts in cooperation with Toll-like receptors (TLRs) to amplify innate host defense. Anaphylatoxin C5a binds C5a receptor (C5aR) resulting in a synergistic enhancement of the TLR and C5aR-mediated proinflammatory cytokine response to infection. This interplay is negatively modulated by co-ligation of TLR and the second C5a receptor, C5L2, suggesting the existence of complex immunomodulatory interactions (Kohl J 2006; Hajishengallis G and Lambris JD 2010). In addition to C5aR and C5L2, complement receptor 3 (CR3) facilitates TLR2 or TLR4 signaling pathways by promoting a recruitment of their sorting adaptor TIRAP (MAL) to the receptor complex (van Bruggen R et al. 2007; Kagan JC and Medzhitov R 2006). Complement may activate platelets or facilitate biochemical and morphological changes in the endothelium potentiating coagulation and contributing to homeostasis in response to injury (Oikonomopoulou K et al. 2012). The interplay of complement and coagulation also involves cleavage of C3 and C5 convertases by coagulation proteases, generating biologically active anaphylatoxins (Amara U et al. 2010). Complement is believed to link the innate response to both humoral and cell-mediated immunity (Toapanta FR and Ross TM 2006; Mongini PK et al. 1997). The majority of published data is based on experiments using mouse as a model organism. Further characterization of the influence of complement on B or T cell activation is required for the human system, since differences between murine models and the human system are not yet fully determined. Complement is also involved in regulation of mobilization and homing of hematopoietic stem/progenitor cells (HSPCs) from bone marrow to the circulation and peripheral tissue in order to accommodate blood cell replenishment (Reca R et al. 2006). Thus, the complement system orchestrates the host defense by sensing a danger signal and transmitting it into specific cellular responses while extensively communicating with associated biological pathways ranging from immunity and inflammation to homeostasis and development. Originally the larger fragment of Complement Factor 2 (C2) was designated C2a. However, complement scientists decided that the smaller of all C fragments should be designated with an &apos;a&apos;, the larger with a &apos;b&apos;, changing the nomenclature for C2. Recent literature may use the updated nomenclature and refer to the larger C2 fragment as C2b, and refer to the classical C3 convertase as C4bC2b. Throughout this pathway Reactome adheres to the original convention to agree with the current (Sep 2013) Uniprot names for C2 fragments. The complement cascade pathway is organised into the following sections: initial triggering, activation of C3 and C5, terminal pathway and regulation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway258">
 <bp:pathwayOrder rdf:resource="#PathwayStep2093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2092" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1835" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Terminal pathway of complement</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After cleavage of C5, C5b undergoes conformational changes and exposes a binding site for C6. C5b6 binds C7 resulting in the exposure of membrane binding sites and incorporation into target membranes. The membrane-bound C5b-7 complex can then bind C8. C5b-8 acts as a polymerizing agent for C9. The first C9 bound to C5b-8 undergoes major structural changes enabling formation of an elongated molecule and allows binding of additional C9 molecules and insertion of C9 cylinders into the target membrane. The number of C9 molecules varies from 1-12 in the membrane, although polymers containing up to fifteen C9 molecules are also possible.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway255">
 <bp:pathwayOrder rdf:resource="#PathwayStep2071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1820" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway256">
 <bp:pathwayOrder rdf:resource="#PathwayStep2079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2088" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2078" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2089" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2081" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1825" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1834" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1822" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1833" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1830" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TLR by endogenous ligand</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Diverse molecules of host-cell origin may serve as endogenous ligands of Toll-like receptors (TLRs) (Erridge C 2010; Piccinini AM    Midwood KS 2010). These molecules are known as damage-associated molecular patterns (DAMPs). DAMPs are immunologically silent in healthy tissues but become active upon tissue damage during both infectious and sterile insult. DAMPs are released from necrotic cells or secreted from activated cells in response to tissue damage to mediate tissue repair by promoting inflammatory responses. However, DAMPs have also been implicated in the pathogenesis of many inflammatory and autoimmune diseases, including rheumatoid arthritis (RA), cancer, and atherosclerosis. The mechanism underlying the switch from DAMPs that initiate controlled tissue repair, to those that mediate chronic, uncontrolled inflammation is still unclear. Recent evidence suggests that an abnormal increase in protein citrullination is involved in disease pathophysiology (Anzilotti C et al. 2010; Sanchez-Pernaute O et al. 2013; Sokolove J et al. 2011; Sharma P et al. 2012). Citrullination is a post-translational modification event mediated by peptidyl-arginine deaminase enzymes which catalyze the deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway253">
 <bp:pathwayOrder rdf:resource="#PathwayStep2046" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1794" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway254">
 <bp:pathwayOrder rdf:resource="#PathwayStep2060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2054" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2055" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2056" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1803" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1802" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1801" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1800" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway251">
 <bp:pathwayOrder rdf:resource="#PathwayStep2040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1790" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1789" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1788" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway252">
 <bp:pathwayOrder rdf:resource="#PathwayStep2050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1792" />
 <bp:pathwayComponent rdf:resource="#Pathway253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1799" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1798" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1795" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis166">
 <bp:controlled rdf:resource="#BiochemicalReaction758" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis167">
 <bp:controlled rdf:resource="#BiochemicalReaction768" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway250">
 <bp:pathwayOrder rdf:resource="#PathwayStep2032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2035" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2036" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2033" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1784" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1783" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis168">
 <bp:controlled rdf:resource="#BiochemicalReaction775" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis169">
 <bp:controlled rdf:resource="#BiochemicalReaction781" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis160">
 <bp:controlled rdf:resource="#BiochemicalReaction700" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis161">
 <bp:controlled rdf:resource="#BiochemicalReaction701" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis162">
 <bp:controlled rdf:resource="#BiochemicalReaction703" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis163">
 <bp:controlled rdf:resource="#BiochemicalReaction708" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis164">
 <bp:controlled rdf:resource="#BiochemicalReaction711" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis165">
 <bp:controlled rdf:resource="#BiochemicalReaction714" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway239">
 <bp:pathwayOrder rdf:resource="#PathwayStep1965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1959" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1960" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1726" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1721" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway237">
 <bp:pathwayOrder rdf:resource="#PathwayStep1954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1955" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1949" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1720" />
 <bp:pathwayComponent rdf:resource="#Pathway238" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway238">
 <bp:pathwayOrder rdf:resource="#PathwayStep1952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1714" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway246">
 <bp:pathwayOrder rdf:resource="#PathwayStep2020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2024" />
 <bp:pathwayComponent rdf:resource="#Pathway247" />
 <bp:pathwayComponent rdf:resource="#Pathway254" />
 <bp:pathwayComponent rdf:resource="#Pathway248" />
 <bp:pathwayComponent rdf:resource="#Pathway249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway247">
 <bp:pathwayOrder rdf:resource="#PathwayStep2021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1775" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway244">
 <bp:pathwayOrder rdf:resource="#PathwayStep2008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2006" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2007" />
 <bp:pathwayComponent rdf:resource="#Pathway245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1750" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway245">
 <bp:pathwayOrder rdf:resource="#PathwayStep1998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1995" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1756" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1755" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1761" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway242">
 <bp:pathwayOrder rdf:resource="#PathwayStep1986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2014" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2011" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1991" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2012" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2067" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1770" />
 <bp:pathwayComponent rdf:resource="#Pathway246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1808" />
 <bp:pathwayComponent rdf:resource="#Pathway244" />
 <bp:pathwayComponent rdf:resource="#Pathway255" />
 <bp:pathwayComponent rdf:resource="#Pathway243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1812" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1767" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1811" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1744" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1810" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1772" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway243">
 <bp:pathwayOrder rdf:resource="#PathwayStep1987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1748" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1747" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1745" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway240">
 <bp:pathwayOrder rdf:resource="#PathwayStep1976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1740" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway241">
 <bp:pathwayOrder rdf:resource="#PathwayStep2075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1984" />
 <bp:pathwayComponent rdf:resource="#Pathway242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1743" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor TLR1:TLR2 Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1 is expressed by monocytes. TLR1 and TLR2 cotranslationally form heterodimeric complexes on the cell surface and in the cytosol. The TLR2:TLR1 complex recognizes Neisserial PorB and Mycobacterial triacylated lipoproteins and peptides, amongst others, triggering up-regulation of nuclear factor-kappaB production and apoptotic cascades. Such cooperation between TLR1 and TLR2 on the cell surface of normal human peripheral blood mononuclear cells, for instance, leads to the activation of pro-inflammatory cytokine secretion (Sandor et al. 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis155">
 <bp:controlled rdf:resource="#BiochemicalReaction670" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis156">
 <bp:controlled rdf:resource="#BiochemicalReaction671" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis157">
 <bp:controlled rdf:resource="#BiochemicalReaction674" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis158">
 <bp:controlled rdf:resource="#BiochemicalReaction678" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis159">
 <bp:controlled rdf:resource="#BiochemicalReaction681" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis191">
 <bp:controlled rdf:resource="#BiochemicalReaction808" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis192">
 <bp:controlled rdf:resource="#BiochemicalReaction810" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis193">
 <bp:controlled rdf:resource="#BiochemicalReaction813" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis194">
 <bp:controlled rdf:resource="#BiochemicalReaction814" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis195">
 <bp:controlled rdf:resource="#BiochemicalReaction815" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis196">
 <bp:controlled rdf:resource="#BiochemicalReaction816" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis197">
 <bp:controlled rdf:resource="#BiochemicalReaction817" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis198">
 <bp:controlled rdf:resource="#BiochemicalReaction818" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis190">
 <bp:controlled rdf:resource="#BiochemicalReaction807" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway279">
 <bp:pathwayOrder rdf:resource="#PathwayStep2274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2278" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2000" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1999" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1996" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fas-AssociatedDeathDomain (FADD) and receptor interacting protein 1 (RIP1) are death domain containing molecules that interact with the C-terminal portion of MAVS (IPS-1) and induce NF-kB through interaction and activation of initiator caspases (caspase-8 and -10). Caspases are usually involved in apoptosis and inflammation but they also exhibit nonapoptotic functions. These nonapoptotic caspase functions involve prodomain-mediated activation of NF-kB. Processed caspases (caspase-8/10) encoding the DED (death effector domain) strongly activate NF-kB. The exact mechanism by which caspases mediate NF-kB activation is unclear, but the prodomains of caspase-8/10 may act as a scaffolding and allow the recruitment of the IKK complex in association with other signaling molecules.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway277">
 <bp:pathwayOrder rdf:resource="#PathwayStep2262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1989" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1988" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1987" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1983" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1982" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1981" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3-dependent IRF activation pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS via its TRAF-interaction motif (TIM) directly interacts with TRAF3 and recruits TRAF3 to the signaling complex. TRAF3 acts as a scaffold for the assembly of a signaling complex composed of IKK epsilon/TBK1, leading to the activation of transcription factors IRF3/IRF7.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway278">
 <bp:pathwayOrder rdf:resource="#PathwayStep2270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1993" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1992" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated NF-kB activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TRAF6/TAK1 signal activates a canonical IKK complex, resulting in the activation of NF-kappaB as well as MAPK cascades leading to the activation of AP-1. Although TRAF6/TAK1 has been implicated in Tool like receptor (TLR) mediated cytokine production, the involvement of these molecules in the regulation of type I IFN induction mediated by RIG-I (DDX58)/MDA5 (IFIH1) pathway is largely unknown. According to the study done by Yoshida et al. the DDX58:MAVS pathway requires TRAF6 and MAP3K, MEKK1 to activate NF-kappaB and MAP Kinases for optimal induction of type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway275">
 <bp:pathwayOrder rdf:resource="#PathwayStep2239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2279" />
 <bp:pathwayComponent rdf:resource="#Pathway279" />
 <bp:pathwayComponent rdf:resource="#Pathway277" />
 <bp:pathwayComponent rdf:resource="#Pathway278" />
 <bp:pathwayComponent rdf:resource="#Pathway276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1979" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1964" />
 <bp:pathwayComponent rdf:resource="#Pathway280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2014" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX58/IFIH1-mediated induction of interferon-alpha/beta</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIG-I-like helicases (RLHs) the retinoic acid inducible gene-I (RIG-I, DDX58) and melanoma differentiation associated gene 5 (MDA5, IFIH1) are RNA helicases that recognize viral double-stranded RNA (dsRNA) present within the cytoplasm (Yoneyama M    Fujita T 2007, 2008). Upon viral infection dsRNA is generated by positive-strand RNA virus families such as Flaviviridae and Coronaviridae, negative-strand RNA virus families including Orthomyxoviridae and Paramyxoviridae, and DNA virus families such as Herpesviridae and Adenoviridae (Weber F et al. 2006; Son KN et al. 2015). Functionally RIG-I (DDX58) and MDA5 (IFIH1) positively regulate the IFN genes in a similar fashion, however they differ in their response to different viral species. DDX58 (RIG-I) is essential for detecting influenza virus, Sendai virus, VSV and Japanese encephalitis virus (JEV), whereas IFIH1 (MDA5) is essential in sensing encephalomyocarditis virus (EMCV), Mengo virus and Theiler&apos;s virus, all of which belong to the picornavirus family. RIG-I and MDA5 signalling results in the activation of IKK epsilon and (TKK binding kinase 1) TBK1, two serine/threonine kinases that phosphorylate interferon regulatory factor 3 and 7 (IRF3 and IRF7). Upon phosphorylation, IRF3 and IRF7 translocate to the nucleus and subsequently induce interferon alpha (IFNA) and interferon beta (IFNB) gene transcription (Yoneyama M et al. 2004; Yoneyama M    Fujita T 2007, 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway276">
 <bp:pathwayOrder rdf:resource="#PathwayStep2244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1968" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1978" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1966" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1977" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1976" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1975" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1970" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulators of DDX58/IFIH1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">As with other cytokine systems, production of type I IFN is a transient process, and can be hazardous to the host if unregulated, resulting in chronic cellular toxicity or inflammatory and autoimmune diseases. RIG-I-mediated production of IFN can, in turn, increase the transcription of RIG-I itself, thus setting into motion an IFN amplification loop, which if left unchecked, could become deleterious to the host. This module mainly focuses on the endogenous negative regulation of the RIG-I-like receptor (RLR) family proteins RIG-I (DDX58) and MDA5 (IFIH1).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway273">
 <bp:pathwayOrder rdf:resource="#PathwayStep2219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1958" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1957" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1956" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1943" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1953" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1960" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP3 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP3 (Cryopyrin) inflammasome is currently the best characterized. It consists of NLRP3, ASC (PYCARD) and procaspase-1; CARD8 (Cardinal) is also suggested to be a component. It is activated by a number of pathogens and bacterial toxins as well as diverse PAMPs, danger-associated molecular patterns (DAMPS) such as hyaluronan and uric acid, and exogenous irritants such as silica and asbestos (see Table S1 Schroder    Tschopp, 2010).  Mutations in NLRP3 which lead to constitutive activation are linked to the human diseases Muckle-Wells syndrome, familial cold autoinflammatory syndrome and NOMID (Ting et al. 2006), characterized by skin rashes and other symptoms associated with generalized inflammation. The cause of these symptoms is uncontrolled IL-1 beta production. Multiple studies have shown that activation of the NLRP3 inflammasome by particulate activators (e.g. Hornung et al. 2008) requires phagocytosis, but this is not required for the response to ATP, which is mediated by the P2X7 receptor (Kahlenberg    Dubyak, 2004) and appears to involve the pannexin membrane channel (Pellegrin    Suprenenant 2006). Direct binding of activators to NLRP3 has not been demonstrated and the exact process of activation is unclear, though it is speculated to involve changes in conformation that free the NACHT domain for oligomerization (Inohara    Nunez 2001, 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway274">
 <bp:pathwayOrder rdf:resource="#PathwayStep2234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1961" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IPAF inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IPAF (NLRC4) inflammasome can be activated by several stimuli, most notably by Gram-negative bacteria with either type III or type IV secretion systems that result in cytosolic flagellin, which is recognized by the IPAF inflammasome (Miao et al. 2006). IPAF also recognizes the rod-component of the type III secretion system which shares a sequence motif with flagellin that is essential for detection (Miao et al. 2010). Detection of Legionella and/or flagellin may also involve NAIP5 (Zamboni et al. 2006, Lightfield et al. 2008). IPAF contains a CARD domain and can interact directly with procaspase-1 (Poyet et al. 2001) but ASC increases the maximal activation of caspase-1 in response to S. typhimurium (Mariathasan et al. 2004), S. flexneri, and P. aeruginosa suggesting a possible collaboration with a PYD-containing NLRP for responses to these pathogens (Schroder    Tschopp, 2010). IPAF mediated caspase-1 activation can lead to a particular type of cell death called &apos;pyroptosis&apos; (see Schroder    Tschopp 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis188">
 <bp:controlled rdf:resource="#BiochemicalReaction804" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway271">
 <bp:pathwayOrder rdf:resource="#PathwayStep2208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1935" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The AIM2 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 is a member of the PYHIN or HIN200 family. It has a C-terminal HIN domain which can bind double-stranded DNA (dsDNA) and a PYD domain that can bind ASC via a PYD-PYD interaction. In cells expressing procaspase-1, The interaction of AIM2 with ASC leads to recruitment of procaspase-1  forming the ASC pyroptosome which induces pyroptotic cell death by generating active caspase-1. Data from AIM2 deficient mice indicates that the AIM2 inflammasome is a nonredundant sensor for dsDNA that regulates the caspase-1-dependent maturation of IL-1beta and IL-18 (Rathinam et al. 2010, Hornung    Latz, 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis189">
 <bp:controlled rdf:resource="#BiochemicalReaction806" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway272">
 <bp:pathwayOrder rdf:resource="#PathwayStep2211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1939" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1940" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP1 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 is activated by MDP (Faustin et al. 2007). The NLRP1 inflammasome was the first to be characterized. It was described as a complex containing NALP1, ASC, caspase-1 and caspase-5 (Martinon et al. 2002). Unlike NLRP3, NLRP1 has a C-terminal extension containing a CARD domain, which has been reported to interact directly with procaspase-1, obviating a requirement for ASC (Faustin et al. 2007), though ASC was found to augment the interaction. Mouse NLRP1 has no PYD domain and would therefore not be expected to interact directly with procaspase-1. Like the NLRP3 inflammasome, K+ efflux appears to be essential for caspase-1 activation (Wickliffe et al. 2008). Ribonucleoside triphosphates (NTPs) are required for NALP1-mediated caspase-1 activation with ATP being the most efficient, Mg2+ was also required (Faustin et al. 2007). The human NLRP1 gene has 3 paralogues in mouse that are highly polymorphic. Differences between mouse strains underlie susceptibility to anthrax lethal toxin (Boyden    Dietrich 2006). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway270">
 <bp:pathwayOrder rdf:resource="#PathwayStep2209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2214" />
 <bp:pathwayComponent rdf:resource="#Pathway273" />
 <bp:pathwayComponent rdf:resource="#Pathway274" />
 <bp:pathwayComponent rdf:resource="#Pathway271" />
 <bp:pathwayComponent rdf:resource="#Pathway272" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inflammasomes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In contrast to NOD1/2 some NLRPs function as large macromolecular complexes called &apos;Inflammasomes&apos;. These multiprotein platforms control activation of the cysteinyl aspartate protease caspase-1 and thereby the subsequent cleavage of pro-interleukin 1B (pro-IL1B) into the active proinflammatory cytokine IL1B. Activation of caspase-1 is essential for production of IL1B and IL18, which respectively bind and activate the IL1 receptor (IL1R) and IL18 receptor (IL18R) complexes. IL1R and IL18R activate NFkappaB and other signaling cascades.  As the activation of inflammasomes leads to caspase-1 activation, inflammasomes can be considered an upstream step of the IL1R and IL18R signaling cascades, linking intracellular pathogen sensing to immune response pathways mediated by Toll-Like Receptors (TLRs). Monocytes and macrophages do not express pro-IL1B until stimulated, typically by TLRs (Franchi et al. 2009). The resulting pro-IL1B is not converted to IL1B unless a second stimulus activates an inflammasome. This requirement for two distinct stimuli allows tight regulation of IL1B/IL18 production, necessary because excessive IL-1B production is associated with numerous inflammatory diseases such as  gout and rheumatoid arthritis (Masters et al. 2009).  There are at least four subtypes of the inflammasome, characterized by the NLRP. In addition the protein AIM2 can form an inflammasome. All activate caspase-1. NLRP1 (NALP1), NLRP3 (Cryopyrin, NALP3), IPAF (CARD12, NLRC4) and AIM2 inflammasomes all have clear physiological roles in vivo. NLRP2, NLRP6, NLRP7, NLRP10 and NLRP12 have been demonstrated to modulate caspase-1 activity in vitro but the significance of this is unclear (Mariathasan and Monack, 2007).  NLRP3 and AIM2 bind the protein &apos;apoptosis-associated speck-like protein containing a CARD&apos; (ASC, also called PYCARD), via a PYD-PYD domain interaction. This in turn recruits procaspase-1 through a CARD-CARD interaction. NLRP1 and IPAF contain CARD domains and can bind procaspase-1 directly, though both are stimulated by ASC. Oligomerization of NLRPs is believed to bring procaspases into close proximity, leading to &apos;induced proximity&apos; auto-activation (Boatright et al. 2003). This leads to formation of the active caspase tetramer. NLRPs are generally considered to be cytoplasmic proteins, but there is evidence for cytoplasmic-nuclear shuttling of the family member CIITA (LeibundGut-Landmann et al. 2004) and tissue/cell dependent NALP1 expression in the nucleus of neurons and lymphocytes (Kummer et al. 2007); the significance of this remains unclear. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis180">
 <bp:controlled rdf:resource="#BiochemicalReaction796" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis181">
 <bp:controlled rdf:resource="#BiochemicalReaction797" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis182">
 <bp:controlled rdf:resource="#BiochemicalReaction798" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis183">
 <bp:controlled rdf:resource="#BiochemicalReaction799" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis184">
 <bp:controlled rdf:resource="#BiochemicalReaction800" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis185">
 <bp:controlled rdf:resource="#BiochemicalReaction801" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis186">
 <bp:controlled rdf:resource="#BiochemicalReaction802" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis187">
 <bp:controlled rdf:resource="#BiochemicalReaction803" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway259">
 <bp:pathwayOrder rdf:resource="#PathwayStep2109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1858" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1879" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1878" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1877" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1872" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1869" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1845" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1867" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1866" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1843" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1860" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of Complement cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Two inherent features of complement activation make its regulation very important:  1. There is an inherent positive feedback loop because the product of C3 activation forms part of an enzyme that causes more C3 activation. 2. There is continuous low-level activation of the alternative pathway (see Spontaneous hydrolysis of C3 thioester).  Complement cascade activation is regulated by a family of related proteins termed the regulators of complement activation (RCA). These are expressed on healthy host cells. Most pathogens do not express RCA proteins on their surface, but many have found ways to evade the complement system by stably binding the RCA that circulates in human plasma (Lambris et al. 2008); trapping RCA is by far the most widely employed strategy for avoiding the complement response. RCA recruitment is common in bacteria such as E. coli and streptococci (Kraiczy    Wurzner 2006) and has also been described for viruses, fungi and  parasites. RCA deposition and the complement system also have an important role in tissue homeostasis, clearing dead cells and debris, and preventing damage from oxidative stress (Weismann et al. 2011).  RCA proteins control complement activation in two different ways; by promoting the irreversible dissociation (decay acceleration) of complement convertases and by acting as cofactors for Complement factor I (CFI)-mediated cleavage of C3b and C4b. Decay accelerating factor (DAF, CD55), Complement factor H (FH), Membrane Cofactor Protein (MCP) and Complement receptor 1 (CR1) are composed of arrays of tandem globular domains termed CCPs (complement control protein repeats) or SCRs (short consensus repeats). CR1, MCP and FH are cofactors for the CFI-mediated cleavage of C3b, generating iC3b. CR1 and MCP are also cofactors for C4b cleavage.  C4BP is an additional cofactor for the CFI-mediated cleavage of C4b.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway268">
 <bp:pathwayOrder rdf:resource="#PathwayStep2184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2203" />
 <bp:pathwayComponent rdf:resource="#Pathway269" />
 <bp:pathwayComponent rdf:resource="#Pathway270" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The innate immune system is the first line of defense against invading microorganisms, a broad specificity response characterized by the recruitment and activation of phagocytes and the release of anti-bacterial peptides. The receptors involved recognize conserved molecules present in microbes called pathogen-associated molecular patterns (PAMPs), and/or molecules that are produced as a result of tissue injury, the damage associated molecular pattern molecules (DAMPs). PAMPs are essential to the pathogen and therefore unlikely to vary. Examples are lipopolysaccharide (LPS), peptidoglycans (PGNs) and viral RNA. DAMPs include intracellular proteins, such as heat-shock proteins and extracellular matrix proteins released by tissue injury, such as hyaluronan fragments. Non-protein DAMPs include ATP, uric acid, heparin sulfate and dsDNA. The receptors for these factors are referred to collectively as pathogen- or pattern-recognition receptors (PRRs). The best studied of these are the membrane-associated Toll-like receptor family. Less well studied but more numerous are the intracellular nucleotide-binding domain, leucine rich repeat containing receptors (NLRs) also called nucleotide binding oligomerization domain (NOD)-like receptors, a family with over 20 members in humans and over 30 in mice. These recognise PAMPs/DAMPs from phagocytosed microorganisms or from intracellular infections (Kobayashi et al. 2003, Proell et al. 2008, Wilmanski et al. 2008). Some NLRs are involved in process unrelated to pathogen detection such as tissue homeostasis, apoptosis, graft-versus-host disease and early development (Kufer    Sansonetti 2011).    Structurally NLRs can be subdivided into the caspase-recruitment domain (CARD)-containing NLRCs (NODs) and the pyrin domain (PYD)-containing NLRPs (NALPs), plus outliers including ice protease (caspase-1) activating factor (IPAF) (Martinon    Tschopp, 2005). In practical terms, NLRs can be divided into the relatively well characterized NOD1/2 which signal via RIP2 primarily to NFkappaB, and the remainder, some of which participate in macromolecular structures called Inflammasomes that activate caspases. Mutations in several members of the NLR protein family have been linked to inflammatory diseases, suggesting these molecules play important roles in maintaining host-pathogen interactions and inflammatory responses.   Most NLRs have a tripartite structure consisting of a variable amino-terminal domain, a central nucleotide-binding oligomerization domain (NOD or NACHT) that is believed to mediate the formation of self oligomers, and a carboxy-terminal leucine-rich repeat (LRR) that detects PAMPs/DAMPs. In most cases the amino-terminal domain includes protein-interaction modules, such as CARD or PYD, some harbour baculovirus inhibitor repeat (BIR) or other domains. For most characterised NLRs these domains have been attributed to downstream signaling  Under resting conditions, NLRs are thought to be present  in an autorepressed form, with the LRR folded back onto the NACHT domain preventing oligomerization. Accessory proteins may help maintain the inactive state. PAMP/DAMP exposure is thought to triggers conformational changes that expose the NACHT domain enabling oligomerization and recruitment of effectors, though it should be noted that due to the lack of availability of structural data, the mechanistic details of NLR activation remain largely elusive.  New terminology for NOD-like receptors was adopted by the Human Genome Organization (HUGO) in 2008 to standardize the nomenclature of NLRs. The acronym NLR, once standing for NOD-like receptor, now is an abbreviation of &apos;nucleotide-binding domain, leucine-rich repeat containing&apos; protein. The term NOD-like receptor is officially outdated and replaced by NLRC where the C refers to the CARD domain. However the official gene symbols for NOD1 and NOD2 still contain NOD and this general term is still widely used.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway269">
 <bp:pathwayOrder rdf:resource="#PathwayStep2189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1918" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1927" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1926" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1924" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1922" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1933" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1921" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1920" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1930" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1/2 Signaling Pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1 is ubiquitously expressed, while NOD2 expression is restricted to monocytes, macrophages, dendritic cells, and intestinal Paneth cells (Inohara et al. 2005). NOD1 and NOD2 activation induces transcription of immune response genes, predominantly mediated by the proinflammatory transcriptional factor NFkappaB but also by AP-1 and Elk-1 (Inohara et al. 2005). NFkappaB translocates to the nucleus following release from IkappaB proteins. NOD1 and NOD2 signaling involves an interaction between their caspase-recruitment domain (CARD) and the CARD of the kinase RIPK2 (RIP2/RICK). This leads to the activation of the NFkappaB pathway and MAPK pathways (Windheim et al. 2007). Activated NODs oligomerize via their NACHT domains, inducing physical proximity of RIP2 proteins that is believed to trigger their K63-linked polyubiquitination, facilitating recruitment of the TAK1 complex. RIP2 also recruits NEMO, bringing the TAK1 and IKK complexes into proximity, leading to NF-kappaB activation and activation of MAPK signaling. Recent studies have demonstrated that K63-linked regulatory ubiquitination of RIP2 is essential for the recruitment of TAK1 (Hasegawa et al. 2008, Hitosumatsu et al. 2008). As observed for toll-like receptor (TLR) signaling, ubiquitination can be removed by the deubiquitinating enzyme A20, thereby dampening NOD1/NOD2-induced NF-kappaB activation. NOD1 and NOD2 both induce K63-linked ubiquitination of RIP2, but NOD2-signaling appears to preferentially utilize the E3 ligase TRAF6, while TRAF2 and TRAF5 were shown to be important for NOD1-mediated signaling. In both cases, activation of NF-kappaB results in the upregulated transcription and production of inflammatory mediators.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway266">
 <bp:pathwayOrder rdf:resource="#PathwayStep2170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1903" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C3 and C5</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 3 pathways of complement activation converge on the cleavage of C3  by C3 convertases. C3 convertase cleaves C3 into C3a and C3b - a central  step of complement activation. C3a remains in the fluid phase and acts  as an anaphylatoxin, whereas C3b can form additional C3 convertases hastening the production of C3b. Besides, C3b binds to C3 convertases to form C5 convertase, which can act as an opsonin, or is degraded into fragments which  cannot form an active convertase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway267">
 <bp:pathwayOrder rdf:resource="#PathwayStep2181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1913" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1912" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1911" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1909" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neutrophil degranulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neutrophils are the most abundant leukocytes (white blood cells), indispensable in defending the body against invading microorganisms. In response to infection, neutrophils leave the circulation and migrate towards the inflammatory focus. They contain several subsets of granules that are mobilized to fuse with the cell membrane or phagosomal membrane, resulting in the exocytosis or exposure of membrane proteins. Traditionally, neutrophil granule constituents are described as antimicrobial or proteolytic, but granules also introduce membrane proteins to the cell surface, changing how the neutrophil responds to its environment (Borregaard et al. 2007). Primed neutrophils actively secrete cytokines and other inflammatory mediators and can present antigens via MHC II, stimulating T-cells (Wright et al. 2010).  Granules form during neutrophil differentiation. Granule subtypes can be distinguished by their content but overlap in structure and composition. The differences are believed to be a consequence of changing protein expression and differential timing of granule formation during the terminal processes of neutrophil differentiation, rather than sorting (Le Cabec et al. 1996).    The classical granule subsets are Azurophil or primary granules (AG), secondary granules (SG) and gelatinase granules (GG). Neutrophils also contain exocytosable storage cell organelles, storage vesicles (SV), formed by endocytosis they contain many cell-surface markers and extracellular, plasma proteins (Borregaard et al. 1992). Ficolin-1-rich granules (FG) are like GGs highly exocytosable but gelatinase-poor (Rorvig et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway264">
 <bp:pathwayOrder rdf:resource="#PathwayStep2160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2166" />
 <bp:pathwayComponent rdf:resource="#Pathway265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1901" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1897" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lectin pathway of complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the lectin pathway (LP) is initiated by Mannose-binding lectin (MBL), the hetero-complex CL-LK formed from COLEC11 (Collectin liver 1, CL-L1) and COLEC10 (Collectin kidney 1, CL-K1), and the ficolins (FCN1, FCN2, FCN3). All are Ca-dependent (C-type) lectins that initiate the complement cascade after binding to specific carbohydrate patterns on the target cell surface. All form trimers and larger oligomers (Jensen et al. 2005, Dommett et al. 2006, Garlatti et al. 2010). MBL and ficolins circulate in plasma as complexes with homodimers of MBL-associated serine proteases (MASP) (Fujita et al. 2004, Hajela et al. 2002). MASP1, MASP2 and MASP3 have all been reported to mediate complement activation. Upon binding of human lectin to the target surface, the complex of lectin:MASP undergoes conformational changes that result in MASP cleavage and activation (Matsushita M et al. 2000, Fujita et al. 2004). Active MASP2 cleaves C4 to generate C4a and C4b. C4b binds to the target cell surface via its thioester bond, then binds circulating C2 (Law and Dodds 1997). Bound C2 is cleaved by MASP2 to yield the C3 convertase C4b:C2a. The active form of MASP1 was reported to cleave C2 in a manner similar to MASP2 (Matsushita et al. 2000, Chen    Wallis 2004). MASP1 can cleave proenzyme MASP2, leading to complement activation (Heja et al. 2012). MASP1 can also cleave fibrinogen to yield fibrinopeptide B, and activates factor XIII. MASP1 may have a role in removal of &apos;dead C3&apos;, i.e. C3(H2O) (Hajela et al. 2002). In addition to MASP1 to 3, two alternatively-slpiced forms of MASP1 (MAp44) and MASP2 (sMAP) have been implicated in complement cascade signaling (Takahashi et al. 1999, Degn et al. 2010). The functions of MASP3, sMAP and MAp44 in the lectin pathway remain to be clarified.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway265">
 <bp:pathwayOrder rdf:resource="#PathwayStep2163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1899" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1898" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolins bind to repetitive carbohydrate structures on the target cell surface</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolins are recognition molecules in the lectin pathway of complement activation. Three types of ficolin have been identified in humans: M-ficolin (ficolin-1, FCN1), L-ficolin (ficolin-2, FCN2) and H-ficolin (ficolin-3, FCN3). FCN2 and 3 circulate in blood plasma whereas FCN1 is locally secreted by immune response cells (Teh et al. 2000, Liu et al. 2005, Matsushita et al. 2002). Plasma ficolins circulate as complexes with MBL-associated serine proteases (MASPs). Upon binding of ficolins to carbohydrates on the target cell surface, MASPs are activated and subsequently activate the complement cascade (Matsushita et al. 2002, Gout et al. 2009). Ficolins function as trimers and larger oligomers. Ficolin peptide sequences contain an amino-terminal cysteine-rich region, a collagen-like domain, a neck region and a carboxy-terminal fibrinogen-like domain. The fibrinogen-like domain binds to pathogen- or apoptotic cell-associated molecular patterns. Different ficolins have distinct recognition specificities (Endo et al. 2007, Thiel and Gadjeva 2009, Garlatti et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway262">
 <bp:pathwayOrder rdf:resource="#PathwayStep2156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2159" />
 <bp:pathwayComponent rdf:resource="#Pathway264" />
 <bp:pathwayComponent rdf:resource="#Pathway263" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Creation of C4 and C2 activators</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Two pathways lead to a complex capable of activating C4 and C2.  The classical pathway is triggered by activation of the C1-complex, which consists of hexameric molecule C1q and a tetramer comprising two C1r and two C1s serine proteinases. This occurs when C1q binds to IgM or IgG complexed with antigens, a single IgM can initiate the pathway while multiple IgGs are needed, or when C1q binds directly to the surface of the pathogen. Binding leads to conformational changes in C1q, activating the serine protease activity of C1r, which then cleaves C1s, another serine protease. The C1r:C1s component is now capable of splitting C4 and C2 to produce the classical C3-convertase C4b2a. C1r and C1s are additionally controlled by C1-inhibitor.(Kerr MA 1980) The lectin pathway is similar in operation but has different components.  Mannose-binding lectin (MBL) or ficolins (L-ficolin, M-ficolin and H-ficolin) initiate the lectin pathway cascade by binding to specific carbohydrate patterns on pathogenic cell surfaces. MBL and ficolins circulate in plasma in complexes with homodimers of MBL-associated serine proteases (MASP) (Fujita et al. 2004; Hajela et al. 2002). Upon binding of human lectin (MBL or ficolins) to the target surface the complex of lectin:MASP undergoes conformational changes, which results in the activation of MASPs by cleavage (Matsushita M et al. 2000; Fujita et al. 2004). Activated MASPs become capable of C4 and C2 cleavage, giving rise to the same C3 convertase C4b:C2a as the classical pathway. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway263">
 <bp:pathwayOrder rdf:resource="#PathwayStep2157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1895" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Classical antibody-mediated complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1, the first component of complement is a complex containing three protein species, C1q, C1r, and C1s. C1q is assembled from six identical subunits each of which consists of three homologous chains (A, B, and C). These chains form a globular domain at the C-terminus, followed by the &quot;neck&quot; and a coil in the &quot;stalk.&quot; The six subunits are held together by the collagenous stalk parts (giving rise to the comparison of C1q with a &quot;bunch of six tulips&quot;). The stalks also interact with the [C1s:C1r:C1r:C1s] tetramer assembled in a linear chain. Binding of an antigen to an antibody of the IgM or IgG class induces a conformational change in the Fc domain of the antibody that allows it to bind to the C1q component of C1. C1 activation requires interaction with two separate Fc domains, so pentavalent IgM antibody is far more efficient at complement activation than IgG antibody. Antibody binding results in a conformational change in the C1r component of the C1 complex and a proteolytic cleavage of C1r, activating it. Active C1r then cleaves and activates the C1s component of the C1 complex (Muller-Eberhard 1988).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis177">
 <bp:controlled rdf:resource="#BiochemicalReaction793" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway260">
 <bp:pathwayOrder rdf:resource="#PathwayStep2141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1892" />
 <bp:pathwayComponent rdf:resource="#Pathway262" />
 <bp:pathwayComponent rdf:resource="#Pathway261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1893" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Initial triggering of complement</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement activation is due to a cascade of proteolytic steps, performed by serine protease domains in some of the components. Three different pathways of activation are distinguished triggered by target-bound antibody (the classical pathway); microbial polysaccharide structures (the lectin pathway); or recognition of other &quot;foreign&quot; surface structures (the alternative pathway) by C3b. All three merge in the pivotal activation of C3 and, subsequently, of C5 by highly specific enzymatic complexes, the so-called C3/C5 convertases. A complement system with three C3 activation pathways and a common lytic pathway is found only in jawed vertebrates.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis178">
 <bp:controlled rdf:resource="#BiochemicalReaction794" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway261">
 <bp:pathwayOrder rdf:resource="#PathwayStep2150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1889" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1888" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1883" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alternative complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The proteins participating in alternative pathway activation are C3 (and C3b), the factors B, D, and properdin. In the first place, alternative pathway activation is a positive feedback mechanism to increase C3b. When C3b binds covalently to sugars on a cell surface, it can become protected. Then Factor B binds to C3b. In the presence of Factor D, bound Factor B is cleaved to Ba and Bb. Bb contains the active site for a C3 convertase. Properdin then binds to C3bBb to stabilize the C3bBb convertase on cell surface leading to cleavage of C3. Finally, a C3bBb3b complex forms and this is a C5 convertase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis179">
 <bp:controlled rdf:resource="#BiochemicalReaction795" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2068">
 <bp:evidence rdf:resource="#Evidence2351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite and carbon dioxide react to nitrosoperoxycarbonate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2067">
 <bp:evidence rdf:resource="#Evidence2350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N2O3 enters bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2066">
 <bp:evidence rdf:resource="#Evidence2349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrogen peroxide enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2065">
 <bp:evidence rdf:resource="#Evidence2348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide and O2 react to NO2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2064">
 <bp:evidence rdf:resource="#Evidence2347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis130">
 <bp:controlled rdf:resource="#BiochemicalReaction552" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2063">
 <bp:evidence rdf:resource="#Evidence2346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Membrane-bound myeloperoxidase (MPO) produces hypochlorous acid (HOCl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis131">
 <bp:controlled rdf:resource="#BiochemicalReaction557" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2062">
 <bp:evidence rdf:resource="#Evidence2345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) produces hypochlorous acid (HOCl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis132">
 <bp:controlled rdf:resource="#BiochemicalReaction560" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2061">
 <bp:evidence rdf:resource="#Evidence2344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) reacts with Lys residue to form Lys-monochloramine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2060">
 <bp:evidence rdf:resource="#Evidence2343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCl) reacts with unsaturated lipid to form lipid chlorohydrins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway299">
 <bp:pathwayOrder rdf:resource="#PathwayStep2503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2201" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dectin-1 mediated noncanonical NF-kB signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to the activation of canonical NF-kB subunits, activation of SYK pathway by Dectin-1 leads to the induction of the non-canonical NF-kB pathway, which mediates the nuclear translocation of RELB-p52 dimers through the successive activation of NF-kB-inducing kinase (NIK) and IkB kinase-alpha (IKKa) (Geijtenbeek    Gringhuis 2009, Gringhuis et al. 2009). Noncanonical activity tends to build more slowly and remain sustained several hours longer than does the activation of canonical NF-kB. The noncanonical NF-kB pathway is characterized by the post-translational processing of NFKB2 (Nuclear factor NF-kappa-B) p100 subunit to the mature p52 subunit. This subsequently leads to nuclear translocation of p52:RELB (Transcription factor RelB) complexes to induce cytokine expression of some genes (C-C motif chemokine 17 (CCL17) and CCL22) and transcriptional repression of others (IL12B) (Gringhuis et al. 2009, Geijtenbeek    Gringhuis 2009, Plato et al. 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway297">
 <bp:pathwayOrder rdf:resource="#PathwayStep2490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2190" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 (DC-SIGN) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 (also called as DC-SIGN (DC-specific intracellular adhesion molecule-3-grabbing non-integrin)) is a type II transmembrane C-type lectin receptor preferentially expressed on dendritic cells (DCs). CD209 functions as a pattern recognition receptor (PRR) that recognises several microorganisms and pathogens, contributing to generation of pathogen-tailored immune responses (Gringhuis    Geijtenbeek 2010, den Dunnen et al. 2009, Svajger et al. 2010). CD209 interacts with different mannose-expressing pathogens such as Mycobacterium tuberculosis and HIV-1 (Gringhuis et al. 2007, Geijtenbeek et al. 2000a). It also acts as an adhesion receptor that interacts with ICAM2 (intracellular adhesion molecule-2) on endothelial cells and ICAM3 on T cells (Geijtenbeek et al. 2000b,c).  CD209 functions not only as an independent PRR, but is also implicated in the modulation of Toll-like receptor (TLR) signaling at the level of the transcription factor NF-kB (Gringhuis et al. 2009). CLEC7A (Dectin-1) and CD209 (DC-SIGN) signalling modulates Toll-like receptor (TLR) signalling through the kinase RAF1 that is independent of the SYK pathway but integrated with it at the level of NF-kB activation. The activation of RAF1 by CLEC7A or CD209 does not lead to activation of extracellular signal-regulated kinase 1 (ERK1)/2 or Mitogen-activated protein kinase kinase 1 (MEK1)/2 but leads to the phosphorylation and subsequent acetylation of RELA (p65). RELA phosphorylated on S276 not only positively regulates the activity of p65 through acetylation of p65, but also represses RELB activity by sequestering active RELB into inactive p65-RELB dimers that do not bind DNA (Gringhuis et al. 2007, Svajger et al. 2010, Jacque et al. 2005). RAF1-dependent signaling pathway is crucial in dectin-1 mediated immunity as it modulates both the canonical (promoting p65 phosphorylation and acetylation) and non-canonical (forming inactive p65-RELB dimers) NK-kB activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway298">
 <bp:pathwayOrder rdf:resource="#PathwayStep2505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2520" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2540" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2522" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2518" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2240" />
 <bp:pathwayComponent rdf:resource="#Pathway299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2230" />
 <bp:pathwayComponent rdf:resource="#Pathway301" />
 <bp:pathwayComponent rdf:resource="#Pathway300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2213" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (also known as Dectin-1) is a pattern-recognition receptor (PRR) expressed by myeloid cells (macrophages, dendritic cells and neutrophils) that detects pathogens by binding to beta-1,3-glucans in fungal cell walls and triggers direct innate immune responses to fungal and bacterial infections. CLEC7A belongs to thetype-II C-type lectin receptor (CLR) family that can mediate its own intracellular signaling. Upon binding particulate beta-1,3-glucans, CLEC7A mediates intracellular signalling through its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM)-like motif (Brown 2006). CLEC7A signaling can induce the production of various cytokines and chemokines, including tumour-necrosis factor (TNF), CXC-chemokine ligand 2 (CXCL2, also known as MIP2), interleukin-1beta (IL-1b), IL-2, IL-10 and IL-12 (Brown et al. 2003), it also triggers phagocytosis and stimulates the production of reactive oxygen species (ROS), thus contributing to microbial killing (Gantner et al. 2003, Herre et al. 2004, Underhill et al. 2005, Goodridge at al. 2011, Reid et al. 2009). These cellular responses mediated by CLEC7A rely on both Syk-dependent and Syk-independent signaling cascades. The pathways leading to the Syk-dependent activation of NF-kB can be categorised into both canonical and non-canonical routes (Gringhuis et al. 2009). Activation of the canonical NF-kB pathway is essential for innate immunity, whereas activation of the non-canonical pathway is involved in lymphoid organ development and adaptive immunity (Plato et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway295">
 <bp:pathwayOrder rdf:resource="#PathwayStep2482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2469" />
 <bp:pathwayComponent rdf:resource="#Pathway297" />
 <bp:pathwayComponent rdf:resource="#Pathway298" />
 <bp:pathwayComponent rdf:resource="#Pathway296" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-type lectin receptors (CLRs)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pathogen recognition is central to the induction of T cell differentiation. Groups of pathogens share similar structures known as pathogen-associated molecular patterns (PAMPs), which are recognised by pattern recognition receptors (PRRs) expressed on dendritic cells (DCs) to induce cytokine expression. PRRs include archetypical Toll-like receptors (TLRs) and non-TLRs such as retinoic acid-inducible gene I (RIG-I)-like receptors, C-type lectin receptors (CLRs) and intracellular nucleotide-binding domain and leucine-rich-repeat-containing family (NLRs). PRR recognition of PAMPs can lead to the activation of intracellular signalling pathways that elicit innate responses against pathogens and direct the development of adaptive immunity. CLRs comprises a large family of receptors which bind carbohydrates, through one or more carbohydrate recognition domains (CRDs), or which possess structurally similar C-type lectin-like domains (CTLDs) which do not necessarily recognise carbohydrate ligands. Some CLRs can induce signalling pathways that directly activate nuclear factor-kB (NF-kB), whereas other CLRs affect signalling by Toll-like receptors. These signalling pathways trigger cellular responses, including phagocytosis, DC maturation, chemotaxis, the respiratory burst, inflammasome activation, and cytokine production.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway296">
 <bp:pathwayOrder rdf:resource="#PathwayStep2471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2481" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2179" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dectin-2 family</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dendritic cell-associated C-type lectin-2 (Dectin-2) family of C-type lectin receptors (CLRs) includes Dectin-2 (CLEC6A), blood dendritic antigen 2 (BDCA2/CLEC4C), macrophage C-type lectin (MCL/CLEC4D), Dendritic cell immunoreceptor (DCIR/CLEC4A) and macrophage inducible C-type lectin (Mincle/CLEC4E). These receptors possesses a single extracellular conserved C-type lectin domain (CTLD) with a short cytoplasmic tail that induces intracellular signalling indirectly by binding with the FCERG (High affinity immunoglobulin epsilon receptor subunit gamma) except for DCIR that has a longer cytoplasmic tail with an integral inhibitory signalling motif (Graham    Brown. 2009, Kerschera et al. 2013). CLEC6A (Dectin-2) binds to high mannose containing pathogen-associated molecular patterns (PAMPs) expressed by fungal hyphae, and CLEC4E (mincle) binds to alpha-mannaosyl PAMPs on fungal, mycobacterial and necrotic cell ligands. Both signaling pathways lead to Toll-like receptor (TLR)-independent production of cytokines such as tumor necrosis factor (TNF) and interleukin 6 (IL6). Similarities with Dectin-1 (CLC7A) signaling pathway suggests that both these CLRs couple SYK activation to NF-kB activation using a complex involving CARD9, BCL10 and MALT1 (Geijtenbeek    Gringhuis 2009). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis122">
 <bp:controlled rdf:resource="#BiochemicalReaction481" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway293">
 <bp:pathwayOrder rdf:resource="#PathwayStep2459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2168" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of phospholipids in phagocytosis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipases play an integral role in phagocytosis by generating essential second messengers. An early step in phagocytic signaling is the association of PIP2 and IP3 with the phagocytic cup. These are formed by the activity of phosphoinositol kinases and phospholipases. PI3K is has been shown to accumulate at phagocytic cups and converts PI (4,5)P2 to PI (3,4,5)P3. These phosphoinositides are capable of binding and increasing the activity of proteins that regulate the actin cytoskeleton. Phospholipases are lipid modifying enzymes that produce lipid mediators such as diacylglycerol (DAG), arachidonic acid (AA) and IP3. Phopsholipases PLA, PLC and PLD have been shown to be involved in antibody (IgG) mediated phagocytosis. The PLC product IP3 stimulates release of calcium from the endoplasmic reticulum. This Ca+2 concentration increase is greatest in the cytoplasm surrounding the phagocytic cup. Calcium is involved in the various stages of phagosome formation, including phagocytic ingestion and phagosome maturation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis123">
 <bp:controlled rdf:resource="#BiochemicalReaction529" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway294">
 <bp:pathwayOrder rdf:resource="#PathwayStep2464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2171" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced glycosylation endproduct receptor signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced Glycosylation End- product-specific Receptor (AGER) also known as Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand membrane receptor belonging to the immunoglobulin superfamily. It is considered to be a Pattern Recognition Receptor (Liliensiek et al. 2004). It recognizes a large variety of modified proteins known as advanced glycation/glycosylation endproducts (AGEs), a heterogenous group of structures that are generated by the Maillard reaction, a consequence of long-term incubation of proteins with glucose (Ikeda et al. 1996). Their accumulation is associated with diabetes, atherosclerosis, renal failure and ageing (Schmidt et al. 1999). The most prevalent class of AGE in vivo are N(6)-carboxymethyllysine (NECML) adducts (Kislinger et al. 1991). In addition to AGEs, AGER is a signal transduction receptor for amyloid-beta peptide (Ab) (Yan et al. 1996), mediating Ab neurotoxicity and promoting Ab influx into the brain. AGER also responds to the proinflammatory S100/calgranulins (Hofmann et al. 1999) and High mobility group protein B1 (HMGB1/Amphoterin/DEF), a protein linked to neurite outgrowth and cellular motility (Hori et al. 1995).  The major inflammatory pathway stimulated by AGER activation is NFkappaB. Though the signaling cascade is unclear, several pieces of experimental data suggest that activation of AGER leads to sustained activation and upregulation of NFkappaB, measured as NFkappaB translocation to the nucleus, and increased levels of de novo synthesized NFkappaB (Bierhaus et al. 2001). As this is clearly an indirect effect it is represented here as positive regulation of NFkappaB translocation to the nucleus. AGER can bind ERK1/2 and thereby activate the MAPK and JNK cascades (Bierhaus et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis124">
 <bp:controlled rdf:resource="#BiochemicalReaction534" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway291">
 <bp:pathwayOrder rdf:resource="#PathwayStep2419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2129" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCGR activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRs with IgG coated immune complexes results in tyrosine phosphorylation of the immuno tyrosine activation motif (ITAMs) of the rececptor by membrane-bound tyrosine kinases of the SRC family. The phosphorylated ITAM tyrosines serve as docking sites for Src homology 2 (SH2) domain-containing SYK kinase. Recruitment and activation of SYK is critical for FCGR-mediated signaling in phagocytosis, but the exact role of SYK in this process is unclear. Activated SYK then transmits downstream signals leading to actin polymerization and particle internalization.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis125">
 <bp:controlled rdf:resource="#BiochemicalReaction538" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway292">
 <bp:pathwayOrder rdf:resource="#PathwayStep2428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2441" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2150" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2157" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of actin dynamics for phagocytic cup formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The actin cytoskeleton is fundamental for phagocytosis and members of the Rho family GTPases RAC and CDC42 are involved in actin cytoskeletal regulation leading to pseudopod extension. Active RAC and CDC42 exert their action through the members of WASP family proteins (WASP/N-WASP/WAVE) and ARP2/3 complex. Actin filaments move from the bottom toward the top of the phagocytic cup during pseudopod extension.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis126">
 <bp:controlled rdf:resource="#BiochemicalReaction540" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis127">
 <bp:controlled rdf:resource="#BiochemicalReaction544" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway290">
 <bp:pathwayOrder rdf:resource="#PathwayStep2418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2425" />
 <bp:pathwayComponent rdf:resource="#Pathway293" />
 <bp:pathwayComponent rdf:resource="#Pathway291" />
 <bp:pathwayComponent rdf:resource="#Pathway292" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fcgamma receptor (FCGR) dependent phagocytosis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phagocytosis is one of the important innate immune responses that function to eliminate invading infectious agents. Monocytes, macrophages, and neutrophils are the professional phagocytic cells. Phagocytosis is a complex process involving the recognition of invading foreign particles by specific types of phagocytic receptors and the subsequent internalization of the particles. Fc gamma receptors (FCGRs) are among the best studied phagocytic receptors that bind to Fc portion of immunoglobulin G (IgG). Through their antigen binding F(ab) end, antibodies bind to specific antigen while their constant (Fc) region binds to FCGRs on phagocytes. The clustering of FCGRs by IgG antibodies on the phagocyte initiates a variety of signals, which lead, through the reorganisation of actin cytoskeleton and membrane remodelling, to the formation of pseudopod and phagosome. Fc gamma receptors are classified into three classes: FCGRI, FCGRII and FCGRIII. Each class of these FCGRs consists of several individual isoforms. Among all these isoforms FCGRI, FCGRIIA and FCGRIIIA, are able to mediate phagocytosis (Joshi et al. 2006, Garcia Garcia    Rosales 2002, Nimmerjahn    Ravetch 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis128">
 <bp:controlled rdf:resource="#BiochemicalReaction550" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis129">
 <bp:controlled rdf:resource="#BiochemicalReaction551" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2069">
 <bp:evidence rdf:resource="#Evidence2352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNO2 produces N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2079">
 <bp:evidence rdf:resource="#Evidence2365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-pro-defensins are cleaved to remove the signal peptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2078">
 <bp:evidence rdf:resource="#Evidence2364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins bind microbial membranes causing disruption</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2077">
 <bp:evidence rdf:resource="#Evidence2363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta defensin 103 activates TLR1:TLR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2076">
 <bp:evidence rdf:resource="#Evidence2362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins are secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2075">
 <bp:evidence rdf:resource="#Evidence2361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins 1, 4A and 103 bind CCR6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2074">
 <bp:evidence rdf:resource="#Evidence2360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins 4A and 103 bind CCR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis120">
 <bp:controlled rdf:resource="#BiochemicalReaction470" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2073">
 <bp:evidence rdf:resource="#Evidence2358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of defensins to lipid II</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis121">
 <bp:controlled rdf:resource="#BiochemicalReaction472" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2072">
 <bp:evidence rdf:resource="#Evidence2356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trypsin cleaves REG3A or REG3G to generate REG3A,G(38-175)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2071">
 <bp:evidence rdf:resource="#Evidence2355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD peptide binds bacterial membrane phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2070">
 <bp:evidence rdf:resource="#Evidence2353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitrite ion and HNO2 form a conjugated acid-base pair</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis119">
 <bp:controlled rdf:resource="#BiochemicalReaction465" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway288">
 <bp:pathwayOrder rdf:resource="#PathwayStep2391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2104" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metal sequestration by antimicrobial proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metals are necessary for all forms of life including microorganisms, evidenced by the fact that metal cations are constituents of approximately 40% of all proteins crystallized to date (Waldron KJ et al. 2009; Foster AW et al. 2014; Guengerich FP 2014, 2015). The ability of microorganisms to maintain the intracellular metal quota is essential and allows microorganisms to adapt to a variety of environments. Accordingly, the ability of the host to control metal quota at inflammation sites can influence host-pathogen interactions. The host may restrict microbial growth either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms (Becker KW    Skaar EP 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway289">
 <bp:pathwayOrder rdf:resource="#PathwayStep2415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2416" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2127" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ion influx/efflux at host-pathogen interface</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Essential metal ions act as co-factors that enable enzymes to catalyse a wider range of chemical transformations than would be achievable using solely organic catalysts. The precise metal requirements of organisms vary between species, environmental niches, metabolic states and circadian rhythms.  Metals are required cofactors for numerous processes that are essential to both pathogen and host. They are coordinated in enzymes responsible for DNA replication and transcription, relief from oxidative stress, and cellular respiration. However, excess transition metals can be toxic due to their ability to cause spontaneous redox cycling and disrupt normal metabolic processes. Vertebrates have evolved intricate mechanisms to limit the availability of some crucial metals while concurrently flooding sites of infection with antimicrobial concentrations of other metals.   Both pathogens and hosts have complex regulatory systems for metal homeostasis. Understanding these provides strategies for fighting pathogens, either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway286">
 <bp:pathwayOrder rdf:resource="#PathwayStep2361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2076" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2074" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans have 38 beta-defensin genes plus 9-10 pseudogenes (details available on the HGNC website at http://www.genenames.org/genefamilies/DEFB). Many beta-defensins are encoded by recently duplicated genes giving rise to identical transcripts. Nomenclature is confusing and currently in transition. Uniprot recommended names are used throughout this pathway. Many beta-defensins show expression that correlates with infection (Sahl et al. 2005, Pazgier et al. 2006). All so far characterized beta-defensins, i.e. beta-defensin 1 (hBD1), 4A (hBD2), 103 (hBD3), 104 (hBD4), 106 (hBD6), 118 (hBD18) and 128 (hBD28) have antimicrobial properties (Pazgier et al. 2006). For beta-defensins 4A, 103 and 118 (hBD2, 3, and 18) this has been shown to correlate with membrane permeabilization effects (Antcheva et al. 2004, Sahl et al. 2005, Yenugu et al. 2004). Electrostatic interaction and disruption of microbial membranes is widely believed to the primary mechanism of action for beta-defensins. Two models explain how membrane disruption takes place, the &apos;pore model&apos; which postulates that beta-defensins form transmembrane pores in a similar manner to alpha-defensins, and the &apos;carpet model&apos;, which suggests that beta-defensins act as detergents. Beta-defensins contain 6 conserved cysteine residues that in beta-defensins 1, 4A and 103 (hBD1-3) are experimentally confirmed to be cross-linked 1-5, 2-4, 3-6. The canonical sequence for beta-defensins is x2-10Cx5-6(G/A)xCX3-4Cx9-13Cx4-7CCxn. Structurally they are similar to alpha-defensins but with much shorter pre-regions. Though dimerization of some beta-defensins has been reported this is not the case for all and it is unclear whether it is required for function. The majority of functional studies have focused on beta-defensin 103 (hBD3), which has the most significant antimicrobial activity at physiological salt concentrations (Harder et al. 2001). Beta-defensin 103  is highly cationic with a net charge of +11 e0.  It exhibits broad-spectrum antimicrobial activity against gram-positive bacteria and some gram-negative bacteria (Harder et al. 2001), though some species are highly resistant (Sahly et al. 2003). Sensitivity correlates with lipid composition of the membrane, with more negatively-charged lipids correlating with larger beta-defensin 103-induced changes in membrane capacitance (Bohling et al. 2006). Though membrane disruption is widely believed to be the primary mechanism of action of beta-defensins they have other antimicrobial properties, such as inhibition of cell wall biosynthesis (Sass et al. 2010), and chemoattractant effects (Yang et al. 1999, Niyonsaba et al. 2002, 2004). The chemotactic activity of beta-defensins 1, 4A and 103 (hBD1-3) for memory T cells and immature DCs is mediated through binding to the chemokine receptor CCR6 and probably another unidentified Gi-coupled receptor (Yang et al. 1999, 2000).    Like defensins, the human cathelicidin LL37 peptide is rich in positively-charged  residues (Lehrer    Ganz 2002). Expression of certain beta-defensins can be induced in response to various signals, such as bacteria, pathogen-associated molecular patterns (PAMPs), or proinflammatory cytokines (Ganz 2003, Yang et al. 2004). Like the alpha-defensins, copy number variation has been reported for DEFB4, DEFB103 and DEFB104 with individuals having 2-12 copies per diploid genome. In contrast DEFB1 does not show such variation but exhibits a number of SNPs (Hollox et al. 2003, Linzmier    Ganz 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway287">
 <bp:pathwayOrder rdf:resource="#PathwayStep2372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2086" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2083" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2082" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2091" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2090" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans have 7 alpha defensin genes plus 5 pseudogenes (see HGNC at http://www.genenames.org/genefamilies/DEFA). Alpha-defensins have six cysteines linked 1-6, 2-4, 3-5. The canonical sequence of alpha-defensins in humans is x1-2CXCRx2-3Cx3Ex3GxCx3Gx5CCx1-4, where x represents any amino acid residue.  Human alpha-defensins 1-4 are often called human neutrophil peptides (HNP1-4) as they were initially identified in neutrophil primary (azurophilic) granules. Alpha-defensins 5 and 6 (HD5, HD6) are products of Paneth cells. HNP-1 and -3 peptides are 30 residues long, differing only in the first amino acid. They are encoded by the genes DEFA1 and DEFA3 respectively. These exhibit copy number polymorphism, with some individuals having  4-14 copies per diploid  genome, while 10-37% of individuals have no copies of DEFA3 (Aldred et al. 2005, Linzmier    Ganz 2005, Ballana et al. 2007). HNP-4, encoded by DEFA4, is 33 amino acids long of which 22 differ from the other HNPs (Wilde et al. 1989). It is a minor component of neutrophil granules compared to HNP1-3. In contrast to DEFA1 and DEFA3, the genes for HNP-4, HD-5 and HD-6 are only found as two copies per diploid genome (Linzmeier    Ganz 2005). HNP-2 is 29 amino acids in length and is the proteolytic product of cleavage of the N-terminal amino acid from either HNP-1 and/or HNP-3 (Selsted et al. 1985). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway284">
 <bp:pathwayOrder rdf:resource="#PathwayStep2406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2397" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2379" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2412" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2099" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2095" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2071" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2092" />
 <bp:pathwayComponent rdf:resource="#Pathway288" />
 <bp:pathwayComponent rdf:resource="#Pathway289" />
 <bp:pathwayComponent rdf:resource="#Pathway285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2113" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antimicrobial peptides</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antimicrobial peptides (AMPs) are small molecular weight proteins with broad spectrum of antimicrobial activity against bacteria, viruses, and fungi (Zasloff M 2002; Radek K    Gallo R 2007). The majority of known AMPs are cationic peptides with common structural characteristics where domains of hydrophobic and cationic amino acids are spatially arranged into an amphipathic design, which facilitates their interaction with bacterial membranes (Shai Y 2002; Yeaman MR    Yount NY 2003; Brown KL    Hancock RE 2006; Dennison SR et al. 2005; Zelezetsky I    Tossi A 2006). It is generally excepted that the electrostatic interaction facilitates the initial binding of the positively charged peptides to the negatively charged bacterial membrane. Moreover, the structural amphiphilicity of AMPs is thought to promote their integration into lipid bilayers of pathogenic cells, leading to membrane disintegration and finally to the microbial cell death. In addition to cationic AMPs a few anionic antimicrobial peptides have been found in humans, however their mechanism of action remains to be clarified (Lai Y et al. 2007; Harris F et al. 2009; Paulmann M et al. 2012). Besides the direct neutralizing effects on bacteria AMPs may modulate cells of the adaptive immunity (neutrophils, T-cells, macrophages) to control inflammation and/or to increase bacterial clearance. AMPs have also been referred to as cationic host defense peptides, anionic antimicrobial peptides/proteins, cationic amphipathic peptides, cationic AMPs, host defense peptides and alpha-helical antimicrobial peptides (Brown KL    Hancock RE 2006; Harris F et al. 2009; Groenink J et al. 1999; Bradshaw J 2003; Riedl S et al. 2011; Huang Y et al. 2010). The Reactome module describes the interaction events of various types of human AMPs, such as cathelicidin, histatins and neutrophil serine proteases, with conserved patterns of microbial membranes at the host-pathogen interface. The module includes also proteolytic processing events for dermcidin (DCD) and cathelicidin (CAMP) that become functional upon cleavage. In addition, the module highlights an AMP-associated ability of the host to control metal quota at inflammation sites to influence host-pathogen interactions.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway285">
 <bp:pathwayOrder rdf:resource="#PathwayStep2365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2079" />
 <bp:pathwayComponent rdf:resource="#Pathway286" />
 <bp:pathwayComponent rdf:resource="#Pathway287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2073" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The defensins are a family of antimicrobial cationic peptide molecules which in mammals have a characteristic  beta-sheet-rich fold and framework of six disulphide-linked cysteines (Selsted    Ouellette 2005, Ganz 2003). Human defensin peptides have two subfamilies, alpha- and beta-defensins, differing in the length of peptide chain between the six cysteines and the order of disulphide bond pairing between them. A third subfamily, the theta defensins, is derived from alpha-defensins prematurely truncated by a stop codon between the third and fourth cysteine residues. The translated products are shortened to nonapeptides, covalently dimerized by disulfide linkages, and cyclized via new peptide bonds between the first and ninth residues. Humans have one pseudogene but no translated representatives of the theta class. In solution most alpha and beta defensins are monomers but can form dimers and higher order structures.   The primary cellular sources of defensins are neutrophils, epithelial cells and intestinal Paneth cells.Those expressed in neutrophils and the gut are predominantly constitutive, while those in epithelial tissues such as skin are often inducible by proinflammatory stimuli such as LPS or TNF-alpha.  Defensins are translated as precursor polypeptides that include a typical signal peptide or prepiece that is cleaved in the Golgi body, and a propiece, cleaved by differing mechanisms to produce the mature defensin. Mature defensin peptides can be further processed by removal of individual N-terminal residues (Yang et al. 2004). This may be a mechanism to broaden the activity profile of defensins (Ghosh et al. 2002).  Defensins have direct antimicrobial effects and kill a wide range of Gram-positive and negative bacteria, fungi and some viruses. The primary antimicrobial action of defensins is permeabilization of microbial target membranes but several additional mechanisms have been suggested (Brogden 2005, Wilmes et al. 2011). Defensins and related antimicrobial peptides such as cathelicidin bridge the innate and acquired immune responses. In addition to their antimicrobial properties, cathelicidin and several defensins show receptor-mediated chemotactic activity for immune cells such as monocytes, T cells or immature DCs, induce cytokine production by monocytes and epithelial cells, modulate angiogenesis and stimulate wound healing (Yang et al. 1999, 2000, 2004, Rehaume    Hancock 2008, Yeung et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis111">
 <bp:controlled rdf:resource="#BiochemicalReaction436" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway282">
 <bp:pathwayOrder rdf:resource="#PathwayStep2307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2068" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2044" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2041" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2040" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2029" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2028" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2026" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2035" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2032" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2070" />
 <bp:pathwayComponent rdf:resource="#Pathway283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2039" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2036" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROS and RNS production in phagocytes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first line of defense against infectious agents involves an active recruitment of phagocytes to the site of infection. Recruited cells include polymorhonuclear (PMN) leukocytes (i.e., neutrophils) and monocytes/macrophages, which function together as innate immunity sentinels (Underhill DM    Ozinsky A 2002; Stuart LM    Ezekowitz RA 2005; Flannagan RS et al. 2012). Dendritic cells are also present, serving as important players in antigen presentation for ensuing adaptive responses (Savina A    Amigorena S 2007). These cell types are able to bind and engulf invading microbes into a membrane-enclosed vacuole - the phagosome, in a process termed phagocytosis. Phagocytosis can be defined as the receptor-mediated engulfment of particles greater than 0.5 micron in diameter. It is initiated by the cross-linking of host cell membrane receptors following engagement with their cognate ligands on the target surface (Underhill DM    Ozinsky A 2002; Stuart LM    Ezekowitz RA 2005; Flannagan RS et al. 2012). When engulfed by phagocytes, microorganisms are exposed to a number of host defense microbicidal events within the resulting phagosome. These include the production of reactive oxygen and nitrogen species (ROS and RNS, RONS) by specialized enzymes (Fang FC et al. 2004; Kohchi C et al. 2009; Gostner JM et al. 2013; Vatansever F et al. 2013). NADPH oxidase (NOX) complex consume oxygen to produce superoxide radical anion (O2.-) and hydrogen peroxide (H2O2) (Robinson et al. 2004). Induced NO synthase (iNOS) is involved in the production of NO, which is the primary source of all RNS in biological systems (Evans TG et al. 1996). The phagocyte NADPH oxidase and iNOS are expressed in both PMN and mononuclear phagocytes and both cell types have the capacity for phagosomal burst activity. However, the magnitude of ROS generation in neutrophils far exceeds that observed in macrophages (VanderVen BC et al. 2009). Macrophages are thought to produce considerably more RNS than neutrophils (Fang FC et al. 2004; Nathan    Shiloh 2000). The presence of RONS characterized by a relatively low reactivity, such as H2O2, O2&#729;&#8722; or NO, has no deleterious effect on biological environment (Attia SM 2010; Weidinger A    and Kozlov AV 2015). Their activity is controlled by endogenous antioxidants (both enzymatic and non-enzymatic) that are induced by oxidative stress. However the relatively low reactive species can initiate a cascade of reactions to generate more damaging &#8220;secondary&#8221; species such as hydroxyl radical (&#8226;OH), singlet oxygen or peroxinitrite (Robinson JM 2008; Fang FC et al. 2004). These &quot;secondary&quot; RONS are extremely toxic causing irreversible damage to all classes of biomolecules (Weidinger A    and Kozlov AV 2015; Fang FC et al. 2004; Kohchi C et al. 2009; Gostner JM et al. 2013; Vatansever F et al. 2013). Although macrophages and neutrophils use similar mechanisms for the internalization of targets, there are differences in how they perform phagocytosis and in the final outcome of the process (Tapper H    Grinstein S 1997; Vierira OV et al. 2002). Once formed, the phagosome undergoes an extensive maturation process whereby it develops into a microbicidal organelle able to eliminate the invading pathogen. Maturation involves re-modeling both the membrane of the phagosome and its luminal contents (Vierira OV et al. 2002). In macrophages, phagosome formation and maturation follows a series of strictly coordinated membrane fission/fusion events between the phagosome and compartments of the endo/lysosomal network gradually transforming the nascent phagosome into a phagolysosome, a degradative organelle endowed with potent microbicidal properties (Zimmerli S et al. 1996; Vierira OV et al. 2002). Neutrophils instead contain a large number of preformed granules such as azurophilic and specific granules that can rapidly fuse with phagosomes delivering antimicrobial substances (Karlsson A    Dahlgren C 2002; Naucler C et al. 2002; Nordenfelt P and Tapper H 2011). Phagosomal pH dynamics may also contribute to the maturation process by regulating membrane traffic events. The microbicidal activity of macrophages is characterized by progressive acidification of the lumen (down to pH 4&#8211;5) by the proton pumping vATPase. A low pH is a prerequisite for optimal enzymatic activity of most late endosomal/lysosomal hydrolases reported in macrophages. Neutrophil phagosome pH regulation differs significantly from what is observed in macrophages (Nordenfelt P and Tapper H 2011; Winterbourn CC et al. 2016). The massive activation of the oxidative burst is thought to result in early alkalization of neutrophil phagosomes which is linked to proton consumption during the generation of hydrogen peroxide (Segal AW et al. 1981; Levine AP et al. 2015). Other studies showed that neutrophil phagosome maintained neutral pH values before the pH gradually decreased (Jankowski A et al. 2002). Neutrophil phagosomes also exhibited a high proton leak, which was initiated upon activation of the NADPH oxidase, and this activation counteracted phagosomal acidification (Jankowski A et al. 2002). The Reactome module describes ROS and RNS production by phagocytic cells. The module includes cell-type specific events, for example, myeloperoxidase (MPO)-mediated production of hypochlorous acid in neutrophils. It also highlights differences between phagosomal pH dynamics in neutrophils and macrophages. The module describes microbicidal activity of selective RONS such as hydroxyl radical or peroxynitrite. However, detection of any of these species in the phagosomal environment is subject to many uncertainties (N&#252;sse O 2011; Erard M et al. 2018). The mechanisms by which reactive oxygen/nitrogen species kill pathogens in phagocytic immune cells are still not fully understood. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis112">
 <bp:controlled rdf:resource="#BiochemicalReaction438" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway283">
 <bp:pathwayOrder rdf:resource="#PathwayStep2338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2342" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2053" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2062" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2050" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2058" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Events associated with phagocytolytic activity of PMN cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When neutrophils engulf bacteria they enclose them in small vacuoles (phagosomes) into which superoxide is released by activated NADPH oxidase (NOX2) on the internalized neutrophil membrane. The directional nature of NOX2 activity creates a charge imbalance that must be counteracted to prevent depolarization of the membrane and the shutdown of activity (Winterbourn CC et al. 2016). Also, protons are produced in the cytosol and consumed in the external compartment (for example, the phagosome) through the dismutation of superoxide. Both situations are largely overcome by a balancing flow of protons transported by voltage-gated proton channels, primarily VSOP/HV1, which are activated in parallel with the oxidase (Demaurex N    El Chemaly A 2010; El Chemaly A et al. 2010; Petheo GL et al. 2010; Kovacs I et al. 2014; Henderson LM et al. 1987, 1988). The pH of the phagosome is regulated by these activities. In contrast to the phagosomes of macrophages, in which pH drops following particle ingestion, neutrophil phagosomes remain alkaline during the period that the oxidase is active. Until recently, their pH has been accepted to lie between 7.5 and 8. However, in a 2015 study using a probe that is more sensitive at higher pH, an average pH closer to 9 was measured in individual phagosomes (Levine AP et al. 2015). The superoxide dismutates to hydrogen peroxide, which is used by myeloperoxidase (MPO) to generate other oxidants, including the highly microbicidal species such as hypochlorous acid (Winterbourn CC et al. 2013, 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis113">
 <bp:controlled rdf:resource="#BiochemicalReaction440" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway280">
 <bp:pathwayOrder rdf:resource="#PathwayStep2288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2013" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2001" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2009" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2008" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2003" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 is crucial for both DDX58 (RIG-I)- and IFIH1 (MDA5)-mediated antiviral responses. The absence of TRAF6 resulted in enhanced viral replication and a significant reduction in the production of type I IFNs and IL6 after infection with RNA virus. Activation of NF-kB and IRF7, but not that of IRF3, was significantly impaired during RIG-like helicases (RLHs) signaling in the absence of TRAF6. TRAF6-induced activation of IRF is likely to be specific for IRF7, while TRAF3 is thought to activate both IRF3 and IRF7. These results strongly suggest that the TRAF6- and TRAF3-dependent pathways are likely to bifurcate at mitochondrial antiviral-signaling protein MAVS (IPS-1), but to converge later at IRF7 in order to co-operatively induce sufficient production of type I IFNs during RLH signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis114">
 <bp:controlled rdf:resource="#BiochemicalReaction441" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway281">
 <bp:pathwayOrder rdf:resource="#PathwayStep2305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2019" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2018" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2017" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2016" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2025" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-protein kinase 1 signaling pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Immune recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRR) often activates proinflammatory nuclear factor kappa B (NF-&#954;B) signalling. Lipopolysaccharide (LPS) is a well-known PAMP produced by gram-negative bacteria. LPS is recognized by toll like receptor 4 (TLR4) and is a strong activator of NF-&#954;B inflammatory responses (Akashi S et al. 2003). LPS is also recognized in the cytosol by mouse caspase-11 and related human caspase-4 and caspase-5, which stimulate pyroptosis, a proinflammatory form of cell death (Kayagaki N et al. 2011; Shi J et al. 2015). Key metabolic intermediates in LPS biosynthesis, d-glycero-&#946;-d-manno-heptose 1,7-bisphosphate (HBP) and ADP L-glycero-&#946;-d-manno-heptose (ADP-heptose) were reported to activate the NF-&#954;B pathway and trigger the innate immune responses (Milivojevic M et al. 2017; Zimmermann S et al. 2017; Zhou P et al. 2018; Garc&#237;a-Weber D; 2018). ADP-heptose but not HBP can enter host cells autonomously (Zhou P et al. 2018). During infection, ADP-heptose or HBP translocate into the host cytosol where their presence is sensed by alpha-protein kinase 1 (ALPK1) (Zimmermann S et al. 2017; Zhou P et al. 2018). ADP-heptose directly binds and activates ALPK1 (Garcia-Weber D et al. 2018; Zhou P et al. 2018); instead, HBP is converted by host-derived adenylyltransferases, such as nicotinamide nucleotide adenylyltransferases, to ADP-heptose 7-P, a substrate which can then activate ALPK1 (Zhou P et al. 2018). The ADP-heptose binding to ALPK1 is thought to trigger conformational changes and stimulate the kinase domain of ALPK1 (Zhou P et al. 2018). ALPK1 kinase activity in turn leads to the phosphorylation-dependent oligomerization of the tumor necrosis factor (TNF-&#945;) receptor&#8211;associated factor (TRAF)&#8211;interacting protein with the forkhead-associated domain (TIFA) (Zimmermann S et al. 2017; Zhou P et al. 2018). This process activates TRAF6 oligomerization and ubiquitination, and the recruitment of transforming growth factor &#946;-activated kinase 1 (TAK1)-binding protein 2 (TAB2), a component of the TAK1 (MAP3K7) complex (Ea CK et al. 2004; Gaudet RG et al. 2017). This TIFA oligomer signaling platform was given the term: TIFAsome. TIFAsome-activated TAK1 induces NF-&#954;B nuclear translocation and proinflammatory gene expression. The ALPK1-TIFA signaling pathway has been identified in human embryonic kidney cells, intestinal epithelial cells, gastric cells and cervical cancer cells (Gaudet RG et al. 2015, 2017; Stein SC et al. 2017; Gall A et al. 2017; Zimmermann S et al. 2017; Milivojevic M et al. 2017; Zhou P et al. 2018). In vivo studies demonstrate that ADP-heptose and Burkholderia cenocepacia trigger massive inflammatory responses with increased production of several NF-&#954;B-dependent cytokines and chemokines in wild type (WT), but not in Alpk1-/- mice (Zhou P et al. 2018). This Reactome module describes ALPK1 as a cytosolic innate immune receptor for bacterial ADP-heptose.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis115">
 <bp:controlled rdf:resource="#BiochemicalReaction446" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis116">
 <bp:controlled rdf:resource="#BiochemicalReaction449" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis117">
 <bp:controlled rdf:resource="#BiochemicalReaction451" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis118">
 <bp:controlled rdf:resource="#BiochemicalReaction458" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2089">
 <bp:evidence rdf:resource="#Evidence2376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-3 bind CD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2088">
 <bp:evidence rdf:resource="#Evidence2375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-4 are stored in primary neutrophil granules</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis150">
 <bp:controlled rdf:resource="#BiochemicalReaction649" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2087">
 <bp:evidence rdf:resource="#Evidence2374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensin dimers adsorb onto microbial membrane anionic phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis151">
 <bp:controlled rdf:resource="#BiochemicalReaction652" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2086">
 <bp:evidence rdf:resource="#Evidence2373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensins form biologically active dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis152">
 <bp:controlled rdf:resource="#BiochemicalReaction654" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2085">
 <bp:evidence rdf:resource="#Evidence2372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensin dimers multimerize to form a pore complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis153">
 <bp:controlled rdf:resource="#BiochemicalReaction659" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2084">
 <bp:evidence rdf:resource="#Evidence2371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-3 bind gp120</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis154">
 <bp:controlled rdf:resource="#BiochemicalReaction665" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2083">
 <bp:evidence rdf:resource="#Evidence2370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-defensin alpha 5 is stored in Paneth cell granules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2082">
 <bp:evidence rdf:resource="#Evidence2369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-4 are released into phagocytic vacuoles</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2081">
 <bp:evidence rdf:resource="#Evidence2368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-HD5 is cleaved by trypsin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2080">
 <bp:evidence rdf:resource="#Evidence2367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADP-Ribosylation of HNP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction400">
 <bp:evidence rdf:resource="#Evidence437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK3 binds JAK3 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction402">
 <bp:evidence rdf:resource="#Evidence439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAG1:RAG2 recombinase binds immunoglobulin kappa locus in a BRWD1-dependent manner</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction401">
 <bp:evidence rdf:resource="#Evidence438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7:p-Y449-IL7R:JAK1:IL2RG:p-JAK3:STAT5A,STAT5B phosphorylates STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction408">
 <bp:evidence rdf:resource="#Evidence445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RG binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis144">
 <bp:controlled rdf:resource="#BiochemicalReaction593" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction407">
 <bp:evidence rdf:resource="#Evidence444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT3 dissociates from TSLP:IL7R:CRLF2:p-STAT3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis145">
 <bp:controlled rdf:resource="#BiochemicalReaction595" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis146">
 <bp:controlled rdf:resource="#BiochemicalReaction615" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction409">
 <bp:evidence rdf:resource="#Evidence446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 binds CISH, SOCS1 and SOCS2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis147">
 <bp:controlled rdf:resource="#BiochemicalReaction641" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction404">
 <bp:evidence rdf:resource="#Evidence441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of STAT5 upregulated genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis148">
 <bp:controlled rdf:resource="#BiochemicalReaction644" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction403">
 <bp:evidence rdf:resource="#Evidence440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5A, p-STAT5B dissociate from IL7:p-Y449-IL7R:JAK1:IL2RG:p-JAK3:p-STAT5A,p-STAT5B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis149">
 <bp:controlled rdf:resource="#BiochemicalReaction647" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction406">
 <bp:evidence rdf:resource="#Evidence443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7 binds HGF(495-728) to form PPBSF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction405">
 <bp:evidence rdf:resource="#Evidence442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 binds TSLP:IL7R:CRLF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2099">
 <bp:evidence rdf:resource="#Evidence2386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cathelicidin LL-37 binds to bacterial cell wall</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2098">
 <bp:evidence rdf:resource="#Evidence2385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP2 hydrolyzes bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis140">
 <bp:controlled rdf:resource="#BiochemicalReaction584" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2097">
 <bp:evidence rdf:resource="#Evidence2384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP2 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis141">
 <bp:controlled rdf:resource="#BiochemicalReaction587" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2096">
 <bp:evidence rdf:resource="#Evidence2383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INTL1 binds bacterial glycans</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis142">
 <bp:controlled rdf:resource="#BiochemicalReaction591" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2095">
 <bp:evidence rdf:resource="#Evidence2382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD forms oligomeric complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis143">
 <bp:controlled rdf:resource="#BiochemicalReaction592" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2094">
 <bp:evidence rdf:resource="#Evidence2381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BPI binds LPS on the bacterial surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2093">
 <bp:evidence rdf:resource="#Evidence2380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A oligomerize to form a pore complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2092">
 <bp:evidence rdf:resource="#Evidence2379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3 binds the bacterial surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2091">
 <bp:evidence rdf:resource="#Evidence2378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pro-HNP1-4 are cleaved to biologically active defensin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2090">
 <bp:evidence rdf:resource="#Evidence2377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-defensin alpha 5 is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction411">
 <bp:evidence rdf:resource="#Evidence448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7 binds IL7R:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep505">
 <bp:stepProcess rdf:resource="#Pathway39" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction410">
 <bp:evidence rdf:resource="#Evidence447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL7:p-Y449-IL7R:JAK1:IL2RG:p-JAK3 binds STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction468" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction413">
 <bp:evidence rdf:resource="#Evidence451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL26:IL20RA:JAK1:IL10RB:TYK2 phosphorylates JAK1, TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction469" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction412">
 <bp:evidence rdf:resource="#Evidence450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL26:IL10RB:p-TYK2:IL20RA:p-JAK1:STAT1,STAT3  phosphorylates STAT1,STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep508">
 <bp:stepProcess rdf:resource="#Catalysis120" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction471" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction419">
 <bp:evidence rdf:resource="#Evidence457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1:p-Y434,Y517-IFNLR1:p-JAK1:IL10RB:p-TYK2 binds STAT1, STAT2, STAT3, STAT4, STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis133">
 <bp:controlled rdf:resource="#BiochemicalReaction562" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction418">
 <bp:evidence rdf:resource="#Evidence456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24:IL20RA:p-JAK1:IL20RB:STAT1,STAT3 phosphorylates STAT1 or STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis134">
 <bp:controlled rdf:resource="#BiochemicalReaction567" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis135">
 <bp:controlled rdf:resource="#BiochemicalReaction569" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction463" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis136">
 <bp:controlled rdf:resource="#BiochemicalReaction570" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction415">
 <bp:evidence rdf:resource="#Evidence453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 binds IFNLR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction464" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis137">
 <bp:controlled rdf:resource="#BiochemicalReaction571" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction414">
 <bp:evidence rdf:resource="#Evidence452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:IL22RA1:p-JAK1:IL10RB:p-TYK2 phosphorylates IL22RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep502">
 <bp:stepProcess rdf:resource="#Catalysis119" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction465" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis138">
 <bp:controlled rdf:resource="#BiochemicalReaction573" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction417">
 <bp:evidence rdf:resource="#Evidence455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction466" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis139">
 <bp:controlled rdf:resource="#BiochemicalReaction578" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction416">
 <bp:evidence rdf:resource="#Evidence454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL26:IL20RA:JAK1 binds IL10RB:TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction467" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2024">
 <bp:evidence rdf:resource="#Evidence2305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 within the ALPK1:ADP-heptose:p-T9-TIFA:pUb-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 :MAP3K7 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2023">
 <bp:evidence rdf:resource="#Evidence2304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose:TIFA oligomer recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2022">
 <bp:evidence rdf:resource="#Evidence2303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of TRAF6 bound to ALPK1:ADP-heptose:TIFA oligomer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2021">
 <bp:evidence rdf:resource="#Evidence2302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1 binds ADP-heptose</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2020">
 <bp:evidence rdf:resource="#Evidence2301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose binds TIFA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction422">
 <bp:evidence rdf:resource="#Evidence460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20 binds IL20RA:JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction421">
 <bp:evidence rdf:resource="#Evidence459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24:IL22RA1:JAK1:IL20RB phosphorylates JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction424">
 <bp:evidence rdf:resource="#Evidence462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:p-Y251,p-Y301-IL22RA1:p-JAK1:PTPN11:IL10RB:p-TYK2 binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction423">
 <bp:evidence rdf:resource="#Evidence461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1,p-STAT3 dissociate from IL24:IL20RA:p-Y1022,Y1023-JAK1:IL20RB:p-STAT1, p-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction420">
 <bp:evidence rdf:resource="#Evidence458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20:IL20RA:JAK1:IL20RB:p-JAK3,p-JAK2:STAT3 phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction429">
 <bp:evidence rdf:resource="#Evidence467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1 binds IL20RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2029">
 <bp:evidence rdf:resource="#Evidence2311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protonation of superoxide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction426">
 <bp:evidence rdf:resource="#Evidence464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1, p-Y-STAT2, p-STAT3, p-STAT4, p-STAT5 dissociates from IFNL1:p-Y343,Y517-IFNLR1:p-JAK1:IL10RB:p-TYK2:p-STAT1,p-STAT2,p-STAT3,p-STAT4,p-STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2028">
 <bp:evidence rdf:resource="#Evidence2310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOX2 generates superoxide anion from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction425">
 <bp:evidence rdf:resource="#Evidence463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT3 dissociates from IL24:IL22RA1:p&#8209;JAK1:IL20RB:p&#8209;STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2027">
 <bp:evidence rdf:resource="#Evidence2309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric Oxide Synthase (NOS) produces Nitric Oxide (NO)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction428">
 <bp:evidence rdf:resource="#Evidence466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of SOCS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2026">
 <bp:evidence rdf:resource="#Evidence2308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NO and NO2 react to N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction427">
 <bp:evidence rdf:resource="#Evidence465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1 binds IL10RB:TYK2 and IFNLR1:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2025">
 <bp:evidence rdf:resource="#Evidence2306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon ALPK1:ADP-heptose stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2035">
 <bp:evidence rdf:resource="#Evidence2317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2034">
 <bp:evidence rdf:resource="#Evidence2316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H2O2 oxidizes Cys residues to form Cys-sulfenic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2033">
 <bp:evidence rdf:resource="#Evidence2315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide anion reacts with Fe-S cluster</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2032">
 <bp:evidence rdf:resource="#Evidence2314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrogen peroxide and Fe2+ react to hydroxyl, hydroxide and Fe3+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2031">
 <bp:evidence rdf:resource="#Evidence2313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide diffuses into the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2030">
 <bp:evidence rdf:resource="#Evidence2312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide anion dismutates to H2O2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction433">
 <bp:evidence rdf:resource="#Evidence471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL19:IL20RA:p&#8209;JAK1:IL20RB binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction432">
 <bp:evidence rdf:resource="#Evidence470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p&#8209;Y705-STAT3 dissociates from IL19:IL20RA:p-JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction435">
 <bp:evidence rdf:resource="#Evidence473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT3 dissociates from IL20:IL20RA:JAK1:IL20RB:p-Y1007,Y1008-JAK2,p-JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction434">
 <bp:evidence rdf:resource="#Evidence472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dimer translocates from cytosol to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction431">
 <bp:evidence rdf:resource="#Evidence469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction430">
 <bp:evidence rdf:resource="#Evidence468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL19:IL20RA:p-JAK1:IL20RB:STAT3 phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction437">
 <bp:evidence rdf:resource="#Evidence475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT3 dimer translocates from cytosol to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2039">
 <bp:evidence rdf:resource="#Evidence2321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite oxidizes Peptide-Methionine residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction436">
 <bp:evidence rdf:resource="#Evidence474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20:IL20RA:JAK1:IL20RB:JAK2,JAK3 phosphorylates JAK2,JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2038">
 <bp:evidence rdf:resource="#Evidence2320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroxyl-initiated lipid peroxidation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction439">
 <bp:evidence rdf:resource="#Evidence477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22RA1 binds JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2037">
 <bp:evidence rdf:resource="#Evidence2319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide and nitric oxide react to peroxynitrite</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction438">
 <bp:evidence rdf:resource="#Evidence476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1:IFNLR1:p-JAK1:IL10RB:p-TYK2 phosphorylates IFNLR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2036">
 <bp:evidence rdf:resource="#Evidence2318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroperoxyl enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2046">
 <bp:evidence rdf:resource="#Evidence2328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2045">
 <bp:evidence rdf:resource="#Evidence2327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N2O3 diffuses to phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2044">
 <bp:evidence rdf:resource="#Evidence2326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glutathione scavenges nitrosyl</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2043">
 <bp:evidence rdf:resource="#Evidence2325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide oxidizes to nitrosyl ion</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2042">
 <bp:evidence rdf:resource="#Evidence2324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HV1-mediated H+ transfer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2041">
 <bp:evidence rdf:resource="#Evidence2323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroxyl radical reacts with the base and sugar moiety of DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2040">
 <bp:evidence rdf:resource="#Evidence2322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite oxidizes Cys residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis110">
 <bp:controlled rdf:resource="#BiochemicalReaction430" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis108">
 <bp:controlled rdf:resource="#BiochemicalReaction420" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction444">
 <bp:evidence rdf:resource="#Evidence482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20 binds to IL22RA1:JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis109">
 <bp:controlled rdf:resource="#BiochemicalReaction421" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction443">
 <bp:evidence rdf:resource="#Evidence481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL26:IL10RB:p-TYK2:IL20RA:p-JAK1 binds STAT1, STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction446">
 <bp:evidence rdf:resource="#Evidence484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL19:IL20RA:JAK1:IL20RB phosphorylates JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction445">
 <bp:evidence rdf:resource="#Evidence483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24 binds to IL22RA1:JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction7">
 <bp:evidence rdf:resource="#Evidence10" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction440">
 <bp:evidence rdf:resource="#Evidence478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:IL22RA1:JAK1:IL10RB:TYK2 phosphorylates JAK1,TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction8">
 <bp:evidence rdf:resource="#Evidence11" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR-bound STAT5 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction9">
 <bp:evidence rdf:resource="#Evidence12" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolactin receptor ligands bind the prolactin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction442">
 <bp:evidence rdf:resource="#Evidence480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24:IL22RA1:p-JAK1:IL20RB binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction441">
 <bp:evidence rdf:resource="#Evidence479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22:p-Y251,p-Y301-IL22RA1:p-JAK1:IL10RB:p-TYK2:STAT3 phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction3">
 <bp:evidence rdf:resource="#Evidence6" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR is phosphorylated at Ser-349</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis100">
 <bp:controlled rdf:resource="#BiochemicalReaction389" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction4">
 <bp:evidence rdf:resource="#Evidence7" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolactin receptor is internalized</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis101">
 <bp:controlled rdf:resource="#BiochemicalReaction394" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction5">
 <bp:evidence rdf:resource="#Evidence8" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR associates with JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis102">
 <bp:controlled rdf:resource="#BiochemicalReaction397" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction6">
 <bp:evidence rdf:resource="#Evidence9" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR:JAK2 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis103">
 <bp:controlled rdf:resource="#BiochemicalReaction401" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis104">
 <bp:controlled rdf:resource="#BiochemicalReaction412" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction448">
 <bp:evidence rdf:resource="#Evidence486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL26 binds IL20RA:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis105">
 <bp:controlled rdf:resource="#BiochemicalReaction413" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction447">
 <bp:evidence rdf:resource="#Evidence485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT3 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2049">
 <bp:evidence rdf:resource="#Evidence2331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S-nitrosylation of cysteine residues in proteins by N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1">
 <bp:evidence rdf:resource="#Evidence4" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyrosine phosphorylation of PRLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis106">
 <bp:controlled rdf:resource="#BiochemicalReaction414" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2048">
 <bp:evidence rdf:resource="#Evidence2330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide and nitric oxide react to peroxynitrite in the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2">
 <bp:evidence rdf:resource="#Evidence5" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRLR activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis107">
 <bp:controlled rdf:resource="#BiochemicalReaction418" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction449">
 <bp:evidence rdf:resource="#Evidence487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1:IFNLR1:JAK1:IL10RB:TYK2 phosphorylates JAK1,TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2047">
 <bp:evidence rdf:resource="#Evidence2329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intraphagosomal pH is lowered to 5 by V-ATPase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2057">
 <bp:evidence rdf:resource="#Evidence2340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid and nitrite react to nitryl chloride (NO2Cl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2056">
 <bp:evidence rdf:resource="#Evidence2339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) catalyzes oxidation of nitrite to nitrogen dioxide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2055">
 <bp:evidence rdf:resource="#Evidence2338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) reacts with Lys-monochloramine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2054">
 <bp:evidence rdf:resource="#Evidence2337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OSCN- reacts with Cys residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2053">
 <bp:evidence rdf:resource="#Evidence2336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cys-sulfenyl chloride is converted to Cys-sulfenic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2052">
 <bp:evidence rdf:resource="#Evidence2335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) binds to the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2051">
 <bp:evidence rdf:resource="#Evidence2334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) oxidizes Cys residues to form Cys-sulfenyl chloride</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2050">
 <bp:evidence rdf:resource="#Evidence2333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HOCl-induced glycosaminoglycan fragmentation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction460">
 <bp:evidence rdf:resource="#Evidence498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22 binds IL22RA1:JAK1 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction455">
 <bp:evidence rdf:resource="#Evidence493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL20:IL20RA:JAK1:IL20RB binds JAK2,JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction454">
 <bp:evidence rdf:resource="#Evidence492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 dimer translocates from the cytosol to the nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction457">
 <bp:evidence rdf:resource="#Evidence495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10RB binds TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction456">
 <bp:evidence rdf:resource="#Evidence494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL19 binds IL20RA:JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction451">
 <bp:evidence rdf:resource="#Evidence489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24:IL22RA1:p-JAK1:IL20RB:STAT3 phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction450">
 <bp:evidence rdf:resource="#Evidence488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24:p-IL20RA:p-JAK1:IL20RB binds STAT1,STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction453">
 <bp:evidence rdf:resource="#Evidence491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 and p-STAT3 dissociates from IL26:IL10RB:p-TYK2:IL20RA:p-JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction452">
 <bp:evidence rdf:resource="#Evidence490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL24 binds IL20RA:JAK1:IL20RB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction459">
 <bp:evidence rdf:resource="#Evidence497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL22RA2 binds IL22</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction458">
 <bp:evidence rdf:resource="#Evidence496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNL1:p-Y343,Y517-IFNLR1:p-JAK1:IL10RB:p-TYK2:STAT1 phosphorylates STAT1, STAT2, STAT3, STAT4 and STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2059">
 <bp:evidence rdf:resource="#Evidence2342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lactoperoxidase (LPO) produces OSCN-</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2058">
 <bp:evidence rdf:resource="#Evidence2341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chloride ion and N-acyl group react to chloramide</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep430">
 <bp:stepProcess rdf:resource="#Catalysis101" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction394" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2403">
 <bp:stepProcess rdf:resource="#Catalysis705" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction403" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction395" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction396" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction397" />
 <bp:stepProcess rdf:resource="#Catalysis102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction398" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction399" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep436">
 <bp:stepProcess rdf:resource="#BiochemicalReaction400" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction401" />
 <bp:stepProcess rdf:resource="#Catalysis103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep438">
 <bp:stepProcess rdf:resource="#BiochemicalReaction402" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2417">
 <bp:stepProcess rdf:resource="#Pathway290" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2418">
 <bp:stepProcess rdf:resource="#Pathway291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2415">
 <bp:stepProcess rdf:resource="#Catalysis707" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2416">
 <bp:stepProcess rdf:resource="#Catalysis708" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction405" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2123" />
 <bp:stepProcess rdf:resource="#Catalysis706" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2414">
 <bp:stepProcess rdf:resource="#Pathway289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction406" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction407" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep444">
 <bp:stepProcess rdf:resource="#BiochemicalReaction408" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep445">
 <bp:stepProcess rdf:resource="#BiochemicalReaction409" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction410" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction411" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep448">
 <bp:stepProcess rdf:resource="#Pathway38" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction412" />
 <bp:stepProcess rdf:resource="#Catalysis104" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2002">
 <bp:evidence rdf:resource="#Evidence2282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAF/pIRF7:CBP/p300 binds the promoters of type-I IFN genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2137" />
 <bp:stepProcess rdf:resource="#Catalysis712" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2001">
 <bp:evidence rdf:resource="#Evidence2281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TBK1/IKBKE</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2138" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2000">
 <bp:evidence rdf:resource="#Evidence2279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Processing of caspases</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2136" />
 <bp:stepProcess rdf:resource="#Catalysis711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction413" />
 <bp:stepProcess rdf:resource="#Catalysis105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction414" />
 <bp:stepProcess rdf:resource="#Catalysis106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction415" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2130" />
 <bp:stepProcess rdf:resource="#Catalysis709" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2425">
 <bp:stepProcess rdf:resource="#Pathway292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2132" />
 <bp:stepProcess rdf:resource="#Catalysis710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep453">
 <bp:stepProcess rdf:resource="#BiochemicalReaction416" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep454">
 <bp:stepProcess rdf:resource="#BiochemicalReaction417" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2009">
 <bp:evidence rdf:resource="#Evidence2289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TANK to TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction418" />
 <bp:stepProcess rdf:resource="#Catalysis107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2008">
 <bp:evidence rdf:resource="#Evidence2288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction419" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2007">
 <bp:evidence rdf:resource="#Evidence2287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep457">
 <bp:stepProcess rdf:resource="#Catalysis108" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction420" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2006">
 <bp:evidence rdf:resource="#Evidence2286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF6/TRAF2 to MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction421" />
 <bp:stepProcess rdf:resource="#Catalysis109" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2005">
 <bp:evidence rdf:resource="#Evidence2285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TBK1/IKK epsilon complex to TANK:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction422" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2004">
 <bp:evidence rdf:resource="#Evidence2284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2003">
 <bp:evidence rdf:resource="#Evidence2283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of VAF (virus-activated factor) complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1107">
 <bp:stepProcess rdf:resource="#Catalysis260" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1017" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2013">
 <bp:evidence rdf:resource="#Evidence2293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Interferon-alpha and beta mediated by VAF/pIRF7:CBP/p300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2439">
 <bp:stepProcess rdf:resource="#Catalysis718" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1016" />
 <bp:stepProcess rdf:resource="#Catalysis259" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2012">
 <bp:evidence rdf:resource="#Evidence2292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF7 to TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1109">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1019" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2011">
 <bp:evidence rdf:resource="#Evidence2291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE form homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1108">
 <bp:stepProcess rdf:resource="#Catalysis261" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1018" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2010">
 <bp:evidence rdf:resource="#Evidence2290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-IRF7 dimer interacts with coactivator CBP/p300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2438">
 <bp:stepProcess rdf:resource="#Catalysis717" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1011" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1100">
 <bp:stepProcess rdf:resource="#Pathway91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2430">
 <bp:stepProcess rdf:resource="#Catalysis713" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1103">
 <bp:stepProcess rdf:resource="#Catalysis258" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1013" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2144" />
 <bp:stepProcess rdf:resource="#Catalysis716" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1012" />
 <bp:stepProcess rdf:resource="#Catalysis257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2436">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1015" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2433">
 <bp:stepProcess rdf:resource="#Catalysis714" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1014" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2143" />
 <bp:stepProcess rdf:resource="#Catalysis715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep464">
 <bp:stepProcess rdf:resource="#BiochemicalReaction427" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction428" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep466">
 <bp:stepProcess rdf:resource="#BiochemicalReaction429" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2019">
 <bp:evidence rdf:resource="#Evidence2300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIFA oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction430" />
 <bp:stepProcess rdf:resource="#Catalysis110" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2018">
 <bp:evidence rdf:resource="#Evidence2299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1 phosphorylates TIFA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep468">
 <bp:stepProcess rdf:resource="#BiochemicalReaction431" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2017">
 <bp:evidence rdf:resource="#Evidence2298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose:p-T9-TIFA oligomer:K63pUb-TRAF6 oligomer recruits MAP3K7 (TAK1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction432" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2016">
 <bp:evidence rdf:resource="#Evidence2297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomerizes within the ALPK1:ADP-heptose:TIFA oligomer complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2015">
 <bp:evidence rdf:resource="#Evidence2295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA:IFIH1, viral dsRNA:K63polyUb-DDX58 bind MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2014">
 <bp:evidence rdf:resource="#Evidence2294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX58 is K63 polyubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence406">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction372" />
 <bp:stepProcess rdf:resource="#Catalysis98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep400">
 <bp:stepProcess rdf:resource="#Pathway36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction370" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence429">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence421">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction383" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence422">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction384" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence426">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence428">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction375" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction376" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction378" />
 <bp:stepProcess rdf:resource="#Catalysis99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction381" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence410">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction392" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence411">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction393" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence415">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence417">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep421">
 <bp:stepProcess rdf:resource="#Pathway37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction386" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction387" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction389" />
 <bp:stepProcess rdf:resource="#Catalysis100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction390" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction391" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1055" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1054" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2487">
 <bp:stepProcess rdf:resource="#Catalysis735" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1156">
 <bp:stepProcess rdf:resource="#Catalysis278" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1057" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2188" />
 <bp:stepProcess rdf:resource="#Catalysis734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1056" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1059" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1157">
 <bp:stepProcess rdf:resource="#Catalysis279" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1058" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1159">
 <bp:stepProcess rdf:resource="#Pathway101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2489">
 <bp:stepProcess rdf:resource="#Catalysis736" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2193" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence444">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2194" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence447">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1061" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2197" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence448">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1060" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2494">
 <bp:stepProcess rdf:resource="#Pathway298" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence449">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1163">
 <bp:stepProcess rdf:resource="#Catalysis280" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1063" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1062" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2492">
 <bp:stepProcess rdf:resource="#Catalysis737" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2196" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence440">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence442">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1065" />
 <bp:stepProcess rdf:resource="#Catalysis281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1064" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1067" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2495">
 <bp:stepProcess rdf:resource="#Pathway299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1066" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2198" />
 <bp:stepProcess rdf:resource="#Catalysis738" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1169">
 <bp:stepProcess rdf:resource="#Catalysis283" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1168">
 <bp:stepProcess rdf:resource="#Catalysis282" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1068" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2201" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence434">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1170">
 <bp:stepProcess rdf:resource="#Pathway102" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence436">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1172">
 <bp:stepProcess rdf:resource="#Catalysis284" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1071" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence437">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1070" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence438">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1073" />
 <bp:stepProcess rdf:resource="#Catalysis285" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence439">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1072" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence431">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1074" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1175">
 <bp:stepProcess rdf:resource="#Pathway103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1076" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1075" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1077" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence467">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1181">
 <bp:stepProcess rdf:resource="#Catalysis286" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1079" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence468">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1078" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence469">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1183">
 <bp:stepProcess rdf:resource="#Catalysis287" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1080" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1182">
 <bp:stepProcess rdf:resource="#Pathway104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1082" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1081" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence464">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1084" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1083" />
 <bp:stepProcess rdf:resource="#Catalysis288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1086" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1085" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence454">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1087" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence456">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1089" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence457">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1088" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence458">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1091" />
 <bp:stepProcess rdf:resource="#Catalysis289" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence459">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1090" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1093" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1092" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence453">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1027" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1117">
 <bp:stepProcess rdf:resource="#Catalysis265" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1026" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1028" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep473">
 <bp:stepProcess rdf:resource="#Catalysis111" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction437" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1020" />
 <bp:stepProcess rdf:resource="#Catalysis262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2152" />
 <bp:stepProcess rdf:resource="#Catalysis721" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1021" />
 <bp:stepProcess rdf:resource="#Catalysis263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2440">
 <bp:stepProcess rdf:resource="#Catalysis719" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2149" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1111">
 <bp:stepProcess rdf:resource="#Pathway92" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2150" />
 <bp:stepProcess rdf:resource="#Catalysis720" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1023" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1022" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1116">
 <bp:stepProcess rdf:resource="#Catalysis264" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1025" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2444">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2153" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1024" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2445">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2154" />
 <bp:stepProcess rdf:resource="#Catalysis722" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence489">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2450">
 <bp:stepProcess rdf:resource="#Pathway293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep475">
 <bp:stepProcess rdf:resource="#Catalysis112" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction439" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence480">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction440" />
 <bp:stepProcess rdf:resource="#Catalysis113" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence481">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction441" />
 <bp:stepProcess rdf:resource="#Catalysis114" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence482">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction442" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence486">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1036" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1035" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction443" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2167" />
 <bp:stepProcess rdf:resource="#Catalysis728" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction444" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction445" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep483">
 <bp:stepProcess rdf:resource="#BiochemicalReaction446" />
 <bp:stepProcess rdf:resource="#Catalysis115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction447" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction448" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1029" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2453">
 <bp:stepProcess rdf:resource="#Catalysis725" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1120">
 <bp:stepProcess rdf:resource="#Pathway93" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2454">
 <bp:stepProcess rdf:resource="#Catalysis726" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1031" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2159" />
 <bp:stepProcess rdf:resource="#Catalysis723" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1030" />
 <bp:stepProcess rdf:resource="#Catalysis266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2452">
 <bp:stepProcess rdf:resource="#Catalysis724" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1033" />
 <bp:stepProcess rdf:resource="#Catalysis267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2457">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1032" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2166" />
 <bp:stepProcess rdf:resource="#Catalysis727" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1034" />
 <bp:stepProcess rdf:resource="#Catalysis268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2163" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1126">
 <bp:stepProcess rdf:resource="#Pathway94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2164" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence479">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2461">
 <bp:stepProcess rdf:resource="#Catalysis729" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1037" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep486">
 <bp:stepProcess rdf:resource="#Catalysis116" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction450" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence470">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction451" />
 <bp:stepProcess rdf:resource="#Catalysis117" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence471">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction452" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence475">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction453" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1044" />
 <bp:stepProcess rdf:resource="#Catalysis270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction454" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction455" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction456" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction457" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep495">
 <bp:stepProcess rdf:resource="#BiochemicalReaction458" />
 <bp:stepProcess rdf:resource="#Catalysis118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1132">
 <bp:stepProcess rdf:resource="#Pathway95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2464">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2171" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway309">
 <bp:pathwayOrder rdf:resource="#PathwayStep2592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2585" />
 <bp:pathwayComponent rdf:resource="#Pathway310" />
 <bp:pathwayComponent rdf:resource="#Pathway311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2283" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1(DAI) mediated induction of type I IFNs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Z-DNA-binding protein-1 (ZBP1), also known as, DNA-dependent activator of IFN-regulatory factors (DAI) was reported to initiate innate immune responses in murine L929 cells upon stimulation by multiple types of exogenously added DNA (Takaoka A et al 2007). Human cytomegalovirus (HCMV) was shown to stimulate ZBP1-mediated induction of IRF3 in human foreskin (DeFilippis VR et al 2010). ZBP1 was also implicated in activation of NF-kappaB pathways in human embryonic kidney HEK293T cells (Kaiser WJ et al 2008, Rebsamen M et al 2009). However, the role and importance ofZBP1 as dsDNA sensor remain controversial, since knocking down ZBP1 expression in other human or murine cell types by siRNA had very little effect on cellular responses to cytosolic DNA, suggesting the presence of alternative pathway (Wang ZC et al 2008, Lippmann J et al 2008). Tissue-specific expression of human ZBP1 also suggests that ZBP1 may function in cell-type specific way (Rothenburg S et al 2002). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1038" />
 <bp:stepProcess rdf:resource="#Catalysis269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1040" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2170" />
 <bp:stepProcess rdf:resource="#Catalysis730" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway307">
 <bp:pathwayOrder rdf:resource="#PathwayStep2569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2260" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT6-mediated induction of chemokines</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal transducer and activator of transcription 6 (STAT6) may function as a signaling molecule and as a transcription factor. The canonical activation of STAT6 in IL4 and IL13 signaling pathways is mediated by the tyrosine kinases JAK (Hebenstreit D et al. 2006). Virus-induced STAT6 activation was found to be cytokine- and JAK-independent (Chen H et al. 2011). Infection of human cells with RNA or DNA viruses resulted in an interaction of STAT6 with STING. The kinase TBK1 was shown to phosphorylate STAT6, which in turn induced STAT6 dimerization and translocation to the nucleus, leading to induction of chemokines CCL2, CCL20, and CCL26 in IFN-independent manner (Chen H et al. 2011). RNA virus infection triggers STAT6 activation through STING, TBK1 and adaptor protein MAVS interaction (Chen H et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1039" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2463">
 <bp:stepProcess rdf:resource="#Pathway294" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway308">
 <bp:pathwayOrder rdf:resource="#PathwayStep2575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2268" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3-mediated induction of type I IFN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) are central regulators of type-I interferon induction during bacterial or viral infection. TBK1 was found to form complexes with distinct scaffolding proteins that appeared to target TBK1 to different subcellular compartments [Hemmi H et al 2004; Oganesyan G et al 2006; Chariot A et al 2002; Huang J et al 2005]. STING interacted with both TBK1 and IRF3. Once STING is stimulated, its C-terminus served as a signaling scaffold to recruit IRF3 anhd TBK1, which led to TBK1-dependent phosphorylation of IRF3. Phosphorylation of IRF3 promoted its dimerization and translocation to the nucleus, where it triggered the transcription of interferon stimulated genes (ISGs) (Tanaka Y and Chen ZJ 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1041" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2468">
 <bp:stepProcess rdf:resource="#Pathway295" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway305">
 <bp:pathwayOrder rdf:resource="#PathwayStep2558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2256" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) can bind exogenous double-stranded RNA and double-stranded DNA (Wilson SA et al. 1998; Yang P et al. 2010). LRRFIP1 was shown to mediate Listeria monocytogenes- and vesicular stomatitis virus (VSV)-induced IFN-beta production in mouse primary macrophages by regulating beta-catenin activity. Beta-catenin possibly functions as a transcriptional cofactor of IRF3 to initiate Ifnb1 transcription (Yang P et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1135">
 <bp:stepProcess rdf:resource="#Pathway96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2469">
 <bp:stepProcess rdf:resource="#Pathway296" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway306">
 <bp:pathwayOrder rdf:resource="#PathwayStep2581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2562" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2273" />
 <bp:pathwayComponent rdf:resource="#Pathway307" />
 <bp:pathwayComponent rdf:resource="#Pathway308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2267" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING mediated induction of host immune responses</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING (stimulator of IFN genes; also known as MITA/ERIS/MPYS/TMEM173) is an endoplasmic reticulum (ER) resident, which is required for effective type I IFN production in response to nucleic acids. Indeed, select pathogen-derived DNA or RNA were shown to activate STING in human and mouse cells (Ishikawa H and Barber GN 2008; Ishikawa H et al. 2009; Sun W et al. 2009; Prantner D et al. 2010). Importantly, in vitro studies have shown that STING is essential for Mycobacterium tuberculosis (Manzanillo PS et al. 2012), Plasmodium falciparum (Sharma S et al. 2011) and human immunodeficiency virus (HIV) induced type I IFN production [Yan N et al 2010]. Mycobacterium tuberculosis, plasmodium falciparum and HIV are three deadliest pathogens, which kill millions of people each year worldwide. STING has been also implicated in type I IFN response which was stimulated by fusion of viral and target-cell membrane in a manner independent of DNA, RNA and viral capsid  [Holm CK et al 2012]. Under steady state conditions, STING is positioned at the translocon complex within the ER membrane. However upon stimulation with intracellular DNA it translocates from ER to perinuclear vesicles via the Golgi by mechanisms that remain unclear (Ishikawa H and Barber GN 2008; Sun W et al. 2009; Ishikawa H et al. 2009; Saitoh T et al. 2009). Mouse Sting trafficking in dsDNA-stimulated mouse embryonic fibroblasts (MEF) cells was found to depend on autophagy-related gene 9a (Atg9a) (Saitoh T et al. 2009). STING was reported to function as a signaling adaptor or coreceptor in response to cytosolic dsDNA (Unterholzner L et al. 2010; Zhang Z et al. 2011). STING was also shown to function as a direct DNA sensor to induce the innate immune response in human telomerase fibroblasts (hTERT-BJ1) and murine embryonic fibroblasts (MEFs) (Abe T et al. 2013). Additionally, STING is thought to function as a direct sensor of cyclic dinucleotides. STING was shown to interact directly with c-di-GMP in human embryonic kidney HEK293T cell lysates (Burdette DL et al. 2011). Once STING is stimulated, its C-terminus serves as a signaling scaffold to recruit IRF3 and TBK1, which leads to TBK1-dependent phosphorylation of IRF3 (Tanaka Y and Chen ZJ 2012). Mouse, but not human STING, can also bind vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and the antiviral small molecule 10-carboxymethyl-9-acridanone (CMA) to induce type I IFN production, suggesting a species-specific drug effect on the STING-mediated host response (Conlon J et al. 2013; Cavlar T et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1043" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2466">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2173" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway303">
 <bp:pathwayOrder rdf:resource="#PathwayStep2549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2548" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2551" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2245" />
 <bp:pathwayComponent rdf:resource="#Pathway304" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of innate immune responses to cytosolic DNA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate immune responses are coordinated and regulated to provide an efficient first line of defense against pathogens and at the same time to prevent host self-damage. Here we present some regulatory events involved in the detection of cytosolic nucleic acids.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1042" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2174" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway304">
 <bp:pathwayOrder rdf:resource="#PathwayStep2552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation by TREX1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Three prime repair exonuclease 1 (TREX1) is a DNase type III enzyme, which targets and digests unpaired nucleotides on ssDNA and dsDNA ends through a 3&apos;to 5&apos; exonuclease activity (Perrino FW et al. 1994; de Silva U et al. 2007; Lehtinen DA et al. 2008; Fye JM et al 2011). TREX1 is an endoplasmic reticulum (ER)-associated protein, which is anchored to ER membrane via the C-terminal transmembrane domain (Chowdhury D et al. 2006; Richards A et al. 2007; Stetson DB et al. 2009). TREX1 has been implicated in innate immune responses against self (damaged or retrotransposons-derived DNA) and retroviral-derived DNA (Stetson DB et al. 2009; Yan N et al. 2010; Hasan M et al. 2012). TREX1 deficiency in human and mouse cells led to accumulation of cytosolic DNA which resulted in a continual activation of cytosolic DNA-sensors. In addition, cells lacking TREX1 function were less susceptible to infection with different types of RNA viruses (Yan N et al. 2010; Hasan M et al. 2012).Thus, the physiological role of the exonuclease TREX1 is to digest cytosolic host DNA to avoid autoimmunity. Loss-of-function mutations in the gene encoding human TREX1 are associated with several autoimmune diseases (Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus (SLE)) that result in increased levels of interferon and circulating antibodies to DNA (Crow YJ et al. 2006; Rice G et al. 2007; Lee-Kirsch MA et al. 2007). During infection with human immunodeficiency virus (HIV) or other RNA viruses, TREX1 activity may inhibit the innate immune responses by processing viral DNA generated during reverse transcription (Yan N et al. 2010; Hasan M et al. 2012). It&apos;s not yet known whether TREX1 is also involved in regulation of host responses to DNA viruses. Detection of nucleic acids is known to launch signaling cascades leading to induction of type I interferons, which in turn orchestrate an immune response that involves the expression of hundreds of interferon-stimulated genes (ISGs). It is interesting to note that interferon(IFN)-independent activation of a subset of ISGs was detected in mouse and human cells lacking functional TREX1 (Hasan M et al. 2012).  Hasan et al. have also observed that TREX1-deficiency resulted in an increased lysosomal compartment. Trex1 was found to control mTORC1 activity in mouse embryonic fibroblasts (MEF), which in turn negatively regulates translocation of transcription factor EB (TFEB) to the nucleus thereby controlling lysosomal biogenesis (Hasan M et al. 2012; Roczniak-Ferguson A et al. 2012). The authors linked the altered lysosomal compartment to innate immune responses by suggesting that lysosomal biogenesis (regulated by TFEB and mTORC1)  acted upstream of IFN-independent ISG expression (regulated by IRF3 and IRF7) (Hasan M et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway312">
 <bp:pathwayOrder rdf:resource="#PathwayStep2604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2289" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DEx/H-box helicases activate type I IFN and inflammatory cytokines production </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 and DHX9 are aspartate-glutamate-any amino acid aspartate/histidine (DExD/H) box helicase (DHX) proteins that localize in the cytosol. The DHX RNA helicases family includes a large number of proteins that are implicated in RNA metabolism. Members of this family, RIG-1 and MDA5, have been shown to sense a non-self RNA leading to type I IFN production. RNA helicases DHX36 and DHX9 were found to trigger host responses to non-self DNA in MyD88-dependent manner. DHX36 sensed CpG class A, while DHX9 sensed CpG class B. Both DHX36 and DHX9 were critical for antiviral immune responses in viral DNA-stimulated human plasmacytoid dendritic cells (pDC) (Kim T et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway313">
 <bp:pathwayOrder rdf:resource="#PathwayStep2615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2296" />
 <bp:pathwayComponent rdf:resource="#Pathway314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2300" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNAX activation protein of 12kDa (DAP12) is an immunoreceptor tyrosine-based activation motif (ITAM)-bearing adapter molecule that transduces activating signals in natural killer (NK) and myeloid cells. It mediates signalling for multiple cell-surface receptors expressed by these cells, associating with receptor chains through complementary charged transmembrane amino acids that form a salt-bridge in the context of the hydrophobic lipid bilayer (Lanier et al. 1998). DAP12 homodimers associate with a variety of receptors expressed by macrophages, monocytes and myeloid cells including TREM2, Siglec H and SIRP-beta, as well as activating KIR, LY49 and the NKG2C proteins expressed by NK cells. DAP12 is expressed at the cell surface, with most of the protein lying on the cytoplasmic side of the membrane (Turnbull    Colonna 2007, Tessarz    Cerwenka 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway310">
 <bp:pathwayOrder rdf:resource="#PathwayStep2590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2278" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3 mediated activation of type 1 IFN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon regulatory factors (IRF) IRF-3 and IRF-7 are the major modulators of IFN gene expression in response to pathogenic molecules. The relative contribution of IRF3 and IRF7 depends on the signaling pathway that is activated. Type I IFN production in cytosolic DNA-sensing pathway is mediated predominantly by IRF3 and partially by IRF7, since DNA-stimulated IFN-beta and IFN-alpha4 mRNA induction was strongly inhibited in IRF3-deficient mouse embryonic fibroblasts (MEFs), while remained normal (IFN-beta) or reduced (IFN-alpha4) in IRF7-deficient MEFs (Takaoke A et al 2007).  IRF3 activation in response to B-DNA stimulation occurs via its co-recruitment with serine/threonine kinase TANK-binding kinase 1 (TBK1) or inducible IkB kinase (IKKi/IKKepsilon) to the C-terminal region of DAI.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway311">
 <bp:pathwayOrder rdf:resource="#PathwayStep2596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2284" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP-mediated NFkB activation via ZBP1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Overexpression of human or murine ZBP1 (DAI) in human embryonic kidney 293T cells (HEK293T) activated NF-kB-dependent promoter in a dose-dependent manner. Two RHIM-contaning kinases RIP1 and RIP3 are implicated in ZBP1-induced NFkB activation (Rebsamen M et al 2009; Kaiser WJ et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2177" />
 <bp:stepProcess rdf:resource="#Catalysis732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1141">
 <bp:stepProcess rdf:resource="#Pathway98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1140">
 <bp:stepProcess rdf:resource="#Pathway97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2175" />
 <bp:stepProcess rdf:resource="#Catalysis731" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction460" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction462" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1143">
 <bp:stepProcess rdf:resource="#Catalysis272" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1046" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1045" />
 <bp:stepProcess rdf:resource="#Catalysis271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1145">
 <bp:stepProcess rdf:resource="#Catalysis274" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1048" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2473">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1144">
 <bp:stepProcess rdf:resource="#Catalysis273" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1047" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1050" />
 <bp:stepProcess rdf:resource="#Catalysis275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1049" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1052" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1051" />
 <bp:stepProcess rdf:resource="#Catalysis276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2183" />
 <bp:stepProcess rdf:resource="#Catalysis733" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence498">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway301">
 <bp:pathwayOrder rdf:resource="#PathwayStep2536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2234" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A/inflammasome pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antifungal immunity through the induction of T-helper 17 cells (TH17) responses requires the production of mature, active interleukin-1beta (IL1B). CLEC7A (dectin-1) through the SYK route induces activation of NF-kB and transcription of the gene encoding pro-IL1B via the CARD9-BCL10-MALT1 complex as well as the formation and activation of a MALT1-caspase-8-ASC complex that mediated the processing of pro-IL1B. The inactive precursor pro-IL1B has to be processed into mature bioactive form of IL1B and is usually mediated by inflammatory cysteine protease caspase-1. Gringhuis et al. showed that CLEC7A mediated processing of IL1B occurs through two distinct mechanisms: CLEC7A triggering induced a primary noncanonical caspase-8 inflammasome for pro-IL1B processing that was independent of caspase-1 activity, whereas some fungi triggered a second additional mechanism that required activation of the NLRP3/caspase 1 inflammasome. Unlike the canonical caspase-1 inflammasome, CLEC7A mediated noncanonical caspase-8-dependent inflammasome is independent of pathogen internalization. CLEC7A/inflammasome pathway enables the host immune system to mount a protective TH17 response against fungi and bacterial infection (Gringhuis et al. 2012, Cheng et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence499">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway302">
 <bp:pathwayOrder rdf:resource="#PathwayStep2605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2555" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2288" />
 <bp:pathwayComponent rdf:resource="#Pathway312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2294" />
 <bp:pathwayComponent rdf:resource="#Pathway309" />
 <bp:pathwayComponent rdf:resource="#Pathway305" />
 <bp:pathwayComponent rdf:resource="#Pathway306" />
 <bp:pathwayComponent rdf:resource="#Pathway303" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytosolic sensors of pathogen-associated DNA </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Presence of pathogen-associated DNA in cytosol induces type I IFN production. Several intracellular receptors have been implicated to some degree. These include DNA-dependent activator of interferon (IFN)-regulatory factors (DAI) (also called Z-DNA-binding protein 1, ZBP1), absent in melanoma 2 (AIM2), RNA polymerase III (Pol III), IFN-inducible protein IFI16, leucine-rich repeat flightless interacting protein-1 (LRRFIP1), DEAH-box helicases (DHX9 and DHX36), DEAD-box helicase DDX41, meiotic recombination 11 homolog A (MRE11), DNA-dependent protein kinase (DNA-PK), cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Detection of cytosolic DNA requires multiple and possibly redundant sensors leading to activation of the transcription factor NF-kappaB and TBK1-mediated phosphorylation of the transcription factor IRF3. Cytosolic DNA also activates caspase-1-dependent maturation of the pro-inflammatory cytokines interleukin IL-1beta and IL-18. This pathway is mediated by AIM2.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway300">
 <bp:pathwayOrder rdf:resource="#PathwayStep2506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2212" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) induces NFAT activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) signals through the classic calcineurin/NFAT pathway through Syk activation phospholipase C-gamma 2 (PLCG2) leading to increased soluble IP3 (inositol trisphosphate). IP3 is able to bind endoplasmic Ca2+ channels, resulting in an influx of Ca2+ into the cytoplasm. This increase in calcium concentration induces calcineurin activation and consequently, dephosphorylation of NFAT and its translocation into the nucleus, triggering gene transcription and extracellular release of Interleukin-2 (Plato et al. 2013, Goodridge et al. 2007, Mourao-Sa et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1053" />
 <bp:stepProcess rdf:resource="#Catalysis277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2482">
 <bp:stepProcess rdf:resource="#Pathway297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2483">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1152">
 <bp:stepProcess rdf:resource="#Pathway100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1151">
 <bp:stepProcess rdf:resource="#Pathway99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2186" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence490">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence493">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence494">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence495">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence497">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction103">
 <bp:evidence rdf:resource="#Evidence113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of ISGF3 complex to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction102">
 <bp:evidence rdf:resource="#Evidence112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction105">
 <bp:evidence rdf:resource="#Evidence115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFN alpha/beta binds to IFNAR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction104">
 <bp:evidence rdf:resource="#Evidence114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-STAT1:p-STAT1 dimer to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction101">
 <bp:evidence rdf:resource="#Evidence111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IFNAR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction100">
 <bp:evidence rdf:resource="#Evidence110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of IRF9 with p-STAT2:p-STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction107">
 <bp:evidence rdf:resource="#Evidence117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IFN-induced genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction106">
 <bp:evidence rdf:resource="#Evidence116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of p-STAT2:p-STAT1 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction109">
 <bp:evidence rdf:resource="#Evidence119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of p-STAT1 homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction108">
 <bp:evidence rdf:resource="#Evidence118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of STAT2 to p-IFNAR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction114">
 <bp:evidence rdf:resource="#Evidence125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of TYK2 by PTP1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction113">
 <bp:evidence rdf:resource="#Evidence124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of STAT1 by SHP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction116">
 <bp:evidence rdf:resource="#Evidence127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGF3 binds the ISRE promoter elements in IFN-stimulated genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction115">
 <bp:evidence rdf:resource="#Evidence126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UBP43 binds IFNAR2 and prevents JAK1 interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction110">
 <bp:evidence rdf:resource="#Evidence120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT1 dimer binds KPNA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction112">
 <bp:evidence rdf:resource="#Evidence123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibition of JAK kinase activity by SOCS1/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction111">
 <bp:evidence rdf:resource="#Evidence122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of JAK1 by SHP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction118">
 <bp:evidence rdf:resource="#Evidence131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1-mediated phosphorylation of RAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction117">
 <bp:evidence rdf:resource="#Evidence130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JAK1 binds RAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction119">
 <bp:evidence rdf:resource="#Evidence132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1-activated RAF1 phosphorylates MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction130">
 <bp:evidence rdf:resource="#Evidence144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of p-STAT1 dimer by nuclear isoform of TCPTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction125">
 <bp:evidence rdf:resource="#Evidence138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNG dimer binds IFNGR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2291">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction124">
 <bp:evidence rdf:resource="#Evidence137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of STAT1 dimer from active receptor unit</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2290">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction127">
 <bp:evidence rdf:resource="#Evidence140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of STAT1 to p-IFNGR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction126">
 <bp:evidence rdf:resource="#Evidence139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of IFNG-stimulated genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction121">
 <bp:evidence rdf:resource="#Evidence134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 stimulates SMAD7 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2295">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction120">
 <bp:evidence rdf:resource="#Evidence133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNG dimer binds IFNG inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2294">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction123">
 <bp:evidence rdf:resource="#Evidence136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IFNGR1 by JAK kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2293">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction122">
 <bp:evidence rdf:resource="#Evidence135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2-activated MAPKs phosphorylate YBX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2296">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction129">
 <bp:evidence rdf:resource="#Evidence143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS-1 and SOCS-3 binds to p-JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction128">
 <bp:evidence rdf:resource="#Evidence142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIAS1 binds p-STAT1 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction141">
 <bp:evidence rdf:resource="#Evidence156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:CSFR:LYN:JAK1 binds CSFR:LYN:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction140">
 <bp:evidence rdf:resource="#Evidence155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xCSF3R:LYN:JAK1 induces phosphorylation of JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction136">
 <bp:evidence rdf:resource="#Evidence150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNGR1:JAK1:INFGR2:JAK2 binds JAK1,2 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction135">
 <bp:evidence rdf:resource="#Evidence149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of STAT1 dimer to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction138">
 <bp:evidence rdf:resource="#Evidence152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transphosphorylation of JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction137">
 <bp:evidence rdf:resource="#Evidence151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction132">
 <bp:evidence rdf:resource="#Evidence146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAF binds the GAS promoter elements in the IFNG-regulated genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction131">
 <bp:evidence rdf:resource="#Evidence145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of JAKs by PTPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction134">
 <bp:evidence rdf:resource="#Evidence148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated YBX1 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction133">
 <bp:evidence rdf:resource="#Evidence147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STAT1 by JAK kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction139">
 <bp:evidence rdf:resource="#Evidence153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STAT1 at Ser727</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction176" />
 <bp:stepProcess rdf:resource="#Catalysis63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep194">
 <bp:stepProcess rdf:resource="#Catalysis64" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep197">
 <bp:stepProcess rdf:resource="#Catalysis65" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction183" />
 <bp:stepProcess rdf:resource="#Catalysis66" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction150">
 <bp:evidence rdf:resource="#Evidence166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimer binds SOCS1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction152">
 <bp:evidence rdf:resource="#Evidence168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-TYK2 binds and phosphorylates SHC1, GRB2, GAB2, and PTPN11 (SHP2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction151">
 <bp:evidence rdf:resource="#Evidence167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimer translocates from the cytosol to the nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction175" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction147">
 <bp:evidence rdf:resource="#Evidence163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS1,3:p-4Y-CSF3R:CSF3 dimer:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2 is endocytosed</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction146">
 <bp:evidence rdf:resource="#Evidence162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimer binds SOCS3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction149">
 <bp:evidence rdf:resource="#Evidence165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS1,3:p-4Y-CSF3R:CSF3 dimer:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2 binds CUL5, ELOB, ELOC, RNF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction148">
 <bp:evidence rdf:resource="#Evidence164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimer enhances expression of SOCS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction143">
 <bp:evidence rdf:resource="#Evidence159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS1,3 ubiquitinates CSF3R in SOCS1,3:p-4Y-CSF3R:CSF3 dimer:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2:CUL5:ELOB:ELOC:RNF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2273">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction142">
 <bp:evidence rdf:resource="#Evidence158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS1,3 binds p-4Y-CSF3R:CSF3 dimer:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2272">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction145">
 <bp:evidence rdf:resource="#Evidence161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xK48polyUb-K655,p-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-Y-SYK:p-HCK:p-TYK2 translocates from the endocytic vesicle membrane to the lysosomal membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2271">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction144">
 <bp:evidence rdf:resource="#Evidence160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimer enhances expression of SOCS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2278">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction161">
 <bp:evidence rdf:resource="#Evidence178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction160">
 <bp:evidence rdf:resource="#Evidence176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT1,3,5 dimerize</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction163">
 <bp:evidence rdf:resource="#Evidence180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone receptor binds JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction162">
 <bp:evidence rdf:resource="#Evidence179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GHR internalization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction158">
 <bp:evidence rdf:resource="#Evidence174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-JAK1,2 phosphorylates STAT1,3,5 in CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-Y-JAK2:p-TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2280">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction157">
 <bp:evidence rdf:resource="#Evidence173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1 binds and activates JAK2, TYK2, SYK, and HCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction159">
 <bp:evidence rdf:resource="#Evidence175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer (GCSF dimer) binds CSF3R:JAK1:LYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction154">
 <bp:evidence rdf:resource="#Evidence170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2:p-Y-STAT1,3,5 dissociates yielding CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2 and p-Y-STAT1,3,5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2284">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction153">
 <bp:evidence rdf:resource="#Evidence169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-JAK1 phosphorylates CSF3R in CSF3 dimer:2xCSF3R:LYN:p-Y-JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2283">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction156">
 <bp:evidence rdf:resource="#Evidence172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y546,Y584-PTPN11 (in CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2:SHC:GRB2:PTPN11) dephosphorylates KRAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2282">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction155">
 <bp:evidence rdf:resource="#Evidence171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF3 dimer:2xp-4Y-CSF3R:LYN:p-Y-JAK1:p-JAK2:p-SYK:p-HCK:p-TYK2 binds STAT1,3,5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2289">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction172">
 <bp:evidence rdf:resource="#Evidence189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 tyrosine phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction171">
 <bp:evidence rdf:resource="#Evidence188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lyn activates ERK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction174">
 <bp:evidence rdf:resource="#Evidence191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone forms dimers and oligomers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction173">
 <bp:evidence rdf:resource="#Evidence190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GHBP binds GH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction170">
 <bp:evidence rdf:resource="#Evidence187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone receptor binds Lyn</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction169">
 <bp:evidence rdf:resource="#Evidence186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylation of GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction168">
 <bp:evidence rdf:resource="#Evidence185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metalloprotease cleavage of GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction165">
 <bp:evidence rdf:resource="#Evidence182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2251">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction164">
 <bp:evidence rdf:resource="#Evidence181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 binds STAT1/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2250">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction167">
 <bp:evidence rdf:resource="#Evidence184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 association with GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction166">
 <bp:evidence rdf:resource="#Evidence183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP1 (PTPN6) binds JAK2 in the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2256">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction183">
 <bp:evidence rdf:resource="#Evidence200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylation of IRS-1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction182">
 <bp:evidence rdf:resource="#Evidence199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GHBP binds GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction185">
 <bp:evidence rdf:resource="#Evidence202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone receptor dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction184">
 <bp:evidence rdf:resource="#Evidence201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS binding to GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction181">
 <bp:evidence rdf:resource="#Evidence198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP1 (PTPN6) dephosphorylates JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction180">
 <bp:evidence rdf:resource="#Evidence197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Growth hormone binds the growth hormone receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction179">
 <bp:evidence rdf:resource="#Evidence196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5A/B dissociates from the Growth Hormone receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction176">
 <bp:evidence rdf:resource="#Evidence193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTP1B dephosphorylates JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2262">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction175">
 <bp:evidence rdf:resource="#Evidence192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2261">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction178">
 <bp:evidence rdf:resource="#Evidence195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylates STAT1/STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2260">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction177">
 <bp:evidence rdf:resource="#Evidence194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTP1B binds the GH receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2267">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1099">
 <bp:evidence rdf:resource="#Evidence1206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UNC93B1 delivers endosomal full-length TLRs to endolysosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1098">
 <bp:evidence rdf:resource="#Evidence1205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Folded full-length TLR7/8/9 dissociates from the GP96:CNPY3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1097">
 <bp:evidence rdf:resource="#Evidence1204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR9 processing at neutral pH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1096">
 <bp:evidence rdf:resource="#Evidence1203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endosomal TLRs pass through the Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1095">
 <bp:evidence rdf:resource="#Evidence1199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Erp57 with MHC class I HC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1094">
 <bp:evidence rdf:resource="#Evidence1198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Loading of antigenic peptides on to class I MHC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1093">
 <bp:evidence rdf:resource="#Evidence1197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of beta-2-microglobulin (B2M) chain with  class I HC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1092">
 <bp:evidence rdf:resource="#Evidence1196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of newly synthesized MHC class I heavy chain (HC) with calnexin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1091">
 <bp:evidence rdf:resource="#Evidence1195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of Antigen peptide in to ER</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1090">
 <bp:evidence rdf:resource="#Evidence1194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Coat Assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1503">
 <bp:stepProcess rdf:resource="#Catalysis412" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1344" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1502">
 <bp:stepProcess rdf:resource="#Catalysis411" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1346" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1345" />
 <bp:stepProcess rdf:resource="#Catalysis413" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1507">
 <bp:stepProcess rdf:resource="#Pathway162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1506">
 <bp:stepProcess rdf:resource="#Pathway161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1348" />
 <bp:stepProcess rdf:resource="#Catalysis414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1347" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1500">
 <bp:stepProcess rdf:resource="#Pathway160" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1056">
 <bp:evidence rdf:resource="#Evidence1156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of particulate antigens with dendritic cell receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2387">
 <bp:evidence rdf:resource="#Evidence2706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1055">
 <bp:evidence rdf:resource="#Evidence1155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfment of particulate antigen into phagocytic vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2386">
 <bp:evidence rdf:resource="#Evidence2705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1054">
 <bp:evidence rdf:resource="#Evidence1154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Escape of antigens from phagosome to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2385">
 <bp:evidence rdf:resource="#Evidence2704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1053">
 <bp:evidence rdf:resource="#Evidence1151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasomal cleavage of substrate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2384">
 <bp:evidence rdf:resource="#Evidence2703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1052">
 <bp:evidence rdf:resource="#Evidence1150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of E3 from polyubiquitinated substrate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2383">
 <bp:evidence rdf:resource="#Evidence2702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1051">
 <bp:evidence rdf:resource="#Evidence1149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trimming of N-ter extended precursor fragments by cytosolic aminopeptidases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2382">
 <bp:evidence rdf:resource="#Evidence2701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SHC by SYK kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1050">
 <bp:evidence rdf:resource="#Evidence1148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">THOP1 cleaves oligopeptide fragment (8-16aa)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2381">
 <bp:evidence rdf:resource="#Evidence2700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation and activation of MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2380">
 <bp:evidence rdf:resource="#Evidence2699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1059">
 <bp:evidence rdf:resource="#Evidence1159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Maturation of phagosome into phagolysosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1058">
 <bp:evidence rdf:resource="#Evidence1158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alkalization of the phagosomal lumen by NOX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2389">
 <bp:evidence rdf:resource="#Evidence2708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GADS:SLP-76 to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1057">
 <bp:evidence rdf:resource="#Evidence1157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Partial proteolysis of antigen in phagolysosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2388">
 <bp:evidence rdf:resource="#Evidence2707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of GRB2:SOS complex with p-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1067">
 <bp:evidence rdf:resource="#Evidence1168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fusion of ERC and phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1066">
 <bp:evidence rdf:resource="#Evidence1167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CALR, TAP, TAPBP dissociate from SEC22B:STX4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1065">
 <bp:evidence rdf:resource="#Evidence1166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasomal cleavage of substrate (26S proteasome catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1064">
 <bp:evidence rdf:resource="#Evidence1165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SEC22B, CALR, STX4, TAP and TAPBP bind</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1063">
 <bp:evidence rdf:resource="#Evidence1164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of antigenic peptides back to phagosomes via TAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1062">
 <bp:evidence rdf:resource="#Evidence1163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Export of peptide loaded MHC class I complex to PM</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2393">
 <bp:evidence rdf:resource="#Evidence2712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MEK7 by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1061">
 <bp:evidence rdf:resource="#Evidence1162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peptide loading on MHC class I in phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2392">
 <bp:evidence rdf:resource="#Evidence2711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1060">
 <bp:evidence rdf:resource="#Evidence1161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of SEC22B, TAP and PLC from ER to ERGIC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2391">
 <bp:evidence rdf:resource="#Evidence2710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MEK4 by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2390">
 <bp:evidence rdf:resource="#Evidence2709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS mediated nucleotide exchange of RAS (SHC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1069">
 <bp:evidence rdf:resource="#Evidence1170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKKB phosphorylates SNAP23</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1068">
 <bp:evidence rdf:resource="#Evidence1169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Egress of internalized antigen to the cytosol via sec61</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1078">
 <bp:evidence rdf:resource="#Evidence1181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of exogenous soluble antigen with its corresponding receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1077">
 <bp:evidence rdf:resource="#Evidence1180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Movement of clathrin coated vesicles into early endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1076">
 <bp:evidence rdf:resource="#Evidence1179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Egress of internalized antigen into cytosol from early endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1075">
 <bp:evidence rdf:resource="#Evidence1178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exogenous soluble antigen targeted to more stable early endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1074">
 <bp:evidence rdf:resource="#Evidence1177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Internalization of receptor bound antigen into clathrin coted vesicles</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1073">
 <bp:evidence rdf:resource="#Evidence1175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen processing by cathepsin S in endosoytic vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1072">
 <bp:evidence rdf:resource="#Evidence1174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of peptide bound MHC class I complex to cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1071">
 <bp:evidence rdf:resource="#Evidence1173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trimming of peptides by IRAP in endocytic vesicles</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1070">
 <bp:evidence rdf:resource="#Evidence1172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Loading of antigen peptide onto MHC class I molecule</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1079">
 <bp:evidence rdf:resource="#Evidence1182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasomal clevage of exogenous antigen (26S proteasome catalyst)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1089">
 <bp:evidence rdf:resource="#Evidence1193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of peptide loading complex (PLC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1088">
 <bp:evidence rdf:resource="#Evidence1192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of peptide bound class I MHC on cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1087">
 <bp:evidence rdf:resource="#Evidence1191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of MHC heterotrimer to ER exit site</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1086">
 <bp:evidence rdf:resource="#Evidence1190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Capturing cargo and formation of prebudding complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1085">
 <bp:evidence rdf:resource="#Evidence1189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of Sec31p:Sec13p to prebudding complex and formation of COPII vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1084">
 <bp:evidence rdf:resource="#Evidence1188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Budding of COPII coated vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1083">
 <bp:evidence rdf:resource="#Evidence1187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassembly of COPII coated vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1082">
 <bp:evidence rdf:resource="#Evidence1186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Journey of cargo through Golgi complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1081">
 <bp:evidence rdf:resource="#Evidence1185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the Antigenic peptide:MHC:B2M peptide loading complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1080">
 <bp:evidence rdf:resource="#Evidence1184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trimming of peptides in ER</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1012">
 <bp:evidence rdf:resource="#Evidence1103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 bound PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1437">
 <bp:stepProcess rdf:resource="#Catalysis383" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1290" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2343">
 <bp:evidence rdf:resource="#Evidence2660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-TRCP ubiquitinates IkB-alpha in p-S32,33-IkB-alpha:NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1011">
 <bp:evidence rdf:resource="#Evidence1102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT binds PDPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1436">
 <bp:stepProcess rdf:resource="#Catalysis382" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1289" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2342">
 <bp:evidence rdf:resource="#Evidence2659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NEMO by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1010">
 <bp:evidence rdf:resource="#Evidence1100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gads binds CD28</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1291" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2341">
 <bp:evidence rdf:resource="#Evidence2658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TAK1 kinase complex to oligo-K63-pUb-TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1438">
 <bp:stepProcess rdf:resource="#Pathway149" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2340">
 <bp:evidence rdf:resource="#Evidence2656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to p-FCERI gamma subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1286" />
 <bp:stepProcess rdf:resource="#Catalysis380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1285" />
 <bp:stepProcess rdf:resource="#Catalysis379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1433">
 <bp:stepProcess rdf:resource="#Pathway147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1287" />
 <bp:stepProcess rdf:resource="#Catalysis381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1434">
 <bp:stepProcess rdf:resource="#Pathway148" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1019">
 <bp:evidence rdf:resource="#Evidence1110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits PDPK1 to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1018">
 <bp:evidence rdf:resource="#Evidence1109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates AKT at T308</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2349">
 <bp:evidence rdf:resource="#Evidence2666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IKK-beta by TAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1017">
 <bp:evidence rdf:resource="#Evidence1108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT interacts and phosphorylates Cot</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2348">
 <bp:evidence rdf:resource="#Evidence2665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1016">
 <bp:evidence rdf:resource="#Evidence1107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S400-Cot phosphorylates NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2347">
 <bp:evidence rdf:resource="#Evidence2664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S177,S181-IKKB:IKKA:pUb-NEMO phosphorylates IkB-alpha:NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1015">
 <bp:evidence rdf:resource="#Evidence1106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits AKT to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2346">
 <bp:evidence rdf:resource="#Evidence2663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1014">
 <bp:evidence rdf:resource="#Evidence1105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds CD28</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2345">
 <bp:evidence rdf:resource="#Evidence2662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1013">
 <bp:evidence rdf:resource="#Evidence1104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TORC2 (mTOR) phosphorylates AKT at S473</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2344">
 <bp:evidence rdf:resource="#Evidence2661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CARMA1 by PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1023">
 <bp:evidence rdf:resource="#Evidence1115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Grb2 binds CD28</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1298" />
 <bp:stepProcess rdf:resource="#Catalysis388" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2354">
 <bp:evidence rdf:resource="#Evidence2671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PKC theta to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1022">
 <bp:evidence rdf:resource="#Evidence1114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of Vav1 to CD28</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1297" />
 <bp:stepProcess rdf:resource="#Catalysis387" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2353">
 <bp:evidence rdf:resource="#Evidence2670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of BCL10 and MALT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1021">
 <bp:evidence rdf:resource="#Evidence1113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Vav1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2352">
 <bp:evidence rdf:resource="#Evidence2669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1020">
 <bp:evidence rdf:resource="#Evidence1111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CD28</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1449">
 <bp:stepProcess rdf:resource="#Catalysis389" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1299" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2351">
 <bp:evidence rdf:resource="#Evidence2668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex to form NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2350">
 <bp:evidence rdf:resource="#Evidence2667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF6 to CBM complex by binding to MALT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1292" />
 <bp:stepProcess rdf:resource="#Catalysis384" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1294" />
 <bp:stepProcess rdf:resource="#Catalysis386" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1293" />
 <bp:stepProcess rdf:resource="#Catalysis385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1444">
 <bp:stepProcess rdf:resource="#Pathway150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1445">
 <bp:stepProcess rdf:resource="#Pathway151" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1029">
 <bp:evidence rdf:resource="#Evidence1122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDCD1 binds PDCD1 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1028">
 <bp:evidence rdf:resource="#Evidence1120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 homodimer binds B7-1 homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2359">
 <bp:evidence rdf:resource="#Evidence2676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of p-CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1027">
 <bp:evidence rdf:resource="#Evidence1119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD28 homodimer binds B7-2 monomer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2358">
 <bp:evidence rdf:resource="#Evidence2675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1026">
 <bp:evidence rdf:resource="#Evidence1118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rac1 by pVav1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2357">
 <bp:evidence rdf:resource="#Evidence2674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RasGRP interacts with DAG and Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1025">
 <bp:evidence rdf:resource="#Evidence1117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Cdc42 by pVav1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2356">
 <bp:evidence rdf:resource="#Evidence2673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TAK1 complex bound to pUb-TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1024">
 <bp:evidence rdf:resource="#Evidence1116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of PAKs by RAC1 and CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2355">
 <bp:evidence rdf:resource="#Evidence2672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of BCL10:MALT1 with CARMA1 to form CBM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1034">
 <bp:evidence rdf:resource="#Evidence1128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CTLA-4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1459">
 <bp:stepProcess rdf:resource="#Catalysis395" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1306" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2365">
 <bp:evidence rdf:resource="#Evidence2683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds and dephosphorylates NFAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1033">
 <bp:evidence rdf:resource="#Evidence1126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PD-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1458">
 <bp:stepProcess rdf:resource="#Pathway154" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2364">
 <bp:evidence rdf:resource="#Evidence2682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of CaN:CaM:NFAT to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1032">
 <bp:evidence rdf:resource="#Evidence1125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PD-1 binds B7DC and B7H1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2363">
 <bp:evidence rdf:resource="#Evidence2681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TEC kinases to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1031">
 <bp:evidence rdf:resource="#Evidence1124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SHP-1 or SHP-2 with phospho PD-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2362">
 <bp:evidence rdf:resource="#Evidence2679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1030">
 <bp:evidence rdf:resource="#Evidence1123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of CD3-zeta by PD-1 bound phosphatases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2361">
 <bp:evidence rdf:resource="#Evidence2678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IgE binds omalizumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2360">
 <bp:evidence rdf:resource="#Evidence2677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of LYN kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence506">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1451">
 <bp:stepProcess rdf:resource="#Pathway152" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence507">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1300" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence508">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1453">
 <bp:stepProcess rdf:resource="#Catalysis391" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1302" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence509">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1452">
 <bp:stepProcess rdf:resource="#Catalysis390" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1455">
 <bp:stepProcess rdf:resource="#Catalysis393" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1454">
 <bp:stepProcess rdf:resource="#Catalysis392" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1457">
 <bp:stepProcess rdf:resource="#Catalysis394" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1456">
 <bp:stepProcess rdf:resource="#Pathway153" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence500">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence504">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1307" />
 <bp:stepProcess rdf:resource="#Catalysis396" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence505">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1039">
 <bp:evidence rdf:resource="#Evidence1134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds ICOS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1038">
 <bp:evidence rdf:resource="#Evidence1132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of AKT by PP2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2369">
 <bp:evidence rdf:resource="#Evidence2687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1037">
 <bp:evidence rdf:resource="#Evidence1131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTLA-4 binds B7-1/B7-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2368">
 <bp:evidence rdf:resource="#Evidence2686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of BTK/ITK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1036">
 <bp:evidence rdf:resource="#Evidence1130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A binds CTLA4 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2367">
 <bp:evidence rdf:resource="#Evidence2685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of PIP2 by PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1035">
 <bp:evidence rdf:resource="#Evidence1129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 phosphatase binds CTLA-4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2366">
 <bp:evidence rdf:resource="#Evidence2684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TEC kinases by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1045">
 <bp:evidence rdf:resource="#Evidence1143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of ubiquitin from E1 to E2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2376">
 <bp:evidence rdf:resource="#Evidence2695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1044">
 <bp:evidence rdf:resource="#Evidence1140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HVEM induses BTLA phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1315" />
 <bp:stepProcess rdf:resource="#Catalysis403" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2375">
 <bp:evidence rdf:resource="#Evidence2694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1043">
 <bp:evidence rdf:resource="#Evidence1139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP-1 and SHP-2 bind pBTLA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2374">
 <bp:evidence rdf:resource="#Evidence2693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PAK to the membrane by binding active RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1042">
 <bp:evidence rdf:resource="#Evidence1138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTLA interacts with HVEM</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2373">
 <bp:evidence rdf:resource="#Evidence2691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLC-gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1041">
 <bp:evidence rdf:resource="#Evidence1137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Grb2 binds pBTLA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2372">
 <bp:evidence rdf:resource="#Evidence2690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1040">
 <bp:evidence rdf:resource="#Evidence1135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ICOS binds ICOSL/B7-H2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2371">
 <bp:evidence rdf:resource="#Evidence2689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2370">
 <bp:evidence rdf:resource="#Evidence2688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Calcineurin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep100">
 <bp:stepProcess rdf:resource="#Pathway10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1309" />
 <bp:stepProcess rdf:resource="#Catalysis398" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1308" />
 <bp:stepProcess rdf:resource="#Catalysis397" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1464">
 <bp:stepProcess rdf:resource="#Catalysis400" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1463">
 <bp:stepProcess rdf:resource="#Catalysis399" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1466">
 <bp:stepProcess rdf:resource="#Pathway155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1465">
 <bp:stepProcess rdf:resource="#Catalysis401" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1468">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1314" />
 <bp:stepProcess rdf:resource="#Catalysis402" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep109">
 <bp:stepProcess rdf:resource="#BiochemicalReaction100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1316" />
 <bp:stepProcess rdf:resource="#Catalysis404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction92" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction93" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction96" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1049">
 <bp:evidence rdf:resource="#Evidence1147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of E3 with substrate and E2-Ub complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep106">
 <bp:stepProcess rdf:resource="#Catalysis37" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction97" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1048">
 <bp:evidence rdf:resource="#Evidence1146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of Ub from E2 to substrate and release of E2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2379">
 <bp:evidence rdf:resource="#Evidence2698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction98" />
 <bp:stepProcess rdf:resource="#Catalysis38" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1047">
 <bp:evidence rdf:resource="#Evidence1145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitination of substrate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2378">
 <bp:evidence rdf:resource="#Evidence2697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SLP-76 by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep108">
 <bp:stepProcess rdf:resource="#Catalysis39" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction99" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1046">
 <bp:evidence rdf:resource="#Evidence1144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E1 mediated ubiquitin activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2377">
 <bp:evidence rdf:resource="#Evidence2696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence526">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2309">
 <bp:evidence rdf:resource="#Evidence2623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLC-gamma by p-BTK/p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence527">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2308">
 <bp:evidence rdf:resource="#Evidence2622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of VAV2/VAV3 by SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2307">
 <bp:evidence rdf:resource="#Evidence2621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of p-PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2306">
 <bp:evidence rdf:resource="#Evidence2620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of BTK by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2305">
 <bp:evidence rdf:resource="#Evidence2618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2304">
 <bp:evidence rdf:resource="#Evidence2617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and NKG2D</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2303">
 <bp:evidence rdf:resource="#Evidence2616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and TREM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2302">
 <bp:evidence rdf:resource="#Evidence2615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2301">
 <bp:evidence rdf:resource="#Evidence2614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR3DS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2300">
 <bp:evidence rdf:resource="#Evidence2613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SIGLEC14/15/16 and DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1261" />
 <bp:stepProcess rdf:resource="#Catalysis369" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2310">
 <bp:evidence rdf:resource="#Evidence2624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1260" />
 <bp:stepProcess rdf:resource="#Catalysis368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1405">
 <bp:stepProcess rdf:resource="#Pathway145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1408">
 <bp:stepProcess rdf:resource="#Pathway146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1264" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence519">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1400">
 <bp:stepProcess rdf:resource="#Pathway144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1258" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence516">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2319">
 <bp:evidence rdf:resource="#Evidence2633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2318">
 <bp:evidence rdf:resource="#Evidence2632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SLP-76 by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2317">
 <bp:evidence rdf:resource="#Evidence2631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GADS:SLP-76 to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2316">
 <bp:evidence rdf:resource="#Evidence2630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2315">
 <bp:evidence rdf:resource="#Evidence2629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to p-DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2314">
 <bp:evidence rdf:resource="#Evidence2628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2313">
 <bp:evidence rdf:resource="#Evidence2627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2312">
 <bp:evidence rdf:resource="#Evidence2626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p85 regulatory unit of PI3K binds p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2311">
 <bp:evidence rdf:resource="#Evidence2625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV and BTK to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1415">
 <bp:stepProcess rdf:resource="#Catalysis372" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1270" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2321">
 <bp:evidence rdf:resource="#Evidence2635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1269" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2320">
 <bp:evidence rdf:resource="#Evidence2634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS mediated nucleotide exchange of RAS (SHC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1265" />
 <bp:stepProcess rdf:resource="#Catalysis370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1413">
 <bp:stepProcess rdf:resource="#Catalysis371" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1267" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence549">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2329">
 <bp:evidence rdf:resource="#Evidence2645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PIP2 to PIP3 by PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2328">
 <bp:evidence rdf:resource="#Evidence2642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRP beta binds TYROBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2327">
 <bp:evidence rdf:resource="#Evidence2641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and NKp44</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2326">
 <bp:evidence rdf:resource="#Evidence2640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and CLM7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2325">
 <bp:evidence rdf:resource="#Evidence2639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2324">
 <bp:evidence rdf:resource="#Evidence2638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence540">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2323">
 <bp:evidence rdf:resource="#Evidence2637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and IREM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence541">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2322">
 <bp:evidence rdf:resource="#Evidence2636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LAT by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1001">
 <bp:evidence rdf:resource="#Evidence1088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of MHC II:Ii complex along Golgi to TGN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1281" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2332">
 <bp:evidence rdf:resource="#Evidence2648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GAB2 to PM and FCERI by binding to GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1000">
 <bp:evidence rdf:resource="#Evidence1087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MHC class II antigen processing</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1280" />
 <bp:stepProcess rdf:resource="#Catalysis376" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2331">
 <bp:evidence rdf:resource="#Evidence2647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-10Y-NTAL</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1283" />
 <bp:stepProcess rdf:resource="#Catalysis377" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2330">
 <bp:evidence rdf:resource="#Evidence2646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of NTAL by p-SYK/Lyn</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1284" />
 <bp:stepProcess rdf:resource="#Catalysis378" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence539">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1275" />
 <bp:stepProcess rdf:resource="#Catalysis373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1422">
 <bp:stepProcess rdf:resource="#Catalysis374" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1423">
 <bp:stepProcess rdf:resource="#Catalysis375" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1278" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence538">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1009">
 <bp:evidence rdf:resource="#Evidence1097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTN1A1 binds xanthine oxidoreductase (XDH)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1008">
 <bp:evidence rdf:resource="#Evidence1096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTN2A2 binds T cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2339">
 <bp:evidence rdf:resource="#Evidence2655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of beta and gamma subunits by LYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1007">
 <bp:evidence rdf:resource="#Evidence1095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTN3A1 and BTN1A1 binds periplakin (PPL)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2338">
 <bp:evidence rdf:resource="#Evidence2654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Allergen dependent IgE bound FCERI aggregation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1006">
 <bp:evidence rdf:resource="#Evidence1094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTN3A1 binds prenylated phosphoantigens</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2337">
 <bp:evidence rdf:resource="#Evidence2653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LAT by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1005">
 <bp:evidence rdf:resource="#Evidence1093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTNL8 binds resting T cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2336">
 <bp:evidence rdf:resource="#Evidence2652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IgE binds FCERI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1004">
 <bp:evidence rdf:resource="#Evidence1092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTNL9 binds immune cell surfaces</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2335">
 <bp:evidence rdf:resource="#Evidence2651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K associates with phosphorylated GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1003">
 <bp:evidence rdf:resource="#Evidence1091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTN2A1 binds DC-SIGN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2334">
 <bp:evidence rdf:resource="#Evidence2650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of GAB2 by SYK/FYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence530">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1002">
 <bp:evidence rdf:resource="#Evidence1090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTNL2 binds activated T cells surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2333">
 <bp:evidence rdf:resource="#Evidence2649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PDK1 to Plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction137" />
 <bp:stepProcess rdf:resource="#Catalysis52" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2239">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction138" />
 <bp:stepProcess rdf:resource="#Catalysis53" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2238">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep152">
 <bp:stepProcess rdf:resource="#Catalysis54" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep153">
 <bp:stepProcess rdf:resource="#Pathway15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction141" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence569">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep156">
 <bp:stepProcess rdf:resource="#Pathway16" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2233">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction142" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2232">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction143" />
 <bp:stepProcess rdf:resource="#Catalysis55" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2231">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep159">
 <bp:stepProcess rdf:resource="#BiochemicalReaction144" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2234">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction147" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2249">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction149" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction151" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence559">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction152" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2244">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction153" />
 <bp:stepProcess rdf:resource="#Catalysis56" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2243">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction154" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2245">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction155" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2219">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction156" />
 <bp:stepProcess rdf:resource="#Catalysis57" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2218">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep172">
 <bp:stepProcess rdf:resource="#BiochemicalReaction157" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2217">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction158" />
 <bp:stepProcess rdf:resource="#Catalysis58" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2216">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep176">
 <bp:stepProcess rdf:resource="#Pathway17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction161" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence586">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence588">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence589">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction162" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2211">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction163" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence580">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence581">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence582">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence583">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence584">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence585">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2212">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction166" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2229">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2228">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction168" />
 <bp:stepProcess rdf:resource="#Catalysis59" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2227">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction169" />
 <bp:stepProcess rdf:resource="#Catalysis60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction170" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep187">
 <bp:stepProcess rdf:resource="#Catalysis61" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep188">
 <bp:stepProcess rdf:resource="#Catalysis62" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction164" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence579">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction173" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2221">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2220">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence570">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence571">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2223">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction102" />
 <bp:stepProcess rdf:resource="#Catalysis40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1473">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1319" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1472">
 <bp:stepProcess rdf:resource="#Catalysis405" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1318" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep118">
 <bp:stepProcess rdf:resource="#Catalysis41" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction110" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2205">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep120">
 <bp:stepProcess rdf:resource="#Pathway11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep121">
 <bp:stepProcess rdf:resource="#Catalysis42" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction112" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2209">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1483">
 <bp:stepProcess rdf:resource="#Pathway156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1331" />
 <bp:stepProcess rdf:resource="#Catalysis406" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1330" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1488">
 <bp:stepProcess rdf:resource="#Catalysis408" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1487">
 <bp:stepProcess rdf:resource="#Catalysis407" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1334" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence597">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence598">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence599">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction113" />
 <bp:stepProcess rdf:resource="#Catalysis43" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2200">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction114" />
 <bp:stepProcess rdf:resource="#Catalysis44" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence590">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction115" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence591">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction116" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence592">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep127">
 <bp:stepProcess rdf:resource="#Pathway12" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence593">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2204">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep128">
 <bp:stepProcess rdf:resource="#Pathway13" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence594">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2203">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction117" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence595">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence596">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2201">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep130">
 <bp:stepProcess rdf:resource="#Catalysis45" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep131">
 <bp:stepProcess rdf:resource="#Catalysis46" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep132">
 <bp:stepProcess rdf:resource="#BiochemicalReaction120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1495">
 <bp:stepProcess rdf:resource="#Pathway158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1494">
 <bp:stepProcess rdf:resource="#Pathway157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1339" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1496">
 <bp:stepProcess rdf:resource="#Pathway159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1341" />
 <bp:stepProcess rdf:resource="#Catalysis410" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1340" />
 <bp:stepProcess rdf:resource="#Catalysis409" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction122" />
 <bp:stepProcess rdf:resource="#Catalysis47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction123" />
 <bp:stepProcess rdf:resource="#Catalysis48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep140">
 <bp:stepProcess rdf:resource="#Pathway14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction130" />
 <bp:stepProcess rdf:resource="#Catalysis49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction131" />
 <bp:stepProcess rdf:resource="#Catalysis50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep146">
 <bp:stepProcess rdf:resource="#Catalysis51" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction136" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction224">
 <bp:evidence rdf:resource="#Evidence245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:GRB2:p-Y-GAB2 binds PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2192">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction223">
 <bp:evidence rdf:resource="#Evidence244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT-phosphorylated FOXO3 translocates to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2191">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction226">
 <bp:evidence rdf:resource="#Evidence247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates FOXO3 downstream of FLT3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2190">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction225">
 <bp:evidence rdf:resource="#Evidence246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 phosphorylates CDKN1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction220">
 <bp:evidence rdf:resource="#Evidence241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3-dependent BCL2L11 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2195">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction222">
 <bp:evidence rdf:resource="#Evidence243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:GRB2:p-GAB2:PIK3R1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2194">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction221">
 <bp:evidence rdf:resource="#Evidence242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3-dependent CDKN1B gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2197">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction228">
 <bp:evidence rdf:resource="#Evidence249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:GRB2 binds GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction227">
 <bp:evidence rdf:resource="#Evidence248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:p-Y-GRB10 binds PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction229">
 <bp:evidence rdf:resource="#Evidence250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction240">
 <bp:evidence rdf:resource="#Evidence263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OX40L binds OX40</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction235">
 <bp:evidence rdf:resource="#Evidence258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFSF18 binds TNFRSF18</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction234">
 <bp:evidence rdf:resource="#Evidence257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDA:EDAR binds EDARADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction237">
 <bp:evidence rdf:resource="#Evidence260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFSF8 binds TNFRSF8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction236">
 <bp:evidence rdf:resource="#Evidence259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFSF11 binds TNFRSF11A, B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction231">
 <bp:evidence rdf:resource="#Evidence252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:p-Y GRB10:PIK3R1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction230">
 <bp:evidence rdf:resource="#Evidence251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 phosphorylates GRB10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction233">
 <bp:evidence rdf:resource="#Evidence256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LTA trimer binds TNFRSF1A,1B,14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction232">
 <bp:evidence rdf:resource="#Evidence254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26Sproteasome degrades K48polyUb-NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction239">
 <bp:evidence rdf:resource="#Evidence262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD70 binds CD27</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction238">
 <bp:evidence rdf:resource="#Evidence261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFRSF6B binds TNFSF6,14,15</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction251">
 <bp:evidence rdf:resource="#Evidence275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK:p-S176,180-IKKA dimer phosphorylates p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction250">
 <bp:evidence rdf:resource="#Evidence274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction246">
 <bp:evidence rdf:resource="#Evidence269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-alpha inhibitors bind to TNF(1-233) trimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2170">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction245">
 <bp:evidence rdf:resource="#Evidence268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDA binds EDAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction248">
 <bp:evidence rdf:resource="#Evidence272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP binds p-7S-p100 in active NIK:p-S176,180-IKKA dimer:p-7S-p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction247">
 <bp:evidence rdf:resource="#Evidence271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK phosphorylates IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction242">
 <bp:evidence rdf:resource="#Evidence265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">sBAFF,sAPRIL binds TACI,BCMA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2174">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction241">
 <bp:evidence rdf:resource="#Evidence264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFSF9 binds TNFRSF9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2173">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction244">
 <bp:evidence rdf:resource="#Evidence267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFSF15 binds TNFRSF25</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2172">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction243">
 <bp:evidence rdf:resource="#Evidence266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDA-3 binds EDA2R</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2175">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction249">
 <bp:evidence rdf:resource="#Evidence273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p100:RELB binds active NIK:p-IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2179">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction260">
 <bp:evidence rdf:resource="#Evidence284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2 ubiquitinates cIAP1,2 in cIAP1,2:TRAF1:TRAF2:TRAF3:NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction262">
 <bp:evidence rdf:resource="#Evidence287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD40L binds CD40</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction261">
 <bp:evidence rdf:resource="#Evidence285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2xTNFR2 binds TNFA trimer:TNFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction257">
 <bp:evidence rdf:resource="#Evidence281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cIAP1,2:TRAF2:TRAF3:NIK complex binds TNFR2 trimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2181">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction256">
 <bp:evidence rdf:resource="#Evidence280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protesomal degradation of K48polyUb-TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2180">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction259">
 <bp:evidence rdf:resource="#Evidence283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3:NIK binds TRAF2:cIAP1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction258">
 <bp:evidence rdf:resource="#Evidence282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-cIAP1,2 ubiquitinates TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction253">
 <bp:evidence rdf:resource="#Evidence277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP ubiquitinates p-7S-p100:RELB in active NIK:p-176,S180-IKKA dimer:p-7S-p100:SCF-beta-TRCP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2185">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction252">
 <bp:evidence rdf:resource="#Evidence276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p52:RELB translocates from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2184">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction255">
 <bp:evidence rdf:resource="#Evidence279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes p-7S-p100:RELB to form p52:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2183">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction254">
 <bp:evidence rdf:resource="#Evidence278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NIK autophosphorylates on T559</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2186">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction271">
 <bp:evidence rdf:resource="#Evidence296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3 binds BAFFR:BAFF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction270">
 <bp:evidence rdf:resource="#Evidence295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LA,TNFSF14 binds LTBR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction273">
 <bp:evidence rdf:resource="#Evidence298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2:cIAP1/2 complex binds FN14:TWEAK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction272">
 <bp:evidence rdf:resource="#Evidence297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">sBAFF trimer binds BAFFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction268">
 <bp:evidence rdf:resource="#Evidence293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAFs bind RANK:RANKL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction267">
 <bp:evidence rdf:resource="#Evidence292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2xRANK binds RANKL,sRANKL trimer:RANK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction269">
 <bp:evidence rdf:resource="#Evidence294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2:TRAF1:cIAP1,2:TRAF3:NIK regulatory complex binds CD40</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction264">
 <bp:evidence rdf:resource="#Evidence289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TWEAK binds FN14</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2152">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction263">
 <bp:evidence rdf:resource="#Evidence288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RANKL,sRANKL trimer binds RANK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2151">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction266">
 <bp:evidence rdf:resource="#Evidence291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2:TRAF1:cIAP1,2:TRAF3:NIK regulatory complex binds LTBR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2150">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction265">
 <bp:evidence rdf:resource="#Evidence290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2xLTBR binds LTBR:lymphotoxin,TNFSF14 trimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2157">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction282">
 <bp:evidence rdf:resource="#Evidence309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 positively regulates extracellular inflammatory mediators</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction281">
 <bp:evidence rdf:resource="#Evidence308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 dimer:2xIL10RA1:JAK1 binds IL10RB:TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction284">
 <bp:evidence rdf:resource="#Evidence311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dissociates from IL10 dimer:2xp-Y-IL10RA:p-Y-JAK1:2xIL10RB:p-Y-TYK2:p-Y705-STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction283">
 <bp:evidence rdf:resource="#Evidence310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 negatively regulates plasma membrane-associated inflammatory mediators</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction280">
 <bp:evidence rdf:resource="#Evidence307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK1,TYK2 phosphorylate JAK1,TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction279">
 <bp:evidence rdf:resource="#Evidence306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction278">
 <bp:evidence rdf:resource="#Evidence305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction275">
 <bp:evidence rdf:resource="#Evidence300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cIAP1,2 ubiquitinates NIK in cIAP1,2:TRAF2::TRAF3:NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2163">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction274">
 <bp:evidence rdf:resource="#Evidence299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFA binds TNFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2162">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction277">
 <bp:evidence rdf:resource="#Evidence304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705-STAT3 dimer translocates from cytosol to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2161">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction276">
 <bp:evidence rdf:resource="#Evidence303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 positively regulates plasma membrane-associated inflammatory mediators</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2139">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction293">
 <bp:evidence rdf:resource="#Evidence322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3 binds STAT3 and STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction292">
 <bp:evidence rdf:resource="#Evidence321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA binds IL2RB:JAK1 and IL2RG:JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction295">
 <bp:evidence rdf:resource="#Evidence324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3:p-Y-SHC1:GRB2 binds SOS1,SOS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction294">
 <bp:evidence rdf:resource="#Evidence323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-STAT3:p-STAT5 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction291">
 <bp:evidence rdf:resource="#Evidence319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HAVCR2 binds LGALS9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction290">
 <bp:evidence rdf:resource="#Evidence317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 is phosphorylated by p-Y-JAK1,P-Y-TYK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis3">
 <bp:controlled rdf:resource="#BiochemicalReaction18" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis4">
 <bp:controlled rdf:resource="#BiochemicalReaction21" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction289">
 <bp:evidence rdf:resource="#Evidence316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-JAK1,p-Y-TYK2 phosphorylate IL10RA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis1">
 <bp:controlled rdf:resource="#BiochemicalReaction8" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis2">
 <bp:controlled rdf:resource="#BiochemicalReaction11" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis7">
 <bp:controlled rdf:resource="#BiochemicalReaction29" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction286">
 <bp:evidence rdf:resource="#Evidence313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PTGS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2130">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis8">
 <bp:controlled rdf:resource="#BiochemicalReaction30" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction285">
 <bp:evidence rdf:resource="#Evidence312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 dimer binds IL10RA:JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis5">
 <bp:controlled rdf:resource="#BiochemicalReaction22" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction288">
 <bp:evidence rdf:resource="#Evidence315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 dimer:2xp-Y-IL10RA:p-Y-JAK1:2xIL10RB:p-Y-TYK2 binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis6">
 <bp:controlled rdf:resource="#BiochemicalReaction25" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction287">
 <bp:evidence rdf:resource="#Evidence314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL10 negatively regulates extracellular inflammatory mediators</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2133">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis9">
 <bp:controlled rdf:resource="#BiochemicalReaction32" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2135">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction297">
 <bp:evidence rdf:resource="#Evidence326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RB and IL2RG are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2141">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction296">
 <bp:evidence rdf:resource="#Evidence325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:IL2RB:JAK1:IL2RG:JAK3 translocates from the plasma membrane to the endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2140">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction299">
 <bp:evidence rdf:resource="#Evidence328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15:IL15RA:p-Y-IL2RB:p-Y-JAK1:p-Y-IL2RG:p-Y-JAK3:p-Y-SHC1 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction298">
 <bp:evidence rdf:resource="#Evidence327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL15RA:IL15:IL2RB:JAK1:IL2RG:JAK3 phosphorylates JAK3 and JAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2146">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2703">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2386" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2701">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2384" />
 <bp:stepProcess rdf:resource="#Catalysis805" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2389" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2708">
 <bp:stepProcess rdf:resource="#Catalysis807" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2390" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2387" />
 <bp:stepProcess rdf:resource="#Catalysis806" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2700">
 <bp:stepProcess rdf:resource="#Catalysis804" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2382" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2391" />
 <bp:stepProcess rdf:resource="#Catalysis808" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2393" />
 <bp:stepProcess rdf:resource="#Catalysis809" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2266">
 <bp:evidence rdf:resource="#Evidence2573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGAS produces cyclic GMP-AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2265">
 <bp:evidence rdf:resource="#Evidence2572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407-STAT6 is phosphorylated at Tyr641</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2264">
 <bp:evidence rdf:resource="#Evidence2571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING recruits TBK1 and STAT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2263">
 <bp:evidence rdf:resource="#Evidence2570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 phosphorylates STAT6 at Ser407</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2262">
 <bp:evidence rdf:resource="#Evidence2569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407,Y641-STAT6 dimer migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2261">
 <bp:evidence rdf:resource="#Evidence2568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407,Y641-STAT6 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2260">
 <bp:evidence rdf:resource="#Evidence2567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within STING:TBK1:STAT6 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2269">
 <bp:evidence rdf:resource="#Evidence2577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within STING:TBK1:IRF3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2268">
 <bp:evidence rdf:resource="#Evidence2576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2267">
 <bp:evidence rdf:resource="#Evidence2574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 binds viral dsDNA </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2277">
 <bp:evidence rdf:resource="#Evidence2587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2276">
 <bp:evidence rdf:resource="#Evidence2584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2275">
 <bp:evidence rdf:resource="#Evidence2583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2274">
 <bp:evidence rdf:resource="#Evidence2582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds c-di-GMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2273">
 <bp:evidence rdf:resource="#Evidence2581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI16 binds cytosolic dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2272">
 <bp:evidence rdf:resource="#Evidence2580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING recruits TBK1 and IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2271">
 <bp:evidence rdf:resource="#Evidence2579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3 is phosphorylated by TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2270">
 <bp:evidence rdf:resource="#Evidence2578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3 migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2279">
 <bp:evidence rdf:resource="#Evidence2589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment TBK1 to dsDNA:ZBP1 followed by its activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2278">
 <bp:evidence rdf:resource="#Evidence2588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2288">
 <bp:evidence rdf:resource="#Evidence2599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNA-PK binds microbial dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2287">
 <bp:evidence rdf:resource="#Evidence2598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1(DAI) recruits RIP1 and RIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2286">
 <bp:evidence rdf:resource="#Evidence2597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFkB complex translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2285">
 <bp:evidence rdf:resource="#Evidence2596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP1 facilitates IKK complex phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2284">
 <bp:evidence rdf:resource="#Evidence2595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKK Complex phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2283">
 <bp:evidence rdf:resource="#Evidence2593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1 binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2282">
 <bp:evidence rdf:resource="#Evidence2592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF3 to activated ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2281">
 <bp:evidence rdf:resource="#Evidence2591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3 migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2280">
 <bp:evidence rdf:resource="#Evidence2590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 binds amlexanox</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction202">
 <bp:evidence rdf:resource="#Evidence222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SH2B3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction201">
 <bp:evidence rdf:resource="#Evidence220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to GRAP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction204">
 <bp:evidence rdf:resource="#Evidence224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SOCS6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction203">
 <bp:evidence rdf:resource="#Evidence223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to CSK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction200">
 <bp:evidence rdf:resource="#Evidence219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:GRB2:p-Y-GAB2 binds PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction209">
 <bp:evidence rdf:resource="#Evidence229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 phosphorylates CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction206">
 <bp:evidence rdf:resource="#Evidence226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to ABL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction205">
 <bp:evidence rdf:resource="#Evidence225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SOCS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction208">
 <bp:evidence rdf:resource="#Evidence228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPRJ dephosphorylates active FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction207">
 <bp:evidence rdf:resource="#Evidence227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SLA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2289">
 <bp:evidence rdf:resource="#Evidence2601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 binds DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2299">
 <bp:evidence rdf:resource="#Evidence2612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and MDL-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2298">
 <bp:evidence rdf:resource="#Evidence2611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2297">
 <bp:evidence rdf:resource="#Evidence2610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 interacts with NKG2C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2296">
 <bp:evidence rdf:resource="#Evidence2609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and TREM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2295">
 <bp:evidence rdf:resource="#Evidence2607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MRE11 binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2294">
 <bp:evidence rdf:resource="#Evidence2606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase III transcribes microbial dsDNA to dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2293">
 <bp:evidence rdf:resource="#Evidence2605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFkB complex translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2292">
 <bp:evidence rdf:resource="#Evidence2604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX9 binds DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2291">
 <bp:evidence rdf:resource="#Evidence2603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-IRF7:p-IRF7 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2290">
 <bp:evidence rdf:resource="#Evidence2602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 or DHX9 binds MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction213">
 <bp:evidence rdf:resource="#Evidence233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction212">
 <bp:evidence rdf:resource="#Evidence232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction215">
 <bp:evidence rdf:resource="#Evidence235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3:GRB2 binds SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction214">
 <bp:evidence rdf:resource="#Evidence234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3LG dimer:FLT3 binds FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction211">
 <bp:evidence rdf:resource="#Evidence231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SLA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction210">
 <bp:evidence rdf:resource="#Evidence230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Internalization of ubiquitinated FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction217">
 <bp:evidence rdf:resource="#Evidence238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dissociates from activator:STAT5 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction216">
 <bp:evidence rdf:resource="#Evidence236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS1-mediated nucleotide exchange of RAS downstream of FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction219">
 <bp:evidence rdf:resource="#Evidence240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator phosphorylates STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction218">
 <bp:evidence rdf:resource="#Evidence239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activators bind STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1316">
 <bp:stepProcess rdf:resource="#Catalysis339" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1187" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2222">
 <bp:evidence rdf:resource="#Evidence2522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A binds 1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1186" />
 <bp:stepProcess rdf:resource="#Catalysis338" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2221">
 <bp:evidence rdf:resource="#Evidence2521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIKA2 binds K63polyUb-TRAF6 oligomer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2649">
 <bp:stepProcess rdf:resource="#Catalysis779" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1318">
 <bp:stepProcess rdf:resource="#Pathway131" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2220">
 <bp:evidence rdf:resource="#Evidence2520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomer autoubiquitinates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2646">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1319">
 <bp:stepProcess rdf:resource="#Catalysis340" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1189" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence605">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2640">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2327" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence606">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2328" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence607">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1183" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence609">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1312">
 <bp:stepProcess rdf:resource="#Pathway130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2329" />
 <bp:stepProcess rdf:resource="#Catalysis777" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1311">
 <bp:stepProcess rdf:resource="#Pathway129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2330" />
 <bp:stepProcess rdf:resource="#Catalysis778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1185" />
 <bp:stepProcess rdf:resource="#Catalysis337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2642">
 <bp:stepProcess rdf:resource="#Pathway315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2643">
 <bp:stepProcess rdf:resource="#Pathway316" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence604">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2229">
 <bp:evidence rdf:resource="#Evidence2529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NEMO by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2228">
 <bp:evidence rdf:resource="#Evidence2528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta translocates to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2227">
 <bp:evidence rdf:resource="#Evidence2527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y753,Y759-PLCG2 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2226">
 <bp:evidence rdf:resource="#Evidence2526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-TAK1 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2225">
 <bp:evidence rdf:resource="#Evidence2525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL10 binds CARD9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2224">
 <bp:evidence rdf:resource="#Evidence2524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y753,Y759-PLCG2 translocates from cytosol to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2223">
 <bp:evidence rdf:resource="#Evidence2523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARD9 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1195" />
 <bp:stepProcess rdf:resource="#Catalysis346" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2233">
 <bp:evidence rdf:resource="#Evidence2534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 binds MALT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2343" />
 <bp:stepProcess rdf:resource="#Catalysis783" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1194" />
 <bp:stepProcess rdf:resource="#Catalysis345" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2232">
 <bp:evidence rdf:resource="#Evidence2532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta phosphorylates CARD9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1197" />
 <bp:stepProcess rdf:resource="#Catalysis348" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2231">
 <bp:evidence rdf:resource="#Evidence2531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1196" />
 <bp:stepProcess rdf:resource="#Catalysis347" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2230">
 <bp:evidence rdf:resource="#Evidence2530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-TRCP ubiquitinates IkB-alpha in p-S32,33-IkB-alpha:NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2342" />
 <bp:stepProcess rdf:resource="#Catalysis782" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2652">
 <bp:stepProcess rdf:resource="#Catalysis780" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1191" />
 <bp:stepProcess rdf:resource="#Catalysis342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1320">
 <bp:stepProcess rdf:resource="#Catalysis341" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2650">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1323">
 <bp:stepProcess rdf:resource="#Pathway132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2340" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1192" />
 <bp:stepProcess rdf:resource="#Catalysis343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2656">
 <bp:stepProcess rdf:resource="#Pathway317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1325">
 <bp:stepProcess rdf:resource="#Pathway133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2653">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1193" />
 <bp:stepProcess rdf:resource="#Catalysis344" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2654">
 <bp:stepProcess rdf:resource="#Catalysis781" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2339" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction186" />
 <bp:stepProcess rdf:resource="#Catalysis67" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2239">
 <bp:evidence rdf:resource="#Evidence2540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MALT1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction187" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2238">
 <bp:evidence rdf:resource="#Evidence2539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL10 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction188" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2237">
 <bp:evidence rdf:resource="#Evidence2538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-p-3T,1S-TAK1 phosphorylates IKK-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep205">
 <bp:stepProcess rdf:resource="#Pathway18" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2236">
 <bp:evidence rdf:resource="#Evidence2537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ASC binds Caspase-8 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction189" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2235">
 <bp:evidence rdf:resource="#Evidence2536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 cleaves IL1B precursor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep207">
 <bp:stepProcess rdf:resource="#BiochemicalReaction190" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2234">
 <bp:evidence rdf:resource="#Evidence2535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1B gene is transcribed</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1205" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2244">
 <bp:evidence rdf:resource="#Evidence2547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds TRIM32 or TRIM56 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1337">
 <bp:stepProcess rdf:resource="#Catalysis354" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1204" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2243">
 <bp:evidence rdf:resource="#Evidence2546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX4 ubiquitinates p-S172-TBK1 within NLRP4:DTX4:STING:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2242">
 <bp:evidence rdf:resource="#Evidence2543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex to form NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1206" />
 <bp:stepProcess rdf:resource="#Catalysis355" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2241">
 <bp:evidence rdf:resource="#Evidence2542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds p-Y15-CLEC7A:1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2353" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2240">
 <bp:evidence rdf:resource="#Evidence2541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S177,S181-IKKB:IKKA:pUb-NEMO phosphorylates IkB-alpha:NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep210">
 <bp:stepProcess rdf:resource="#Catalysis68" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction193" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence627">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1198" />
 <bp:stepProcess rdf:resource="#Catalysis349" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2662">
 <bp:stepProcess rdf:resource="#Catalysis785" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2346" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence628">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2347" />
 <bp:stepProcess rdf:resource="#Catalysis786" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence629">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1332">
 <bp:stepProcess rdf:resource="#Catalysis351" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2660">
 <bp:stepProcess rdf:resource="#Catalysis784" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2344" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1199" />
 <bp:stepProcess rdf:resource="#Catalysis350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1333">
 <bp:stepProcess rdf:resource="#Pathway134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2667">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2351" />
 <bp:stepProcess rdf:resource="#Catalysis789" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1336">
 <bp:stepProcess rdf:resource="#Catalysis353" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2348" />
 <bp:stepProcess rdf:resource="#Catalysis787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1335">
 <bp:stepProcess rdf:resource="#Catalysis352" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2349" />
 <bp:stepProcess rdf:resource="#Catalysis788" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction201" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence621">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence624">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2354" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence626">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep213">
 <bp:stepProcess rdf:resource="#Pathway19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction196" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2249">
 <bp:evidence rdf:resource="#Evidence2553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TREX1 binds retroviral-derived DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction197" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2248">
 <bp:evidence rdf:resource="#Evidence2551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP4 and DTX4 associate with p-S172-TBK1 within dsDNA:ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction198" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2247">
 <bp:evidence rdf:resource="#Evidence2550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING ubiquitination by TRIM32 or TRIM56</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction199" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2246">
 <bp:evidence rdf:resource="#Evidence2549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX4 ubiquitinates p-S172-TBK1 within NLRP4:DTX4:dsDNA:ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction200" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2245">
 <bp:evidence rdf:resource="#Evidence2548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 ubiquitination by TRIM21</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1214" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2255">
 <bp:evidence rdf:resource="#Evidence2560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 associates with beta-catenin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1213" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2254">
 <bp:evidence rdf:resource="#Evidence2559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin enhances association of IRF3 with CBP/p300 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2253">
 <bp:evidence rdf:resource="#Evidence2558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2679">
 <bp:stepProcess rdf:resource="#Pathway318" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2252">
 <bp:evidence rdf:resource="#Evidence2557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2251">
 <bp:evidence rdf:resource="#Evidence2555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP4 and DTX4 associate with p-S172-TBK1 within STING:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2250">
 <bp:evidence rdf:resource="#Evidence2554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral DNA cleavage by TREX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep220">
 <bp:stepProcess rdf:resource="#Pathway20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction202" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence616">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2357" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence617">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1207" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2358" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence618">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2355" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence619">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1342">
 <bp:stepProcess rdf:resource="#Pathway135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2672">
 <bp:stepProcess rdf:resource="#Catalysis790" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2356" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1345">
 <bp:stepProcess rdf:resource="#Pathway136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2362" />
 <bp:stepProcess rdf:resource="#Catalysis792" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1347">
 <bp:stepProcess rdf:resource="#Catalysis356" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2359" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2360" />
 <bp:stepProcess rdf:resource="#Catalysis791" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence610">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence611">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence612">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2363" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence613">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2364" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence614">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1215" />
 <bp:stepProcess rdf:resource="#Catalysis357" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence615">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction207" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2259">
 <bp:evidence rdf:resource="#Evidence2565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGAS binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction208" />
 <bp:stepProcess rdf:resource="#Catalysis69" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2258">
 <bp:evidence rdf:resource="#Evidence2564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 binds bacterial c-di-AMP, c-di-GMP  </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep228">
 <bp:stepProcess rdf:resource="#Catalysis70" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction209" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2257">
 <bp:evidence rdf:resource="#Evidence2563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds cyclic GMP-AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction210" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2256">
 <bp:evidence rdf:resource="#Evidence2561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of beta-catenin at Ser552</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2294" />
 <bp:stepProcess rdf:resource="#Catalysis766" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2603">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2608">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2607">
 <bp:stepProcess rdf:resource="#Pathway313" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence649">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2601">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2290" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence641">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence642">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence643">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence640">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2615">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2301" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2614">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2306" />
 <bp:stepProcess rdf:resource="#Catalysis767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2618">
 <bp:stepProcess rdf:resource="#Pathway314" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence639">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2300" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2298" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence630">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence637">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2200">
 <bp:evidence rdf:resource="#Evidence2499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p100:RELB binds active NIK:p-IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2626">
 <bp:stepProcess rdf:resource="#Catalysis771" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2627">
 <bp:stepProcess rdf:resource="#Catalysis772" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2624">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2625">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2622">
 <bp:stepProcess rdf:resource="#Catalysis769" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2310" />
 <bp:stepProcess rdf:resource="#Catalysis770" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2621">
 <bp:stepProcess rdf:resource="#Catalysis768" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2308" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence663">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence664">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence665">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence666">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence667">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence669">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2209">
 <bp:evidence rdf:resource="#Evidence2509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2208">
 <bp:evidence rdf:resource="#Evidence2508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds and dephosphorylates NFAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2207">
 <bp:evidence rdf:resource="#Evidence2507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of CaN:CaM:NFAT to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2206">
 <bp:evidence rdf:resource="#Evidence2505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCL17 and CCL22 genes are transcribed</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2205">
 <bp:evidence rdf:resource="#Evidence2504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes p-7S-p100:RELB to form p52:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2204">
 <bp:evidence rdf:resource="#Evidence2503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP ubiquitinates p-7S-p100:RELB in active NIK:p-176,S180-IKKA dimer:p-7S-p100:SCF-beta-TRCP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence660">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2203">
 <bp:evidence rdf:resource="#Evidence2502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p52:RELB translocates from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence661">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2202">
 <bp:evidence rdf:resource="#Evidence2501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK:p-S176,180-IKKA dimer phosphorylates p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence662">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2201">
 <bp:evidence rdf:resource="#Evidence2500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1305">
 <bp:stepProcess rdf:resource="#Pathway128" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2211">
 <bp:evidence rdf:resource="#Evidence2511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1304">
 <bp:stepProcess rdf:resource="#Catalysis333" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1178" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2210">
 <bp:evidence rdf:resource="#Evidence2510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Calcineurin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1180" />
 <bp:stepProcess rdf:resource="#Catalysis334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2635">
 <bp:stepProcess rdf:resource="#Catalysis776" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1182" />
 <bp:stepProcess rdf:resource="#Catalysis336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1308">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1181" />
 <bp:stepProcess rdf:resource="#Catalysis335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2639">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1301">
 <bp:stepProcess rdf:resource="#Pathway127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2633">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2320" />
 <bp:stepProcess rdf:resource="#Catalysis775" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1300">
 <bp:stepProcess rdf:resource="#Pathway126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1177" />
 <bp:stepProcess rdf:resource="#Catalysis332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2318" />
 <bp:stepProcess rdf:resource="#Catalysis773" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2632">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2319" />
 <bp:stepProcess rdf:resource="#Catalysis774" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence652">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence653">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence654">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence656">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence659">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2219">
 <bp:evidence rdf:resource="#Evidence2519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-TRAF6 ubiquitinates TAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2218">
 <bp:evidence rdf:resource="#Evidence2518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2217">
 <bp:evidence rdf:resource="#Evidence2517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MALT1 oligomers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2216">
 <bp:evidence rdf:resource="#Evidence2516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MALT1 binds BCL10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2215">
 <bp:evidence rdf:resource="#Evidence2515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">1,3-beta-D-glucan:p-Y15-CLEC7A:SYK phosphorylates PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2214">
 <bp:evidence rdf:resource="#Evidence2514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC kinase phosphorylates CLEC7A:1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence650">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2213">
 <bp:evidence rdf:resource="#Evidence2513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence651">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2212">
 <bp:evidence rdf:resource="#Evidence2512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction247" />
 <bp:stepProcess rdf:resource="#Catalysis77" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2119">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction248" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2118">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction249" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2117">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep274">
 <bp:stepProcess rdf:resource="#Catalysis78" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction253" />
 <bp:stepProcess rdf:resource="#Catalysis79" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction194">
 <bp:evidence rdf:resource="#Evidence212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to GRB10</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1396">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1255" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction193">
 <bp:evidence rdf:resource="#Evidence211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3LG dimer:FLT3 dimer autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1254" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction196">
 <bp:evidence rdf:resource="#Evidence215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to LCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1398">
 <bp:stepProcess rdf:resource="#Pathway143" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction195">
 <bp:evidence rdf:resource="#Evidence213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 dimer binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1256" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction190">
 <bp:evidence rdf:resource="#Evidence208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 binds type II TKI</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1257" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction192">
 <bp:evidence rdf:resource="#Evidence210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB2 in Active FLT3:GRB2:GAB2 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction191">
 <bp:evidence rdf:resource="#Evidence209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3 binds type I TKI</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence685">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence688">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction187">
 <bp:evidence rdf:resource="#Evidence204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS binding to JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence689">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction186">
 <bp:evidence rdf:resource="#Evidence203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTP1B dephosphorylates GHR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction189">
 <bp:evidence rdf:resource="#Evidence207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT3LG dimer binds FLT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction188">
 <bp:evidence rdf:resource="#Evidence205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GH:GHR:JAK2 complex undergoes a conformational change</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep277">
 <bp:stepProcess rdf:resource="#Catalysis80" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction254" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2112">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep278">
 <bp:stepProcess rdf:resource="#Catalysis81" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction255" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2111">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep279">
 <bp:stepProcess rdf:resource="#Catalysis82" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction256" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence680">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence681">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence682">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence683">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence684">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2113">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction258" />
 <bp:stepProcess rdf:resource="#Catalysis83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction259" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2129">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep283">
 <bp:stepProcess rdf:resource="#Catalysis84" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction260" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction261" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep285">
 <bp:stepProcess rdf:resource="#Pathway25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction263" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence674">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence676">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence677">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction198">
 <bp:evidence rdf:resource="#Evidence217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds HCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence678">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction197">
 <bp:evidence rdf:resource="#Evidence216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds FYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence679">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction199">
 <bp:evidence rdf:resource="#Evidence218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active FLT3 binds to SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction264" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2123">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction265" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence670">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence671">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence673">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2124">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction275" />
 <bp:stepProcess rdf:resource="#Catalysis85" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence696">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence699">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence690">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence691">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence692">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence693">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence695">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2102">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1359">
 <bp:stepProcess rdf:resource="#Catalysis360" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep230">
 <bp:stepProcess rdf:resource="#BiochemicalReaction211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep231">
 <bp:stepProcess rdf:resource="#Catalysis71" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1217" />
 <bp:stepProcess rdf:resource="#Catalysis358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2684">
 <bp:stepProcess rdf:resource="#Catalysis795" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2685">
 <bp:stepProcess rdf:resource="#Catalysis796" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2365" />
 <bp:stepProcess rdf:resource="#Catalysis793" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2683">
 <bp:stepProcess rdf:resource="#Catalysis794" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2688">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2689">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2372" />
 <bp:stepProcess rdf:resource="#Catalysis797" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1357">
 <bp:stepProcess rdf:resource="#Catalysis359" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2691">
 <bp:stepProcess rdf:resource="#Pathway319" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1361">
 <bp:stepProcess rdf:resource="#Pathway137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1360">
 <bp:stepProcess rdf:resource="#Catalysis361" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2373" />
 <bp:stepProcess rdf:resource="#Catalysis798" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep235">
 <bp:stepProcess rdf:resource="#Catalysis72" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep236">
 <bp:stepProcess rdf:resource="#Pathway21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2696">
 <bp:stepProcess rdf:resource="#Catalysis801" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2378" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1365">
 <bp:stepProcess rdf:resource="#Pathway138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2375" />
 <bp:stepProcess rdf:resource="#Catalysis799" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1364">
 <bp:stepProcess rdf:resource="#Catalysis362" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2376" />
 <bp:stepProcess rdf:resource="#Catalysis800" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2699">
 <bp:stepProcess rdf:resource="#Catalysis803" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1232" />
 <bp:stepProcess rdf:resource="#Catalysis363" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2698">
 <bp:stepProcess rdf:resource="#Catalysis802" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction225" />
 <bp:stepProcess rdf:resource="#Catalysis73" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction226" />
 <bp:stepProcess rdf:resource="#Catalysis74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep250">
 <bp:stepProcess rdf:resource="#Catalysis75" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep252">
 <bp:stepProcess rdf:resource="#Pathway22" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction232" />
 <bp:stepProcess rdf:resource="#Catalysis76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep254">
 <bp:stepProcess rdf:resource="#Pathway23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1375">
 <bp:stepProcess rdf:resource="#Catalysis364" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1377">
 <bp:stepProcess rdf:resource="#Pathway139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1382">
 <bp:stepProcess rdf:resource="#Pathway140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1385">
 <bp:stepProcess rdf:resource="#Catalysis365" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1389">
 <bp:stepProcess rdf:resource="#Pathway141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1249" />
 <bp:stepProcess rdf:resource="#Catalysis366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1252" />
 <bp:stepProcess rdf:resource="#Catalysis367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1394">
 <bp:stepProcess rdf:resource="#Pathway142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep269">
 <bp:stepProcess rdf:resource="#Pathway24" />
</bp:PathwayStep>
</rdf:RDF>